id	sid	tid	token	lemma	pos
bionys-572	1	1	kravchun	kravchun	PROPN
bionys-572	1	2	et	et	PROPN
bionys-572	1	3	al	al	PROPN
bionys-572	1	4	.	.	PROPN
bionys-572	1	5	2025	2025	NUM
bionys-572	1	6	,	,	PUNCT
bionys-572	1	7	biologica	biologica	PROPN
bionys-572	1	8	nyssana	nyssana	PROPN
bionys-572	1	9	16(1	16(1	PROPN
bionys-572	1	10	)	)	PUNCT
bionys-572	1	11	247	247	NUM
bionys-572	1	12	16	16	NUM
bionys-572	1	13	(	(	PUNCT
bionys-572	1	14	1	1	NUM
bionys-572	1	15	)	)	PUNCT
bionys-572	1	16	june	june	PROPN
bionys-572	1	17	2025	2025	NUM
bionys-572	1	18	:	:	PUNCT
bionys-572	1	19	247	247	NUM
bionys-572	1	20	-	-	SYM
bionys-572	1	21	257	257	NUM
bionys-572	1	22	doi	doi	NOUN
bionys-572	1	23	:	:	PUNCT
bionys-572	1	24	10.46793	10.46793	NUM
bionys-572	1	25	/	/	SYM
bionys-572	1	26	biolnyss.16.1.19k	biolnyss.16.1.19k	VERB
bionys-572	1	27	different	different	ADJ
bionys-572	1	28	types	type	NOUN
bionys-572	1	29	of	of	ADP
bionys-572	1	30	crystalluria	crystalluria	PROPN
bionys-572	1	31	in	in	ADP
bionys-572	1	32	patients	patient	NOUN
bionys-572	1	33	with	with	ADP
bionys-572	1	34	bone	bone	NOUN
bionys-572	1	35	and	and	CCONJ
bionys-572	1	36	joint	joint	ADJ
bionys-572	1	37	tissue	tissue	NOUN
bionys-572	1	38	pathology	pathology	NOUN
bionys-572	1	39	:	:	PUNCT
bionys-572	1	40	hematological	hematological	ADJ
bionys-572	1	41	and	and	CCONJ
bionys-572	1	42	biochemical	biochemical	ADJ
bionys-572	1	43	profiles	profile	NOUN
bionys-572	1	44	original	original	ADJ
bionys-572	1	45	article	article	NOUN
bionys-572	1	46	pavlo	pavlo	PROPN
bionys-572	1	47	grigorovich	grigorovich	PROPN
bionys-572	1	48	kravchun	kravchun	PROPN
bionys-572	1	49	department	department	PROPN
bionys-572	1	50	of	of	ADP
bionys-572	1	51	internal	internal	ADJ
bionys-572	1	52	medicine	medicine	NOUN
bionys-572	1	53	no	no	NOUN
bionys-572	1	54	.	.	NOUN
bionys-572	1	55	2	2	NUM
bionys-572	1	56	,	,	PUNCT
bionys-572	1	57	clinical	clinical	ADJ
bionys-572	1	58	immunology	immunology	NOUN
bionys-572	1	59	and	and	CCONJ
bionys-572	1	60	allergology	allergology	NOUN
bionys-572	1	61	named	name	VERB
bionys-572	1	62	after	after	ADP
bionys-572	1	63	academician	academician	PROPN
bionys-572	1	64	l.t	l.t	PROPN
bionys-572	1	65	.	.	PROPN
bionys-572	1	66	malaya	malaya	PROPN
bionys-572	1	67	inna	inna	PROPN
bionys-572	1	68	pavlivna	pavlivna	PROPN
bionys-572	1	69	dunayeva	dunayeva	PROPN
bionys-572	1	70	department	department	PROPN
bionys-572	1	71	of	of	ADP
bionys-572	1	72	internal	internal	ADJ
bionys-572	1	73	medicine	medicine	NOUN
bionys-572	1	74	no	no	NOUN
bionys-572	1	75	.	.	NOUN
bionys-572	1	76	2	2	NUM
bionys-572	1	77	,	,	PUNCT
bionys-572	1	78	clinical	clinical	ADJ
bionys-572	1	79	immunology	immunology	NOUN
bionys-572	1	80	and	and	CCONJ
bionys-572	1	81	allergology	allergology	NOUN
bionys-572	1	82	named	name	VERB
bionys-572	1	83	after	after	SCONJ
bionys-572	1	84	academician	academician	PROPN
bionys-572	1	85	l.t	l.t	PROPN
bionys-572	1	86	.	.	PROPN
bionys-572	1	87	malaya	malaya	PROPN
bionys-572	1	88	frida	frida	PROPN
bionys-572	1	89	solomonivna	solomonivna	VERB
bionys-572	1	90	leontyeva	leontyeva	PROPN
bionys-572	1	91	sytenko	sytenko	PROPN
bionys-572	1	92	institute	institute	PROPN
bionys-572	1	93	of	of	ADP
bionys-572	1	94	spine	spine	NOUN
bionys-572	1	95	and	and	CCONJ
bionys-572	1	96	joint	joint	ADJ
bionys-572	1	97	pathology	pathology	NOUN
bionys-572	1	98	,	,	PUNCT
bionys-572	1	99	national	national	PROPN
bionys-572	1	100	academy	academy	PROPN
bionys-572	1	101	of	of	ADP
bionys-572	1	102	medical	medical	PROPN
bionys-572	1	103	sciences	sciences	PROPN
bionys-572	1	104	of	of	ADP
bionys-572	1	105	ukraine	ukraine	PROPN
bionys-572	1	106	olena	olena	PROPN
bionys-572	1	107	dmytrivna	dmytrivna	PROPN
bionys-572	1	108	povelychenko	povelychenko	PROPN
bionys-572	1	109	sytenko	sytenko	PROPN
bionys-572	1	110	institute	institute	PROPN
bionys-572	1	111	of	of	ADP
bionys-572	1	112	spine	spine	NOUN
bionys-572	1	113	and	and	CCONJ
bionys-572	1	114	joint	joint	ADJ
bionys-572	1	115	pathology	pathology	NOUN
bionys-572	1	116	,	,	PUNCT
bionys-572	1	117	national	national	PROPN
bionys-572	1	118	academy	academy	PROPN
bionys-572	1	119	of	of	ADP
bionys-572	1	120	medical	medical	PROPN
bionys-572	1	121	sciences	sciences	PROPN
bionys-572	1	122	of	of	ADP
bionys-572	1	123	ukraine	ukraine	PROPN
bionys-572	1	124	valentyna	valentyna	NOUN
bionys-572	1	125	yuriivna	yuriivna	PROPN
bionys-572	1	126	dielievska	dielievska	PROPN
bionys-572	1	127	department	department	PROPN
bionys-572	1	128	of	of	ADP
bionys-572	1	129	internal	internal	ADJ
bionys-572	1	130	medicine	medicine	NOUN
bionys-572	1	131	no	no	NOUN
bionys-572	1	132	.	.	NOUN
bionys-572	1	133	2	2	NUM
bionys-572	1	134	,	,	PUNCT
bionys-572	1	135	clinical	clinical	ADJ
bionys-572	1	136	immunology	immunology	NOUN
bionys-572	1	137	and	and	CCONJ
bionys-572	1	138	allergology	allergology	NOUN
bionys-572	1	139	named	name	VERB
bionys-572	1	140	after	after	SCONJ
bionys-572	1	141	academician	academician	PROPN
bionys-572	1	142	l.t	l.t	PROPN
bionys-572	1	143	.	.	PROPN
bionys-572	1	144	malaya	malaya	PROPN
bionys-572	1	145	valentinka_1987@ukr.net	valentinka_1987@ukr.net	PROPN
bionys-572	1	146	(	(	PUNCT
bionys-572	1	147	corresponding	correspond	VERB
bionys-572	1	148	author	author	NOUN
bionys-572	1	149	)	)	PUNCT
bionys-572	1	150	received	receive	VERB
bionys-572	1	151	:	:	PUNCT
bionys-572	1	152	december	december	PROPN
bionys-572	1	153	26	26	NUM
bionys-572	1	154	,	,	PUNCT
bionys-572	1	155	2024	2024	NUM
bionys-572	1	156	revised	revise	VERB
bionys-572	1	157	:	:	PUNCT
bionys-572	1	158	march	march	PROPN
bionys-572	1	159	03	03	NUM
bionys-572	1	160	,	,	PUNCT
bionys-572	1	161	2025	2025	NUM
bionys-572	1	162	accepted	accept	VERB
bionys-572	1	163	:	:	PUNCT
bionys-572	1	164	march	march	PROPN
bionys-572	1	165	17	17	NUM
bionys-572	1	166	,	,	PUNCT
bionys-572	1	167	2025	2025	NUM
bionys-572	1	168	abstract	abstract	NOUN
bionys-572	1	169	:	:	PUNCT
bionys-572	2	1	crystalluria	crystalluria	PROPN
bionys-572	2	2	,	,	PUNCT
bionys-572	2	3	as	as	ADP
bionys-572	2	4	a	a	DET
bionys-572	2	5	sign	sign	NOUN
bionys-572	2	6	of	of	ADP
bionys-572	2	7	dysmetabolic	dysmetabolic	ADJ
bionys-572	2	8	nephropathy	nephropathy	NOUN
bionys-572	2	9	,	,	PUNCT
bionys-572	2	10	has	have	AUX
bionys-572	2	11	been	be	AUX
bionys-572	2	12	associated	associate	VERB
bionys-572	2	13	with	with	ADP
bionys-572	2	14	bone	bone	NOUN
bionys-572	2	15	and	and	CCONJ
bionys-572	2	16	joint	joint	ADJ
bionys-572	2	17	tissue	tissue	NOUN
bionys-572	2	18	pathology	pathology	NOUN
bionys-572	2	19	.	.	PUNCT
bionys-572	3	1	the	the	DET
bionys-572	3	2	aim	aim	NOUN
bionys-572	3	3	of	of	ADP
bionys-572	3	4	the	the	DET
bionys-572	3	5	study	study	NOUN
bionys-572	3	6	was	be	AUX
bionys-572	3	7	to	to	PART
bionys-572	3	8	reveal	reveal	VERB
bionys-572	3	9	the	the	DET
bionys-572	3	10	structure	structure	NOUN
bionys-572	3	11	of	of	ADP
bionys-572	3	12	crystalluria	crystalluria	PROPN
bionys-572	3	13	in	in	ADP
bionys-572	3	14	patients	patient	NOUN
bionys-572	3	15	with	with	ADP
bionys-572	3	16	bone	bone	NOUN
bionys-572	3	17	and	and	CCONJ
bionys-572	3	18	joint	joint	ADJ
bionys-572	3	19	tissue	tissue	NOUN
bionys-572	3	20	pathology	pathology	NOUN
bionys-572	3	21	and	and	CCONJ
bionys-572	3	22	to	to	PART
bionys-572	3	23	investigate	investigate	VERB
bionys-572	3	24	the	the	DET
bionys-572	3	25	characteristics	characteristic	NOUN
bionys-572	3	26	of	of	ADP
bionys-572	3	27	biochemical	biochemical	ADJ
bionys-572	3	28	parameters	parameter	NOUN
bionys-572	3	29	according	accord	VERB
bionys-572	3	30	to	to	ADP
bionys-572	3	31	the	the	DET
bionys-572	3	32	type	type	NOUN
bionys-572	3	33	of	of	ADP
bionys-572	3	34	dysmetabolic	dysmetabolic	ADJ
bionys-572	3	35	nephropathy	nephropathy	NOUN
bionys-572	3	36	.	.	PUNCT
bionys-572	4	1	in	in	ADP
bionys-572	4	2	this	this	DET
bionys-572	4	3	study	study	NOUN
bionys-572	4	4	,	,	PUNCT
bionys-572	4	5	common	common	ADJ
bionys-572	4	6	blood	blood	NOUN
bionys-572	4	7	analyses	analysis	NOUN
bionys-572	4	8	and	and	CCONJ
bionys-572	4	9	biochemical	biochemical	ADJ
bionys-572	4	10	parameters	parameter	NOUN
bionys-572	4	11	were	be	AUX
bionys-572	4	12	investigated	investigate	VERB
bionys-572	4	13	.	.	PUNCT
bionys-572	5	1	individuals	individual	NOUN
bionys-572	5	2	with	with	ADP
bionys-572	5	3	bone	bone	NOUN
bionys-572	5	4	and	and	CCONJ
bionys-572	5	5	joint	joint	ADJ
bionys-572	5	6	tissue	tissue	NOUN
bionys-572	5	7	pathology	pathology	NOUN
bionys-572	5	8	demonstrated	demonstrate	VERB
bionys-572	5	9	prevalence	prevalence	NOUN
bionys-572	5	10	of	of	ADP
bionys-572	5	11	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	5	12	(	(	PUNCT
bionys-572	5	13	59	59	NUM
bionys-572	5	14	%	%	NOUN
bionys-572	5	15	)	)	PUNCT
bionys-572	5	16	with	with	ADP
bionys-572	5	17	less	less	ADJ
bionys-572	5	18	frequency	frequency	NOUN
bionys-572	5	19	of	of	ADP
bionys-572	5	20	uraturia	uraturia	NOUN
bionys-572	5	21	(	(	PUNCT
bionys-572	5	22	25.7	25.7	NUM
bionys-572	5	23	%	%	NOUN
bionys-572	5	24	)	)	PUNCT
bionys-572	5	25	and	and	CCONJ
bionys-572	5	26	phosphaturia	phosphaturia	PROPN
bionys-572	5	27	(	(	PUNCT
bionys-572	5	28	15.1	15.1	NUM
bionys-572	5	29	%	%	NOUN
bionys-572	5	30	)	)	PUNCT
bionys-572	5	31	.	.	PUNCT
bionys-572	6	1	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	6	2	was	be	AUX
bionys-572	6	3	associated	associate	VERB
bionys-572	6	4	with	with	ADP
bionys-572	6	5	high	high	ADJ
bionys-572	6	6	incidence	incidence	NOUN
bionys-572	6	7	of	of	ADP
bionys-572	6	8	ligamentum	ligamentum	NOUN
bionys-572	6	9	ruptures	rupture	NOUN
bionys-572	6	10	and	and	CCONJ
bionys-572	6	11	bone	bone	NOUN
bionys-572	6	12	fractures	fracture	NOUN
bionys-572	6	13	(	(	PUNCT
bionys-572	6	14	21.6	21.6	NUM
bionys-572	6	15	%	%	NOUN
bionys-572	6	16	)	)	PUNCT
bionys-572	6	17	.	.	PUNCT
bionys-572	7	1	the	the	DET
bionys-572	7	2	patients	patient	NOUN
bionys-572	7	3	with	with	ADP
bionys-572	7	4	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	7	5	showed	show	VERB
bionys-572	7	6	presence	presence	NOUN
bionys-572	7	7	of	of	ADP
bionys-572	7	8	eosinophilia	eosinophilia	PROPN
bionys-572	7	9	,	,	PUNCT
bionys-572	7	10	increased	increase	VERB
bionys-572	7	11	levels	level	NOUN
bionys-572	7	12	of	of	ADP
bionys-572	7	13	platelets	platelet	NOUN
bionys-572	7	14	,	,	PUNCT
bionys-572	7	15	leukocytes	leukocyte	NOUN
bionys-572	7	16	,	,	PUNCT
bionys-572	7	17	erythrocyte	erythrocyte	NOUN
bionys-572	7	18	sedimentation	sedimentation	NOUN
bionys-572	7	19	rate	rate	NOUN
bionys-572	7	20	,	,	PUNCT
bionys-572	7	21	c	c	NOUN
bionys-572	7	22	-	-	PUNCT
bionys-572	7	23	reactive	reactive	ADJ
bionys-572	7	24	protein	protein	NOUN
bionys-572	7	25	and	and	CCONJ
bionys-572	7	26	serum	serum	NOUN
bionys-572	7	27	alkaline	alkaline	NOUN
bionys-572	7	28	phosphatase	phosphatase	NOUN
bionys-572	7	29	,	,	PUNCT
bionys-572	7	30	whereas	whereas	SCONJ
bionys-572	7	31	the	the	DET
bionys-572	7	32	patients	patient	NOUN
bionys-572	7	33	with	with	ADP
bionys-572	7	34	uraturia	uraturia	PROPN
bionys-572	7	35	demonstrated	demonstrate	VERB
bionys-572	7	36	decreased	decrease	VERB
bionys-572	7	37	level	level	NOUN
bionys-572	7	38	of	of	ADP
bionys-572	7	39	platelets	platelet	NOUN
bionys-572	7	40	and	and	CCONJ
bionys-572	7	41	increased	increase	VERB
bionys-572	7	42	level	level	NOUN
bionys-572	7	43	of	of	ADP
bionys-572	7	44	serum	serum	NOUN
bionys-572	7	45	glucose	glucose	NOUN
bionys-572	7	46	,	,	PUNCT
bionys-572	7	47	uric	uric	ADJ
bionys-572	7	48	acid	acid	NOUN
bionys-572	7	49	and	and	CCONJ
bionys-572	7	50	creatinine	creatinine	NOUN
bionys-572	7	51	.	.	PUNCT
bionys-572	8	1	patients	patient	NOUN
bionys-572	8	2	with	with	ADP
bionys-572	8	3	phosphaturia	phosphaturia	NOUN
bionys-572	8	4	demonstrated	demonstrate	VERB
bionys-572	8	5	increased	increase	VERB
bionys-572	8	6	serum	serum	NOUN
bionys-572	8	7	alanine	alanine	NOUN
bionys-572	8	8	aminotransferase	aminotransferase	PROPN
bionys-572	8	9	.	.	PUNCT
bionys-572	9	1	the	the	DET
bionys-572	9	2	results	result	NOUN
bionys-572	9	3	presented	present	VERB
bionys-572	9	4	in	in	ADP
bionys-572	9	5	this	this	DET
bionys-572	9	6	paper	paper	NOUN
bionys-572	9	7	revealed	reveal	VERB
bionys-572	9	8	the	the	DET
bionys-572	9	9	differences	difference	NOUN
bionys-572	9	10	in	in	ADP
bionys-572	9	11	biochemical	biochemical	ADJ
bionys-572	9	12	parameters	parameter	NOUN
bionys-572	9	13	of	of	ADP
bionys-572	9	14	patients	patient	NOUN
bionys-572	9	15	with	with	ADP
bionys-572	9	16	different	different	ADJ
bionys-572	9	17	types	type	NOUN
bionys-572	9	18	of	of	ADP
bionys-572	9	19	crystalluria	crystalluria	PROPN
bionys-572	9	20	,	,	PUNCT
bionys-572	9	21	suggesting	suggest	VERB
bionys-572	9	22	the	the	DET
bionys-572	9	23	necessity	necessity	NOUN
bionys-572	9	24	of	of	ADP
bionys-572	9	25	its	its	PRON
bionys-572	9	26	control	control	NOUN
bionys-572	9	27	to	to	PART
bionys-572	9	28	improve	improve	VERB
bionys-572	9	29	the	the	DET
bionys-572	9	30	prognosis	prognosis	NOUN
bionys-572	9	31	of	of	ADP
bionys-572	9	32	the	the	DET
bionys-572	9	33	treatment	treatment	NOUN
bionys-572	9	34	of	of	ADP
bionys-572	9	35	patients	patient	NOUN
bionys-572	9	36	with	with	ADP
bionys-572	9	37	bone	bone	NOUN
bionys-572	9	38	and	and	CCONJ
bionys-572	9	39	joint	joint	ADJ
bionys-572	9	40	tissue	tissue	NOUN
bionys-572	9	41	pathology	pathology	NOUN
bionys-572	9	42	.	.	PUNCT
bionys-572	10	1	key	key	ADJ
bionys-572	10	2	words	word	NOUN
bionys-572	10	3	:	:	PUNCT
bionys-572	10	4	calcium	calcium	NOUN
bionys-572	10	5	,	,	PUNCT
bionys-572	10	6	joint	joint	ADJ
bionys-572	10	7	,	,	PUNCT
bionys-572	10	8	oxalates	oxalate	NOUN
bionys-572	10	9	,	,	PUNCT
bionys-572	10	10	urates	urate	NOUN
bionys-572	10	11	,	,	PUNCT
bionys-572	10	12	urea	urea	PROPN
bionys-572	10	13	apstrakt	apstrakt	NOUN
bionys-572	10	14	:	:	PUNCT
bionys-572	10	15	različiti	različiti	PROPN
bionys-572	10	16	tipovi	tipovi	PROPN
bionys-572	10	17	kristalurije	kristalurije	PROPN
bionys-572	10	18	kod	kod	PROPN
bionys-572	10	19	pacijenata	pacijenata	PROPN
bionys-572	10	20	sa	sa	PROPN
bionys-572	10	21	patologijom	patologijom	PROPN
bionys-572	10	22	koštanozglobnog	koštanozglobnog	PROPN
bionys-572	10	23	tkiva	tkiva	PROPN
bionys-572	10	24	:	:	PUNCT
bionys-572	10	25	hematološki	hematološki	NOUN
bionys-572	10	26	i	i	PRON
bionys-572	10	27	biohemijski	biohemijski	VERB
bionys-572	10	28	profili	profili	NOUN
bionys-572	10	29	kristalurija	kristalurija	NOUN
bionys-572	10	30	,	,	PUNCT
bionys-572	10	31	kao	kao	PROPN
bionys-572	10	32	znak	znak	PROPN
bionys-572	10	33	dismetaboličke	dismetaboličke	PROPN
bionys-572	10	34	nefropatije	nefropatije	NOUN
bionys-572	10	35	,	,	PUNCT
bionys-572	10	36	povezuje	povezuje	PROPN
bionys-572	10	37	se	se	PROPN
bionys-572	10	38	sa	sa	PROPN
bionys-572	10	39	patologijom	patologijom	PROPN
bionys-572	10	40	koštano	koštano	PROPN
bionys-572	10	41	-	-	PUNCT
bionys-572	10	42	zglobnog	zglobnog	PROPN
bionys-572	10	43	tkiva	tkiva	PROPN
bionys-572	10	44	.	.	PUNCT
bionys-572	11	1	cilj	cilj	PROPN
bionys-572	11	2	ove	ove	PROPN
bionys-572	11	3	studije	studije	PROPN
bionys-572	11	4	bio	bio	PROPN
bionys-572	11	5	je	je	PROPN
bionys-572	11	6	da	da	PROPN
bionys-572	11	7	se	se	PROPN
bionys-572	11	8	utvrdi	utvrdi	PROPN
bionys-572	11	9	struktura	struktura	PROPN
bionys-572	11	10	kristalurije	kristalurije	PROPN
bionys-572	11	11	kod	kod	PROPN
bionys-572	11	12	osoba	osoba	PROPN
bionys-572	11	13	sa	sa	PROPN
bionys-572	11	14	patologijom	patologijom	PROPN
bionys-572	11	15	koštano	koštano	PROPN
bionys-572	11	16	-	-	PUNCT
bionys-572	11	17	zglobnog	zglobnog	NOUN
bionys-572	11	18	tkiva	tkiva	NOUN
bionys-572	11	19	i	i	PROPN
bionys-572	11	20	da	da	PROPN
bionys-572	11	21	se	se	PROPN
bionys-572	11	22	ispitaju	ispitaju	PROPN
bionys-572	11	23	karakteristike	karakteristike	PROPN
bionys-572	11	24	biohemijskih	biohemijskih	ADJ
bionys-572	11	25	parametara	parametara	NOUN
bionys-572	11	26	u	u	PROPN
bionys-572	11	27	zavisnosti	zavisnosti	PROPN
bionys-572	11	28	od	od	PROPN
bionys-572	11	29	tipa	tipa	PROPN
bionys-572	11	30	dismetaboličke	dismetaboličke	PROPN
bionys-572	11	31	nefropatije	nefropatije	NOUN
bionys-572	11	32	.	.	PUNCT
bionys-572	12	1	u	u	NOUN
bionys-572	12	2	ovoj	ovoj	PROPN
bionys-572	12	3	studiji	studiji	PROPN
bionys-572	12	4	analizirane	analizirane	NOUN
bionys-572	12	5	su	su	PROPN
bionys-572	12	6	rutinske	rutinske	PROPN
bionys-572	12	7	analize	analize	PROPN
bionys-572	12	8	krvi	krvi	PROPN
bionys-572	12	9	i	i	PRON
bionys-572	12	10	biohemijski	biohemijski	VERB
bionys-572	12	11	parametri	parametri	PROPN
bionys-572	12	12	.	.	PUNCT
bionys-572	13	1	kod	kod	PROPN
bionys-572	13	2	osoba	osoba	PROPN
bionys-572	13	3	sa	sa	PROPN
bionys-572	13	4	patologijom	patologijom	PROPN
bionys-572	13	5	koštano	koštano	PROPN
bionys-572	13	6	-	-	PUNCT
bionys-572	13	7	zglobnog	zglobnog	NOUN
bionys-572	13	8	tkiva	tkiva	PROPN
bionys-572	13	9	preovlađivala	preovlađivala	PROPN
bionys-572	13	10	je	je	PROPN
bionys-572	13	11	hiperoksalurija	hiperoksalurija	PROPN
bionys-572	13	12	(	(	PUNCT
bionys-572	13	13	59	59	NUM
bionys-572	13	14	%	%	NOUN
bionys-572	13	15	)	)	PUNCT
bionys-572	13	16	,	,	PUNCT
bionys-572	13	17	a	a	DET
bionys-572	13	18	ređe	ređe	NOUN
bionys-572	13	19	su	su	PROPN
bionys-572	13	20	zabeležene	zabeležene	PROPN
bionys-572	13	21	uraturija	uraturija	NOUN
bionys-572	13	22	(	(	PUNCT
bionys-572	13	23	25.7	25.7	NUM
bionys-572	13	24	%	%	NOUN
bionys-572	13	25	)	)	PUNCT
bionys-572	14	1	i	i	PRON
bionys-572	14	2	fosfaturija	fosfaturija	VERB
bionys-572	14	3	(	(	PUNCT
bionys-572	14	4	15.1	15.1	NUM
bionys-572	14	5	%	%	NOUN
bionys-572	14	6	)	)	PUNCT
bionys-572	14	7	.	.	PUNCT
bionys-572	15	1	hiperoksalurija	hiperoksalurija	PROPN
bionys-572	15	2	je	je	PROPN
bionys-572	15	3	bila	bila	PROPN
bionys-572	15	4	povezana	povezana	PROPN
bionys-572	15	5	sa	sa	PROPN
bionys-572	15	6	visokim	visokim	PROPN
bionys-572	15	7	udelom	udelom	PROPN
bionys-572	15	8	ruptura	ruptura	PROPN
bionys-572	15	9	ligamenata	ligamenata	PROPN
bionys-572	15	10	i	i	PRON
bionys-572	15	11	preloma	preloma	VERB
bionys-572	15	12	kostiju	kostiju	NOUN
bionys-572	15	13	(	(	PUNCT
bionys-572	15	14	21.6	21.6	NUM
bionys-572	15	15	%	%	NOUN
bionys-572	15	16	)	)	PUNCT
bionys-572	15	17	.	.	PUNCT
bionys-572	16	1	pacijenti	pacijenti	PROPN
bionys-572	16	2	sa	sa	PROPN
bionys-572	16	3	hiperoksalurijom	hiperoksalurijom	PROPN
bionys-572	16	4	imali	imali	PROPN
bionys-572	16	5	su	su	PROPN
bionys-572	16	6	eozinofiliju	eozinofiliju	PROPN
bionys-572	16	7	,	,	PUNCT
bionys-572	16	8	povećane	povećane	NOUN
bionys-572	16	9	vrednosti	vrednosti	NOUN
bionys-572	16	10	trombocita	trombocita	PROPN
bionys-572	16	11	,	,	PUNCT
bionys-572	16	12	leukocita	leukocita	PROPN
bionys-572	16	13	,	,	PUNCT
bionys-572	16	14	brzine	brzine	PROPN
bionys-572	16	15	sedimentacije	sedimentacije	PROPN
bionys-572	16	16	eritrocita	eritrocita	PROPN
bionys-572	16	17	,	,	PUNCT
bionys-572	16	18	c	c	X
bionys-572	16	19	-	-	PUNCT
bionys-572	16	20	reaktivnog	reaktivnog	NOUN
bionys-572	16	21	proteina	proteina	NOUN
bionys-572	16	22	i	i	PRON
bionys-572	16	23	serumske	serumske	VERB
bionys-572	16	24	alkalne	alkalne	NOUN
bionys-572	16	25	fosfataze	fosfataze	NOUN
bionys-572	16	26	.	.	PUNCT
bionys-572	17	1	s	s	PART
bionys-572	17	2	druge	druge	PROPN
bionys-572	17	3	strane	strane	NOUN
bionys-572	17	4	,	,	PUNCT
bionys-572	17	5	pacijenti	pacijenti	PROPN
bionys-572	17	6	sa	sa	PROPN
bionys-572	17	7	uraturijom	uraturijom	PROPN
bionys-572	17	8	pokazali	pokazali	PROPN
bionys-572	17	9	su	su	PROPN
bionys-572	17	10	snižene	snižene	PROPN
bionys-572	17	11	vrednosti	vrednosti	PROPN
bionys-572	17	12	trombocita	trombocita	VERB
bionys-572	17	13	i	i	PRON
bionys-572	17	14	povišene	povišene	PROPN
bionys-572	17	15	vrednosti	vrednosti	PROPN
bionys-572	17	16	glukoze	glukoze	PROPN
bionys-572	17	17	u	u	PROPN
bionys-572	17	18	serumu	serumu	PROPN
bionys-572	17	19	,	,	PUNCT
bionys-572	17	20	mokraćne	mokraćne	PROPN
bionys-572	17	21	kiseline	kiseline	PROPN
bionys-572	18	1	i	i	PRON
bionys-572	18	2	kreatinina	kreatinina	PROPN
bionys-572	18	3	.	.	PUNCT
bionys-572	19	1	kod	kod	PROPN
bionys-572	19	2	pacijenata	pacijenata	PROPN
bionys-572	19	3	sa	sa	PROPN
bionys-572	19	4	fosfaturijom	fosfaturijom	PROPN
bionys-572	19	5	primećene	primećene	PROPN
bionys-572	19	6	su	su	PROPN
bionys-572	19	7	povišene	povišene	PROPN
bionys-572	19	8	vrednosti	vrednosti	PROPN
bionys-572	19	9	alanin	alanin	ADJ
bionys-572	19	10	-	-	PUNCT
bionys-572	19	11	aminotransferaze	aminotransferaze	NOUN
bionys-572	19	12	u	u	PROPN
bionys-572	19	13	serumu	serumu	PROPN
bionys-572	19	14	.	.	PUNCT
bionys-572	20	1	rezultati	rezultati	PROPN
bionys-572	20	2	predstavljeni	predstavljeni	PROPN
bionys-572	20	3	u	u	PROPN
bionys-572	20	4	ovom	ovom	PROPN
bionys-572	20	5	radu	radu	VERB
bionys-572	20	6	ukazuju	ukazuju	NOUN
bionys-572	20	7	na	na	PART
bionys-572	20	8	razlike	razlike	VERB
bionys-572	20	9	u	u	PROPN
bionys-572	20	10	biohemijskim	biohemijskim	PROPN
bionys-572	20	11	parametrima	parametrima	PROPN
bionys-572	20	12	pacijenata	pacijenata	PROPN
bionys-572	20	13	sa	sa	ADP
bionys-572	20	14	različitim	različitim	PROPN
bionys-572	20	15	tipovima	tipovima	NOUN
bionys-572	20	16	kristalurije	kristalurije	NOUN
bionys-572	20	17	,	,	PUNCT
bionys-572	20	18	što	što	PROPN
bionys-572	20	19	sugeriše	sugeriše	X
bionys-572	20	20	potrebu	potrebu	PROPN
bionys-572	20	21	za	za	PROPN
bionys-572	20	22	njenom	njenom	PROPN
bionys-572	20	23	kontrolom	kontrolom	PROPN
bionys-572	20	24	radi	radi	PROPN
bionys-572	20	25	poboljšanja	poboljšanja	PROPN
bionys-572	20	26	prognoze	prognoze	NOUN
bionys-572	20	27	lečenja	lečenja	NOUN
bionys-572	20	28	osoba	osoba	PROPN
bionys-572	20	29	sa	sa	PROPN
bionys-572	20	30	patologijom	patologijom	PROPN
bionys-572	20	31	koštano	koštano	PROPN
bionys-572	20	32	-	-	PUNCT
bionys-572	20	33	zglobnog	zglobnog	PROPN
bionys-572	20	34	tkiva	tkiva	PROPN
bionys-572	20	35	.	.	PUNCT
bionys-572	21	1	ključne	ključne	PROPN
bionys-572	21	2	reči	reči	NOUN
bionys-572	21	3	:	:	PUNCT
bionys-572	21	4	zglob	zglob	NOUN
bionys-572	21	5	,	,	PUNCT
bionys-572	21	6	kalcijum	kalcijum	PROPN
bionys-572	21	7	,	,	PUNCT
bionys-572	21	8	oksalati	oksalati	NOUN
bionys-572	21	9	,	,	PUNCT
bionys-572	21	10	urati	urati	ADJ
bionys-572	21	11	,	,	PUNCT
bionys-572	21	12	urea	urea	NOUN
bionys-572	21	13	introduction	introduction	NOUN
bionys-572	21	14	dysmetabolic	dysmetabolic	ADJ
bionys-572	21	15	nephropathies	nephropathy	NOUN
bionys-572	21	16	are	be	AUX
bionys-572	21	17	a	a	DET
bionys-572	21	18	group	group	NOUN
bionys-572	21	19	of	of	ADP
bionys-572	21	20	diseases	disease	NOUN
bionys-572	21	21	characterized	characterize	VERB
bionys-572	21	22	by	by	ADP
bionys-572	21	23	an	an	DET
bionys-572	21	24	interstitial	interstitial	ADJ
bionys-572	21	25	process	process	NOUN
bionys-572	21	26	in	in	ADP
bionys-572	21	27	the	the	DET
bionys-572	21	28	kidneys	kidney	NOUN
bionys-572	21	29	with	with	ADP
bionys-572	21	30	crystalluria	crystalluria	PROPN
bionys-572	21	31	due	due	ADP
bionys-572	21	32	to	to	ADP
bionys-572	21	33	metabolic	metabolic	NOUN
bionys-572	21	34	disorders	disorder	NOUN
bionys-572	21	35	(	(	PUNCT
bionys-572	21	36	colaci	colaci	PROPN
bionys-572	21	37	et	et	PROPN
bionys-572	21	38	al	al	PROPN
bionys-572	21	39	.	.	PROPN
bionys-572	21	40	,	,	PUNCT
bionys-572	21	41	2024	2024	NUM
bionys-572	21	42	)	)	PUNCT
bionys-572	21	43	.	.	PUNCT
bionys-572	22	1	crystalluria	crystalluria	PROPN
bionys-572	22	2	may	may	AUX
bionys-572	22	3	be	be	AUX
bionys-572	22	4	transient	transient	ADJ
bionys-572	22	5	(	(	PUNCT
bionys-572	22	6	monotonous	monotonous	ADJ
bionys-572	22	7	diet	diet	NOUN
bionys-572	22	8	or	or	CCONJ
bionys-572	22	9	enzyme	enzyme	NOUN
bionys-572	22	10	disorders	disorder	NOUN
bionys-572	22	11	)	)	PUNCT
bionys-572	22	12	and	and	CCONJ
bionys-572	22	13	permanent	permanent	ADJ
bionys-572	22	14	(	(	PUNCT
bionys-572	22	15	chronic	chronic	ADJ
bionys-572	22	16	diseases	disease	NOUN
bionys-572	22	17	,	,	PUNCT
bionys-572	22	18	metabolic	metabolic	NOUN
bionys-572	22	19	disorders	disorder	NOUN
bionys-572	22	20	)	)	PUNCT
bionys-572	22	21	.	.	PUNCT
bionys-572	23	1	the	the	DET
bionys-572	23	2	factors	factor	NOUN
bionys-572	23	3	contributing	contribute	VERB
bionys-572	23	4	to	to	ADP
bionys-572	23	5	the	the	DET
bionys-572	23	6	formation	formation	NOUN
bionys-572	23	7	of	of	ADP
bionys-572	23	8	crystals	crystal	NOUN
bionys-572	23	9	include	include	VERB
bionys-572	23	10	a	a	DET
bionys-572	23	11	high	high	ADJ
bionys-572	23	12	concentration	concentration	NOUN
bionys-572	23	13	of	of	ADP
bionys-572	23	14	salts	salt	NOUN
bionys-572	23	15	in	in	ADP
bionys-572	23	16	urine	urine	NOUN
bionys-572	23	17	,	,	PUNCT
bionys-572	23	18	weak	weak	ADJ
bionys-572	23	19	water	water	NOUN
bionys-572	23	20	regime	regime	NOUN
bionys-572	23	21	,	,	PUNCT
bionys-572	23	22	use	use	NOUN
bionys-572	23	23	of	of	ADP
bionys-572	23	24	medications	medication	NOUN
bionys-572	23	25	,	,	PUNCT
bionys-572	23	26	urinary	urinary	ADJ
bionys-572	23	27	tract	tract	NOUN
bionys-572	23	28	infection	infection	NOUN
bionys-572	23	29	and	and	CCONJ
bionys-572	23	30	digestive	digestive	ADJ
bionys-572	23	31	disorders	disorder	NOUN
bionys-572	23	32	(	(	PUNCT
bionys-572	23	33	shastri	shastri	PROPN
bionys-572	23	34	et	et	PROPN
bionys-572	23	35	al	al	PROPN
bionys-572	23	36	.	.	PROPN
bionys-572	23	37	,	,	PUNCT
bionys-572	23	38	©	©	PROPN
bionys-572	23	39	2025	2025	NUM
bionys-572	23	40	kravchun	kravchun	PROPN
bionys-572	23	41	et	et	PROPN
bionys-572	23	42	al	al	PROPN
bionys-572	23	43	.	.	PUNCT
bionys-572	24	1	this	this	PRON
bionys-572	24	2	is	be	AUX
bionys-572	24	3	an	an	DET
bionys-572	24	4	open	open	ADJ
bionys-572	24	5	-	-	PUNCT
bionys-572	24	6	access	access	NOUN
bionys-572	24	7	article	article	NOUN
bionys-572	24	8	distributed	distribute	VERB
bionys-572	24	9	under	under	ADP
bionys-572	24	10	the	the	DET
bionys-572	24	11	terms	term	NOUN
bionys-572	24	12	of	of	ADP
bionys-572	24	13	the	the	DET
bionys-572	24	14	creative	creative	ADJ
bionys-572	24	15	commons	common	NOUN
bionys-572	24	16	attribution	attribution	NOUN
bionys-572	24	17	license	license	NOUN
bionys-572	24	18	,	,	PUNCT
bionys-572	24	19	which	which	PRON
bionys-572	24	20	permits	permit	VERB
bionys-572	24	21	unrestricted	unrestricted	ADJ
bionys-572	24	22	use	use	NOUN
bionys-572	24	23	,	,	PUNCT
bionys-572	24	24	distribution	distribution	NOUN
bionys-572	24	25	,	,	PUNCT
bionys-572	24	26	and	and	CCONJ
bionys-572	24	27	build	build	VERB
bionys-572	24	28	upon	upon	SCONJ
bionys-572	24	29	your	your	PRON
bionys-572	24	30	work	work	NOUN
bionys-572	24	31	non	non	ADJ
bionys-572	24	32	-	-	ADJ
bionys-572	24	33	commercially	commercially	ADV
bionys-572	24	34	under	under	ADP
bionys-572	24	35	the	the	DET
bionys-572	24	36	same	same	ADJ
bionys-572	24	37	license	license	NOUN
bionys-572	24	38	as	as	ADP
bionys-572	24	39	the	the	DET
bionys-572	24	40	original	original	NOUN
bionys-572	24	41	.	.	PUNCT
bionys-572	25	1	248	248	NUM
bionys-572	25	2	2023	2023	NUM
bionys-572	25	3	)	)	PUNCT
bionys-572	25	4	.	.	PUNCT
bionys-572	26	1	the	the	DET
bionys-572	26	2	formation	formation	NOUN
bionys-572	26	3	of	of	ADP
bionys-572	26	4	crystals	crystal	NOUN
bionys-572	26	5	in	in	ADP
bionys-572	26	6	body	body	NOUN
bionys-572	26	7	fluids	fluid	NOUN
bionys-572	26	8	in	in	ADP
bionys-572	26	9	dysmetabolic	dysmetabolic	ADJ
bionys-572	26	10	nephropathies	nephropathy	NOUN
bionys-572	26	11	contributes	contribute	VERB
bionys-572	26	12	to	to	ADP
bionys-572	26	13	the	the	DET
bionys-572	26	14	development	development	NOUN
bionys-572	26	15	of	of	ADP
bionys-572	26	16	bone	bone	NOUN
bionys-572	26	17	and	and	CCONJ
bionys-572	26	18	joint	joint	ADJ
bionys-572	26	19	tissue	tissue	NOUN
bionys-572	26	20	pathology	pathology	NOUN
bionys-572	26	21	.	.	PUNCT
bionys-572	27	1	the	the	DET
bionys-572	27	2	urinary	urinary	ADJ
bionys-572	27	3	syndrome	syndrome	NOUN
bionys-572	27	4	in	in	ADP
bionys-572	27	5	dysmetabolic	dysmetabolic	ADJ
bionys-572	27	6	nephropathy	nephropathy	NOUN
bionys-572	27	7	is	be	AUX
bionys-572	27	8	characterized	characterize	VERB
bionys-572	27	9	by	by	ADP
bionys-572	27	10	the	the	DET
bionys-572	27	11	presence	presence	NOUN
bionys-572	27	12	of	of	ADP
bionys-572	27	13	urates	urate	NOUN
bionys-572	27	14	,	,	PUNCT
bionys-572	27	15	phosphates	phosphate	NOUN
bionys-572	27	16	,	,	PUNCT
bionys-572	27	17	oxalates	oxalate	NOUN
bionys-572	27	18	,	,	PUNCT
bionys-572	27	19	leukocyturia	leukocyturia	NOUN
bionys-572	27	20	,	,	PUNCT
bionys-572	27	21	erythrocyturia	erythrocyturia	NOUN
bionys-572	27	22	and	and	CCONJ
bionys-572	27	23	proteinuria	proteinuria	NOUN
bionys-572	27	24	(	(	PUNCT
bionys-572	27	25	timo	timo	PROPN
bionys-572	27	26	et	et	PROPN
bionys-572	27	27	al	al	PROPN
bionys-572	27	28	.	.	PROPN
bionys-572	27	29	,	,	PUNCT
bionys-572	27	30	2023	2023	NUM
bionys-572	27	31	)	)	PUNCT
bionys-572	27	32	.	.	PUNCT
bionys-572	28	1	crystalluria	crystalluria	PROPN
bionys-572	28	2	and	and	CCONJ
bionys-572	28	3	urolithiasis	urolithiasis	NOUN
bionys-572	28	4	occupy	occupy	VERB
bionys-572	28	5	one	one	NUM
bionys-572	28	6	of	of	ADP
bionys-572	28	7	the	the	DET
bionys-572	28	8	leading	lead	VERB
bionys-572	28	9	places	place	NOUN
bionys-572	28	10	in	in	ADP
bionys-572	28	11	the	the	DET
bionys-572	28	12	structure	structure	NOUN
bionys-572	28	13	of	of	ADP
bionys-572	28	14	metabolic	metabolic	NOUN
bionys-572	28	15	diseases	disease	NOUN
bionys-572	28	16	.	.	PUNCT
bionys-572	29	1	thus	thus	ADV
bionys-572	29	2	,	,	PUNCT
bionys-572	29	3	8–15	8–15	ADJ
bionys-572	29	4	%	%	NOUN
bionys-572	29	5	of	of	ADP
bionys-572	29	6	the	the	DET
bionys-572	29	7	population	population	NOUN
bionys-572	29	8	of	of	ADP
bionys-572	29	9	europe	europe	PROPN
bionys-572	29	10	and	and	CCONJ
bionys-572	29	11	north	north	PROPN
bionys-572	29	12	america	america	PROPN
bionys-572	29	13	suffer	suffer	VERB
bionys-572	29	14	from	from	ADP
bionys-572	29	15	urolithiasis	urolithiasis	NOUN
bionys-572	29	16	(	(	PUNCT
bionys-572	29	17	verdesca	verdesca	PROPN
bionys-572	29	18	et	et	PROPN
bionys-572	29	19	al	al	PROPN
bionys-572	29	20	.	.	PROPN
bionys-572	29	21	,	,	PUNCT
bionys-572	29	22	2011	2011	NUM
bionys-572	29	23	;	;	PUNCT
bionys-572	29	24	qian	qian	PROPN
bionys-572	29	25	et	et	PROPN
bionys-572	29	26	al	al	PROPN
bionys-572	29	27	.	.	PROPN
bionys-572	29	28	,	,	PUNCT
bionys-572	29	29	2022	2022	NUM
bionys-572	29	30	)	)	PUNCT
bionys-572	29	31	.	.	PUNCT
bionys-572	30	1	the	the	DET
bionys-572	30	2	enzymes	enzyme	NOUN
bionys-572	30	3	involved	involve	VERB
bionys-572	30	4	in	in	ADP
bionys-572	30	5	glyoxylate	glyoxylate	NOUN
bionys-572	30	6	metabolism	metabolism	NOUN
bionys-572	30	7	have	have	AUX
bionys-572	30	8	been	be	AUX
bionys-572	30	9	related	relate	VERB
bionys-572	30	10	to	to	ADP
bionys-572	30	11	primary	primary	ADJ
bionys-572	30	12	hyperoxalurias	hyperoxaluria	NOUN
bionys-572	30	13	(	(	PUNCT
bionys-572	30	14	moya	moya	PROPN
bionys-572	30	15	et	et	PROPN
bionys-572	30	16	al	al	PROPN
bionys-572	30	17	.	.	PROPN
bionys-572	30	18	,	,	PUNCT
bionys-572	30	19	2024	2024	NUM
bionys-572	30	20	)	)	PUNCT
bionys-572	30	21	.	.	PUNCT
bionys-572	31	1	the	the	DET
bionys-572	31	2	oxalate	oxalate	NOUN
bionys-572	31	3	metabolism	metabolism	NOUN
bionys-572	31	4	is	be	AUX
bionys-572	31	5	associated	associate	VERB
bionys-572	31	6	with	with	ADP
bionys-572	31	7	coagulation	coagulation	NOUN
bionys-572	31	8	system	system	NOUN
bionys-572	31	9	.	.	PUNCT
bionys-572	32	1	thus	thus	ADV
bionys-572	32	2	,	,	PUNCT
bionys-572	32	3	f1	f1	ADJ
bionys-572	32	4	fragment	fragment	NOUN
bionys-572	32	5	of	of	ADP
bionys-572	32	6	prothrombin	prothrombin	NOUN
bionys-572	32	7	is	be	AUX
bionys-572	32	8	excreted	excrete	VERB
bionys-572	32	9	in	in	ADP
bionys-572	32	10	urine	urine	NOUN
bionys-572	32	11	and	and	CCONJ
bionys-572	32	12	precipitates	precipitate	NOUN
bionys-572	32	13	into	into	ADP
bionys-572	32	14	calcium	calcium	NOUN
bionys-572	32	15	oxalate	oxalate	NOUN
bionys-572	32	16	crystals	crystal	NOUN
bionys-572	32	17	,	,	PUNCT
bionys-572	32	18	acting	act	VERB
bionys-572	32	19	as	as	ADP
bionys-572	32	20	inhibitor	inhibitor	NOUN
bionys-572	32	21	of	of	ADP
bionys-572	32	22	calcium	calcium	NOUN
bionys-572	32	23	crystallization	crystallization	NOUN
bionys-572	32	24	in	in	ADP
bionys-572	32	25	urine	urine	NOUN
bionys-572	32	26	(	(	PUNCT
bionys-572	32	27	grover	grover	NOUN
bionys-572	32	28	et	et	PROPN
bionys-572	32	29	al	al	PROPN
bionys-572	32	30	.	.	PROPN
bionys-572	32	31	,	,	PUNCT
bionys-572	32	32	1999	1999	NUM
bionys-572	32	33	)	)	PUNCT
bionys-572	32	34	.	.	PUNCT
bionys-572	33	1	people	people	NOUN
bionys-572	33	2	with	with	ADP
bionys-572	33	3	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	33	4	have	have	AUX
bionys-572	33	5	demonstrated	demonstrate	VERB
bionys-572	33	6	increased	increase	VERB
bionys-572	33	7	serum	serum	NOUN
bionys-572	33	8	level	level	NOUN
bionys-572	33	9	of	of	ADP
bionys-572	33	10	glycoproteins	glycoprotein	NOUN
bionys-572	33	11	and	and	CCONJ
bionys-572	33	12	chondroitin	chondroitin	NOUN
bionys-572	33	13	sulfates	sulfate	NOUN
bionys-572	33	14	(	(	PUNCT
bionys-572	33	15	hesse	hesse	PROPN
bionys-572	33	16	et	et	PROPN
bionys-572	33	17	al	al	PROPN
bionys-572	33	18	.	.	PROPN
bionys-572	33	19	,	,	PUNCT
bionys-572	33	20	1991	1991	NUM
bionys-572	33	21	)	)	PUNCT
bionys-572	33	22	.	.	PUNCT
bionys-572	34	1	uraturia	uraturia	PROPN
bionys-572	34	2	patients	patient	NOUN
bionys-572	34	3	are	be	AUX
bionys-572	34	4	characterized	characterize	VERB
bionys-572	34	5	by	by	ADP
bionys-572	34	6	accumulation	accumulation	NOUN
bionys-572	34	7	of	of	ADP
bionys-572	34	8	monosodium	monosodium	NOUN
bionys-572	34	9	urate	urate	NOUN
bionys-572	34	10	crystals	crystal	NOUN
bionys-572	34	11	in	in	ADP
bionys-572	34	12	joint	joint	ADJ
bionys-572	34	13	tissue	tissue	NOUN
bionys-572	34	14	,	,	PUNCT
bionys-572	34	15	causing	cause	VERB
bionys-572	34	16	inflammation	inflammation	NOUN
bionys-572	34	17	(	(	PUNCT
bionys-572	34	18	han	han	PROPN
bionys-572	34	19	et	et	PROPN
bionys-572	34	20	al	al	PROPN
bionys-572	34	21	.	.	PROPN
bionys-572	34	22	,	,	PUNCT
bionys-572	34	23	2024	2024	NUM
bionys-572	34	24	)	)	PUNCT
bionys-572	34	25	.	.	PUNCT
bionys-572	35	1	high	high	ADJ
bionys-572	35	2	serum	serum	PROPN
bionys-572	35	3	uric	uric	PROPN
bionys-572	35	4	acid	acid	PROPN
bionys-572	35	5	has	have	AUX
bionys-572	35	6	been	be	AUX
bionys-572	35	7	found	find	VERB
bionys-572	35	8	to	to	PART
bionys-572	35	9	be	be	AUX
bionys-572	35	10	associated	associate	VERB
bionys-572	35	11	with	with	ADP
bionys-572	35	12	hypercoagulation	hypercoagulation	NOUN
bionys-572	35	13	,	,	PUNCT
bionys-572	35	14	endothelial	endothelial	ADJ
bionys-572	35	15	dysfunction	dysfunction	NOUN
bionys-572	35	16	and	and	CCONJ
bionys-572	35	17	inflammation	inflammation	NOUN
bionys-572	35	18	.	.	PUNCT
bionys-572	36	1	the	the	DET
bionys-572	36	2	uric	uric	ADJ
bionys-572	36	3	acid	acid	NOUN
bionys-572	36	4	correlated	correlate	VERB
bionys-572	36	5	with	with	ADP
bionys-572	36	6	thromboembolism	thromboembolism	NOUN
bionys-572	36	7	and	and	CCONJ
bionys-572	36	8	left	leave	VERB
bionys-572	36	9	atrial	atrial	ADJ
bionys-572	36	10	thrombosis	thrombosis	NOUN
bionys-572	36	11	in	in	ADP
bionys-572	36	12	systemic	systemic	ADJ
bionys-572	36	13	diseases	disease	NOUN
bionys-572	36	14	,	,	PUNCT
bionys-572	36	15	metabolic	metabolic	NOUN
bionys-572	36	16	syndrome	syndrome	NOUN
bionys-572	36	17	and	and	CCONJ
bionys-572	36	18	arterial	arterial	ADJ
bionys-572	36	19	hypertension	hypertension	NOUN
bionys-572	36	20	(	(	PUNCT
bionys-572	36	21	chen	chen	PROPN
bionys-572	36	22	et	et	PROPN
bionys-572	36	23	al	al	PROPN
bionys-572	36	24	.	.	PROPN
bionys-572	36	25	,	,	PUNCT
bionys-572	36	26	2016	2016	NUM
bionys-572	36	27	;	;	PUNCT
bionys-572	36	28	liu	liu	PROPN
bionys-572	36	29	et	et	PROPN
bionys-572	36	30	al	al	PROPN
bionys-572	36	31	.	.	PROPN
bionys-572	36	32	,	,	PUNCT
bionys-572	36	33	2022	2022	NUM
bionys-572	36	34	)	)	PUNCT
bionys-572	36	35	.	.	PUNCT
bionys-572	37	1	in	in	ADP
bionys-572	37	2	high	high	ADJ
bionys-572	37	3	concentrations	concentration	NOUN
bionys-572	37	4	,	,	PUNCT
bionys-572	37	5	uric	uric	ADJ
bionys-572	37	6	acid	acid	NOUN
bionys-572	37	7	has	have	AUX
bionys-572	37	8	been	be	AUX
bionys-572	37	9	shown	show	VERB
bionys-572	37	10	to	to	PART
bionys-572	37	11	predispose	predispose	VERB
bionys-572	37	12	to	to	PART
bionys-572	37	13	type	type	VERB
bionys-572	37	14	2	2	NUM
bionys-572	37	15	diabetes	diabetes	NOUN
bionys-572	37	16	mellitus	mellitus	NOUN
bionys-572	37	17	due	due	ADP
bionys-572	37	18	to	to	ADP
bionys-572	37	19	the	the	DET
bionys-572	37	20	increased	increase	VERB
bionys-572	37	21	production	production	NOUN
bionys-572	37	22	of	of	ADP
bionys-572	37	23	reactive	reactive	ADJ
bionys-572	37	24	oxygen	oxygen	NOUN
bionys-572	37	25	species	specie	NOUN
bionys-572	37	26	that	that	PRON
bionys-572	37	27	reduce	reduce	VERB
bionys-572	37	28	blood	blood	NOUN
bionys-572	37	29	glucose	glucose	NOUN
bionys-572	37	30	uptake	uptake	ADJ
bionys-572	37	31	(	(	PUNCT
bionys-572	37	32	wardhana	wardhana	PROPN
bionys-572	37	33	et	et	PROPN
bionys-572	37	34	al	al	PROPN
bionys-572	37	35	.	.	PROPN
bionys-572	37	36	,	,	PUNCT
bionys-572	37	37	2018	2018	NUM
bionys-572	37	38	;	;	PUNCT
bionys-572	37	39	wang	wang	PROPN
bionys-572	37	40	et	et	PROPN
bionys-572	37	41	al	al	PROPN
bionys-572	37	42	.	.	PROPN
bionys-572	37	43	,	,	PUNCT
bionys-572	37	44	2022	2022	NUM
bionys-572	37	45	)	)	PUNCT
bionys-572	37	46	.	.	PUNCT
bionys-572	38	1	the	the	DET
bionys-572	38	2	role	role	NOUN
bionys-572	38	3	of	of	ADP
bionys-572	38	4	phosphorus	phosphorus	NOUN
bionys-572	38	5	in	in	ADP
bionys-572	38	6	aminotransferase	aminotransferase	NOUN
bionys-572	38	7	activity	activity	NOUN
bionys-572	38	8	has	have	AUX
bionys-572	38	9	been	be	AUX
bionys-572	38	10	also	also	ADV
bionys-572	38	11	discussed	discuss	VERB
bionys-572	38	12	(	(	PUNCT
bionys-572	38	13	zechner	zechner	NOUN
bionys-572	38	14	et	et	PROPN
bionys-572	38	15	al	al	PROPN
bionys-572	38	16	.	.	PROPN
bionys-572	38	17	,	,	PUNCT
bionys-572	38	18	2021	2021	NUM
bionys-572	38	19	)	)	PUNCT
bionys-572	38	20	.	.	PUNCT
bionys-572	39	1	meanwhile	meanwhile	ADV
bionys-572	39	2	,	,	PUNCT
bionys-572	39	3	the	the	DET
bionys-572	39	4	association	association	NOUN
bionys-572	39	5	of	of	ADP
bionys-572	39	6	oxalates	oxalate	NOUN
bionys-572	39	7	,	,	PUNCT
bionys-572	39	8	uric	uric	ADJ
bionys-572	39	9	acid	acid	NOUN
bionys-572	39	10	and	and	CCONJ
bionys-572	39	11	phosphates	phosphate	NOUN
bionys-572	39	12	with	with	ADP
bionys-572	39	13	bone	bone	NOUN
bionys-572	39	14	and	and	CCONJ
bionys-572	39	15	joint	joint	ADJ
bionys-572	39	16	tissue	tissue	NOUN
bionys-572	39	17	pathology	pathology	NOUN
bionys-572	39	18	has	have	AUX
bionys-572	39	19	been	be	AUX
bionys-572	39	20	scarcely	scarcely	ADV
bionys-572	39	21	studied	study	VERB
bionys-572	39	22	.	.	PUNCT
bionys-572	40	1	the	the	DET
bionys-572	40	2	aim	aim	NOUN
bionys-572	40	3	of	of	ADP
bionys-572	40	4	the	the	DET
bionys-572	40	5	study	study	NOUN
bionys-572	40	6	was	be	AUX
bionys-572	40	7	to	to	PART
bionys-572	40	8	analyze	analyze	VERB
bionys-572	40	9	the	the	DET
bionys-572	40	10	incidence	incidence	NOUN
bionys-572	40	11	and	and	CCONJ
bionys-572	40	12	the	the	DET
bionys-572	40	13	structure	structure	NOUN
bionys-572	40	14	of	of	ADP
bionys-572	40	15	crystalluria	crystalluria	PROPN
bionys-572	40	16	in	in	ADP
bionys-572	40	17	patients	patient	NOUN
bionys-572	40	18	with	with	ADP
bionys-572	40	19	bone	bone	NOUN
bionys-572	40	20	and	and	CCONJ
bionys-572	40	21	joint	joint	ADJ
bionys-572	40	22	tissue	tissue	NOUN
bionys-572	40	23	pathology	pathology	NOUN
bionys-572	40	24	and	and	CCONJ
bionys-572	40	25	to	to	PART
bionys-572	40	26	investigate	investigate	VERB
bionys-572	40	27	the	the	DET
bionys-572	40	28	serum	serum	NOUN
bionys-572	40	29	biochemical	biochemical	ADJ
bionys-572	40	30	parameters	parameter	NOUN
bionys-572	40	31	in	in	ADP
bionys-572	40	32	every	every	DET
bionys-572	40	33	type	type	NOUN
bionys-572	40	34	of	of	ADP
bionys-572	40	35	crystalluria	crystalluria	PROPN
bionys-572	40	36	.	.	PUNCT
bionys-572	41	1	materials	material	NOUN
bionys-572	41	2	and	and	CCONJ
bionys-572	41	3	methods	method	NOUN
bionys-572	41	4	the	the	DET
bionys-572	41	5	examined	examine	VERB
bionys-572	41	6	patients	patient	NOUN
bionys-572	41	7	a	a	DET
bionys-572	41	8	total	total	NOUN
bionys-572	41	9	of	of	ADP
bionys-572	41	10	728	728	NUM
bionys-572	41	11	patients	patient	NOUN
bionys-572	41	12	(	(	PUNCT
bionys-572	41	13	382	382	NUM
bionys-572	41	14	female	female	NOUN
bionys-572	41	15	,	,	PUNCT
bionys-572	41	16	346	346	NUM
bionys-572	41	17	male	male	NOUN
bionys-572	41	18	)	)	PUNCT
bionys-572	41	19	,	,	PUNCT
bionys-572	41	20	aged	age	VERB
bionys-572	41	21	32	32	NUM
bionys-572	41	22	to	to	PART
bionys-572	41	23	81	81	NUM
bionys-572	41	24	years	year	NOUN
bionys-572	41	25	,	,	PUNCT
bionys-572	41	26	with	with	SCONJ
bionys-572	41	27	bone	bone	NOUN
bionys-572	41	28	and	and	CCONJ
bionys-572	41	29	joint	joint	ADJ
bionys-572	41	30	tissue	tissue	NOUN
bionys-572	41	31	pathology	pathology	NOUN
bionys-572	41	32	(	(	PUNCT
bionys-572	41	33	including	include	VERB
bionys-572	41	34	coxarthrosis	coxarthrosis	NOUN
bionys-572	41	35	,	,	PUNCT
bionys-572	41	36	gonarthrosis	gonarthrosis	NOUN
bionys-572	41	37	,	,	PUNCT
bionys-572	41	38	ligament	ligament	NOUN
bionys-572	41	39	ruptures	rupture	NOUN
bionys-572	41	40	,	,	PUNCT
bionys-572	41	41	and	and	CCONJ
bionys-572	41	42	bone	bone	NOUN
bionys-572	41	43	fractures	fracture	NOUN
bionys-572	41	44	)	)	PUNCT
bionys-572	41	45	treated	treat	VERB
bionys-572	41	46	at	at	ADP
bionys-572	41	47	the	the	DET
bionys-572	41	48	sytenko	sytenko	PROPN
bionys-572	41	49	institute	institute	NOUN
bionys-572	41	50	of	of	ADP
bionys-572	41	51	spine	spine	ADJ
bionys-572	41	52	and	and	CCONJ
bionys-572	41	53	joint	joint	ADJ
bionys-572	41	54	pathology	pathology	NOUN
bionys-572	41	55	were	be	AUX
bionys-572	41	56	included	include	VERB
bionys-572	41	57	in	in	ADP
bionys-572	41	58	the	the	DET
bionys-572	41	59	study	study	NOUN
bionys-572	41	60	following	follow	VERB
bionys-572	41	61	institutional	institutional	ADJ
bionys-572	41	62	ethical	ethical	ADJ
bionys-572	41	63	approval	approval	NOUN
bionys-572	41	64	.	.	PUNCT
bionys-572	42	1	among	among	ADP
bionys-572	42	2	them	they	PRON
bionys-572	42	3	,	,	PUNCT
bionys-572	42	4	66	66	NUM
bionys-572	42	5	patients	patient	NOUN
bionys-572	42	6	exhibited	exhibit	VERB
bionys-572	42	7	crystalluria	crystalluria	NOUN
bionys-572	42	8	and	and	CCONJ
bionys-572	42	9	signs	sign	NOUN
bionys-572	42	10	of	of	ADP
bionys-572	42	11	dysmetabolic	dysmetabolic	ADJ
bionys-572	42	12	nephropathy	nephropathy	NOUN
bionys-572	42	13	and	and	CCONJ
bionys-572	42	14	were	be	AUX
bionys-572	42	15	assigned	assign	VERB
bionys-572	42	16	to	to	ADP
bionys-572	42	17	the	the	DET
bionys-572	42	18	study	study	NOUN
bionys-572	42	19	group	group	NOUN
bionys-572	42	20	.	.	PUNCT
bionys-572	43	1	this	this	DET
bionys-572	43	2	group	group	NOUN
bionys-572	43	3	was	be	AUX
bionys-572	43	4	further	far	ADV
bionys-572	43	5	divided	divide	VERB
bionys-572	43	6	into	into	ADP
bionys-572	43	7	group	group	NOUN
bionys-572	43	8	i	i	PRON
bionys-572	43	9	:	:	PUNCT
bionys-572	43	10	patients	patient	NOUN
bionys-572	43	11	with	with	ADP
bionys-572	43	12	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	43	13	(	(	PUNCT
bionys-572	43	14	n=39	n=39	PROPN
bionys-572	43	15	)	)	PUNCT
bionys-572	43	16	,	,	PUNCT
bionys-572	43	17	group	group	NOUN
bionys-572	43	18	ii	ii	PROPN
bionys-572	43	19	:	:	PUNCT
bionys-572	43	20	patients	patient	NOUN
bionys-572	43	21	with	with	ADP
bionys-572	43	22	uraturia	uraturia	PROPN
bionys-572	43	23	(	(	PUNCT
bionys-572	43	24	n=17	n=17	NOUN
bionys-572	43	25	)	)	PUNCT
bionys-572	43	26	,	,	PUNCT
bionys-572	43	27	and	and	CCONJ
bionys-572	43	28	group	group	PROPN
bionys-572	43	29	iii	iii	PROPN
bionys-572	43	30	:	:	PUNCT
bionys-572	43	31	patients	patient	NOUN
bionys-572	43	32	with	with	ADP
bionys-572	43	33	phosphaturia	phosphaturia	PROPN
bionys-572	43	34	(	(	PUNCT
bionys-572	43	35	n=10	n=10	NOUN
bionys-572	43	36	)	)	PUNCT
bionys-572	43	37	.	.	PUNCT
bionys-572	44	1	an	an	DET
bionys-572	44	2	additional	additional	ADJ
bionys-572	44	3	61	61	NUM
bionys-572	44	4	patients	patient	NOUN
bionys-572	44	5	with	with	ADP
bionys-572	44	6	bone	bone	NOUN
bionys-572	44	7	and	and	CCONJ
bionys-572	44	8	joint	joint	ADJ
bionys-572	44	9	tissue	tissue	NOUN
bionys-572	44	10	pathology	pathology	NOUN
bionys-572	44	11	but	but	CCONJ
bionys-572	44	12	without	without	ADP
bionys-572	44	13	crystalluria	crystalluria	PROPN
bionys-572	44	14	were	be	AUX
bionys-572	44	15	included	include	VERB
bionys-572	44	16	as	as	ADP
bionys-572	44	17	the	the	DET
bionys-572	44	18	control	control	NOUN
bionys-572	44	19	group	group	NOUN
bionys-572	44	20	.	.	PUNCT
bionys-572	45	1	results	result	NOUN
bionys-572	45	2	were	be	AUX
bionys-572	45	3	compared	compare	VERB
bionys-572	45	4	between	between	ADP
bionys-572	45	5	the	the	DET
bionys-572	45	6	crystalluria	crystalluria	PROPN
bionys-572	45	7	subgroups	subgroup	NOUN
bionys-572	45	8	and	and	CCONJ
bionys-572	45	9	the	the	DET
bionys-572	45	10	control	control	NOUN
bionys-572	45	11	group	group	NOUN
bionys-572	45	12	.	.	PUNCT
bionys-572	46	1	clinical	clinical	ADJ
bionys-572	46	2	examination	examination	NOUN
bionys-572	46	3	of	of	ADP
bionys-572	46	4	the	the	DET
bionys-572	46	5	patients	patient	NOUN
bionys-572	46	6	included	include	VERB
bionys-572	46	7	objective	objective	ADJ
bionys-572	46	8	examination	examination	NOUN
bionys-572	46	9	of	of	ADP
bionys-572	46	10	organs	organ	NOUN
bionys-572	46	11	and	and	CCONJ
bionys-572	46	12	systems	system	NOUN
bionys-572	46	13	.	.	PUNCT
bionys-572	47	1	ultrasound	ultrasound	PROPN
bionys-572	47	2	investigation	investigation	NOUN
bionys-572	47	3	of	of	ADP
bionys-572	47	4	kidneys	kidney	NOUN
bionys-572	47	5	,	,	PUNCT
bionys-572	47	6	complete	complete	ADJ
bionys-572	47	7	urinalysis	urinalysis	NOUN
bionys-572	47	8	and	and	CCONJ
bionys-572	47	9	serum	serum	NOUN
bionys-572	47	10	biochemical	biochemical	ADJ
bionys-572	47	11	analysis	analysis	NOUN
bionys-572	47	12	were	be	AUX
bionys-572	47	13	performed	perform	VERB
bionys-572	47	14	,	,	PUNCT
bionys-572	47	15	and	and	CCONJ
bionys-572	47	16	revealed	reveal	VERB
bionys-572	47	17	the	the	DET
bionys-572	47	18	presence	presence	NOUN
bionys-572	47	19	of	of	ADP
bionys-572	47	20	echopositive	echopositive	ADJ
bionys-572	47	21	formations	formation	NOUN
bionys-572	47	22	as	as	ADP
bionys-572	47	23	a	a	DET
bionys-572	47	24	sign	sign	NOUN
bionys-572	47	25	of	of	ADP
bionys-572	47	26	crystals	crystal	NOUN
bionys-572	47	27	.	.	PUNCT
bionys-572	48	1	microscopic	microscopic	ADJ
bionys-572	48	2	examination	examination	NOUN
bionys-572	48	3	of	of	ADP
bionys-572	48	4	crystals	crystal	NOUN
bionys-572	48	5	the	the	DET
bionys-572	48	6	crystals	crystal	NOUN
bionys-572	48	7	were	be	AUX
bionys-572	48	8	observed	observe	VERB
bionys-572	48	9	under	under	ADP
bionys-572	48	10	micromed	microme	VERB
bionys-572	48	11	xs	xs	PROPN
bionys-572	48	12	-3330	-3330	PROPN
bionys-572	48	13	microscope	microscope	PROPN
bionys-572	48	14	at	at	ADP
bionys-572	48	15	×400	×400	ADJ
bionys-572	48	16	magnification	magnification	NOUN
bionys-572	48	17	.	.	PUNCT
bionys-572	49	1	the	the	DET
bionys-572	49	2	salt	salt	NOUN
bionys-572	49	3	excretion	excretion	NOUN
bionys-572	49	4	from	from	ADP
bionys-572	49	5	the	the	DET
bionys-572	49	6	24	24	NUM
bionys-572	49	7	-	-	PUNCT
bionys-572	49	8	hour	hour	NOUN
bionys-572	49	9	urine	urine	NOUN
bionys-572	49	10	collection	collection	NOUN
bionys-572	49	11	was	be	AUX
bionys-572	49	12	investigated	investigate	VERB
bionys-572	49	13	(	(	PUNCT
bionys-572	49	14	fig	fig	NOUN
bionys-572	49	15	.	.	NOUN
bionys-572	49	16	1	1	NUM
bionys-572	49	17	)	)	PUNCT
bionys-572	49	18	.	.	PUNCT
bionys-572	50	1	increased	increase	VERB
bionys-572	50	2	oxalates	oxalate	NOUN
bionys-572	50	3	excretion	excretion	NOUN
bionys-572	50	4	(	(	PUNCT
bionys-572	50	5	more	more	ADJ
bionys-572	50	6	than	than	ADP
bionys-572	50	7	1	1	NUM
bionys-572	50	8	mg	mg	PROPN
bionys-572	50	9	/	/	SYM
bionys-572	50	10	kg	kg	PROPN
bionys-572	50	11	/	/	SYM
bionys-572	50	12	day	day	NOUN
bionys-572	50	13	)	)	PUNCT
bionys-572	50	14	was	be	AUX
bionys-572	50	15	revealed	reveal	VERB
bionys-572	50	16	in	in	ADP
bionys-572	50	17	patients	patient	NOUN
bionys-572	50	18	with	with	ADP
bionys-572	50	19	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	50	20	.	.	PUNCT
bionys-572	51	1	patients	patient	NOUN
bionys-572	51	2	with	with	ADP
bionys-572	51	3	uraturia	uraturia	PROPN
bionys-572	51	4	showed	show	VERB
bionys-572	51	5	increased	increase	VERB
bionys-572	51	6	urinary	urinary	ADJ
bionys-572	51	7	excretion	excretion	NOUN
bionys-572	51	8	of	of	ADP
bionys-572	51	9	uric	uric	ADJ
bionys-572	51	10	acid	acid	NOUN
bionys-572	51	11	and	and	CCONJ
bionys-572	51	12	calcium	calcium	NOUN
bionys-572	51	13	(	(	PUNCT
bionys-572	51	14	uric	uric	ADJ
bionys-572	51	15	acid	acid	NOUN
bionys-572	51	16	level	level	NOUN
bionys-572	51	17	in	in	ADP
bionys-572	51	18	urine	urine	NOUN
bionys-572	51	19	:	:	PUNCT
bionys-572	51	20	more	more	ADJ
bionys-572	51	21	than	than	ADP
bionys-572	51	22	4.0	4.0	NUM
bionys-572	51	23	mmol	mmol	NOUN
bionys-572	51	24	/	/	SYM
bionys-572	51	25	l	l	NOUN
bionys-572	51	26	,	,	PUNCT
bionys-572	51	27	and	and	CCONJ
bionys-572	51	28	calcium	calcium	NOUN
bionys-572	51	29	:	:	PUNCT
bionys-572	51	30	more	more	ADJ
bionys-572	51	31	than	than	ADP
bionys-572	51	32	7.5	7.5	NUM
bionys-572	51	33	mmol	mmol	NOUN
bionys-572	51	34	/	/	SYM
bionys-572	51	35	l	l	NOUN
bionys-572	51	36	)	)	PUNCT
bionys-572	51	37	.	.	PUNCT
bionys-572	52	1	high	high	ADJ
bionys-572	52	2	phosphorus	phosphorus	NOUN
bionys-572	52	3	excretion	excretion	NOUN
bionys-572	52	4	(	(	PUNCT
bionys-572	52	5	more	more	ADJ
bionys-572	52	6	than	than	ADP
bionys-572	52	7	33	33	NUM
bionys-572	52	8	mmol	mmol	NOUN
bionys-572	52	9	/	/	SYM
bionys-572	52	10	l	l	NOUN
bionys-572	52	11	)	)	PUNCT
bionys-572	52	12	was	be	AUX
bionys-572	52	13	detected	detect	VERB
bionys-572	52	14	in	in	ADP
bionys-572	52	15	patients	patient	NOUN
bionys-572	52	16	with	with	ADP
bionys-572	52	17	phosphaturia	phosphaturia	PROPN
bionys-572	52	18	.	.	PUNCT
bionys-572	53	1	urea	urea	VERB
bionys-572	53	2	the	the	DET
bionys-572	53	3	content	content	NOUN
bionys-572	53	4	of	of	ADP
bionys-572	53	5	urea	urea	NOUN
bionys-572	53	6	(	(	PUNCT
bionys-572	53	7	by	by	ADP
bionys-572	53	8	color	color	NOUN
bionys-572	53	9	reaction	reaction	NOUN
bionys-572	53	10	with	with	ADP
bionys-572	53	11	diacetylmonooxime	diacetylmonooxime	NOUN
bionys-572	53	12	,	,	PUNCT
bionys-572	53	13	langenfeld	langenfeld	VERB
bionys-572	53	14	et	et	PROPN
bionys-572	53	15	al	al	PROPN
bionys-572	53	16	.	.	PROPN
bionys-572	53	17	,	,	PUNCT
bionys-572	53	18	2021	2021	NUM
bionys-572	53	19	)	)	PUNCT
bionys-572	53	20	was	be	AUX
bionys-572	53	21	performed	perform	VERB
bionys-572	53	22	with	with	ADP
bionys-572	53	23	a	a	DET
bionys-572	53	24	spectrophotometer	spectrophotometer	NOUN
bionys-572	53	25	.	.	PUNCT
bionys-572	54	1	the	the	DET
bionys-572	54	2	reaction	reaction	NOUN
bionys-572	54	3	between	between	ADP
bionys-572	54	4	diacetyl	diacetyl	PROPN
bionys-572	54	5	monoxime	monoxime	PROPN
bionys-572	54	6	and	and	CCONJ
bionys-572	54	7	urea	urea	NOUN
bionys-572	54	8	,	,	PUNCT
bionys-572	54	9	in	in	ADP
bionys-572	54	10	the	the	DET
bionys-572	54	11	presence	presence	NOUN
bionys-572	54	12	of	of	ADP
bionys-572	54	13	sulfuric	sulfuric	ADJ
bionys-572	54	14	acid	acid	NOUN
bionys-572	54	15	,	,	PUNCT
bionys-572	54	16	phosphoric	phosphoric	ADJ
bionys-572	54	17	acid	acid	NOUN
bionys-572	54	18	,	,	PUNCT
bionys-572	54	19	thiosemicarbazide	thiosemicarbazide	NOUN
bionys-572	54	20	,	,	PUNCT
bionys-572	54	21	and	and	CCONJ
bionys-572	54	22	ferric	ferric	ADJ
bionys-572	54	23	chloride	chloride	NOUN
bionys-572	54	24	,	,	PUNCT
bionys-572	54	25	produces	produce	VERB
bionys-572	54	26	a	a	DET
bionys-572	54	27	chromophore	chromophore	NOUN
bionys-572	54	28	whose	whose	DET
bionys-572	54	29	absorbance	absorbance	NOUN
bionys-572	54	30	was	be	AUX
bionys-572	54	31	measured	measure	VERB
bionys-572	54	32	at	at	ADP
bionys-572	54	33	a	a	DET
bionys-572	54	34	wavelength	wavelength	NOUN
bionys-572	54	35	of	of	ADP
bionys-572	54	36	520	520	NUM
bionys-572	54	37	nm	nm	NOUN
bionys-572	54	38	.	.	PUNCT
bionys-572	55	1	creatinine	creatinine	NOUN
bionys-572	55	2	concentration	concentration	NOUN
bionys-572	55	3	of	of	ADP
bionys-572	55	4	creatinine	creatinine	NOUN
bionys-572	55	5	was	be	AUX
bionys-572	55	6	detected	detect	VERB
bionys-572	55	7	using	use	VERB
bionys-572	55	8	commercial	commercial	ADJ
bionys-572	55	9	kit	kit	NOUN
bionys-572	55	10	(	(	PUNCT
bionys-572	55	11	felicit	felicit	ADJ
bionys-572	55	12	diagnostics	diagnostic	NOUN
bionys-572	55	13	)	)	PUNCT
bionys-572	55	14	by	by	ADP
bionys-572	55	15	color	color	NOUN
bionys-572	55	16	yaffe	yaffe	ADJ
bionys-572	55	17	reaction	reaction	NOUN
bionys-572	55	18	(	(	PUNCT
bionys-572	55	19	toora	toora	INTJ
bionys-572	55	20	et	et	PROPN
bionys-572	55	21	al	al	PROPN
bionys-572	55	22	.	.	PROPN
bionys-572	55	23	,	,	PUNCT
bionys-572	55	24	2002	2002	NUM
bionys-572	55	25	)	)	PUNCT
bionys-572	55	26	,	,	PUNCT
bionys-572	55	27	where	where	SCONJ
bionys-572	55	28	1	1	NUM
bionys-572	55	29	ml	ml	NOUN
bionys-572	55	30	of	of	ADP
bionys-572	55	31	working	working	NOUN
bionys-572	55	32	solution	solution	NOUN
bionys-572	55	33	was	be	AUX
bionys-572	55	34	added	add	VERB
bionys-572	55	35	to	to	ADP
bionys-572	55	36	0.25	0.25	NUM
bionys-572	55	37	ml	ml	NOUN
bionys-572	55	38	of	of	ADP
bionys-572	55	39	serum	serum	NOUN
bionys-572	55	40	,	,	PUNCT
bionys-572	55	41	afterwards	afterwards	ADV
bionys-572	55	42	the	the	DET
bionys-572	55	43	optical	optical	ADJ
bionys-572	55	44	density	density	NOUN
bionys-572	55	45	of	of	ADP
bionys-572	55	46	analyzed	analyze	VERB
bionys-572	55	47	sample	sample	NOUN
bionys-572	55	48	and	and	CCONJ
bionys-572	55	49	standard	standard	ADJ
bionys-572	55	50	sample	sample	NOUN
bionys-572	55	51	was	be	AUX
bionys-572	55	52	measured	measure	VERB
bionys-572	55	53	after	after	ADP
bionys-572	55	54	30	30	NUM
bionys-572	55	55	seconds	second	NOUN
bionys-572	55	56	(	(	PUNCT
bionys-572	55	57	e2	e2	NOUN
bionys-572	55	58	and	and	CCONJ
bionys-572	55	59	e2	e2	PROPN
bionys-572	55	60	)	)	PUNCT
bionys-572	55	61	and	and	CCONJ
bionys-572	55	62	90	90	NUM
bionys-572	55	63	seconds	second	NOUN
bionys-572	55	64	(	(	PUNCT
bionys-572	55	65	e3	e3	NOUN
bionys-572	55	66	and	and	CCONJ
bionys-572	55	67	e4	e4	PROPN
bionys-572	55	68	)	)	PUNCT
bionys-572	55	69	accordingly	accordingly	ADV
bionys-572	55	70	at	at	ADP
bionys-572	55	71	wavelength	wavelength	NOUN
bionys-572	55	72	of	of	ADP
bionys-572	55	73	505	505	NUM
bionys-572	55	74	nm	nm	NOUN
bionys-572	55	75	.	.	PUNCT
bionys-572	56	1	creatinine	creatinine	NOUN
bionys-572	56	2	concentration	concentration	NOUN
bionys-572	56	3	was	be	AUX
bionys-572	56	4	calculated	calculate	VERB
bionys-572	56	5	using	use	VERB
bionys-572	56	6	formula	formula	NOUN
bionys-572	56	7	:	:	PUNCT
bionys-572	56	8	creatinine	creatinine	NOUN
bionys-572	56	9	concentration	concentration	NOUN
bionys-572	56	10	=	=	NOUN
bionys-572	56	11	concentration	concentration	NOUN
bionys-572	56	12	of	of	ADP
bionys-572	56	13	calibrator	calibrator	NOUN
bionys-572	56	14	sample×(e3	sample×(e3	PROPN
bionys-572	56	15	-	-	PUNCT
bionys-572	56	16	e1)/(e4	e1)/(e4	PROPN
bionys-572	56	17	-	-	PUNCT
bionys-572	56	18	e2	e2	NOUN
bionys-572	56	19	)	)	PUNCT
bionys-572	56	20	total	total	ADJ
bionys-572	56	21	protein	protein	NOUN
bionys-572	56	22	4.0	4.0	NUM
bionys-572	56	23	ml	ml	NOUN
bionys-572	56	24	of	of	ADP
bionys-572	56	25	monoreagent	monoreagent	NOUN
bionys-572	56	26	(	(	PUNCT
bionys-572	56	27	pyrrogalol	pyrrogalol	X
bionys-572	56	28	red	red	ADJ
bionys-572	56	29	50	50	NUM
bionys-572	56	30	mmol	mmol	NOUN
bionys-572	56	31	/	/	SYM
bionys-572	56	32	l	l	NOUN
bionys-572	56	33	,	,	PUNCT
bionys-572	56	34	sodium	sodium	NOUN
bionys-572	56	35	molybdate	molybdate	NOUN
bionys-572	56	36	)	)	PUNCT
bionys-572	56	37	were	be	AUX
bionys-572	56	38	added	add	VERB
bionys-572	56	39	to	to	ADP
bionys-572	56	40	0.08	0.08	NUM
bionys-572	56	41	ml	ml	NOUN
bionys-572	56	42	of	of	ADP
bionys-572	56	43	serum	serum	NOUN
bionys-572	56	44	and	and	CCONJ
bionys-572	56	45	incubated	incubate	VERB
bionys-572	56	46	for	for	ADP
bionys-572	56	47	10	10	NUM
bionys-572	56	48	minutes	minute	NOUN
bionys-572	56	49	at	at	ADP
bionys-572	56	50	room	room	NOUN
bionys-572	56	51	temperature	temperature	NOUN
bionys-572	56	52	in	in	ADP
bionys-572	56	53	dark	dark	ADJ
bionys-572	56	54	conditions	condition	NOUN
bionys-572	56	55	.	.	PUNCT
bionys-572	57	1	the	the	DET
bionys-572	57	2	optical	optical	ADJ
bionys-572	57	3	density	density	NOUN
bionys-572	57	4	of	of	ADP
bionys-572	57	5	the	the	DET
bionys-572	57	6	test	test	NOUN
bionys-572	57	7	biologica	biologica	PROPN
bionys-572	57	8	nyssana	nyssana	PROPN
bionys-572	57	9	●	●	PUNCT
bionys-572	57	10	16	16	NUM
bionys-572	57	11	(	(	PUNCT
bionys-572	57	12	1	1	NUM
bionys-572	57	13	)	)	PUNCT
bionys-572	57	14	june	june	PROPN
bionys-572	57	15	2025	2025	NUM
bionys-572	57	16	:	:	PUNCT
bionys-572	57	17	247	247	NUM
bionys-572	57	18	-	-	SYM
bionys-572	57	19	257	257	NUM
bionys-572	57	20	kravchun	kravchun	NOUN
bionys-572	57	21	et	et	PROPN
bionys-572	57	22	al	al	PROPN
bionys-572	57	23	.	.	PUNCT
bionys-572	58	1	●	●	PUNCT
bionys-572	58	2	different	different	ADJ
bionys-572	58	3	types	type	NOUN
bionys-572	58	4	of	of	ADP
bionys-572	58	5	crystalluria	crystalluria	PROPN
bionys-572	58	6	in	in	ADP
bionys-572	58	7	patients	patient	NOUN
bionys-572	58	8	with	with	ADP
bionys-572	58	9	bone	bone	NOUN
bionys-572	58	10	and	and	CCONJ
bionys-572	58	11	joint	joint	ADJ
bionys-572	58	12	tissue	tissue	NOUN
bionys-572	58	13	pathology	pathology	NOUN
bionys-572	58	14	:	:	PUNCT
bionys-572	58	15	hematological	hematological	ADJ
bionys-572	58	16	and	and	CCONJ
bionys-572	58	17	biochemical	biochemical	ADJ
bionys-572	58	18	profiles	profile	NOUN
bionys-572	58	19	249	249	NUM
bionys-572	58	20	biologica	biologica	PROPN
bionys-572	58	21	nyssana	nyssana	PROPN
bionys-572	59	1	●	●	PUNCT
bionys-572	59	2	16	16	NUM
bionys-572	59	3	(	(	PUNCT
bionys-572	59	4	1	1	NUM
bionys-572	59	5	)	)	PUNCT
bionys-572	59	6	june	june	PROPN
bionys-572	59	7	2025	2025	NUM
bionys-572	59	8	:	:	PUNCT
bionys-572	59	9	247	247	NUM
bionys-572	59	10	-	-	SYM
bionys-572	59	11	257	257	NUM
bionys-572	59	12	kravchun	kravchun	NOUN
bionys-572	59	13	et	et	PROPN
bionys-572	59	14	al	al	PROPN
bionys-572	59	15	.	.	PUNCT
bionys-572	60	1	●	●	PUNCT
bionys-572	60	2	different	different	ADJ
bionys-572	60	3	types	type	NOUN
bionys-572	60	4	of	of	ADP
bionys-572	60	5	crystalluria	crystalluria	PROPN
bionys-572	60	6	in	in	ADP
bionys-572	60	7	patients	patient	NOUN
bionys-572	60	8	with	with	ADP
bionys-572	60	9	bone	bone	NOUN
bionys-572	60	10	and	and	CCONJ
bionys-572	60	11	joint	joint	ADJ
bionys-572	60	12	tissue	tissue	NOUN
bionys-572	60	13	pathology	pathology	NOUN
bionys-572	60	14	:	:	PUNCT
bionys-572	60	15	hematological	hematological	ADJ
bionys-572	60	16	and	and	CCONJ
bionys-572	60	17	biochemical	biochemical	ADJ
bionys-572	60	18	profiles	profile	NOUN
bionys-572	60	19	sample	sample	NOUN
bionys-572	60	20	(	(	PUNCT
bionys-572	60	21	e	e	NOUN
bionys-572	60	22	test	test	NOUN
bionys-572	60	23	)	)	PUNCT
bionys-572	60	24	and	and	CCONJ
bionys-572	60	25	the	the	DET
bionys-572	60	26	calibration	calibration	NOUN
bionys-572	60	27	sample	sample	NOUN
bionys-572	60	28	(	(	PUNCT
bionys-572	60	29	e	e	NOUN
bionys-572	60	30	calibration	calibration	NOUN
bionys-572	60	31	)	)	PUNCT
bionys-572	60	32	was	be	AUX
bionys-572	60	33	measured	measure	VERB
bionys-572	60	34	against	against	ADP
bionys-572	60	35	a	a	DET
bionys-572	60	36	blank	blank	ADJ
bionys-572	60	37	sample	sample	NOUN
bionys-572	60	38	.	.	PUNCT
bionys-572	61	1	the	the	DET
bionys-572	61	2	concentration	concentration	NOUN
bionys-572	61	3	of	of	ADP
bionys-572	61	4	total	total	ADJ
bionys-572	61	5	protein	protein	NOUN
bionys-572	61	6	was	be	AUX
bionys-572	61	7	calculated	calculate	VERB
bionys-572	61	8	by	by	ADP
bionys-572	61	9	formula	formula	NOUN
bionys-572	61	10	:	:	PUNCT
bionys-572	61	11	c	c	X
bionys-572	61	12	=	=	SYM
bionys-572	61	13	e	e	NOUN
bionys-572	61	14	test	test	NOUN
bionys-572	61	15	:	:	PUNCT
bionys-572	62	1	e	e	X
bionys-572	62	2	calibration	calibration	NOUN
bionys-572	62	3	×	×	NOUN
bionys-572	62	4	1000	1000	NUM
bionys-572	62	5	mg	mg	PROPN
bionys-572	62	6	/	/	SYM
bionys-572	62	7	l	l	NOUN
bionys-572	62	8	calcium	calcium	NOUN
bionys-572	62	9	,	,	PUNCT
bionys-572	62	10	glycoproteins	glycoprotein	NOUN
bionys-572	62	11	,	,	PUNCT
bionys-572	62	12	and	and	CCONJ
bionys-572	62	13	chondrotin	chondrotin	ADJ
bionys-572	62	14	sulfates	sulfate	NOUN
bionys-572	62	15	total	total	ADJ
bionys-572	62	16	calcium	calcium	NOUN
bionys-572	62	17	(	(	PUNCT
bionys-572	62	18	complexonometric	complexonometric	NOUN
bionys-572	62	19	method	method	NOUN
bionys-572	62	20	with	with	ADP
bionys-572	62	21	murexide	murexide	ADJ
bionys-572	62	22	indicator	indicator	NOUN
bionys-572	62	23	;	;	PUNCT
bionys-572	62	24	ritgen	ritgen	PROPN
bionys-572	62	25	u	u	PROPN
bionys-572	62	26	,	,	PUNCT
bionys-572	62	27	2023	2023	NUM
bionys-572	62	28	)	)	PUNCT
bionys-572	62	29	,	,	PUNCT
bionys-572	62	30	glycoproteins	glycoprotein	NOUN
bionys-572	62	31	(	(	PUNCT
bionys-572	62	32	according	accord	VERB
bionys-572	62	33	to	to	ADP
bionys-572	62	34	the	the	DET
bionys-572	62	35	method	method	NOUN
bionys-572	62	36	of	of	ADP
bionys-572	62	37	steinberg	steinberg	PROPN
bionys-572	62	38	and	and	CCONJ
bionys-572	62	39	docenko	docenko	PROPN
bionys-572	62	40	;	;	PUNCT
bionys-572	62	41	shtenberg	shtenberg	PROPN
bionys-572	62	42	op	op	NOUN
bionys-572	62	43	et	et	PROPN
bionys-572	62	44	al	al	PROPN
bionys-572	62	45	.	.	PROPN
bionys-572	62	46	,	,	PUNCT
bionys-572	62	47	1962	1962	NUM
bionys-572	62	48	)	)	PUNCT
bionys-572	62	49	,	,	PUNCT
bionys-572	62	50	and	and	CCONJ
bionys-572	62	51	chondroitin	chondroitin	NOUN
bionys-572	62	52	sulfates	sulfate	NOUN
bionys-572	62	53	(	(	PUNCT
bionys-572	62	54	measured	measure	VERB
bionys-572	62	55	by	by	ADP
bionys-572	62	56	the	the	DET
bionys-572	62	57	nemeth	nemeth	PROPN
bionys-572	62	58	-	-	PUNCT
bionys-572	62	59	csok	csok	NOUN
bionys-572	62	60	method	method	NOUN
bionys-572	62	61	in	in	ADP
bionys-572	62	62	sluckiy	sluckiy	NOUN
bionys-572	62	63	's	's	PART
bionys-572	62	64	modification	modification	NOUN
bionys-572	62	65	;	;	PUNCT
bionys-572	62	66	de	de	PROPN
bionys-572	62	67	jong	jong	PROPN
bionys-572	62	68	et	et	PROPN
bionys-572	62	69	al	al	PROPN
bionys-572	62	70	.	.	PROPN
bionys-572	62	71	,	,	PUNCT
bionys-572	62	72	1989	1989	NUM
bionys-572	62	73	)	)	PUNCT
bionys-572	62	74	were	be	AUX
bionys-572	62	75	analyzed	analyze	VERB
bionys-572	62	76	in	in	ADP
bionys-572	62	77	patients	patient	NOUN
bionys-572	62	78	with	with	ADP
bionys-572	62	79	bone	bone	NOUN
bionys-572	62	80	and	and	CCONJ
bionys-572	62	81	joint	joint	ADJ
bionys-572	62	82	tissue	tissue	NOUN
bionys-572	62	83	pathology	pathology	NOUN
bionys-572	62	84	using	use	VERB
bionys-572	62	85	the	the	DET
bionys-572	62	86	respective	respective	ADJ
bionys-572	62	87	procedures	procedure	NOUN
bionys-572	62	88	.	.	PUNCT
bionys-572	63	1	b	b	X
bionys-572	63	2	-	-	PUNCT
bionys-572	63	3	lipoproteins	lipoprotein	NOUN
bionys-572	63	4	b	b	NOUN
bionys-572	63	5	-	-	PUNCT
bionys-572	63	6	lipoproteins	lipoprotein	NOUN
bionys-572	63	7	were	be	AUX
bionys-572	63	8	measured	measure	VERB
bionys-572	63	9	using	use	VERB
bionys-572	63	10	a	a	DET
bionys-572	63	11	commercial	commercial	ADJ
bionys-572	63	12	kit	kit	NOUN
bionys-572	63	13	(	(	PUNCT
bionys-572	63	14	cormay	cormay	AUX
bionys-572	63	15	ldl	ldl	VERB
bionys-572	63	16	direct	direct	ADJ
bionys-572	63	17	,	,	PUNCT
bionys-572	63	18	poland	poland	PROPN
bionys-572	63	19	)	)	PUNCT
bionys-572	63	20	and	and	CCONJ
bionys-572	63	21	analyzed	analyze	VERB
bionys-572	63	22	spectrophotometrically	spectrophotometrically	ADV
bionys-572	63	23	at	at	ADP
bionys-572	63	24	a	a	DET
bionys-572	63	25	wavelength	wavelength	NOUN
bionys-572	63	26	of	of	ADP
bionys-572	63	27	630	630	NUM
bionys-572	63	28	nm	nm	NOUN
bionys-572	63	29	,	,	PUNCT
bionys-572	63	30	following	follow	VERB
bionys-572	63	31	the	the	DET
bionys-572	63	32	manufacturer	manufacturer	NOUN
bionys-572	63	33	’s	’s	PART
bionys-572	63	34	instructions	instruction	NOUN
bionys-572	63	35	and	and	CCONJ
bionys-572	63	36	the	the	DET
bionys-572	63	37	method	method	NOUN
bionys-572	63	38	described	describe	VERB
bionys-572	63	39	by	by	ADP
bionys-572	63	40	alan	alan	PROPN
bionys-572	63	41	(	(	PUNCT
bionys-572	63	42	2006	2006	NUM
bionys-572	63	43	)	)	PUNCT
bionys-572	63	44	.	.	PUNCT
bionys-572	64	1	a	a	DET
bionys-572	64	2	total	total	NOUN
bionys-572	64	3	of	of	ADP
bionys-572	64	4	900	900	NUM
bionys-572	64	5	µl	µl	NOUN
bionys-572	64	6	of	of	ADP
bionys-572	64	7	reagent	reagent	ADJ
bionys-572	64	8	1	1	NUM
bionys-572	64	9	was	be	AUX
bionys-572	64	10	mixed	mix	VERB
bionys-572	64	11	with	with	ADP
bionys-572	64	12	9	9	NUM
bionys-572	64	13	µl	µl	NOUN
bionys-572	64	14	of	of	ADP
bionys-572	64	15	serum	serum	NOUN
bionys-572	64	16	and	and	CCONJ
bionys-572	64	17	incubated	incubate	VERB
bionys-572	64	18	for	for	ADP
bionys-572	64	19	5	5	NUM
bionys-572	64	20	minutes	minute	NOUN
bionys-572	64	21	at	at	ADP
bionys-572	64	22	37	37	NUM
bionys-572	64	23	°	°	NOUN
bionys-572	64	24	c	c	NOUN
bionys-572	64	25	.	.	PUNCT
bionys-572	65	1	subsequently	subsequently	ADV
bionys-572	65	2	,	,	PUNCT
bionys-572	65	3	300	300	NUM
bionys-572	65	4	µl	µl	NOUN
bionys-572	65	5	of	of	ADP
bionys-572	65	6	reagent	reagent	ADJ
bionys-572	65	7	2	2	NUM
bionys-572	65	8	was	be	AUX
bionys-572	65	9	added	add	VERB
bionys-572	65	10	to	to	ADP
bionys-572	65	11	the	the	DET
bionys-572	65	12	mixture	mixture	NOUN
bionys-572	65	13	,	,	PUNCT
bionys-572	65	14	followed	follow	VERB
bionys-572	65	15	by	by	ADP
bionys-572	65	16	an	an	DET
bionys-572	65	17	additional	additional	ADJ
bionys-572	65	18	5	5	NUM
bionys-572	65	19	-	-	PUNCT
bionys-572	65	20	minute	minute	NOUN
bionys-572	65	21	incubation	incubation	NOUN
bionys-572	65	22	at	at	ADP
bionys-572	65	23	37	37	NUM
bionys-572	65	24	°	°	NOUN
bionys-572	65	25	c	c	X
bionys-572	65	26	.	.	PUNCT
bionys-572	66	1	uric	uric	ADJ
bionys-572	66	2	acid	acid	VERB
bionys-572	66	3	a	a	DET
bionys-572	66	4	mixture	mixture	NOUN
bionys-572	66	5	of	of	ADP
bionys-572	66	6	2.4	2.4	NUM
bionys-572	66	7	ml	ml	NOUN
bionys-572	66	8	of	of	ADP
bionys-572	66	9	distilled	distil	VERB
bionys-572	66	10	water	water	NOUN
bionys-572	66	11	,	,	PUNCT
bionys-572	66	12	0.3	0.3	NUM
bionys-572	66	13	ml	ml	NOUN
bionys-572	66	14	of	of	ADP
bionys-572	66	15	serum	serum	NOUN
bionys-572	66	16	,	,	PUNCT
bionys-572	66	17	0.15	0.15	NUM
bionys-572	66	18	ml	ml	NOUN
bionys-572	66	19	of	of	ADP
bionys-572	66	20	catalyst	catalyst	NOUN
bionys-572	66	21	solution	solution	NOUN
bionys-572	66	22	,	,	PUNCT
bionys-572	66	23	and	and	CCONJ
bionys-572	66	24	0.15	0.15	NUM
bionys-572	66	25	ml	ml	NOUN
bionys-572	66	26	of	of	ADP
bionys-572	66	27	sodium	sodium	NOUN
bionys-572	66	28	tungstate	tungstate	NOUN
bionys-572	66	29	was	be	AUX
bionys-572	66	30	incubated	incubate	VERB
bionys-572	66	31	for	for	ADP
bionys-572	66	32	10	10	NUM
bionys-572	66	33	minutes	minute	NOUN
bionys-572	66	34	at	at	ADP
bionys-572	66	35	room	room	NOUN
bionys-572	66	36	temperature	temperature	NOUN
bionys-572	66	37	,	,	PUNCT
bionys-572	66	38	then	then	ADV
bionys-572	66	39	centrifuged	centrifuge	VERB
bionys-572	66	40	for	for	ADP
bionys-572	66	41	10	10	NUM
bionys-572	66	42	minutes	minute	NOUN
bionys-572	66	43	at	at	ADP
bionys-572	66	44	2000	2000	NUM
bionys-572	66	45	rpm	rpm	NOUN
bionys-572	66	46	.	.	PROPN
bionys-572	67	1	1.0	1.0	NUM
bionys-572	67	2	ml	ml	NOUN
bionys-572	67	3	of	of	ADP
bionys-572	67	4	the	the	DET
bionys-572	67	5	centrifugate	centrifugate	NOUN
bionys-572	67	6	was	be	AUX
bionys-572	67	7	added	add	VERB
bionys-572	67	8	to	to	ADP
bionys-572	67	9	0.5	0.5	NUM
bionys-572	67	10	ml	ml	NOUN
bionys-572	67	11	of	of	ADP
bionys-572	67	12	sodium	sodium	NOUN
bionys-572	67	13	carbonate	carbonate	NOUN
bionys-572	67	14	solution	solution	NOUN
bionys-572	67	15	and	and	CCONJ
bionys-572	67	16	0.3	0.3	NUM
bionys-572	67	17	ml	ml	NOUN
bionys-572	67	18	of	of	ADP
bionys-572	67	19	phosphotungsten	phosphotungsten	ADJ
bionys-572	67	20	reagent	reagent	NOUN
bionys-572	67	21	,	,	PUNCT
bionys-572	67	22	incubated	incubate	VERB
bionys-572	67	23	for	for	ADP
bionys-572	67	24	30	30	NUM
bionys-572	67	25	minutes	minute	NOUN
bionys-572	67	26	at	at	ADP
bionys-572	67	27	room	room	NOUN
bionys-572	67	28	temperature	temperature	NOUN
bionys-572	67	29	.	.	PUNCT
bionys-572	68	1	the	the	DET
bionys-572	68	2	optical	optical	ADJ
bionys-572	68	3	density	density	NOUN
bionys-572	68	4	was	be	AUX
bionys-572	68	5	measured	measure	VERB
bionys-572	68	6	spectrophotometrically	spectrophotometrically	ADV
bionys-572	68	7	at	at	ADP
bionys-572	68	8	a	a	DET
bionys-572	68	9	wavelength	wavelength	NOUN
bionys-572	68	10	of	of	ADP
bionys-572	68	11	650	650	NUM
bionys-572	68	12	nm	nm	NOUN
bionys-572	68	13	.	.	PUNCT
bionys-572	69	1	aspartate	aspartate	PROPN
bionys-572	69	2	aminotransferase	aminotransferase	NOUN
bionys-572	69	3	activity	activity	NOUN
bionys-572	69	4	aspartate	aspartate	NOUN
bionys-572	69	5	aminotransferase	aminotransferase	NOUN
bionys-572	69	6	(	(	PUNCT
bionys-572	69	7	ast	ast	PROPN
bionys-572	69	8	)	)	PUNCT
bionys-572	69	9	was	be	AUX
bionys-572	69	10	detected	detect	VERB
bionys-572	69	11	spectrophotometrically	spectrophotometrically	ADV
bionys-572	69	12	on	on	ADP
bionys-572	69	13	multiparametric	multiparametric	ADJ
bionys-572	69	14	photocolorimetric	photocolorimetric	ADJ
bionys-572	69	15	biochemical	biochemical	ADJ
bionys-572	69	16	analyser	analyser	NOUN
bionys-572	69	17	alize	alize	PROPN
bionys-572	69	18	(	(	PUNCT
bionys-572	69	19	lisabio	lisabio	PROPN
bionys-572	69	20	,	,	PUNCT
bionys-572	69	21	france	france	PROPN
bionys-572	69	22	)	)	PUNCT
bionys-572	69	23	by	by	ADP
bionys-572	69	24	the	the	DET
bionys-572	69	25	dinitrophenylhydrazine	dinitrophenylhydrazine	NOUN
bionys-572	69	26	method	method	NOUN
bionys-572	69	27	(	(	PUNCT
bionys-572	69	28	huang	huang	PROPN
bionys-572	69	29	,	,	PUNCT
bionys-572	69	30	x.-j	x.-j	PROPN
bionys-572	69	31	.	.	PROPN
bionys-572	69	32	,	,	PUNCT
bionys-572	69	33	et	et	PROPN
bionys-572	69	34	al	al	PROPN
bionys-572	69	35	.	.	PROPN
bionys-572	69	36	,	,	PUNCT
bionys-572	69	37	2006	2006	NUM
bionys-572	69	38	)	)	PUNCT
bionys-572	69	39	.	.	PUNCT
bionys-572	70	1	substrate	substrate	NOUN
bionys-572	70	2	-	-	PUNCT
bionys-572	70	3	buffer	buffer	NOUN
bionys-572	70	4	solution	solution	NOUN
bionys-572	70	5	(	(	PUNCT
bionys-572	70	6	0.25	0.25	NUM
bionys-572	70	7	ml	ml	NOUN
bionys-572	70	8	)	)	PUNCT
bionys-572	70	9	was	be	AUX
bionys-572	70	10	added	add	VERB
bionys-572	70	11	to	to	ADP
bionys-572	70	12	the	the	DET
bionys-572	70	13	blood	blood	NOUN
bionys-572	70	14	serum	serum	NOUN
bionys-572	70	15	(	(	PUNCT
bionys-572	70	16	0.05	0.05	NUM
bionys-572	70	17	ml	ml	NOUN
bionys-572	70	18	)	)	PUNCT
bionys-572	70	19	and	and	CCONJ
bionys-572	70	20	incubated	incubate	VERB
bionys-572	70	21	for	for	ADP
bionys-572	70	22	60	60	NUM
bionys-572	70	23	minutes	minute	NOUN
bionys-572	70	24	at	at	ADP
bionys-572	70	25	37	37	NUM
bionys-572	70	26	°	°	NOUN
bionys-572	70	27	c	c	NOUN
bionys-572	70	28	.	.	NOUN
bionys-572	71	1	0.25	0.25	NUM
bionys-572	71	2	ml	ml	NOUN
bionys-572	71	3	of	of	ADP
bionys-572	71	4	2,4	2,4	NUM
bionys-572	71	5	dinitrophenylhydrazine	dinitrophenylhydrazine	NOUN
bionys-572	71	6	was	be	AUX
bionys-572	71	7	added	add	VERB
bionys-572	71	8	and	and	CCONJ
bionys-572	71	9	incubated	incubate	VERB
bionys-572	71	10	for	for	ADP
bionys-572	71	11	20	20	NUM
bionys-572	71	12	minutes	minute	NOUN
bionys-572	71	13	at	at	ADP
bionys-572	71	14	room	room	NOUN
bionys-572	71	15	temperature	temperature	NOUN
bionys-572	71	16	.	.	PUNCT
bionys-572	72	1	0.4	0.4	NUM
bionys-572	72	2	m	m	PROPN
bionys-572	72	3	sodium	sodium	NOUN
bionys-572	72	4	hydroxide	hydroxide	NOUN
bionys-572	72	5	solution	solution	NOUN
bionys-572	72	6	(	(	PUNCT
bionys-572	72	7	2.5	2.5	NUM
bionys-572	72	8	ml	ml	NOUN
bionys-572	72	9	)	)	PUNCT
bionys-572	72	10	was	be	AUX
bionys-572	72	11	added	add	VERB
bionys-572	72	12	and	and	CCONJ
bionys-572	72	13	incubated	incubate	VERB
bionys-572	72	14	for	for	ADP
bionys-572	72	15	10	10	NUM
bionys-572	72	16	minutes	minute	NOUN
bionys-572	72	17	at	at	ADP
bionys-572	72	18	room	room	NOUN
bionys-572	72	19	temperature	temperature	NOUN
bionys-572	72	20	.	.	PUNCT
bionys-572	73	1	the	the	DET
bionys-572	73	2	optical	optical	ADJ
bionys-572	73	3	density	density	NOUN
bionys-572	73	4	of	of	ADP
bionys-572	73	5	the	the	DET
bionys-572	73	6	test	test	NOUN
bionys-572	73	7	sample	sample	NOUN
bionys-572	73	8	for	for	ADP
bionys-572	73	9	aspartate	aspartate	NOUN
bionys-572	73	10	aminotransferase	aminotransferase	NOUN
bionys-572	73	11	was	be	AUX
bionys-572	73	12	measured	measure	VERB
bionys-572	73	13	against	against	ADP
bionys-572	73	14	a	a	DET
bionys-572	73	15	control	control	NOUN
bionys-572	73	16	sample	sample	NOUN
bionys-572	73	17	on	on	ADP
bionys-572	73	18	a	a	DET
bionys-572	73	19	photometer	photometer	NOUN
bionys-572	73	20	at	at	ADP
bionys-572	73	21	a	a	DET
bionys-572	73	22	wavelength	wavelength	NOUN
bionys-572	73	23	of	of	ADP
bionys-572	73	24	500	500	NUM
bionys-572	73	25	-	-	SYM
bionys-572	73	26	560	560	NUM
bionys-572	73	27	nm	nm	NOUN
bionys-572	73	28	.	.	PUNCT
bionys-572	74	1	determination	determination	NOUN
bionys-572	74	2	of	of	ADP
bionys-572	74	3	enzyme	enzyme	NOUN
bionys-572	74	4	activity	activity	NOUN
bionys-572	74	5	was	be	AUX
bionys-572	74	6	carried	carry	VERB
bionys-572	74	7	out	out	ADP
bionys-572	74	8	according	accord	VERB
bionys-572	74	9	to	to	ADP
bionys-572	74	10	the	the	DET
bionys-572	74	11	calibration	calibration	NOUN
bionys-572	74	12	schedule	schedule	NOUN
bionys-572	74	13	.	.	PUNCT
bionys-572	75	1	the	the	DET
bionys-572	75	2	difference	difference	NOUN
bionys-572	75	3	in	in	ADP
bionys-572	75	4	optical	optical	ADJ
bionys-572	75	5	densities	density	NOUN
bionys-572	75	6	of	of	ADP
bionys-572	75	7	the	the	DET
bionys-572	75	8	test	test	NOUN
bionys-572	75	9	and	and	CCONJ
bionys-572	75	10	control	control	NOUN
bionys-572	75	11	samples	sample	NOUN
bionys-572	75	12	was	be	AUX
bionys-572	75	13	noted	note	VERB
bionys-572	75	14	on	on	ADP
bionys-572	75	15	the	the	DET
bionys-572	75	16	ordinate	ordinate	NOUN
bionys-572	75	17	axis	axis	ADJ
bionys-572	75	18	,	,	PUNCT
bionys-572	75	19	and	and	CCONJ
bionys-572	75	20	the	the	DET
bionys-572	75	21	corresponding	corresponding	ADJ
bionys-572	75	22	value	value	NOUN
bionys-572	75	23	of	of	ADP
bionys-572	75	24	enzyme	enzyme	NOUN
bionys-572	75	25	activity	activity	NOUN
bionys-572	75	26	was	be	AUX
bionys-572	75	27	found	find	VERB
bionys-572	75	28	on	on	ADP
bionys-572	75	29	the	the	DET
bionys-572	75	30	abscissa	abscissa	ADJ
bionys-572	75	31	axis	axis	NOUN
bionys-572	75	32	.	.	PUNCT
bionys-572	76	1	alanine	alanine	NOUN
bionys-572	76	2	aminotransferase	aminotransferase	PROPN
bionys-572	76	3	activity	activity	NOUN
bionys-572	76	4	1	1	NUM
bionys-572	76	5	ml	ml	NOUN
bionys-572	76	6	of	of	ADP
bionys-572	76	7	working	work	VERB
bionys-572	76	8	solution	solution	NOUN
bionys-572	76	9	(	(	PUNCT
bionys-572	76	10	substrate	substrate	NOUN
bionys-572	76	11	solution	solution	NOUN
bionys-572	76	12	and	and	CCONJ
bionys-572	76	13	coenzyme	coenzyme	NOUN
bionys-572	76	14	-	-	PUNCT
bionys-572	76	15	enzyme	enzyme	NOUN
bionys-572	76	16	reagent	reagent	NOUN
bionys-572	76	17	)	)	PUNCT
bionys-572	76	18	was	be	AUX
bionys-572	76	19	mixed	mix	VERB
bionys-572	76	20	with	with	ADP
bionys-572	76	21	0.1	0.1	NUM
bionys-572	76	22	ml	ml	NOUN
bionys-572	76	23	of	of	ADP
bionys-572	76	24	serum	serum	NOUN
bionys-572	76	25	.	.	PUNCT
bionys-572	77	1	the	the	DET
bionys-572	77	2	optical	optical	ADJ
bionys-572	77	3	density	density	NOUN
bionys-572	77	4	was	be	AUX
bionys-572	77	5	measured	measure	VERB
bionys-572	77	6	at	at	ADP
bionys-572	77	7	a	a	DET
bionys-572	77	8	wavelength	wavelength	NOUN
bionys-572	77	9	of	of	ADP
bionys-572	77	10	340	340	NUM
bionys-572	77	11	nm	nm	NOUN
bionys-572	77	12	after	after	ADP
bionys-572	77	13	1	1	NUM
bionys-572	77	14	(	(	PUNCT
bionys-572	77	15	e1	e1	PROPN
bionys-572	77	16	)	)	PUNCT
bionys-572	77	17	and	and	CCONJ
bionys-572	77	18	3	3	NUM
bionys-572	77	19	(	(	PUNCT
bionys-572	77	20	e2	e2	PROPN
bionys-572	77	21	)	)	PUNCT
bionys-572	77	22	minutes	minute	NOUN
bionys-572	77	23	.	.	PUNCT
bionys-572	78	1	the	the	DET
bionys-572	78	2	difference	difference	NOUN
bionys-572	78	3	in	in	ADP
bionys-572	78	4	extinction	extinction	NOUN
bionys-572	78	5	(	(	PUNCT
bionys-572	78	6	e2	e2	PROPN
bionys-572	78	7	-	-	PUNCT
bionys-572	78	8	e1)/3	e1)/3	NOUN
bionys-572	78	9	was	be	AUX
bionys-572	78	10	calculated	calculate	VERB
bionys-572	78	11	.	.	PUNCT
bionys-572	79	1	urinalysis	urinalysis	NOUN
bionys-572	79	2	the	the	DET
bionys-572	79	3	urinalysis	urinalysis	NOUN
bionys-572	79	4	was	be	AUX
bionys-572	79	5	carried	carry	VERB
bionys-572	79	6	out	out	ADP
bionys-572	79	7	according	accord	VERB
bionys-572	79	8	to	to	ADP
bionys-572	79	9	the	the	DET
bionys-572	79	10	methods	method	NOUN
bionys-572	79	11	listed	list	VERB
bionys-572	79	12	in	in	ADP
bionys-572	79	13	urinalysis	urinalysis	NOUN
bionys-572	79	14	:	:	PUNCT
bionys-572	79	15	approved	approve	VERB
bionys-572	79	16	guideline	guideline	NOUN
bionys-572	79	17	(	(	PUNCT
bionys-572	79	18	rabinovitch	rabinovitch	VERB
bionys-572	79	19	et	et	PROPN
bionys-572	79	20	al	al	PROPN
bionys-572	79	21	.	.	PROPN
bionys-572	79	22	,	,	PUNCT
bionys-572	79	23	2009	2009	NUM
bionys-572	79	24	)	)	PUNCT
bionys-572	79	25	and	and	CCONJ
bionys-572	79	26	included	include	VERB
bionys-572	79	27	estimation	estimation	NOUN
bionys-572	79	28	of	of	ADP
bionys-572	79	29	ph	ph	PROPN
bionys-572	79	30	(	(	PUNCT
bionys-572	79	31	ph	ph	ADJ
bionys-572	79	32	meter	meter	NOUN
bionys-572	79	33	,	,	PUNCT
bionys-572	79	34	omega	omega	PROPN
bionys-572	79	35	engineering	engineering	PROPN
bionys-572	79	36	inc	inc	PROPN
bionys-572	79	37	.	.	PROPN
bionys-572	79	38	)	)	PUNCT
bionys-572	79	39	,	,	PUNCT
bionys-572	79	40	specific	specific	ADJ
bionys-572	79	41	gravity	gravity	NOUN
bionys-572	79	42	(	(	PUNCT
bionys-572	79	43	lab	lab	NOUN
bionys-572	79	44	world	world	NOUN
bionys-572	79	45	urinometer	urinometer	PROPN
bionys-572	79	46	,	,	PUNCT
bionys-572	79	47	uk	uk	PROPN
bionys-572	79	48	)	)	PUNCT
bionys-572	79	49	,	,	PUNCT
bionys-572	79	50	leukocytes	leukocyte	NOUN
bionys-572	79	51	,	,	PUNCT
bionys-572	79	52	presence	presence	NOUN
bionys-572	79	53	of	of	ADP
bionys-572	79	54	bacteria	bacteria	NOUN
bionys-572	79	55	,	,	PUNCT
bionys-572	79	56	erythrocytes	erythrocyte	NOUN
bionys-572	79	57	(	(	PUNCT
bionys-572	79	58	under	under	ADP
bionys-572	79	59	micromed	microme	VERB
bionys-572	79	60	xs	xs	PROPN
bionys-572	79	61	-3330	-3330	PROPN
bionys-572	79	62	microscope	microscope	PROPN
bionys-572	79	63	)	)	PUNCT
bionys-572	79	64	,	,	PUNCT
bionys-572	79	65	and	and	CCONJ
bionys-572	79	66	glucose	glucose	NOUN
bionys-572	79	67	in	in	ADP
bionys-572	79	68	the	the	DET
bionys-572	79	69	urine	urine	NOUN
bionys-572	79	70	sample	sample	NOUN
bionys-572	79	71	.	.	PUNCT
bionys-572	80	1	fig	fig	NOUN
bionys-572	80	2	.	.	PUNCT
bionys-572	81	1	1	1	X
bionys-572	81	2	.	.	X
bionys-572	81	3	microscopic	microscopic	ADJ
bionys-572	81	4	appearance	appearance	NOUN
bionys-572	81	5	of	of	ADP
bionys-572	81	6	oxalates	oxalate	NOUN
bionys-572	81	7	(	(	PUNCT
bionys-572	81	8	1	1	NUM
bionys-572	81	9	)	)	PUNCT
bionys-572	81	10	,	,	PUNCT
bionys-572	81	11	phosphates	phosphate	NOUN
bionys-572	81	12	(	(	PUNCT
bionys-572	81	13	2	2	NUM
bionys-572	81	14	)	)	PUNCT
bionys-572	81	15	,	,	PUNCT
bionys-572	81	16	and	and	CCONJ
bionys-572	81	17	urates	urate	NOUN
bionys-572	81	18	(	(	PUNCT
bionys-572	81	19	3	3	NUM
bionys-572	81	20	)	)	PUNCT
bionys-572	81	21	.	.	PUNCT
bionys-572	82	1	250	250	NUM
bionys-572	82	2	biologica	biologica	PROPN
bionys-572	82	3	nyssana	nyssana	PROPN
bionys-572	82	4	●	●	PUNCT
bionys-572	82	5	16	16	NUM
bionys-572	82	6	(	(	PUNCT
bionys-572	82	7	1	1	NUM
bionys-572	82	8	)	)	PUNCT
bionys-572	82	9	june	june	PROPN
bionys-572	82	10	2025	2025	NUM
bionys-572	82	11	:	:	PUNCT
bionys-572	82	12	247	247	NUM
bionys-572	82	13	-	-	SYM
bionys-572	82	14	257	257	NUM
bionys-572	82	15	kravchun	kravchun	NOUN
bionys-572	82	16	et	et	PROPN
bionys-572	82	17	al	al	PROPN
bionys-572	82	18	.	.	PUNCT
bionys-572	83	1	●	●	PUNCT
bionys-572	83	2	different	different	ADJ
bionys-572	83	3	types	type	NOUN
bionys-572	83	4	of	of	ADP
bionys-572	83	5	crystalluria	crystalluria	PROPN
bionys-572	83	6	in	in	ADP
bionys-572	83	7	patients	patient	NOUN
bionys-572	83	8	with	with	ADP
bionys-572	83	9	bone	bone	NOUN
bionys-572	83	10	and	and	CCONJ
bionys-572	83	11	joint	joint	ADJ
bionys-572	83	12	tissue	tissue	NOUN
bionys-572	83	13	pathology	pathology	NOUN
bionys-572	83	14	:	:	PUNCT
bionys-572	83	15	hematological	hematological	ADJ
bionys-572	83	16	and	and	CCONJ
bionys-572	83	17	biochemical	biochemical	ADJ
bionys-572	83	18	profiles	profile	NOUN
bionys-572	83	19	the	the	DET
bionys-572	83	20	renal	renal	ADJ
bionys-572	83	21	function	function	NOUN
bionys-572	83	22	was	be	AUX
bionys-572	83	23	evaluated	evaluate	VERB
bionys-572	83	24	by	by	ADP
bionys-572	83	25	calculation	calculation	NOUN
bionys-572	83	26	of	of	ADP
bionys-572	83	27	glomerular	glomerular	ADJ
bionys-572	83	28	filtration	filtration	NOUN
bionys-572	83	29	rate	rate	NOUN
bionys-572	83	30	(	(	PUNCT
bionys-572	83	31	gfr	gfr	NOUN
bionys-572	83	32	)	)	PUNCT
bionys-572	83	33	(	(	PUNCT
bionys-572	83	34	ckd	ckd	NOUN
bionys-572	83	35	-	-	PUNCT
bionys-572	83	36	epi	epi	NOUN
bionys-572	83	37	,	,	PUNCT
bionys-572	83	38	2021	2021	NUM
bionys-572	83	39	)	)	PUNCT
bionys-572	83	40	using	use	VERB
bionys-572	83	41	the	the	DET
bionys-572	83	42	following	follow	VERB
bionys-572	83	43	formula	formula	NOUN
bionys-572	83	44	:	:	PUNCT
bionys-572	83	45	egfr	egfr	NOUN
bionys-572	83	46	(	(	PUNCT
bionys-572	83	47	ml	ml	PROPN
bionys-572	83	48	/	/	SYM
bionys-572	83	49	min/1.73	min/1.73	NOUN
bionys-572	83	50	m2	m2	PROPN
bionys-572	83	51	)	)	PUNCT
bionys-572	83	52	=	=	SYM
bionys-572	83	53	142	142	NUM
bionys-572	83	54	x	x	SYM
bionys-572	83	55	min	min	PROPN
bionys-572	83	56	(	(	PUNCT
bionys-572	83	57	creatinine	creatinine	NOUN
bionys-572	83	58	/	/	SYM
bionys-572	83	59	k	k	NOUN
bionys-572	83	60	,	,	PUNCT
bionys-572	83	61	1	1	X
bionys-572	83	62	)	)	PUNCT
bionys-572	83	63	α	α	PRON
bionys-572	83	64	×	×	PROPN
bionys-572	83	65	max	max	PROPN
bionys-572	83	66	(	(	PUNCT
bionys-572	83	67	creatinine	creatinine	NOUN
bionys-572	83	68	/	/	SYM
bionys-572	83	69	k	k	NOUN
bionys-572	83	70	,	,	PUNCT
bionys-572	83	71	1	1	X
bionys-572	83	72	)	)	PUNCT
bionys-572	83	73	1.200	1.200	NUM
bionys-572	83	74	×	×	NOUN
bionys-572	83	75	0.9938age	0.9938age	NOUN
bionys-572	83	76	×	×	NOUN
bionys-572	83	77	1.012	1.012	NUM
bionys-572	83	78	(	(	PUNCT
bionys-572	83	79	if	if	SCONJ
bionys-572	83	80	female	female	NOUN
bionys-572	83	81	)	)	PUNCT
bionys-572	83	82	where	where	SCONJ
bionys-572	83	83	k	k	PROPN
bionys-572	83	84	is	be	AUX
bionys-572	83	85	0.7	0.7	NUM
bionys-572	83	86	for	for	ADP
bionys-572	83	87	women	woman	NOUN
bionys-572	83	88	and	and	CCONJ
bionys-572	83	89	0.9	0.9	NUM
bionys-572	83	90	for	for	ADP
bionys-572	83	91	men	man	NOUN
bionys-572	83	92	;	;	PUNCT
bionys-572	83	93	α	α	PROPN
bionys-572	83	94	is	be	AUX
bionys-572	83	95	0.241	0.241	NUM
bionys-572	83	96	for	for	ADP
bionys-572	83	97	women	woman	NOUN
bionys-572	83	98	and	and	CCONJ
bionys-572	83	99	0.302	0.302	NUM
bionys-572	83	100	for	for	ADP
bionys-572	83	101	men	man	NOUN
bionys-572	83	102	(	(	PUNCT
bionys-572	83	103	kirsztajn	kirsztajn	PROPN
bionys-572	83	104	et	et	PROPN
bionys-572	83	105	al	al	PROPN
bionys-572	83	106	.	.	PROPN
bionys-572	83	107	,	,	PUNCT
bionys-572	83	108	2024	2024	NUM
bionys-572	83	109	)	)	PUNCT
bionys-572	83	110	.	.	PUNCT
bionys-572	84	1	ethical	ethical	ADJ
bionys-572	84	2	consent	consent	NOUN
bionys-572	84	3	the	the	DET
bionys-572	84	4	study	study	NOUN
bionys-572	84	5	was	be	AUX
bionys-572	84	6	approved	approve	VERB
bionys-572	84	7	by	by	ADP
bionys-572	84	8	the	the	DET
bionys-572	84	9	ethical	ethical	PROPN
bionys-572	84	10	committee	committee	NOUN
bionys-572	84	11	of	of	ADP
bionys-572	84	12	kharkiv	kharkiv	PROPN
bionys-572	84	13	national	national	PROPN
bionys-572	84	14	medical	medical	PROPN
bionys-572	84	15	university	university	PROPN
bionys-572	84	16	(	(	PUNCT
bionys-572	84	17	protocol	protocol	NOUN
bionys-572	84	18	n	n	PROPN
bionys-572	84	19	21	21	NUM
bionys-572	84	20	,	,	PUNCT
bionys-572	84	21	24.07.23	24.07.23	NUM
bionys-572	84	22	)	)	PUNCT
bionys-572	84	23	.	.	PUNCT
bionys-572	85	1	informed	informed	ADJ
bionys-572	85	2	consent	consent	NOUN
bionys-572	85	3	was	be	AUX
bionys-572	85	4	obtained	obtain	VERB
bionys-572	85	5	from	from	ADP
bionys-572	85	6	all	all	DET
bionys-572	85	7	the	the	DET
bionys-572	85	8	participants	participant	NOUN
bionys-572	85	9	.	.	PUNCT
bionys-572	86	1	the	the	DET
bionys-572	86	2	study	study	NOUN
bionys-572	86	3	adhered	adhere	VERB
bionys-572	86	4	to	to	ADP
bionys-572	86	5	the	the	DET
bionys-572	86	6	ethical	ethical	ADJ
bionys-572	86	7	guidelines	guideline	NOUN
bionys-572	86	8	of	of	ADP
bionys-572	86	9	the	the	DET
bionys-572	86	10	declaration	declaration	NOUN
bionys-572	86	11	of	of	ADP
bionys-572	86	12	helsinki	helsinki	PROPN
bionys-572	86	13	.	.	PUNCT
bionys-572	87	1	statistical	statistical	ADJ
bionys-572	87	2	evaluation	evaluation	NOUN
bionys-572	87	3	statistical	statistical	ADJ
bionys-572	87	4	analysis	analysis	NOUN
bionys-572	87	5	was	be	AUX
bionys-572	87	6	performed	perform	VERB
bionys-572	87	7	using	use	VERB
bionys-572	87	8	the	the	DET
bionys-572	87	9	software	software	NOUN
bionys-572	87	10	statistica	statistica	NOUN
bionys-572	87	11	10.0	10.0	NUM
bionys-572	87	12	(	(	PUNCT
bionys-572	87	13	stat	stat	PROPN
bionys-572	87	14	soft	soft	PROPN
bionys-572	87	15	inc	inc	PROPN
bionys-572	87	16	.	.	PROPN
bionys-572	87	17	,	,	PUNCT
bionys-572	87	18	usa	usa	PROPN
bionys-572	87	19	)	)	PUNCT
bionys-572	87	20	.	.	PUNCT
bionys-572	88	1	all	all	DET
bionys-572	88	2	measurements	measurement	NOUN
bionys-572	88	3	were	be	AUX
bionys-572	88	4	performed	perform	VERB
bionys-572	88	5	in	in	ADP
bionys-572	88	6	triplicate	triplicate	NOUN
bionys-572	88	7	and	and	CCONJ
bionys-572	88	8	the	the	DET
bionys-572	88	9	data	datum	NOUN
bionys-572	88	10	are	be	AUX
bionys-572	88	11	presented	present	VERB
bionys-572	88	12	as	as	ADP
bionys-572	88	13	average	average	ADJ
bionys-572	88	14	±	±	NUM
bionys-572	88	15	standard	standard	ADJ
bionys-572	88	16	deviation	deviation	NOUN
bionys-572	88	17	(	(	PUNCT
bionys-572	88	18	sd	sd	NOUN
bionys-572	88	19	)	)	PUNCT
bionys-572	88	20	(	(	PUNCT
bionys-572	88	21	for	for	ADP
bionys-572	88	22	normally	normally	ADV
bionys-572	88	23	distributed	distribute	VERB
bionys-572	88	24	data	datum	NOUN
bionys-572	88	25	)	)	PUNCT
bionys-572	88	26	.	.	PUNCT
bionys-572	89	1	the	the	DET
bionys-572	89	2	significance	significance	NOUN
bionys-572	89	3	of	of	ADP
bionys-572	89	4	the	the	DET
bionys-572	89	5	differences	difference	NOUN
bionys-572	89	6	was	be	AUX
bionys-572	89	7	determined	determine	VERB
bionys-572	89	8	using	use	VERB
bionys-572	89	9	student	student	NOUN
bionys-572	89	10	’s	’s	PART
bionys-572	89	11	t	t	PROPN
bionys-572	89	12	-	-	PUNCT
bionys-572	89	13	test	test	NOUN
bionys-572	89	14	for	for	ADP
bionys-572	89	15	parametric	parametric	ADJ
bionys-572	89	16	data	datum	NOUN
bionys-572	89	17	.	.	PUNCT
bionys-572	90	1	p	p	NOUN
bionys-572	90	2	values	value	NOUN
bionys-572	90	3	less	less	ADJ
bionys-572	90	4	than	than	ADP
bionys-572	90	5	5	5	NUM
bionys-572	90	6	%	%	NOUN
bionys-572	90	7	were	be	AUX
bionys-572	90	8	accepted	accept	VERB
bionys-572	90	9	as	as	ADP
bionys-572	90	10	positive	positive	ADJ
bionys-572	90	11	in	in	ADP
bionys-572	90	12	the	the	DET
bionys-572	90	13	tests	test	NOUN
bionys-572	90	14	.	.	PUNCT
bionys-572	91	1	correlation	correlation	NOUN
bionys-572	91	2	analysis	analysis	NOUN
bionys-572	91	3	was	be	AUX
bionys-572	91	4	performed	perform	VERB
bionys-572	91	5	using	use	VERB
bionys-572	91	6	spearman	spearman	NOUN
bionys-572	91	7	's	's	PART
bionys-572	91	8	correlation	correlation	NOUN
bionys-572	91	9	test	test	NOUN
bionys-572	91	10	.	.	PUNCT
bionys-572	92	1	results	result	NOUN
bionys-572	92	2	and	and	CCONJ
bionys-572	92	3	discussion	discussion	NOUN
bionys-572	92	4	crystalluria	crystalluria	PROPN
bionys-572	92	5	was	be	AUX
bionys-572	92	6	detected	detect	VERB
bionys-572	92	7	in	in	ADP
bionys-572	92	8	9	9	NUM
bionys-572	92	9	%	%	NOUN
bionys-572	92	10	(	(	PUNCT
bionys-572	92	11	n=66	n=66	NOUN
bionys-572	92	12	)	)	PUNCT
bionys-572	92	13	of	of	ADP
bionys-572	92	14	patients	patient	NOUN
bionys-572	92	15	with	with	ADP
bionys-572	92	16	bone	bone	NOUN
bionys-572	92	17	and	and	CCONJ
bionys-572	92	18	joint	joint	ADJ
bionys-572	92	19	tissue	tissue	NOUN
bionys-572	92	20	pathology	pathology	NOUN
bionys-572	92	21	(	(	PUNCT
bionys-572	92	22	n=728	n=728	PROPN
bionys-572	92	23	)	)	PUNCT
bionys-572	92	24	.	.	PUNCT
bionys-572	93	1	in	in	ADP
bionys-572	93	2	accordance	accordance	NOUN
bionys-572	93	3	with	with	ADP
bionys-572	93	4	the	the	DET
bionys-572	93	5	study	study	NOUN
bionys-572	93	6	objective	objective	NOUN
bionys-572	93	7	,	,	PUNCT
bionys-572	93	8	the	the	DET
bionys-572	93	9	study	study	NOUN
bionys-572	93	10	group	group	NOUN
bionys-572	93	11	(	(	PUNCT
bionys-572	93	12	n=66	n=66	NOUN
bionys-572	93	13	)	)	PUNCT
bionys-572	93	14	comprised	comprise	VERB
bionys-572	93	15	patients	patient	NOUN
bionys-572	93	16	with	with	ADP
bionys-572	93	17	bone	bone	NOUN
bionys-572	93	18	and	and	CCONJ
bionys-572	93	19	joint	joint	ADJ
bionys-572	93	20	tissue	tissue	NOUN
bionys-572	93	21	pathology	pathology	NOUN
bionys-572	93	22	who	who	PRON
bionys-572	93	23	exhibited	exhibit	VERB
bionys-572	93	24	crystalluria	crystalluria	PROPN
bionys-572	93	25	.	.	PUNCT
bionys-572	94	1	this	this	DET
bionys-572	94	2	group	group	NOUN
bionys-572	94	3	was	be	AUX
bionys-572	94	4	further	far	ADV
bionys-572	94	5	subdivided	subdivide	VERB
bionys-572	94	6	into	into	ADP
bionys-572	94	7	three	three	NUM
bionys-572	94	8	subgroups	subgroup	NOUN
bionys-572	94	9	:	:	PUNCT
bionys-572	94	10	patients	patient	NOUN
bionys-572	94	11	with	with	ADP
bionys-572	94	12	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	94	13	(	(	PUNCT
bionys-572	94	14	group	group	NOUN
bionys-572	94	15	i	i	PROPN
bionys-572	94	16	,	,	PUNCT
bionys-572	94	17	n=39	n=39	PROPN
bionys-572	94	18	)	)	PUNCT
bionys-572	94	19	,	,	PUNCT
bionys-572	94	20	uraturia	uraturia	PROPN
bionys-572	94	21	(	(	PUNCT
bionys-572	94	22	group	group	PROPN
bionys-572	94	23	ii	ii	PROPN
bionys-572	94	24	,	,	PUNCT
bionys-572	94	25	n=17	n=17	PROPN
bionys-572	94	26	)	)	PUNCT
bionys-572	94	27	,	,	PUNCT
bionys-572	94	28	and	and	CCONJ
bionys-572	94	29	phosphaturia	phosphaturia	PROPN
bionys-572	94	30	(	(	PUNCT
bionys-572	94	31	group	group	NOUN
bionys-572	94	32	iii	iii	PROPN
bionys-572	94	33	,	,	PUNCT
bionys-572	94	34	n=10	n=10	NOUN
bionys-572	94	35	)	)	PUNCT
bionys-572	94	36	.	.	PUNCT
bionys-572	95	1	patients	patient	NOUN
bionys-572	95	2	with	with	ADP
bionys-572	95	3	bone	bone	NOUN
bionys-572	95	4	and	and	CCONJ
bionys-572	95	5	joint	joint	ADJ
bionys-572	95	6	tissue	tissue	NOUN
bionys-572	95	7	pathology	pathology	NOUN
bionys-572	95	8	but	but	CCONJ
bionys-572	95	9	without	without	ADP
bionys-572	95	10	crystalluria	crystalluria	PROPN
bionys-572	95	11	(	(	PUNCT
bionys-572	95	12	n=61	n=61	NOUN
bionys-572	95	13	)	)	PUNCT
bionys-572	95	14	were	be	AUX
bionys-572	95	15	included	include	VERB
bionys-572	95	16	as	as	ADP
bionys-572	95	17	the	the	DET
bionys-572	95	18	control	control	NOUN
bionys-572	95	19	group	group	NOUN
bionys-572	95	20	.	.	PUNCT
bionys-572	96	1	according	accord	VERB
bionys-572	96	2	to	to	ADP
bionys-572	96	3	the	the	DET
bionys-572	96	4	international	international	ADJ
bionys-572	96	5	kdigo	kdigo	PROPN
bionys-572	96	6	guidelines	guideline	NOUN
bionys-572	96	7	,	,	PUNCT
bionys-572	96	8	group	group	PROPN
bionys-572	96	9	ii	ii	PROPN
bionys-572	96	10	exhibited	exhibit	VERB
bionys-572	96	11	a	a	DET
bionys-572	96	12	lower	low	ADJ
bionys-572	96	13	glomerular	glomerular	ADJ
bionys-572	96	14	filtration	filtration	NOUN
bionys-572	96	15	rate	rate	NOUN
bionys-572	96	16	(	(	PUNCT
bionys-572	96	17	gfr	gfr	NOUN
bionys-572	96	18	)	)	PUNCT
bionys-572	96	19	(	(	PUNCT
bionys-572	96	20	44.52±1.31	44.52±1.31	PROPN
bionys-572	96	21	ml	ml	NOUN
bionys-572	96	22	/	/	SYM
bionys-572	96	23	min/1.73	min/1.73	NOUN
bionys-572	96	24	m²	m²	NOUN
bionys-572	96	25	)	)	PUNCT
bionys-572	96	26	compared	compare	VERB
bionys-572	96	27	to	to	ADP
bionys-572	96	28	the	the	DET
bionys-572	96	29	control	control	NOUN
bionys-572	96	30	group	group	NOUN
bionys-572	96	31	(	(	PUNCT
bionys-572	96	32	86.34±2.30	86.34±2.30	PROPN
bionys-572	96	33	ml	ml	ADP
bionys-572	96	34	/	/	SYM
bionys-572	96	35	min/1.73	min/1.73	NOUN
bionys-572	96	36	m²	m²	PROPN
bionys-572	96	37	)	)	PUNCT
bionys-572	96	38	,	,	PUNCT
bionys-572	96	39	group	group	NOUN
bionys-572	96	40	i	i	PRON
bionys-572	96	41	(	(	PUNCT
bionys-572	96	42	83.22±1.91	83.22±1.91	PROPN
bionys-572	96	43	ml	ml	NOUN
bionys-572	96	44	/	/	SYM
bionys-572	96	45	min/1.73	min/1.73	NOUN
bionys-572	96	46	m²	m²	NOUN
bionys-572	96	47	)	)	PUNCT
bionys-572	96	48	,	,	PUNCT
bionys-572	96	49	and	and	CCONJ
bionys-572	96	50	group	group	NOUN
bionys-572	96	51	iii	iii	PROPN
bionys-572	96	52	(	(	PUNCT
bionys-572	96	53	85.10±2.01	85.10±2.01	NUM
bionys-572	96	54	ml	ml	NOUN
bionys-572	96	55	/	/	SYM
bionys-572	96	56	min/1.73	min/1.73	NOUN
bionys-572	96	57	m²	m²	NOUN
bionys-572	96	58	)	)	PUNCT
bionys-572	96	59	.	.	PUNCT
bionys-572	97	1	patients	patient	NOUN
bionys-572	97	2	with	with	ADP
bionys-572	97	3	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	97	4	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	97	5	was	be	AUX
bionys-572	97	6	the	the	DET
bionys-572	97	7	most	most	ADV
bionys-572	97	8	frequently	frequently	ADV
bionys-572	97	9	observed	observe	VERB
bionys-572	97	10	type	type	NOUN
bionys-572	97	11	of	of	ADP
bionys-572	97	12	crystalluria	crystalluria	NOUN
bionys-572	97	13	among	among	ADP
bionys-572	97	14	individuals	individual	NOUN
bionys-572	97	15	with	with	ADP
bionys-572	97	16	bone	bone	NOUN
bionys-572	97	17	and	and	CCONJ
bionys-572	97	18	joint	joint	ADJ
bionys-572	97	19	tissue	tissue	NOUN
bionys-572	97	20	pathology	pathology	NOUN
bionys-572	97	21	,	,	PUNCT
bionys-572	97	22	identified	identify	VERB
bionys-572	97	23	in	in	ADP
bionys-572	97	24	39	39	NUM
bionys-572	97	25	patients	patient	NOUN
bionys-572	97	26	(	(	PUNCT
bionys-572	97	27	59	59	NUM
bionys-572	97	28	%	%	NOUN
bionys-572	97	29	)	)	PUNCT
bionys-572	97	30	.	.	PUNCT
bionys-572	98	1	individuals	individual	NOUN
bionys-572	98	2	with	with	ADP
bionys-572	98	3	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	98	4	showed	show	VERB
bionys-572	98	5	a	a	DET
bionys-572	98	6	high	high	ADJ
bionys-572	98	7	incidence	incidence	NOUN
bionys-572	98	8	of	of	ADP
bionys-572	98	9	ligament	ligament	NOUN
bionys-572	98	10	ruptures	rupture	NOUN
bionys-572	98	11	and	and	CCONJ
bionys-572	98	12	bone	bone	NOUN
bionys-572	98	13	fractures	fracture	NOUN
bionys-572	98	14	(	(	PUNCT
bionys-572	98	15	21.6	21.6	NUM
bionys-572	98	16	%	%	NOUN
bionys-572	98	17	)	)	PUNCT
bionys-572	98	18	,	,	PUNCT
bionys-572	98	19	a	a	DET
bionys-572	98	20	finding	finding	NOUN
bionys-572	98	21	that	that	PRON
bionys-572	98	22	has	have	AUX
bionys-572	98	23	also	also	ADV
bionys-572	98	24	been	be	AUX
bionys-572	98	25	reported	report	VERB
bionys-572	98	26	by	by	ADP
bionys-572	98	27	other	other	ADJ
bionys-572	98	28	researchers	researcher	NOUN
bionys-572	98	29	(	(	PUNCT
bionys-572	98	30	büscher	büscher	PROPN
bionys-572	98	31	et	et	PROPN
bionys-572	98	32	al	al	PROPN
bionys-572	98	33	.	.	PROPN
bionys-572	98	34	,	,	PUNCT
bionys-572	98	35	2024	2024	NUM
bionys-572	98	36	)	)	PUNCT
bionys-572	98	37	.	.	PUNCT
bionys-572	99	1	however	however	ADV
bionys-572	99	2	,	,	PUNCT
bionys-572	99	3	there	there	PRON
bionys-572	99	4	is	be	VERB
bionys-572	99	5	no	no	DET
bionys-572	99	6	clear	clear	ADJ
bionys-572	99	7	evidence	evidence	NOUN
bionys-572	99	8	in	in	ADP
bionys-572	99	9	the	the	DET
bionys-572	99	10	literature	literature	NOUN
bionys-572	99	11	linking	link	VERB
bionys-572	99	12	the	the	DET
bionys-572	99	13	severity	severity	NOUN
bionys-572	99	14	of	of	ADP
bionys-572	99	15	bone	bone	NOUN
bionys-572	99	16	disease	disease	NOUN
bionys-572	99	17	directly	directly	ADV
bionys-572	99	18	to	to	ADP
bionys-572	99	19	oxalate	oxalate	NOUN
bionys-572	99	20	levels	level	NOUN
bionys-572	99	21	(	(	PUNCT
bionys-572	99	22	ben	ben	PROPN
bionys-572	99	23	-	-	PROPN
bionys-572	99	24	shalom	shalom	PROPN
bionys-572	99	25	et	et	PROPN
bionys-572	99	26	al	al	PROPN
bionys-572	99	27	.	.	PROPN
bionys-572	99	28	,	,	PUNCT
bionys-572	99	29	2021	2021	NUM
bionys-572	99	30	)	)	PUNCT
bionys-572	99	31	.	.	PUNCT
bionys-572	100	1	hage	hage	PROPN
bionys-572	100	2	et	et	PROPN
bionys-572	100	3	al	al	PROPN
bionys-572	100	4	.	.	PROPN
bionys-572	100	5	(	(	PUNCT
bionys-572	100	6	2008	2008	NUM
bionys-572	100	7	)	)	PUNCT
bionys-572	100	8	reported	report	VERB
bionys-572	100	9	that	that	SCONJ
bionys-572	100	10	dense	dense	ADJ
bionys-572	100	11	and	and	CCONJ
bionys-572	100	12	radiolucent	radiolucent	ADJ
bionys-572	100	13	metaphyseal	metaphyseal	NOUN
bionys-572	100	14	bands	band	NOUN
bionys-572	100	15	,	,	PUNCT
bionys-572	100	16	vertebral	vertebral	ADJ
bionys-572	100	17	osteocondensations	osteocondensation	NOUN
bionys-572	100	18	,	,	PUNCT
bionys-572	100	19	and	and	CCONJ
bionys-572	100	20	renal	renal	ADJ
bionys-572	100	21	osteodystrophy	osteodystrophy	NOUN
bionys-572	100	22	are	be	AUX
bionys-572	100	23	characteristic	characteristic	ADJ
bionys-572	100	24	signs	sign	NOUN
bionys-572	100	25	of	of	ADP
bionys-572	100	26	oxalosis	oxalosis	NOUN
bionys-572	100	27	.	.	PUNCT
bionys-572	101	1	although	although	SCONJ
bionys-572	101	2	considerable	considerable	ADJ
bionys-572	101	3	progress	progress	NOUN
bionys-572	101	4	has	have	AUX
bionys-572	101	5	been	be	AUX
bionys-572	101	6	made	make	VERB
bionys-572	101	7	in	in	ADP
bionys-572	101	8	understanding	understand	VERB
bionys-572	101	9	the	the	DET
bionys-572	101	10	pathophysiological	pathophysiological	ADJ
bionys-572	101	11	mechanisms	mechanism	NOUN
bionys-572	101	12	underlying	underlie	VERB
bionys-572	101	13	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	101	14	,	,	PUNCT
bionys-572	101	15	the	the	DET
bionys-572	101	16	diagnosis	diagnosis	NOUN
bionys-572	101	17	of	of	ADP
bionys-572	101	18	oxalaterelated	oxalaterelate	VERB
bionys-572	101	19	bone	bone	NOUN
bionys-572	101	20	disease	disease	NOUN
bionys-572	101	21	is	be	AUX
bionys-572	101	22	often	often	ADV
bionys-572	101	23	delayed	delay	VERB
bionys-572	101	24	,	,	PUNCT
bionys-572	101	25	and	and	CCONJ
bionys-572	101	26	the	the	DET
bionys-572	101	27	prognosis	prognosis	NOUN
bionys-572	101	28	remains	remain	VERB
bionys-572	101	29	poor	poor	ADJ
bionys-572	101	30	(	(	PUNCT
bionys-572	101	31	demoulin	demoulin	PROPN
bionys-572	101	32	et	et	PROPN
bionys-572	101	33	al	al	PROPN
bionys-572	101	34	.	.	PROPN
bionys-572	101	35	,	,	PUNCT
bionys-572	101	36	2022	2022	NUM
bionys-572	101	37	)	)	PUNCT
bionys-572	101	38	.	.	PUNCT
bionys-572	102	1	patients	patient	NOUN
bionys-572	102	2	with	with	ADP
bionys-572	102	3	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	102	4	demonstrated	demonstrate	VERB
bionys-572	102	5	significantly	significantly	ADV
bionys-572	102	6	elevated	elevated	ADJ
bionys-572	102	7	levels	level	NOUN
bionys-572	102	8	of	of	ADP
bionys-572	102	9	leukocytes	leukocyte	NOUN
bionys-572	102	10	(	(	PUNCT
bionys-572	102	11	by	by	ADP
bionys-572	102	12	34.2	34.2	NUM
bionys-572	102	13	%	%	NOUN
bionys-572	102	14	)	)	PUNCT
bionys-572	102	15	,	,	PUNCT
bionys-572	102	16	eosinophils	eosinophil	NOUN
bionys-572	102	17	(	(	PUNCT
bionys-572	102	18	by	by	ADP
bionys-572	102	19	75	75	NUM
bionys-572	102	20	%	%	NOUN
bionys-572	102	21	)	)	PUNCT
bionys-572	102	22	,	,	PUNCT
bionys-572	102	23	erythrocyte	erythrocyte	NOUN
bionys-572	102	24	sedimentation	sedimentation	NOUN
bionys-572	102	25	rate	rate	NOUN
bionys-572	102	26	(	(	PUNCT
bionys-572	102	27	esr	esr	PROPN
bionys-572	102	28	)	)	PUNCT
bionys-572	102	29	(	(	PUNCT
bionys-572	102	30	by	by	ADP
bionys-572	102	31	90	90	NUM
bionys-572	102	32	%	%	NOUN
bionys-572	102	33	)	)	PUNCT
bionys-572	102	34	,	,	PUNCT
bionys-572	102	35	and	and	CCONJ
bionys-572	102	36	platelets	platelet	NOUN
bionys-572	102	37	(	(	PUNCT
bionys-572	102	38	by	by	ADP
bionys-572	102	39	21.8	21.8	NUM
bionys-572	102	40	%	%	NOUN
bionys-572	102	41	)	)	PUNCT
bionys-572	102	42	in	in	ADP
bionys-572	102	43	the	the	DET
bionys-572	102	44	complete	complete	ADJ
bionys-572	102	45	blood	blood	NOUN
bionys-572	102	46	count	count	NOUN
bionys-572	102	47	compared	compare	VERB
bionys-572	102	48	to	to	ADP
bionys-572	102	49	the	the	DET
bionys-572	102	50	control	control	NOUN
bionys-572	102	51	group	group	NOUN
bionys-572	102	52	(	(	PUNCT
bionys-572	102	53	p<0.05	p<0.05	PROPN
bionys-572	102	54	)	)	PUNCT
bionys-572	102	55	(	(	PUNCT
bionys-572	102	56	tab	tab	NOUN
bionys-572	102	57	.	.	NOUN
bionys-572	102	58	1	1	NUM
bionys-572	102	59	)	)	PUNCT
bionys-572	102	60	.	.	PUNCT
bionys-572	103	1	the	the	DET
bionys-572	103	2	increased	increase	VERB
bionys-572	103	3	levels	level	NOUN
bionys-572	103	4	of	of	ADP
bionys-572	103	5	leukocytes	leukocyte	NOUN
bionys-572	103	6	and	and	CCONJ
bionys-572	103	7	esr	esr	PROPN
bionys-572	103	8	suggest	suggest	VERB
bionys-572	103	9	that	that	SCONJ
bionys-572	103	10	disturbances	disturbance	NOUN
bionys-572	103	11	in	in	ADP
bionys-572	103	12	oxalate	oxalate	ADJ
bionys-572	103	13	metabolism	metabolism	NOUN
bionys-572	103	14	are	be	AUX
bionys-572	103	15	accompanied	accompany	VERB
bionys-572	103	16	by	by	ADP
bionys-572	103	17	inflammatory	inflammatory	ADJ
bionys-572	103	18	processes	process	NOUN
bionys-572	103	19	,	,	PUNCT
bionys-572	103	20	possibly	possibly	ADV
bionys-572	103	21	due	due	ADP
bionys-572	103	22	to	to	ADP
bionys-572	103	23	bacterial	bacterial	ADJ
bionys-572	103	24	involvement	involvement	NOUN
bionys-572	103	25	.	.	PUNCT
bionys-572	104	1	the	the	DET
bionys-572	104	2	presence	presence	NOUN
bionys-572	104	3	of	of	ADP
bionys-572	104	4	pathogenic	pathogenic	ADJ
bionys-572	104	5	bacteria	bacteria	NOUN
bionys-572	104	6	in	in	ADP
bionys-572	104	7	calcium	calcium	NOUN
bionys-572	104	8	oxalate	oxalate	NOUN
bionys-572	104	9	stones	stone	NOUN
bionys-572	104	10	has	have	AUX
bionys-572	104	11	been	be	AUX
bionys-572	104	12	previously	previously	ADV
bionys-572	104	13	reported	report	VERB
bionys-572	104	14	,	,	PUNCT
bionys-572	104	15	and	and	CCONJ
bionys-572	104	16	such	such	ADJ
bionys-572	104	17	bacteria	bacteria	NOUN
bionys-572	104	18	are	be	AUX
bionys-572	104	19	known	know	VERB
bionys-572	104	20	to	to	PART
bionys-572	104	21	accelerate	accelerate	VERB
bionys-572	104	22	crystal	crystal	NOUN
bionys-572	104	23	growth	growth	NOUN
bionys-572	104	24	(	(	PUNCT
bionys-572	104	25	cooper	cooper	NOUN
bionys-572	104	26	et	et	PROPN
bionys-572	104	27	al	al	PROPN
bionys-572	104	28	.	.	PROPN
bionys-572	104	29	,	,	PUNCT
bionys-572	104	30	2008	2008	NUM
bionys-572	104	31	)	)	PUNCT
bionys-572	104	32	.	.	PUNCT
bionys-572	105	1	conversely	conversely	ADV
bionys-572	105	2	,	,	PUNCT
bionys-572	105	3	the	the	DET
bionys-572	105	4	beneficial	beneficial	ADJ
bionys-572	105	5	bacterium	bacterium	NOUN
bionys-572	105	6	oxalobacter	oxalobacter	ADJ
bionys-572	105	7	formigenes	formigene	NOUN
bionys-572	105	8	has	have	AUX
bionys-572	105	9	been	be	AUX
bionys-572	105	10	shown	show	VERB
bionys-572	105	11	to	to	PART
bionys-572	105	12	interact	interact	VERB
bionys-572	105	13	with	with	ADP
bionys-572	105	14	the	the	DET
bionys-572	105	15	intestinal	intestinal	ADJ
bionys-572	105	16	mucosa	mucosa	NOUN
bionys-572	105	17	and	and	CCONJ
bionys-572	105	18	enhance	enhance	VERB
bionys-572	105	19	oxalate	oxalate	NOUN
bionys-572	105	20	secretion	secretion	NOUN
bionys-572	105	21	(	(	PUNCT
bionys-572	105	22	nazzal	nazzal	PROPN
bionys-572	105	23	et	et	PROPN
bionys-572	105	24	al	al	PROPN
bionys-572	105	25	.	.	PROPN
bionys-572	105	26	,	,	PUNCT
bionys-572	105	27	2021	2021	NUM
bionys-572	105	28	)	)	PUNCT
bionys-572	105	29	.	.	PUNCT
bionys-572	106	1	the	the	DET
bionys-572	106	2	erythrocyte	erythrocyte	PROPN
bionys-572	106	3	sedimentation	sedimentation	NOUN
bionys-572	106	4	rate	rate	NOUN
bionys-572	106	5	(	(	PUNCT
bionys-572	106	6	esr	esr	PROPN
bionys-572	106	7	)	)	PUNCT
bionys-572	106	8	is	be	AUX
bionys-572	106	9	a	a	DET
bionys-572	106	10	known	know	VERB
bionys-572	106	11	marker	marker	NOUN
bionys-572	106	12	of	of	ADP
bionys-572	106	13	inflammation	inflammation	NOUN
bionys-572	106	14	severity	severity	NOUN
bionys-572	106	15	,	,	PUNCT
bionys-572	106	16	and	and	CCONJ
bionys-572	106	17	some	some	DET
bionys-572	106	18	researchers	researcher	NOUN
bionys-572	106	19	have	have	AUX
bionys-572	106	20	reported	report	VERB
bionys-572	106	21	an	an	DET
bionys-572	106	22	association	association	NOUN
bionys-572	106	23	between	between	ADP
bionys-572	106	24	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	106	25	and	and	CCONJ
bionys-572	106	26	inflammatory	inflammatory	ADJ
bionys-572	106	27	responses	response	NOUN
bionys-572	106	28	(	(	PUNCT
bionys-572	106	29	guo	guo	PROPN
bionys-572	106	30	et	et	PROPN
bionys-572	106	31	al	al	PROPN
bionys-572	106	32	.	.	PROPN
bionys-572	106	33	,	,	PUNCT
bionys-572	106	34	2020	2020	NUM
bionys-572	106	35	)	)	PUNCT
bionys-572	106	36	.	.	PUNCT
bionys-572	107	1	in	in	ADP
bionys-572	107	2	europe	europe	PROPN
bionys-572	107	3	,	,	PUNCT
bionys-572	107	4	a	a	DET
bionys-572	107	5	group	group	NOUN
bionys-572	107	6	of	of	ADP
bionys-572	107	7	scientists	scientist	NOUN
bionys-572	107	8	formed	form	VERB
bionys-572	107	9	the	the	DET
bionys-572	107	10	european	european	PROPN
bionys-572	107	11	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	107	12	consortium	consortium	PROPN
bionys-572	107	13	to	to	PART
bionys-572	107	14	advance	advance	VERB
bionys-572	107	15	research	research	NOUN
bionys-572	107	16	and	and	CCONJ
bionys-572	107	17	collaboration	collaboration	NOUN
bionys-572	107	18	in	in	ADP
bionys-572	107	19	this	this	DET
bionys-572	107	20	field	field	NOUN
bionys-572	107	21	(	(	PUNCT
bionys-572	107	22	bernd	bernd	PROPN
bionys-572	107	23	et	et	PROPN
bionys-572	107	24	al	al	PROPN
bionys-572	107	25	.	.	PROPN
bionys-572	107	26	,	,	PUNCT
bionys-572	107	27	2009	2009	NUM
bionys-572	107	28	)	)	PUNCT
bionys-572	107	29	.	.	PUNCT
bionys-572	108	1	the	the	DET
bionys-572	108	2	increased	increase	VERB
bionys-572	108	3	platelet	platelet	NOUN
bionys-572	108	4	count	count	NOUN
bionys-572	108	5	observed	observe	VERB
bionys-572	108	6	in	in	ADP
bionys-572	108	7	patients	patient	NOUN
bionys-572	108	8	with	with	ADP
bionys-572	108	9	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	108	10	may	may	AUX
bionys-572	108	11	be	be	AUX
bionys-572	108	12	explained	explain	VERB
bionys-572	108	13	by	by	ADP
bionys-572	108	14	a	a	DET
bionys-572	108	15	compensatory	compensatory	ADJ
bionys-572	108	16	response	response	NOUN
bionys-572	108	17	of	of	ADP
bionys-572	108	18	the	the	DET
bionys-572	108	19	bone	bone	NOUN
bionys-572	108	20	marrow	marrow	NOUN
bionys-572	108	21	,	,	PUNCT
bionys-572	108	22	as	as	SCONJ
bionys-572	108	23	oxalic	oxalic	NOUN
bionys-572	108	24	acid	acid	NOUN
bionys-572	108	25	has	have	AUX
bionys-572	108	26	been	be	AUX
bionys-572	108	27	reported	report	VERB
bionys-572	108	28	to	to	PART
bionys-572	108	29	exhibit	exhibit	VERB
bionys-572	108	30	anticoagulant	anticoagulant	ADJ
bionys-572	108	31	properties	property	NOUN
bionys-572	108	32	(	(	PUNCT
bionys-572	108	33	national	national	ADJ
bionys-572	108	34	center	center	NOUN
bionys-572	108	35	for	for	ADP
bionys-572	108	36	biotechnology	biotechnology	NOUN
bionys-572	108	37	information	information	NOUN
bionys-572	108	38	,	,	PUNCT
bionys-572	108	39	2025	2025	NUM
bionys-572	108	40	)	)	PUNCT
bionys-572	108	41	.	.	PUNCT
bionys-572	109	1	oxalate	oxalate	NOUN
bionys-572	109	2	dysmetabolism	dysmetabolism	NOUN
bionys-572	109	3	,	,	PUNCT
bionys-572	109	4	often	often	ADV
bionys-572	109	5	resulting	result	VERB
bionys-572	109	6	from	from	ADP
bionys-572	109	7	low	low	ADJ
bionys-572	109	8	serum	serum	NOUN
bionys-572	109	9	glycine	glycine	NOUN
bionys-572	109	10	levels	level	NOUN
bionys-572	109	11	,	,	PUNCT
bionys-572	109	12	has	have	AUX
bionys-572	109	13	been	be	AUX
bionys-572	109	14	associated	associate	VERB
bionys-572	109	15	with	with	ADP
bionys-572	109	16	disrupted	disrupt	VERB
bionys-572	109	17	redox	redox	NOUN
bionys-572	109	18	homeostasis	homeostasis	NOUN
bionys-572	109	19	,	,	PUNCT
bionys-572	109	20	inflammation	inflammation	NOUN
bionys-572	109	21	,	,	PUNCT
bionys-572	109	22	atherosclerosis	atherosclerosis	NOUN
bionys-572	109	23	,	,	PUNCT
bionys-572	109	24	and	and	CCONJ
bionys-572	109	25	cytopenia	cytopenia	NOUN
bionys-572	109	26	.	.	PUNCT
bionys-572	110	1	furthermore	furthermore	ADV
bionys-572	110	2	,	,	PUNCT
bionys-572	110	3	dysregulated	dysregulated	ADJ
bionys-572	110	4	oxalate	oxalate	NOUN
bionys-572	110	5	metabolism	metabolism	NOUN
bionys-572	110	6	has	have	AUX
bionys-572	110	7	been	be	AUX
bionys-572	110	8	implicated	implicate	VERB
bionys-572	110	9	as	as	ADP
bionys-572	110	10	a	a	DET
bionys-572	110	11	contributing	contribute	VERB
bionys-572	110	12	factor	factor	NOUN
bionys-572	110	13	in	in	ADP
bionys-572	110	14	the	the	DET
bionys-572	110	15	development	development	NOUN
bionys-572	110	16	of	of	ADP
bionys-572	110	17	thrombosis	thrombosis	NOUN
bionys-572	110	18	and	and	CCONJ
bionys-572	110	19	atherosclerosis	atherosclerosis	NOUN
bionys-572	110	20	(	(	PUNCT
bionys-572	110	21	liu	liu	PROPN
bionys-572	110	22	et	et	PROPN
bionys-572	110	23	al	al	PROPN
bionys-572	110	24	.	.	PROPN
bionys-572	110	25	,	,	PUNCT
bionys-572	110	26	2021	2021	NUM
bionys-572	110	27	)	)	PUNCT
bionys-572	110	28	.	.	PUNCT
bionys-572	111	1	therefore	therefore	ADV
bionys-572	111	2	,	,	PUNCT
bionys-572	111	3	the	the	DET
bionys-572	111	4	elevated	elevated	ADJ
bionys-572	111	5	platelet	platelet	NOUN
bionys-572	111	6	levels	level	NOUN
bionys-572	111	7	detected	detect	VERB
bionys-572	111	8	in	in	ADP
bionys-572	111	9	patients	patient	NOUN
bionys-572	111	10	with	with	ADP
bionys-572	111	11	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	111	12	may	may	AUX
bionys-572	111	13	indicate	indicate	VERB
bionys-572	111	14	a	a	DET
bionys-572	111	15	predisposition	predisposition	NOUN
bionys-572	111	16	to	to	ADP
bionys-572	111	17	thrombotic	thrombotic	ADJ
bionys-572	111	18	events	event	NOUN
bionys-572	111	19	.	.	PUNCT
bionys-572	112	1	to	to	ADP
bionys-572	112	2	date	date	NOUN
bionys-572	112	3	,	,	PUNCT
bionys-572	112	4	no	no	DET
bionys-572	112	5	prior	prior	ADJ
bionys-572	112	6	studies	study	NOUN
bionys-572	112	7	have	have	AUX
bionys-572	112	8	reported	report	VERB
bionys-572	112	9	an	an	DET
bionys-572	112	10	association	association	NOUN
bionys-572	112	11	between	between	ADP
bionys-572	112	12	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	112	13	and	and	CCONJ
bionys-572	112	14	elevated	elevated	ADJ
bionys-572	112	15	eosinophil	eosinophil	ADJ
bionys-572	112	16	counts	count	NOUN
bionys-572	112	17	.	.	PUNCT
bionys-572	113	1	biochemical	biochemical	ADJ
bionys-572	113	2	analysis	analysis	NOUN
bionys-572	113	3	revealed	reveal	VERB
bionys-572	113	4	that	that	SCONJ
bionys-572	113	5	individuals	individual	NOUN
bionys-572	113	6	251	251	NUM
bionys-572	113	7	biologica	biologica	PROPN
bionys-572	113	8	nyssana	nyssana	PROPN
bionys-572	113	9	●	●	PUNCT
bionys-572	113	10	16	16	NUM
bionys-572	113	11	(	(	PUNCT
bionys-572	113	12	1	1	NUM
bionys-572	113	13	)	)	PUNCT
bionys-572	113	14	june	june	PROPN
bionys-572	113	15	2025	2025	NUM
bionys-572	113	16	:	:	PUNCT
bionys-572	113	17	247	247	NUM
bionys-572	113	18	-	-	SYM
bionys-572	113	19	257	257	NUM
bionys-572	113	20	kravchun	kravchun	NOUN
bionys-572	113	21	et	et	PROPN
bionys-572	113	22	al	al	PROPN
bionys-572	113	23	.	.	PUNCT
bionys-572	114	1	●	●	PUNCT
bionys-572	114	2	different	different	ADJ
bionys-572	114	3	types	type	NOUN
bionys-572	114	4	of	of	ADP
bionys-572	114	5	crystalluria	crystalluria	PROPN
bionys-572	114	6	in	in	ADP
bionys-572	114	7	patients	patient	NOUN
bionys-572	114	8	with	with	ADP
bionys-572	114	9	bone	bone	NOUN
bionys-572	114	10	and	and	CCONJ
bionys-572	114	11	joint	joint	ADJ
bionys-572	114	12	tissue	tissue	NOUN
bionys-572	114	13	pathology	pathology	NOUN
bionys-572	114	14	:	:	PUNCT
bionys-572	114	15	hematological	hematological	ADJ
bionys-572	114	16	and	and	CCONJ
bionys-572	114	17	biochemical	biochemical	ADJ
bionys-572	114	18	profiles	profile	NOUN
bionys-572	114	19	table	table	VERB
bionys-572	114	20	1	1	NUM
bionys-572	114	21	.	.	PUNCT
bionys-572	115	1	clinical	clinical	ADJ
bionys-572	115	2	blood	blood	NOUN
bionys-572	115	3	parameters	parameter	NOUN
bionys-572	115	4	in	in	ADP
bionys-572	115	5	patients	patient	NOUN
bionys-572	115	6	with	with	ADP
bionys-572	115	7	bone	bone	NOUN
bionys-572	115	8	and	and	CCONJ
bionys-572	115	9	joint	joint	ADJ
bionys-572	115	10	tissue	tissue	NOUN
bionys-572	115	11	pathology	pathology	NOUN
bionys-572	115	12	presenting	present	VERB
bionys-572	115	13	with	with	ADP
bionys-572	115	14	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	115	15	,	,	PUNCT
bionys-572	115	16	uraturia	uraturia	PROPN
bionys-572	115	17	,	,	PUNCT
bionys-572	115	18	and	and	CCONJ
bionys-572	115	19	phosphaturia	phosphaturia	NOUN
bionys-572	115	20	with	with	ADP
bionys-572	115	21	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	115	22	had	have	VERB
bionys-572	115	23	a	a	DET
bionys-572	115	24	23.8	23.8	NUM
bionys-572	115	25	%	%	NOUN
bionys-572	115	26	higher	high	ADJ
bionys-572	115	27	serum	serum	NOUN
bionys-572	115	28	alkaline	alkaline	NOUN
bionys-572	115	29	phosphatase	phosphatase	NOUN
bionys-572	115	30	level	level	NOUN
bionys-572	115	31	compared	compare	VERB
bionys-572	115	32	to	to	ADP
bionys-572	115	33	the	the	DET
bionys-572	115	34	control	control	NOUN
bionys-572	115	35	group	group	NOUN
bionys-572	115	36	(	(	PUNCT
bionys-572	115	37	tab	tab	NOUN
bionys-572	115	38	.	.	NOUN
bionys-572	115	39	2	2	NUM
bionys-572	115	40	)	)	PUNCT
bionys-572	115	41	.	.	PUNCT
bionys-572	116	1	elevated	elevated	ADJ
bionys-572	116	2	alkaline	alkaline	NOUN
bionys-572	116	3	phosphatase	phosphatase	NOUN
bionys-572	116	4	,	,	PUNCT
bionys-572	116	5	a	a	DET
bionys-572	116	6	known	know	VERB
bionys-572	116	7	marker	marker	NOUN
bionys-572	116	8	of	of	ADP
bionys-572	116	9	osteomalacia	osteomalacia	NOUN
bionys-572	116	10	,	,	PUNCT
bionys-572	116	11	may	may	AUX
bionys-572	116	12	help	help	VERB
bionys-572	116	13	explain	explain	VERB
bionys-572	116	14	the	the	DET
bionys-572	116	15	high	high	ADJ
bionys-572	116	16	frequency	frequency	NOUN
bionys-572	116	17	of	of	ADP
bionys-572	116	18	ligament	ligament	NOUN
bionys-572	116	19	ruptures	rupture	NOUN
bionys-572	116	20	and	and	CCONJ
bionys-572	116	21	bone	bone	NOUN
bionys-572	116	22	fractures	fracture	NOUN
bionys-572	116	23	observed	observe	VERB
bionys-572	116	24	in	in	ADP
bionys-572	116	25	this	this	DET
bionys-572	116	26	study	study	NOUN
bionys-572	116	27	.	.	PUNCT
bionys-572	117	1	the	the	DET
bionys-572	117	2	increased	increase	VERB
bionys-572	117	3	serum	serum	NOUN
bionys-572	117	4	alkaline	alkaline	NOUN
bionys-572	117	5	phosphatase	phosphatase	NOUN
bionys-572	117	6	levels	level	NOUN
bionys-572	117	7	in	in	ADP
bionys-572	117	8	hyperoxaluric	hyperoxaluric	ADJ
bionys-572	117	9	individuals	individual	NOUN
bionys-572	117	10	are	be	AUX
bionys-572	117	11	consistent	consistent	ADJ
bionys-572	117	12	with	with	ADP
bionys-572	117	13	previous	previous	ADJ
bionys-572	117	14	findings	finding	NOUN
bionys-572	117	15	(	(	PUNCT
bionys-572	117	16	bchir	bchir	NOUN
bionys-572	117	17	et	et	PROPN
bionys-572	117	18	al	al	PROPN
bionys-572	117	19	.	.	PROPN
bionys-572	117	20	,	,	PUNCT
bionys-572	117	21	2022	2022	NUM
bionys-572	117	22	)	)	PUNCT
bionys-572	117	23	.	.	PUNCT
bionys-572	118	1	b	b	X
bionys-572	118	2	-	-	PUNCT
bionys-572	118	3	lipoprotein	lipoprotein	ADJ
bionys-572	118	4	levels	level	NOUN
bionys-572	118	5	did	do	AUX
bionys-572	118	6	not	not	PART
bionys-572	118	7	differ	differ	VERB
bionys-572	118	8	significantly	significantly	ADV
bionys-572	118	9	between	between	ADP
bionys-572	118	10	groups	group	NOUN
bionys-572	118	11	,	,	PUNCT
bionys-572	118	12	with	with	ADP
bionys-572	118	13	mean	mean	ADJ
bionys-572	118	14	values	value	NOUN
bionys-572	118	15	of	of	ADP
bionys-572	118	16	80.42±6.4	80.42±6.4	PROPN
bionys-572	118	17	units	unit	NOUN
bionys-572	118	18	in	in	ADP
bionys-572	118	19	the	the	DET
bionys-572	118	20	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	118	21	group	group	NOUN
bionys-572	118	22	and	and	CCONJ
bionys-572	118	23	74.0±5.1	74.0±5.1	NUM
bionys-572	118	24	units	unit	NOUN
bionys-572	118	25	in	in	ADP
bionys-572	118	26	the	the	DET
bionys-572	118	27	control	control	NOUN
bionys-572	118	28	group	group	NOUN
bionys-572	118	29	.	.	PUNCT
bionys-572	119	1	during	during	ADP
bionys-572	119	2	periods	period	NOUN
bionys-572	119	3	of	of	ADP
bionys-572	119	4	active	active	ADJ
bionys-572	119	5	oxalate	oxalate	NOUN
bionys-572	119	6	excretion	excretion	NOUN
bionys-572	119	7	,	,	PUNCT
bionys-572	119	8	individuals	individual	NOUN
bionys-572	119	9	with	with	ADP
bionys-572	119	10	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	119	11	demonstrated	demonstrate	VERB
bionys-572	119	12	a	a	DET
bionys-572	119	13	17.3	17.3	NUM
bionys-572	119	14	%	%	NOUN
bionys-572	119	15	increase	increase	NOUN
bionys-572	119	16	in	in	ADP
bionys-572	119	17	serum	serum	NOUN
bionys-572	119	18	alanine	alanine	NOUN
bionys-572	119	19	aminotransferase	aminotransferase	PROPN
bionys-572	119	20	(	(	PUNCT
bionys-572	119	21	alt	alt	ADJ
bionys-572	119	22	)	)	PUNCT
bionys-572	119	23	and	and	CCONJ
bionys-572	119	24	a	a	DET
bionys-572	119	25	77	77	NUM
bionys-572	119	26	%	%	NOUN
bionys-572	119	27	increase	increase	NOUN
bionys-572	119	28	in	in	ADP
bionys-572	119	29	c	c	NOUN
bionys-572	119	30	-	-	PUNCT
bionys-572	119	31	reactive	reactive	ADJ
bionys-572	119	32	protein	protein	NOUN
bionys-572	119	33	(	(	PUNCT
bionys-572	119	34	crp	crp	NOUN
bionys-572	119	35	)	)	PUNCT
bionys-572	119	36	levels	level	NOUN
bionys-572	119	37	(	(	PUNCT
bionys-572	119	38	tab	tab	NOUN
bionys-572	119	39	.	.	PUNCT
bionys-572	119	40	3	3	NUM
bionys-572	119	41	)	)	PUNCT
bionys-572	119	42	.	.	PUNCT
bionys-572	120	1	the	the	DET
bionys-572	120	2	elevated	elevate	VERB
bionys-572	120	3	alt	alt	NOUN
bionys-572	120	4	may	may	AUX
bionys-572	120	5	reflect	reflect	VERB
bionys-572	120	6	liver	liver	NOUN
bionys-572	120	7	cell	cell	NOUN
bionys-572	120	8	damage	damage	NOUN
bionys-572	120	9	,	,	PUNCT
bionys-572	120	10	potentially	potentially	ADV
bionys-572	120	11	due	due	ADJ
bionys-572	120	12	to	to	ADP
bionys-572	120	13	cholestasis	cholestasis	NOUN
bionys-572	120	14	and	and	CCONJ
bionys-572	120	15	the	the	DET
bionys-572	120	16	concomitant	concomitant	ADJ
bionys-572	120	17	rise	rise	NOUN
bionys-572	120	18	in	in	ADP
bionys-572	120	19	alkaline	alkaline	NOUN
bionys-572	120	20	phosphatase	phosphatase	NOUN
bionys-572	120	21	.	.	PUNCT
bionys-572	121	1	variables	variables	PROPN
bionys-572	121	2	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	121	3	(	(	PUNCT
bionys-572	121	4	n=39	n=39	NOUN
bionys-572	121	5	)	)	PUNCT
bionys-572	121	6	uraturia	uraturia	NOUN
bionys-572	121	7	(	(	PUNCT
bionys-572	121	8	n=17	n=17	NOUN
bionys-572	121	9	)	)	PUNCT
bionys-572	121	10	phosphaturia	phosphaturia	NOUN
bionys-572	121	11	(	(	PUNCT
bionys-572	121	12	n=10	n=10	NOUN
bionys-572	121	13	)	)	PUNCT
bionys-572	121	14	control	control	NOUN
bionys-572	121	15	group	group	NOUN
bionys-572	121	16	(	(	PUNCT
bionys-572	121	17	n=61	n=61	NOUN
bionys-572	121	18	)	)	PUNCT
bionys-572	121	19	(	(	PUNCT
bionys-572	121	20	mean±sd	mean±sd	NOUN
bionys-572	121	21	)	)	PUNCT
bionys-572	121	22	erythrocytes	erythrocyte	NOUN
bionys-572	121	23	(	(	PUNCT
bionys-572	121	24	1012	1012	NUM
bionys-572	121	25	/	/	SYM
bionys-572	121	26	l	l	NOUN
bionys-572	121	27	)	)	PUNCT
bionys-572	121	28	4.46±0.35	4.46±0.35	NOUN
bionys-572	121	29	5.02±0.44	5.02±0.44	NUM
bionys-572	121	30	4.82±0.4	4.82±0.4	NUM
bionys-572	121	31	4.84±0.42	4.84±0.42	ADJ
bionys-572	121	32	hemoglobin	hemoglobin	NOUN
bionys-572	121	33	(	(	PUNCT
bionys-572	121	34	g	g	NOUN
bionys-572	121	35	/	/	SYM
bionys-572	121	36	l	l	NOUN
bionys-572	121	37	)	)	PUNCT
bionys-572	121	38	130.62±11.5	130.62±11.5	NUM
bionys-572	121	39	143.6±14.2	143.6±14.2	NUM
bionys-572	121	40	141.7±13.7	141.7±13.7	NOUN
bionys-572	121	41	140.25±13.5	140.25±13.5	NUM
bionys-572	121	42	platelets	platelet	NOUN
bionys-572	121	43	(	(	PUNCT
bionys-572	121	44	109	109	NUM
bionys-572	121	45	/	/	SYM
bionys-572	121	46	l	l	NOUN
bionys-572	121	47	)	)	PUNCT
bionys-572	121	48	334.67±21.4	334.67±21.4	PROPN
bionys-572	121	49	*	*	SYM
bionys-572	121	50	213.6±15.63	213.6±15.63	NUM
bionys-572	121	51	*	*	SYM
bionys-572	121	52	270.63±17.8	270.63±17.8	NUM
bionys-572	121	53	274.22±19.1	274.22±19.1	NUM
bionys-572	121	54	leukocytes	leukocyte	NOUN
bionys-572	121	55	(	(	PUNCT
bionys-572	121	56	109	109	NUM
bionys-572	121	57	/	/	SYM
bionys-572	121	58	l	l	NOUN
bionys-572	121	59	)	)	PUNCT
bionys-572	121	60	8.08±0.85	8.08±0.85	NOUN
bionys-572	121	61	*	*	PUNCT
bionys-572	121	62	5.79±0.6	5.79±0.6	NUM
bionys-572	121	63	6.8±0.74	6.8±0.74	NUM
bionys-572	121	64	5.96±0.63	5.96±0.63	PROPN
bionys-572	121	65	esr	esr	X
bionys-572	121	66	(	(	PUNCT
bionys-572	121	67	mm	mm	PROPN
bionys-572	121	68	/	/	SYM
bionys-572	121	69	h	h	NOUN
bionys-572	121	70	)	)	PUNCT
bionys-572	121	71	19.07±3.2	19.07±3.2	PROPN
bionys-572	121	72	*	*	NOUN
bionys-572	122	1	10.66±1.8	10.66±1.8	NUM
bionys-572	122	2	11.24±2.1	11.24±2.1	NUM
bionys-572	122	3	10.1±1.7	10.1±1.7	NUM
bionys-572	122	4	eosinophils	eosinophil	NOUN
bionys-572	122	5	(	(	PUNCT
bionys-572	122	6	%	%	INTJ
bionys-572	122	7	)	)	PUNCT
bionys-572	122	8	3.5±0.6	3.5±0.6	NUM
bionys-572	122	9	*	*	NUM
bionys-572	122	10	2.2±0.43	2.2±0.43	NUM
bionys-572	122	11	2.25±0.43	2.25±0.43	NUM
bionys-572	122	12	2.0±0.41	2.0±0.41	NUM
bionys-572	122	13	segmented	segment	VERB
bionys-572	122	14	neutrophils	neutrophil	NOUN
bionys-572	122	15	(	(	PUNCT
bionys-572	122	16	%	%	INTJ
bionys-572	122	17	)	)	PUNCT
bionys-572	122	18	58.7±7.2	58.7±7.2	NUM
bionys-572	122	19	59.34±7.56	59.34±7.56	NUM
bionys-572	122	20	57.08±6.54	57.08±6.54	NUM
bionys-572	122	21	53.33±6.1	53.33±6.1	PROPN
bionys-572	122	22	lymphocytes	lymphocyte	NOUN
bionys-572	122	23	(	(	PUNCT
bionys-572	122	24	%	%	INTJ
bionys-572	122	25	)	)	PUNCT
bionys-572	123	1	26.85±3.74	26.85±3.74	NUM
bionys-572	123	2	27.5±3.85	27.5±3.85	NUM
bionys-572	123	3	32.18±4.2	32.18±4.2	NUM
bionys-572	123	4	28.33±4.0	28.33±4.0	PROPN
bionys-572	123	5	monocytes	monocyte	NOUN
bionys-572	123	6	(	(	PUNCT
bionys-572	123	7	%	%	INTJ
bionys-572	123	8	)	)	PUNCT
bionys-572	123	9	8.21±0.78	8.21±0.78	PROPN
bionys-572	123	10	*	*	NOUN
bionys-572	123	11	7.78±0.74	7.78±0.74	NUM
bionys-572	123	12	4.83±0.32	4.83±0.32	NUM
bionys-572	123	13	5.0±0.6	5.0±0.6	NUM
bionys-572	123	14	esr	esr	NOUN
bionys-572	123	15	:	:	PUNCT
bionys-572	123	16	erythrocyte	erythrocyte	PROPN
bionys-572	123	17	sedimentation	sedimentation	NOUN
bionys-572	123	18	rate	rate	NOUN
bionys-572	123	19	;	;	PUNCT
bionys-572	123	20	*	*	PUNCT
bionys-572	123	21	p<0.05	p<0.05	NOUN
bionys-572	123	22	compared	compare	VERB
bionys-572	123	23	to	to	ADP
bionys-572	123	24	control	control	NOUN
bionys-572	123	25	group	group	NOUN
bionys-572	123	26	table	table	NOUN
bionys-572	123	27	2	2	NUM
bionys-572	123	28	.	.	PUNCT
bionys-572	123	29	biochemical	biochemical	ADJ
bionys-572	123	30	parameters	parameter	NOUN
bionys-572	123	31	in	in	ADP
bionys-572	123	32	patients	patient	NOUN
bionys-572	123	33	with	with	ADP
bionys-572	123	34	bone	bone	NOUN
bionys-572	123	35	and	and	CCONJ
bionys-572	123	36	joint	joint	ADJ
bionys-572	123	37	tissue	tissue	NOUN
bionys-572	123	38	pathology	pathology	NOUN
bionys-572	123	39	presenting	present	VERB
bionys-572	123	40	with	with	ADP
bionys-572	123	41	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	123	42	,	,	PUNCT
bionys-572	123	43	uraturia	uraturia	PROPN
bionys-572	123	44	,	,	PUNCT
bionys-572	123	45	and	and	CCONJ
bionys-572	123	46	phosphaturia	phosphaturia	PROPN
bionys-572	123	47	variables	variable	NOUN
bionys-572	123	48	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	123	49	(	(	PUNCT
bionys-572	123	50	n=39	n=39	NOUN
bionys-572	123	51	)	)	PUNCT
bionys-572	123	52	uraturia	uraturia	NOUN
bionys-572	123	53	(	(	PUNCT
bionys-572	123	54	n=17	n=17	NOUN
bionys-572	123	55	)	)	PUNCT
bionys-572	123	56	phosphaturia	phosphaturia	NOUN
bionys-572	123	57	(	(	PUNCT
bionys-572	123	58	n=10	n=10	NOUN
bionys-572	123	59	)	)	PUNCT
bionys-572	123	60	bone	bone	NOUN
bionys-572	123	61	fractures	fracture	NOUN
bionys-572	123	62	(	(	PUNCT
bionys-572	123	63	n=17	n=17	NOUN
bionys-572	123	64	)	)	PUNCT
bionys-572	123	65	control	control	NOUN
bionys-572	123	66	(	(	PUNCT
bionys-572	123	67	n=61	n=61	NOUN
bionys-572	123	68	)	)	PUNCT
bionys-572	123	69	(	(	PUNCT
bionys-572	123	70	mean±sd	mean±sd	NOUN
bionys-572	123	71	)	)	PUNCT
bionys-572	123	72	glucose	glucose	NOUN
bionys-572	123	73	(	(	PUNCT
bionys-572	123	74	mmol	mmol	NOUN
bionys-572	123	75	/	/	SYM
bionys-572	123	76	l	l	NOUN
bionys-572	123	77	)	)	PUNCT
bionys-572	123	78	5.3±0.24	5.3±0.24	NUM
bionys-572	123	79	6.4±0.3	6.4±0.3	NUM
bionys-572	123	80	*	*	PUNCT
bionys-572	123	81	5.05±0.17	5.05±0.17	NUM
bionys-572	123	82	5.97±0.27	5.97±0.27	PROPN
bionys-572	123	83	*	*	PROPN
bionys-572	123	84	5.1±0.2	5.1±0.2	NUM
bionys-572	123	85	total	total	ADJ
bionys-572	123	86	protein	protein	NOUN
bionys-572	123	87	(	(	PUNCT
bionys-572	123	88	g	g	NOUN
bionys-572	123	89	/	/	SYM
bionys-572	123	90	l	l	NOUN
bionys-572	123	91	)	)	PUNCT
bionys-572	123	92	75.7±7.13	75.7±7.13	NUM
bionys-572	124	1	74.55±6.7	74.55±6.7	NOUN
bionys-572	124	2	74.3±6.63	74.3±6.63	NUM
bionys-572	125	1	77.7±7.4	77.7±7.4	NUM
bionys-572	125	2	75.88±7.2	75.88±7.2	NOUN
bionys-572	125	3	calcium	calcium	NOUN
bionys-572	125	4	(	(	PUNCT
bionys-572	125	5	mmol	mmol	NOUN
bionys-572	125	6	/	/	SYM
bionys-572	125	7	l	l	NOUN
bionys-572	125	8	)	)	PUNCT
bionys-572	125	9	2.4±0.15	2.4±0.15	NUM
bionys-572	125	10	2.42±0.17	2.42±0.17	NUM
bionys-572	126	1	2.3±0.11	2.3±0.11	NUM
bionys-572	126	2	2.39±0.13	2.39±0.13	NUM
bionys-572	126	3	2.43±0.18	2.43±0.18	NUM
bionys-572	126	4	alt	alt	NOUN
bionys-572	126	5	(	(	PUNCT
bionys-572	126	6	un	un	PROPN
bionys-572	126	7	/	/	SYM
bionys-572	126	8	l	l	NOUN
bionys-572	126	9	)	)	PUNCT
bionys-572	126	10	24.96±1.6	24.96±1.6	PROPN
bionys-572	126	11	29.83±1.7	29.83±1.7	NUM
bionys-572	126	12	*	*	SYM
bionys-572	126	13	32.14±2.4	32.14±2.4	NUM
bionys-572	126	14	*	*	X
bionys-572	126	15	23.32±1.56	23.32±1.56	NUM
bionys-572	126	16	22.97±2.2	22.97±2.2	NUM
bionys-572	126	17	ast	ast	NOUN
bionys-572	126	18	(	(	PUNCT
bionys-572	126	19	un	un	PROPN
bionys-572	126	20	/	/	SYM
bionys-572	126	21	l	l	NOUN
bionys-572	126	22	)	)	PUNCT
bionys-572	126	23	29.35±1.77	29.35±1.77	NUM
bionys-572	126	24	34.66±2.54	34.66±2.54	NUM
bionys-572	126	25	*	*	PROPN
bionys-572	126	26	33.6±2.41	33.6±2.41	NUM
bionys-572	126	27	*	*	SYM
bionys-572	126	28	26.82±1.64	26.82±1.64	NUM
bionys-572	126	29	27.28±1.7	27.28±1.7	PROPN
bionys-572	126	30	alph(un	alph(un	ADJ
bionys-572	126	31	/	/	SYM
bionys-572	126	32	l	l	NOUN
bionys-572	126	33	)	)	PUNCT
bionys-572	126	34	394.7±26.2	394.7±26.2	NOUN
bionys-572	126	35	*	*	SYM
bionys-572	126	36	302.42±17.4	302.42±17.4	NUM
bionys-572	126	37	318.27±20.1	318.27±20.1	NUM
bionys-572	126	38	urea	urea	NOUN
bionys-572	126	39	(	(	PUNCT
bionys-572	126	40	mmol	mmol	NOUN
bionys-572	126	41	/	/	SYM
bionys-572	126	42	l	l	NOUN
bionys-572	126	43	)	)	PUNCT
bionys-572	126	44	4.05±0.48	4.05±0.48	NOUN
bionys-572	126	45	6.31±0.8	6.31±0.8	NUM
bionys-572	126	46	*	*	PUNCT
bionys-572	127	1	4.55±0.7	4.55±0.7	NUM
bionys-572	127	2	4.41±0.6	4.41±0.6	NUM
bionys-572	127	3	4.21±0.57	4.21±0.57	PROPN
bionys-572	127	4	creatinine	creatinine	NOUN
bionys-572	127	5	(	(	PUNCT
bionys-572	127	6	mcmol	mcmol	NOUN
bionys-572	127	7	/	/	SYM
bionys-572	127	8	l	l	NOUN
bionys-572	127	9	)	)	PUNCT
bionys-572	127	10	95.33±13.1	95.33±13.1	NUM
bionys-572	127	11	164.3±17.2	164.3±17.2	NUM
bionys-572	127	12	*	*	NOUN
bionys-572	127	13	89.33±12.4	89.33±12.4	NUM
bionys-572	127	14	88.22±11.5	88.22±11.5	NUM
bionys-572	127	15	91.32±12.73	91.32±12.73	NUM
bionys-572	127	16	thymol	thymol	NOUN
bionys-572	127	17	probe	probe	NOUN
bionys-572	127	18	(	(	PUNCT
bionys-572	127	19	units	unit	NOUN
bionys-572	127	20	)	)	PUNCT
bionys-572	127	21	2.34±0.2	2.34±0.2	NUM
bionys-572	127	22	2.56±0.24	2.56±0.24	NUM
bionys-572	127	23	*	*	NOUN
bionys-572	127	24	2.06±0.15	2.06±0.15	NUM
bionys-572	127	25	2.64±0.27	2.64±0.27	PROPN
bionys-572	127	26	*	*	PROPN
bionys-572	127	27	1,97±0.11	1,97±0.11	ADJ
bionys-572	127	28	uric	uric	ADJ
bionys-572	127	29	acid	acid	NOUN
bionys-572	127	30	(	(	PUNCT
bionys-572	127	31	mcmol	mcmol	NOUN
bionys-572	127	32	/	/	SYM
bionys-572	127	33	l	l	NOUN
bionys-572	127	34	)	)	PUNCT
bionys-572	127	35	361.4±20.6	361.4±20.6	NOUN
bionys-572	127	36	442.0±25.2	442.0±25.2	PROPN
bionys-572	127	37	*	*	PROPN
bionys-572	127	38	351.2±17.4	351.2±17.4	NUM
bionys-572	127	39	p<0.05	p<0.05	NOUN
bionys-572	127	40	compared	compare	VERB
bionys-572	127	41	to	to	ADP
bionys-572	127	42	control	control	PROPN
bionys-572	127	43	group	group	NOUN
bionys-572	127	44	.	.	PUNCT
bionys-572	128	1	alt	alt	ADJ
bionys-572	128	2	:	:	PUNCT
bionys-572	128	3	alanine	alanine	NOUN
bionys-572	128	4	aminotransferase	aminotransferase	NOUN
bionys-572	128	5	;	;	PUNCT
bionys-572	128	6	ast	ast	NOUN
bionys-572	128	7	:	:	PUNCT
bionys-572	128	8	aspartate	aspartate	NOUN
bionys-572	128	9	aminotransferase	aminotransferase	NOUN
bionys-572	128	10	;	;	PUNCT
bionys-572	128	11	alph	alph	ADJ
bionys-572	128	12	:	:	PUNCT
bionys-572	128	13	alkaline	alkaline	NOUN
bionys-572	128	14	phosphatase	phosphatase	NOUN
bionys-572	128	15	252	252	NUM
bionys-572	129	1	biologica	biologica	ADV
bionys-572	129	2	nyssana	nyssana	PROPN
bionys-572	129	3	●	●	PUNCT
bionys-572	129	4	16	16	NUM
bionys-572	129	5	(	(	PUNCT
bionys-572	129	6	1	1	NUM
bionys-572	129	7	)	)	PUNCT
bionys-572	129	8	june	june	PROPN
bionys-572	129	9	2025	2025	NUM
bionys-572	129	10	:	:	PUNCT
bionys-572	129	11	247	247	NUM
bionys-572	129	12	-	-	SYM
bionys-572	129	13	257	257	NUM
bionys-572	129	14	kravchun	kravchun	NOUN
bionys-572	129	15	et	et	PROPN
bionys-572	129	16	al	al	PROPN
bionys-572	129	17	.	.	PUNCT
bionys-572	130	1	●	●	PUNCT
bionys-572	130	2	different	different	ADJ
bionys-572	130	3	types	type	NOUN
bionys-572	130	4	of	of	ADP
bionys-572	130	5	crystalluria	crystalluria	PROPN
bionys-572	130	6	in	in	ADP
bionys-572	130	7	patients	patient	NOUN
bionys-572	130	8	with	with	ADP
bionys-572	130	9	bone	bone	NOUN
bionys-572	130	10	and	and	CCONJ
bionys-572	130	11	joint	joint	ADJ
bionys-572	130	12	tissue	tissue	NOUN
bionys-572	130	13	pathology	pathology	NOUN
bionys-572	130	14	:	:	PUNCT
bionys-572	130	15	hematological	hematological	ADJ
bionys-572	130	16	and	and	CCONJ
bionys-572	130	17	biochemical	biochemical	ADJ
bionys-572	130	18	profiles	profile	NOUN
bionys-572	130	19	table	table	VERB
bionys-572	130	20	3	3	NUM
bionys-572	130	21	.	.	PUNCT
bionys-572	131	1	dynamics	dynamic	NOUN
bionys-572	131	2	of	of	ADP
bionys-572	131	3	biochemical	biochemical	ADJ
bionys-572	131	4	parameters	parameter	NOUN
bionys-572	131	5	during	during	ADP
bionys-572	131	6	active	active	ADJ
bionys-572	131	7	oxalate	oxalate	NOUN
bionys-572	131	8	excretion	excretion	NOUN
bionys-572	131	9	in	in	ADP
bionys-572	131	10	patients	patient	NOUN
bionys-572	131	11	with	with	ADP
bionys-572	131	12	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	131	13	correlations	correlation	NOUN
bionys-572	131	14	correlation	correlation	NOUN
bionys-572	131	15	analysis	analysis	NOUN
bionys-572	131	16	in	in	ADP
bionys-572	131	17	patients	patient	NOUN
bionys-572	131	18	with	with	ADP
bionys-572	131	19	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	131	20	revealed	reveal	VERB
bionys-572	131	21	a	a	DET
bionys-572	131	22	strong	strong	ADJ
bionys-572	131	23	positive	positive	ADJ
bionys-572	131	24	association	association	NOUN
bionys-572	131	25	between	between	ADP
bionys-572	131	26	serum	serum	NOUN
bionys-572	131	27	glucose	glucose	NOUN
bionys-572	131	28	and	and	CCONJ
bionys-572	131	29	b	b	NOUN
bionys-572	131	30	-	-	PUNCT
bionys-572	131	31	lipoproteins	lipoprotein	NOUN
bionys-572	131	32	(	(	PUNCT
bionys-572	131	33	r=0.74	r=0.74	NOUN
bionys-572	131	34	)	)	PUNCT
bionys-572	131	35	.	.	PUNCT
bionys-572	132	1	serum	serum	NOUN
bionys-572	132	2	total	total	ADJ
bionys-572	132	3	protein	protein	NOUN
bionys-572	132	4	levels	level	NOUN
bionys-572	132	5	were	be	AUX
bionys-572	132	6	significantly	significantly	ADV
bionys-572	132	7	correlated	correlate	VERB
bionys-572	132	8	with	with	ADP
bionys-572	132	9	chondroitin	chondroitin	NOUN
bionys-572	132	10	sulfates	sulfate	NOUN
bionys-572	132	11	(	(	PUNCT
bionys-572	132	12	r=0.68	r=0.68	NOUN
bionys-572	132	13	)	)	PUNCT
bionys-572	132	14	and	and	CCONJ
bionys-572	132	15	calcium	calcium	NOUN
bionys-572	132	16	(	(	PUNCT
bionys-572	132	17	r=0.87	r=0.87	NOUN
bionys-572	132	18	)	)	PUNCT
bionys-572	132	19	(	(	PUNCT
bionys-572	132	20	tab	tab	NOUN
bionys-572	132	21	.	.	NOUN
bionys-572	132	22	4	4	NUM
bionys-572	132	23	)	)	PUNCT
bionys-572	132	24	,	,	PUNCT
bionys-572	132	25	consistent	consistent	ADJ
bionys-572	132	26	with	with	ADP
bionys-572	132	27	previous	previous	ADJ
bionys-572	132	28	studies	study	NOUN
bionys-572	132	29	reporting	report	VERB
bionys-572	132	30	a	a	DET
bionys-572	132	31	relationship	relationship	NOUN
bionys-572	132	32	between	between	ADP
bionys-572	132	33	total	total	ADJ
bionys-572	132	34	protein	protein	NOUN
bionys-572	132	35	and	and	CCONJ
bionys-572	132	36	serum	serum	NOUN
bionys-572	132	37	calcium	calcium	NOUN
bionys-572	132	38	levels	level	NOUN
bionys-572	132	39	.	.	PUNCT
bionys-572	133	1	calcium	calcium	NOUN
bionys-572	133	2	concentration	concentration	NOUN
bionys-572	133	3	was	be	AUX
bionys-572	133	4	inversely	inversely	ADV
bionys-572	133	5	correlated	correlate	VERB
bionys-572	133	6	with	with	ADP
bionys-572	133	7	thymol	thymol	NOUN
bionys-572	133	8	turbidity	turbidity	NOUN
bionys-572	133	9	test	test	NOUN
bionys-572	133	10	results	result	NOUN
bionys-572	133	11	(	(	PUNCT
bionys-572	133	12	r=-0.69	r=-0.69	NOUN
bionys-572	133	13	)	)	PUNCT
bionys-572	133	14	and	and	CCONJ
bionys-572	133	15	positively	positively	ADV
bionys-572	133	16	correlated	correlate	VERB
bionys-572	133	17	with	with	ADP
bionys-572	133	18	chondroitin	chondroitin	NOUN
bionys-572	133	19	sulfates	sulfate	NOUN
bionys-572	133	20	(	(	PUNCT
bionys-572	133	21	r=0.55	r=0.55	NOUN
bionys-572	133	22	)	)	PUNCT
bionys-572	133	23	.	.	PUNCT
bionys-572	134	1	(	(	PUNCT
bionys-572	134	2	p<0.05	p<0.05	NOUN
bionys-572	134	3	)	)	PUNCT
bionys-572	134	4	.	.	PUNCT
bionys-572	135	1	in	in	ADP
bionys-572	135	2	patients	patient	NOUN
bionys-572	135	3	with	with	ADP
bionys-572	135	4	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	135	5	,	,	PUNCT
bionys-572	135	6	serum	serum	NOUN
bionys-572	135	7	calcium	calcium	NOUN
bionys-572	135	8	levels	level	NOUN
bionys-572	135	9	were	be	AUX
bionys-572	135	10	inversely	inversely	ADV
bionys-572	135	11	correlated	correlate	VERB
bionys-572	135	12	with	with	ADP
bionys-572	135	13	alt	alt	ADJ
bionys-572	135	14	,	,	PUNCT
bionys-572	135	15	ast	ast	ADJ
bionys-572	135	16	,	,	PUNCT
bionys-572	135	17	thymol	thymol	NOUN
bionys-572	135	18	turbidity	turbidity	NOUN
bionys-572	135	19	test	test	NOUN
bionys-572	135	20	results	result	NOUN
bionys-572	135	21	,	,	PUNCT
bionys-572	135	22	and	and	CCONJ
bionys-572	135	23	crp	crp	PROPN
bionys-572	135	24	.	.	PUNCT
bionys-572	136	1	in	in	ADP
bionys-572	136	2	contrast	contrast	NOUN
bionys-572	136	3	,	,	PUNCT
bionys-572	136	4	the	the	DET
bionys-572	136	5	control	control	NOUN
bionys-572	136	6	group	group	NOUN
bionys-572	136	7	(	(	PUNCT
bionys-572	136	8	without	without	ADP
bionys-572	136	9	dysmetabolic	dysmetabolic	ADJ
bionys-572	136	10	nephropathies	nephropathy	NOUN
bionys-572	136	11	)	)	PUNCT
bionys-572	136	12	showed	show	VERB
bionys-572	136	13	a	a	DET
bionys-572	136	14	direct	direct	ADJ
bionys-572	136	15	correlation	correlation	NOUN
bionys-572	136	16	between	between	ADP
bionys-572	136	17	serum	serum	NOUN
bionys-572	136	18	calcium	calcium	NOUN
bionys-572	136	19	and	and	CCONJ
bionys-572	136	20	thymol	thymol	NOUN
bionys-572	136	21	probe	probe	NOUN
bionys-572	136	22	(	(	PUNCT
bionys-572	136	23	r=0.57	r=0.57	PROPN
bionys-572	136	24	)	)	PUNCT
bionys-572	136	25	,	,	PUNCT
bionys-572	136	26	crp	crp	PROPN
bionys-572	136	27	(	(	PUNCT
bionys-572	136	28	r=0.36	r=0.36	PROPN
bionys-572	136	29	)	)	PUNCT
bionys-572	136	30	,	,	PUNCT
bionys-572	136	31	alt	alt	VERB
bionys-572	136	32	(	(	PUNCT
bionys-572	136	33	r=0.16	r=0.16	NOUN
bionys-572	136	34	)	)	PUNCT
bionys-572	136	35	,	,	PUNCT
bionys-572	136	36	and	and	CCONJ
bionys-572	136	37	ast	ast	NOUN
bionys-572	136	38	(	(	PUNCT
bionys-572	136	39	r=0.12)(p<0.05	r=0.12)(p<0.05	NOUN
bionys-572	136	40	)	)	PUNCT
bionys-572	136	41	.	.	PUNCT
bionys-572	137	1	these	these	DET
bionys-572	137	2	findings	finding	NOUN
bionys-572	137	3	indicate	indicate	VERB
bionys-572	137	4	that	that	SCONJ
bionys-572	137	5	,	,	PUNCT
bionys-572	137	6	in	in	ADP
bionys-572	137	7	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	137	8	,	,	PUNCT
bionys-572	137	9	reduced	reduce	VERB
bionys-572	137	10	serum	serum	NOUN
bionys-572	137	11	calcium	calcium	NOUN
bionys-572	137	12	levels	level	NOUN
bionys-572	137	13	are	be	AUX
bionys-572	137	14	associated	associate	VERB
bionys-572	137	15	with	with	ADP
bionys-572	137	16	systemic	systemic	ADJ
bionys-572	137	17	inflammation	inflammation	NOUN
bionys-572	137	18	.	.	PUNCT
bionys-572	138	1	patients	patient	NOUN
bionys-572	138	2	with	with	ADP
bionys-572	138	3	uraturia	uraturia	NOUN
bionys-572	138	4	among	among	ADP
bionys-572	138	5	individuals	individual	NOUN
bionys-572	138	6	with	with	ADP
bionys-572	138	7	bone	bone	NOUN
bionys-572	138	8	and	and	CCONJ
bionys-572	138	9	joint	joint	ADJ
bionys-572	138	10	tissue	tissue	NOUN
bionys-572	138	11	pathology	pathology	NOUN
bionys-572	138	12	,	,	PUNCT
bionys-572	138	13	uraturia	uraturia	PROPN
bionys-572	138	14	was	be	AUX
bionys-572	138	15	observed	observe	VERB
bionys-572	138	16	less	less	ADV
bionys-572	138	17	frequently	frequently	ADV
bionys-572	138	18	,	,	PUNCT
bionys-572	138	19	in	in	ADP
bionys-572	138	20	17	17	NUM
bionys-572	138	21	patients	patient	NOUN
bionys-572	138	22	(	(	PUNCT
bionys-572	138	23	25.7	25.7	NUM
bionys-572	138	24	%	%	NOUN
bionys-572	138	25	)	)	PUNCT
bionys-572	138	26	.	.	PUNCT
bionys-572	139	1	the	the	DET
bionys-572	139	2	platelet	platelet	NOUN
bionys-572	139	3	count	count	NOUN
bionys-572	139	4	in	in	ADP
bionys-572	139	5	patients	patient	NOUN
bionys-572	139	6	with	with	ADP
bionys-572	139	7	uraturia	uraturia	PROPN
bionys-572	139	8	was	be	AUX
bionys-572	139	9	22.6	22.6	NUM
bionys-572	139	10	%	%	NOUN
bionys-572	139	11	lower	low	ADJ
bionys-572	139	12	compared	compare	VERB
bionys-572	139	13	to	to	ADP
bionys-572	139	14	the	the	DET
bionys-572	139	15	control	control	NOUN
bionys-572	139	16	group	group	NOUN
bionys-572	139	17	(	(	PUNCT
bionys-572	139	18	p<0.05	p<0.05	NOUN
bionys-572	139	19	)	)	PUNCT
bionys-572	139	20	.	.	PUNCT
bionys-572	140	1	this	this	DET
bionys-572	140	2	reduction	reduction	NOUN
bionys-572	140	3	may	may	AUX
bionys-572	140	4	reflect	reflect	VERB
bionys-572	140	5	a	a	DET
bionys-572	140	6	compensatory	compensatory	ADJ
bionys-572	140	7	response	response	NOUN
bionys-572	140	8	of	of	ADP
bionys-572	140	9	the	the	DET
bionys-572	140	10	bone	bone	NOUN
bionys-572	140	11	marrow	marrow	NOUN
bionys-572	140	12	,	,	PUNCT
bionys-572	140	13	possibly	possibly	ADV
bionys-572	140	14	due	due	ADP
bionys-572	140	15	to	to	ADP
bionys-572	140	16	the	the	DET
bionys-572	140	17	stimulatory	stimulatory	ADJ
bionys-572	140	18	effect	effect	NOUN
bionys-572	140	19	of	of	ADP
bionys-572	140	20	uric	uric	ADJ
bionys-572	140	21	acid	acid	NOUN
bionys-572	140	22	on	on	ADP
bionys-572	140	23	prothrombotic	prothrombotic	ADJ
bionys-572	140	24	factors	factor	NOUN
bionys-572	140	25	.	.	PUNCT
bionys-572	141	1	our	our	PRON
bionys-572	141	2	findings	finding	NOUN
bionys-572	141	3	are	be	AUX
bionys-572	141	4	consistent	consistent	ADJ
bionys-572	141	5	with	with	ADP
bionys-572	141	6	previous	previous	ADJ
bionys-572	141	7	studies	study	NOUN
bionys-572	141	8	reporting	report	VERB
bionys-572	141	9	an	an	DET
bionys-572	141	10	association	association	NOUN
bionys-572	141	11	between	between	ADP
bionys-572	141	12	elevated	elevate	VERB
bionys-572	141	13	serum	serum	NOUN
bionys-572	141	14	uric	uric	ADJ
bionys-572	141	15	acid	acid	NOUN
bionys-572	141	16	and	and	CCONJ
bionys-572	141	17	reduced	reduce	VERB
bionys-572	141	18	platelet	platelet	NOUN
bionys-572	141	19	count	count	NOUN
bionys-572	141	20	,	,	PUNCT
bionys-572	141	21	as	as	SCONJ
bionys-572	141	22	demonstrated	demonstrate	VERB
bionys-572	141	23	by	by	ADP
bionys-572	141	24	regression	regression	NOUN
bionys-572	141	25	analyses	analysis	NOUN
bionys-572	141	26	in	in	ADP
bionys-572	141	27	individuals	individual	NOUN
bionys-572	141	28	with	with	ADP
bionys-572	141	29	hypertension	hypertension	NOUN
bionys-572	141	30	(	(	PUNCT
bionys-572	141	31	tayefi	tayefi	NOUN
bionys-572	141	32	et	et	PROPN
bionys-572	141	33	al	al	PROPN
bionys-572	141	34	.	.	PROPN
bionys-572	141	35	,	,	PUNCT
bionys-572	141	36	2018	2018	NUM
bionys-572	141	37	;	;	PUNCT
bionys-572	141	38	țăpoi	țăpoi	PROPN
bionys-572	141	39	et	et	PROPN
bionys-572	141	40	al	al	PROPN
bionys-572	141	41	.	.	PROPN
bionys-572	141	42	,	,	PUNCT
bionys-572	141	43	2021	2021	NUM
bionys-572	141	44	;	;	PUNCT
bionys-572	141	45	weng	weng	PROPN
bionys-572	141	46	et	et	PROPN
bionys-572	141	47	al	al	PROPN
bionys-572	141	48	.	.	PROPN
bionys-572	141	49	,	,	PUNCT
bionys-572	141	50	2023	2023	NUM
bionys-572	141	51	)	)	PUNCT
bionys-572	141	52	.	.	PUNCT
bionys-572	142	1	serum	serum	PROPN
bionys-572	142	2	creatinine	creatinine	PROPN
bionys-572	142	3	levels	level	NOUN
bionys-572	142	4	in	in	ADP
bionys-572	142	5	the	the	DET
bionys-572	142	6	uraturia	uraturia	PROPN
bionys-572	142	7	group	group	NOUN
bionys-572	142	8	were	be	AUX
bionys-572	142	9	significantly	significantly	ADV
bionys-572	142	10	higher	high	ADJ
bionys-572	142	11	,	,	PUNCT
bionys-572	142	12	by	by	ADP
bionys-572	142	13	81.3	81.3	NUM
bionys-572	142	14	%	%	NOUN
bionys-572	142	15	,	,	PUNCT
bionys-572	142	16	compared	compare	VERB
bionys-572	142	17	to	to	ADP
bionys-572	142	18	the	the	DET
bionys-572	142	19	control	control	NOUN
bionys-572	142	20	group	group	NOUN
bionys-572	142	21	(	(	PUNCT
bionys-572	142	22	165.5±27.4	165.5±27.4	NUM
bionys-572	142	23	µmol	µmol	ADV
bionys-572	142	24	/	/	SYM
bionys-572	142	25	l	l	NOUN
bionys-572	142	26	vs.	vs.	ADP
bionys-572	142	27	91.32±12.73	91.32±12.73	NUM
bionys-572	142	28	µmol	µmol	ADP
bionys-572	142	29	/	/	SYM
bionys-572	142	30	l	l	NOUN
bionys-572	142	31	;	;	PUNCT
bionys-572	142	32	p<0.05	p<0.05	NOUN
bionys-572	142	33	)	)	PUNCT
bionys-572	142	34	,	,	PUNCT
bionys-572	142	35	indicating	indicate	VERB
bionys-572	142	36	impaired	impaired	ADJ
bionys-572	142	37	renal	renal	ADJ
bionys-572	142	38	function	function	NOUN
bionys-572	142	39	.	.	PUNCT
bionys-572	143	1	previous	previous	ADJ
bionys-572	143	2	research	research	NOUN
bionys-572	143	3	has	have	AUX
bionys-572	143	4	shown	show	VERB
bionys-572	143	5	that	that	SCONJ
bionys-572	143	6	uric	uric	ADJ
bionys-572	143	7	acid	acid	NOUN
bionys-572	143	8	exerts	exert	VERB
bionys-572	143	9	a	a	DET
bionys-572	143	10	detrimental	detrimental	ADJ
bionys-572	143	11	effect	effect	NOUN
bionys-572	143	12	on	on	ADP
bionys-572	143	13	kidney	kidney	NOUN
bionys-572	143	14	function	function	NOUN
bionys-572	143	15	.	.	PUNCT
bionys-572	144	1	this	this	DET
bionys-572	144	2	group	group	NOUN
bionys-572	144	3	also	also	ADV
bionys-572	144	4	exhibited	exhibit	VERB
bionys-572	144	5	increased	increase	VERB
bionys-572	144	6	serum	serum	NOUN
bionys-572	144	7	glucose	glucose	NOUN
bionys-572	144	8	levels	level	NOUN
bionys-572	144	9	(	(	PUNCT
bionys-572	144	10	by	by	ADP
bionys-572	144	11	25.4	25.4	NUM
bionys-572	144	12	%	%	NOUN
bionys-572	144	13	)	)	PUNCT
bionys-572	144	14	,	,	PUNCT
bionys-572	144	15	and	and	CCONJ
bionys-572	144	16	uric	uric	ADJ
bionys-572	144	17	acid	acid	NOUN
bionys-572	144	18	levels	level	NOUN
bionys-572	144	19	(	(	PUNCT
bionys-572	144	20	by	by	ADP
bionys-572	144	21	25.9	25.9	NUM
bionys-572	144	22	%	%	NOUN
bionys-572	144	23	)	)	PUNCT
bionys-572	144	24	compared	compare	VERB
bionys-572	144	25	to	to	ADP
bionys-572	144	26	controls	control	NOUN
bionys-572	144	27	(	(	PUNCT
bionys-572	144	28	p<0.05	p<0.05	NOUN
bionys-572	144	29	)	)	PUNCT
bionys-572	144	30	.	.	PUNCT
bionys-572	145	1	elevated	elevated	ADJ
bionys-572	145	2	glucose	glucose	NOUN
bionys-572	145	3	in	in	ADP
bionys-572	145	4	individuals	individual	NOUN
bionys-572	145	5	with	with	ADP
bionys-572	145	6	uraturia	uraturia	PROPN
bionys-572	145	7	suggests	suggest	VERB
bionys-572	145	8	that	that	SCONJ
bionys-572	145	9	uric	uric	ADJ
bionys-572	145	10	acid	acid	NOUN
bionys-572	145	11	may	may	AUX
bionys-572	145	12	be	be	AUX
bionys-572	145	13	involved	involve	VERB
bionys-572	145	14	in	in	ADP
bionys-572	145	15	disorders	disorder	NOUN
bionys-572	145	16	of	of	ADP
bionys-572	145	17	carbohydrate	carbohydrate	ADJ
bionys-572	145	18	metabolism	metabolism	NOUN
bionys-572	145	19	.	.	PUNCT
bionys-572	146	1	hyperuricemia	hyperuricemia	NOUN
bionys-572	146	2	and	and	CCONJ
bionys-572	146	3	liver	liver	ADJ
bionys-572	146	4	dysfunction	dysfunction	NOUN
bionys-572	146	5	have	have	AUX
bionys-572	146	6	been	be	AUX
bionys-572	146	7	reported	report	VERB
bionys-572	146	8	in	in	ADP
bionys-572	146	9	association	association	NOUN
bionys-572	146	10	with	with	ADP
bionys-572	146	11	diabetes	diabetes	NOUN
bionys-572	146	12	,	,	PUNCT
bionys-572	146	13	insulin	insulin	NOUN
bionys-572	146	14	resistance	resistance	NOUN
bionys-572	146	15	,	,	PUNCT
bionys-572	146	16	obesity	obesity	NOUN
bionys-572	146	17	,	,	PUNCT
bionys-572	146	18	and	and	CCONJ
bionys-572	146	19	dyslipidemia	dyslipidemia	NOUN
bionys-572	146	20	.	.	PUNCT
bionys-572	147	1	high	high	ADJ
bionys-572	147	2	serum	serum	PROPN
bionys-572	147	3	uric	uric	ADJ
bionys-572	147	4	acid	acid	PROPN
bionys-572	147	5	levels	level	NOUN
bionys-572	147	6	have	have	AUX
bionys-572	147	7	also	also	ADV
bionys-572	147	8	been	be	AUX
bionys-572	147	9	found	find	VERB
bionys-572	147	10	in	in	ADP
bionys-572	147	11	patients	patient	NOUN
bionys-572	147	12	with	with	ADP
bionys-572	147	13	diabetes	diabetes	NOUN
bionys-572	147	14	mellitus	mellitus	NOUN
bionys-572	147	15	,	,	PUNCT
bionys-572	147	16	showing	show	VERB
bionys-572	147	17	a	a	DET
bionys-572	147	18	positive	positive	ADJ
bionys-572	147	19	correlation	correlation	NOUN
bionys-572	147	20	with	with	ADP
bionys-572	147	21	glycated	glycate	VERB
bionys-572	147	22	hemoglobin	hemoglobin	NOUN
bionys-572	147	23	a1c	a1c	PROPN
bionys-572	147	24	.	.	PUNCT
bionys-572	148	1	previous	previous	ADJ
bionys-572	148	2	studies	study	NOUN
bionys-572	148	3	confirm	confirm	VERB
bionys-572	148	4	that	that	SCONJ
bionys-572	148	5	hyperuricemia	hyperuricemia	NOUN
bionys-572	148	6	,	,	PUNCT
bionys-572	148	7	hyperuricosuria	hyperuricosuria	NOUN
bionys-572	148	8	,	,	PUNCT
bionys-572	148	9	and	and	CCONJ
bionys-572	148	10	urate	urate	NOUN
bionys-572	148	11	nephropathy	nephropathy	NOUN
bionys-572	148	12	are	be	AUX
bionys-572	148	13	common	common	ADJ
bionys-572	148	14	in	in	ADP
bionys-572	148	15	individuals	individual	NOUN
bionys-572	148	16	with	with	ADP
bionys-572	148	17	diabetes	diabetes	NOUN
bionys-572	148	18	.	.	PUNCT
bionys-572	149	1	furthermore	furthermore	ADV
bionys-572	149	2	,	,	PUNCT
bionys-572	149	3	uric	uric	ADJ
bionys-572	149	4	acid	acid	NOUN
bionys-572	149	5	is	be	AUX
bionys-572	149	6	structurally	structurally	ADV
bionys-572	149	7	related	relate	VERB
bionys-572	149	8	to	to	ADP
bionys-572	149	9	alloxan	alloxan	NOUN
bionys-572	149	10	,	,	PUNCT
bionys-572	149	11	a	a	DET
bionys-572	149	12	known	know	VERB
bionys-572	149	13	diabetogenic	diabetogenic	ADJ
bionys-572	149	14	compound	compound	NOUN
bionys-572	149	15	.	.	PUNCT
bionys-572	150	1	experimental	experimental	ADJ
bionys-572	150	2	studies	study	NOUN
bionys-572	150	3	have	have	AUX
bionys-572	150	4	shown	show	VERB
bionys-572	150	5	that	that	SCONJ
bionys-572	150	6	alloxan	alloxan	PROPN
bionys-572	150	7	administration	administration	NOUN
bionys-572	150	8	can	can	AUX
bionys-572	150	9	induce	induce	VERB
bionys-572	150	10	“	"	PUNCT
bionys-572	150	11	uric	uric	ADJ
bionys-572	150	12	acid	acid	NOUN
bionys-572	150	13	diabetes	diabetes	NOUN
bionys-572	150	14	”	"	PUNCT
bionys-572	150	15	(	(	PUNCT
bionys-572	150	16	wang	wang	PROPN
bionys-572	150	17	et	et	PROPN
bionys-572	150	18	al	al	PROPN
bionys-572	150	19	.	.	PROPN
bionys-572	150	20	,	,	PUNCT
bionys-572	150	21	2021	2021	NUM
bionys-572	150	22	;	;	PUNCT
bionys-572	150	23	gapparova	gapparova	PROPN
bionys-572	150	24	et	et	PROPN
bionys-572	150	25	al	al	PROPN
bionys-572	150	26	.	.	PROPN
bionys-572	150	27	,	,	PUNCT
bionys-572	150	28	2023	2023	NUM
bionys-572	150	29	)	)	PUNCT
bionys-572	150	30	.	.	PUNCT
bionys-572	151	1	therefore	therefore	ADV
bionys-572	151	2	,	,	PUNCT
bionys-572	151	3	the	the	DET
bionys-572	151	4	increased	increase	VERB
bionys-572	151	5	serum	serum	NOUN
bionys-572	151	6	glucose	glucose	NOUN
bionys-572	151	7	observed	observe	VERB
bionys-572	151	8	in	in	ADP
bionys-572	151	9	individuals	individual	NOUN
bionys-572	151	10	variables	variable	NOUN
bionys-572	151	11	present	present	ADJ
bionys-572	151	12	oxalate	oxalate	NOUN
bionys-572	151	13	excretion	excretion	NOUN
bionys-572	151	14	(	(	PUNCT
bionys-572	151	15	n=19	n=19	PROPN
bionys-572	151	16	)	)	PUNCT
bionys-572	151	17	absent	absent	ADJ
bionys-572	151	18	oxalate	oxalate	NOUN
bionys-572	151	19	excretion	excretion	NOUN
bionys-572	151	20	(	(	PUNCT
bionys-572	151	21	n=20	n=20	PROPN
bionys-572	151	22	)	)	PUNCT
bionys-572	151	23	(	(	PUNCT
bionys-572	151	24	mean±sd	mean±sd	NOUN
bionys-572	151	25	)	)	PUNCT
bionys-572	151	26	calcium	calcium	NOUN
bionys-572	151	27	(	(	PUNCT
bionys-572	151	28	mmol	mmol	NOUN
bionys-572	151	29	/	/	SYM
bionys-572	151	30	l	l	NOUN
bionys-572	151	31	)	)	PUNCT
bionys-572	152	1	2.37±0.25	2.37±0.25	NOUN
bionys-572	152	2	2.34±0.22	2.34±0.22	NUM
bionys-572	152	3	alt	alt	NOUN
bionys-572	152	4	(	(	PUNCT
bionys-572	152	5	un	un	PROPN
bionys-572	152	6	/	/	SYM
bionys-572	152	7	l	l	NOUN
bionys-572	152	8	)	)	PUNCT
bionys-572	152	9	27.4±1.24	27.4±1.24	NUM
bionys-572	152	10	*	*	SYM
bionys-572	152	11	23.42±1.1	23.42±1.1	NOUN
bionys-572	152	12	ast	ast	NOUN
bionys-572	152	13	(	(	PUNCT
bionys-572	152	14	un	un	PROPN
bionys-572	152	15	/	/	SYM
bionys-572	152	16	l	l	NOUN
bionys-572	152	17	)	)	PUNCT
bionys-572	153	1	29.21±1.4	29.21±1.4	PROPN
bionys-572	153	2	26.87±1.2	26.87±1.2	NUM
bionys-572	153	3	crp	crp	NOUN
bionys-572	153	4	(	(	PUNCT
bionys-572	153	5	mg	mg	PROPN
bionys-572	153	6	/	/	SYM
bionys-572	153	7	l	l	NOUN
bionys-572	153	8	)	)	PUNCT
bionys-572	153	9	62.74±11.7	62.74±11.7	NUM
bionys-572	153	10	*	*	X
bionys-572	153	11	35.7±7.2	35.7±7.2	NUM
bionys-572	153	12	alph	alph	VERB
bionys-572	153	13	(	(	PUNCT
bionys-572	153	14	un	un	PROPN
bionys-572	153	15	/	/	SYM
bionys-572	153	16	l	l	NOUN
bionys-572	153	17	)	)	PUNCT
bionys-572	153	18	345.67±26.8	345.67±26.8	NUM
bionys-572	153	19	334.56±22.1	334.56±22.1	NUM
bionys-572	153	20	p<0.05	p<0.05	NOUN
bionys-572	153	21	table	table	NOUN
bionys-572	153	22	4	4	NUM
bionys-572	153	23	.	.	PUNCT
bionys-572	153	24	correlation	correlation	NOUN
bionys-572	153	25	analysis	analysis	NOUN
bionys-572	153	26	of	of	ADP
bionys-572	153	27	biochemical	biochemical	ADJ
bionys-572	153	28	parameters	parameter	NOUN
bionys-572	153	29	in	in	ADP
bionys-572	153	30	patients	patient	NOUN
bionys-572	153	31	with	with	ADP
bionys-572	153	32	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	153	33	variables	variables	PROPN
bionys-572	153	34	calcium	calcium	NOUN
bionys-572	153	35	ast	ast	PROPN
bionys-572	153	36	alt	alt	PROPN
bionys-572	153	37	rbc	rbc	PROPN
bionys-572	153	38	hb	hb	PROPN
bionys-572	153	39	esr	esr	PROPN
bionys-572	153	40	glucose	glucose	PROPN
bionys-572	153	41	-0.6	-0.6	X
bionys-572	153	42	-0.85	-0.85	X
bionys-572	153	43	-0.6	-0.6	PROPN
bionys-572	153	44	0.57	0.57	NUM
bionys-572	153	45	total	total	ADJ
bionys-572	153	46	protein	protein	NOUN
bionys-572	153	47	0.87	0.87	NUM
bionys-572	153	48	0.2	0.2	NUM
bionys-572	153	49	0.38	0.38	NUM
bionys-572	153	50	-0.82	-0.82	NUM
bionys-572	153	51	esr	esr	PROPN
bionys-572	153	52	-0.55	-0.55	PROPN
bionys-572	153	53	-0.48	-0.48	NUM
bionys-572	153	54	crp	crp	PROPN
bionys-572	153	55	-0.38	-0.38	PROPN
bionys-572	153	56	-0.38	-0.38	PROPN
bionys-572	153	57	0.64	0.64	NUM
bionys-572	153	58	calcium	calcium	NOUN
bionys-572	153	59	-0.56	-0.56	NUM
bionys-572	153	60	-0.3	-0.3	PROPN
bionys-572	153	61	ast	ast	NOUN
bionys-572	153	62	:	:	PUNCT
bionys-572	153	63	aspartate	aspartate	NOUN
bionys-572	153	64	aminotransferase	aminotransferase	NOUN
bionys-572	153	65	;	;	PUNCT
bionys-572	153	66	alt	alt	ADJ
bionys-572	153	67	:	:	PUNCT
bionys-572	153	68	alanine	alanine	NOUN
bionys-572	153	69	aminotransferase	aminotransferase	PROPN
bionys-572	153	70	;	;	PUNCT
bionys-572	153	71	blp	blp	PROPN
bionys-572	153	72	:	:	PUNCT
bionys-572	153	73	b	b	X
bionys-572	153	74	-	-	PUNCT
bionys-572	153	75	lipoproteins	lipoprotein	NOUN
bionys-572	153	76	;	;	PUNCT
bionys-572	153	77	rbc	rbc	PROPN
bionys-572	153	78	:	:	PUNCT
bionys-572	153	79	erythrocytes	erythrocyte	NOUN
bionys-572	153	80	;	;	PUNCT
bionys-572	153	81	hb	hb	X
bionys-572	153	82	:	:	PUNCT
bionys-572	153	83	hemoglobin	hemoglobin	NOUN
bionys-572	153	84	;	;	PUNCT
bionys-572	153	85	crp	crp	PROPN
bionys-572	153	86	:	:	PUNCT
bionys-572	153	87	c	c	X
bionys-572	153	88	-	-	PUNCT
bionys-572	153	89	reactive	reactive	ADJ
bionys-572	153	90	protein	protein	NOUN
bionys-572	153	91	;	;	PUNCT
bionys-572	153	92	esr	esr	NOUN
bionys-572	153	93	:	:	PUNCT
bionys-572	153	94	erythrocyte	erythrocyte	PROPN
bionys-572	153	95	sedimentation	sedimentation	NOUN
bionys-572	153	96	rate	rate	NOUN
bionys-572	153	97	.	.	PUNCT
bionys-572	154	1	only	only	ADV
bionys-572	154	2	correlations	correlation	NOUN
bionys-572	154	3	with	with	ADP
bionys-572	154	4	p<0.05	p<0.05	NOUN
bionys-572	154	5	are	be	AUX
bionys-572	154	6	shown	show	VERB
bionys-572	154	7	urine	urine	NOUN
bionys-572	154	8	specific	specific	ADJ
bionys-572	154	9	gravity	gravity	NOUN
bionys-572	154	10	demonstrated	demonstrate	VERB
bionys-572	154	11	strong	strong	ADJ
bionys-572	154	12	positive	positive	ADJ
bionys-572	154	13	correlations	correlation	NOUN
bionys-572	154	14	with	with	ADP
bionys-572	154	15	serum	serum	NOUN
bionys-572	154	16	glucose	glucose	NOUN
bionys-572	154	17	(	(	PUNCT
bionys-572	154	18	r=0.77	r=0.77	NOUN
bionys-572	154	19	)	)	PUNCT
bionys-572	154	20	and	and	CCONJ
bionys-572	154	21	b	b	X
bionys-572	154	22	-	-	PUNCT
bionys-572	154	23	lipoproteins	lipoprotein	NOUN
bionys-572	154	24	(	(	PUNCT
bionys-572	154	25	r=0.94	r=0.94	NOUN
bionys-572	154	26	)	)	PUNCT
bionys-572	154	27	(	(	PUNCT
bionys-572	154	28	p<0.05	p<0.05	NOUN
bionys-572	154	29	)	)	PUNCT
bionys-572	154	30	.	.	PUNCT
bionys-572	155	1	serum	serum	NOUN
bionys-572	155	2	glucose	glucose	NOUN
bionys-572	155	3	also	also	ADV
bionys-572	155	4	showed	show	VERB
bionys-572	155	5	moderate	moderate	ADJ
bionys-572	155	6	correlations	correlation	NOUN
bionys-572	155	7	with	with	ADP
bionys-572	155	8	total	total	ADJ
bionys-572	155	9	protein	protein	NOUN
bionys-572	155	10	(	(	PUNCT
bionys-572	155	11	r=0.30	r=0.30	NOUN
bionys-572	155	12	)	)	PUNCT
bionys-572	155	13	and	and	CCONJ
bionys-572	155	14	eosinophils	eosinophil	NOUN
bionys-572	155	15	(	(	PUNCT
bionys-572	155	16	r=0.20	r=0.20	X
bionys-572	155	17	)	)	PUNCT
bionys-572	155	18	(	(	PUNCT
bionys-572	155	19	p<0.05	p<0.05	NOUN
bionys-572	155	20	)	)	PUNCT
bionys-572	155	21	,	,	PUNCT
bionys-572	155	22	while	while	SCONJ
bionys-572	155	23	creatinine	creatinine	NOUN
bionys-572	155	24	was	be	AUX
bionys-572	155	25	negatively	negatively	ADV
bionys-572	155	26	correlated	correlate	VERB
bionys-572	155	27	with	with	ADP
bionys-572	155	28	glucose	glucose	NOUN
bionys-572	155	29	(	(	PUNCT
bionys-572	155	30	r=	r=	ADJ
bionys-572	155	31	-0.65	-0.65	NUM
bionys-572	155	32	)	)	PUNCT
bionys-572	155	33	.	.	PUNCT
bionys-572	156	1	a	a	DET
bionys-572	156	2	strong	strong	ADJ
bionys-572	156	3	inverse	inverse	NOUN
bionys-572	156	4	correlation	correlation	NOUN
bionys-572	156	5	was	be	AUX
bionys-572	156	6	observed	observe	VERB
bionys-572	156	7	between	between	ADP
bionys-572	156	8	neutrophil	neutrophil	ADJ
bionys-572	156	9	count	count	NOUN
bionys-572	156	10	and	and	CCONJ
bionys-572	156	11	total	total	ADJ
bionys-572	156	12	protein	protein	NOUN
bionys-572	156	13	(	(	PUNCT
bionys-572	156	14	r=	r=	NOUN
bionys-572	156	15	-0.87	-0.87	NUM
bionys-572	156	16	)	)	PUNCT
bionys-572	157	1	253	253	NUM
bionys-572	157	2	biologica	biologica	PROPN
bionys-572	157	3	nyssana	nyssana	PROPN
bionys-572	157	4	●	●	PUNCT
bionys-572	157	5	16	16	NUM
bionys-572	157	6	(	(	PUNCT
bionys-572	157	7	1	1	NUM
bionys-572	157	8	)	)	PUNCT
bionys-572	157	9	june	june	PROPN
bionys-572	157	10	2025	2025	NUM
bionys-572	157	11	:	:	PUNCT
bionys-572	157	12	247	247	NUM
bionys-572	157	13	-	-	SYM
bionys-572	157	14	257	257	NUM
bionys-572	157	15	kravchun	kravchun	NOUN
bionys-572	157	16	et	et	PROPN
bionys-572	157	17	al	al	PROPN
bionys-572	157	18	.	.	PUNCT
bionys-572	158	1	●	●	PUNCT
bionys-572	158	2	different	different	ADJ
bionys-572	158	3	types	type	NOUN
bionys-572	158	4	of	of	ADP
bionys-572	158	5	crystalluria	crystalluria	PROPN
bionys-572	158	6	in	in	ADP
bionys-572	158	7	patients	patient	NOUN
bionys-572	158	8	with	with	ADP
bionys-572	158	9	bone	bone	NOUN
bionys-572	158	10	and	and	CCONJ
bionys-572	158	11	joint	joint	ADJ
bionys-572	158	12	tissue	tissue	NOUN
bionys-572	158	13	pathology	pathology	NOUN
bionys-572	158	14	:	:	PUNCT
bionys-572	158	15	hematological	hematological	ADJ
bionys-572	158	16	and	and	CCONJ
bionys-572	158	17	biochemical	biochemical	ADJ
bionys-572	158	18	profiles	profile	NOUN
bionys-572	158	19	with	with	ADP
bionys-572	158	20	uraturia	uraturia	NOUN
bionys-572	158	21	in	in	ADP
bionys-572	158	22	this	this	DET
bionys-572	158	23	study	study	NOUN
bionys-572	158	24	supports	support	VERB
bionys-572	158	25	existing	exist	VERB
bionys-572	158	26	evidence	evidence	NOUN
bionys-572	158	27	suggesting	suggest	VERB
bionys-572	158	28	that	that	SCONJ
bionys-572	158	29	elevated	elevated	ADJ
bionys-572	158	30	uric	uric	ADJ
bionys-572	158	31	acid	acid	NOUN
bionys-572	158	32	contributes	contribute	VERB
bionys-572	158	33	to	to	AUX
bionys-572	158	34	carbohydrate	carbohydrate	VERB
bionys-572	158	35	dysmetabolism	dysmetabolism	NOUN
bionys-572	158	36	(	(	PUNCT
bionys-572	158	37	yang	yang	PROPN
bionys-572	158	38	et	et	PROPN
bionys-572	158	39	al	al	PROPN
bionys-572	158	40	.	.	PROPN
bionys-572	158	41	,	,	PUNCT
bionys-572	158	42	2023	2023	NUM
bionys-572	158	43	)	)	PUNCT
bionys-572	158	44	.	.	PUNCT
bionys-572	159	1	the	the	DET
bionys-572	159	2	levels	level	NOUN
bionys-572	159	3	of	of	ADP
bionys-572	159	4	glycoproteins	glycoprotein	NOUN
bionys-572	159	5	in	in	ADP
bionys-572	159	6	individuals	individual	NOUN
bionys-572	159	7	with	with	ADP
bionys-572	159	8	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	159	9	(	(	PUNCT
bionys-572	159	10	0.71±0.11	0.71±0.11	ADV
bionys-572	159	11	g	g	PROPN
bionys-572	159	12	/	/	SYM
bionys-572	159	13	l	l	NOUN
bionys-572	159	14	)	)	PUNCT
bionys-572	159	15	and	and	CCONJ
bionys-572	159	16	uraturia	uraturia	INTJ
bionys-572	159	17	(	(	PUNCT
bionys-572	159	18	0.78±0.13	0.78±0.13	NOUN
bionys-572	159	19	g	g	NOUN
bionys-572	159	20	/	/	SYM
bionys-572	159	21	l	l	NOUN
bionys-572	159	22	)	)	PUNCT
bionys-572	159	23	did	do	AUX
bionys-572	159	24	not	not	PART
bionys-572	159	25	differ	differ	VERB
bionys-572	159	26	significantly	significantly	ADV
bionys-572	159	27	from	from	ADP
bionys-572	159	28	the	the	DET
bionys-572	159	29	control	control	NOUN
bionys-572	159	30	group	group	NOUN
bionys-572	159	31	(	(	PUNCT
bionys-572	159	32	0.65±0.10	0.65±0.10	NOUN
bionys-572	159	33	g	g	PROPN
bionys-572	159	34	/	/	SYM
bionys-572	159	35	l	l	NOUN
bionys-572	159	36	)	)	PUNCT
bionys-572	159	37	.	.	PUNCT
bionys-572	160	1	similarly	similarly	ADV
bionys-572	160	2	,	,	PUNCT
bionys-572	160	3	chondroitin	chondroitin	NOUN
bionys-572	160	4	sulfate	sulfate	NOUN
bionys-572	160	5	levels	level	NOUN
bionys-572	160	6	were	be	AUX
bionys-572	160	7	comparable	comparable	ADJ
bionys-572	160	8	across	across	ADP
bionys-572	160	9	groups	group	NOUN
bionys-572	160	10	:	:	PUNCT
bionys-572	160	11	0.207±0.032	0.207±0.032	NUM
bionys-572	160	12	g	g	NOUN
bionys-572	160	13	/	/	SYM
bionys-572	160	14	l	l	NOUN
bionys-572	160	15	in	in	ADP
bionys-572	160	16	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	160	17	,	,	PUNCT
bionys-572	160	18	0.187±0.020	0.187±0.020	VERB
bionys-572	160	19	g	g	NOUN
bionys-572	160	20	/	/	SYM
bionys-572	160	21	l	l	NOUN
bionys-572	160	22	in	in	ADP
bionys-572	160	23	uraturia	uraturia	NOUN
bionys-572	160	24	,	,	PUNCT
bionys-572	160	25	and	and	CCONJ
bionys-572	160	26	0.190±0.020	0.190±0.020	ADP
bionys-572	160	27	g	g	NOUN
bionys-572	160	28	/	/	SYM
bionys-572	160	29	l	l	NOUN
bionys-572	160	30	in	in	ADP
bionys-572	160	31	controls	control	NOUN
bionys-572	160	32	.	.	PUNCT
bionys-572	161	1	patients	patient	NOUN
bionys-572	161	2	with	with	ADP
bionys-572	161	3	phosphaturia	phosphaturia	PROPN
bionys-572	161	4	phosphaturia	phosphaturia	PROPN
bionys-572	161	5	was	be	AUX
bionys-572	161	6	the	the	DET
bionys-572	161	7	least	least	ADV
bionys-572	161	8	frequently	frequently	ADV
bionys-572	161	9	observed	observe	VERB
bionys-572	161	10	type	type	NOUN
bionys-572	161	11	of	of	ADP
bionys-572	161	12	crystalluria	crystalluria	NOUN
bionys-572	161	13	among	among	ADP
bionys-572	161	14	individuals	individual	NOUN
bionys-572	161	15	with	with	ADP
bionys-572	161	16	bone	bone	NOUN
bionys-572	161	17	and	and	CCONJ
bionys-572	161	18	joint	joint	ADJ
bionys-572	161	19	tissue	tissue	NOUN
bionys-572	161	20	pathology	pathology	NOUN
bionys-572	161	21	,	,	PUNCT
bionys-572	161	22	detected	detect	VERB
bionys-572	161	23	in	in	ADP
bionys-572	161	24	only	only	ADV
bionys-572	161	25	10	10	NUM
bionys-572	161	26	patients	patient	NOUN
bionys-572	161	27	(	(	PUNCT
bionys-572	161	28	15.1	15.1	NUM
bionys-572	161	29	%	%	NOUN
bionys-572	161	30	)	)	PUNCT
bionys-572	161	31	.	.	PUNCT
bionys-572	162	1	this	this	DET
bionys-572	162	2	group	group	NOUN
bionys-572	162	3	demonstrated	demonstrate	VERB
bionys-572	162	4	a	a	DET
bionys-572	162	5	22	22	NUM
bionys-572	162	6	%	%	NOUN
bionys-572	162	7	increase	increase	NOUN
bionys-572	162	8	in	in	ADP
bionys-572	162	9	serum	serum	NOUN
bionys-572	162	10	aspartate	aspartate	NOUN
bionys-572	162	11	aminotransferase	aminotransferase	PROPN
bionys-572	162	12	(	(	PUNCT
bionys-572	162	13	ast	ast	NOUN
bionys-572	162	14	)	)	PUNCT
bionys-572	162	15	levels	level	NOUN
bionys-572	162	16	compared	compare	VERB
bionys-572	162	17	to	to	ADP
bionys-572	162	18	the	the	DET
bionys-572	162	19	control	control	NOUN
bionys-572	162	20	group	group	NOUN
bionys-572	162	21	(	(	PUNCT
bionys-572	162	22	p<0.05	p<0.05	PROPN
bionys-572	162	23	)	)	PUNCT
bionys-572	162	24	.	.	PUNCT
bionys-572	163	1	correlation	correlation	NOUN
bionys-572	163	2	analysis	analysis	NOUN
bionys-572	163	3	in	in	ADP
bionys-572	163	4	the	the	DET
bionys-572	163	5	phosphaturia	phosphaturia	PROPN
bionys-572	163	6	group	group	NOUN
bionys-572	163	7	revealed	reveal	VERB
bionys-572	163	8	only	only	ADJ
bionys-572	163	9	minor	minor	ADJ
bionys-572	163	10	abnormalities	abnormality	NOUN
bionys-572	163	11	.	.	PUNCT
bionys-572	164	1	serum	serum	NOUN
bionys-572	164	2	calcium	calcium	NOUN
bionys-572	164	3	levels	level	NOUN
bionys-572	164	4	correlated	correlate	VERB
bionys-572	164	5	weakly	weakly	ADV
bionys-572	164	6	with	with	ADP
bionys-572	164	7	chondroitin	chondroitin	NOUN
bionys-572	164	8	sulfates	sulfate	NOUN
bionys-572	164	9	(	(	PUNCT
bionys-572	164	10	r=0.25	r=0.25	NOUN
bionys-572	164	11	)	)	PUNCT
bionys-572	164	12	,	,	PUNCT
bionys-572	164	13	while	while	SCONJ
bionys-572	164	14	both	both	DET
bionys-572	164	15	alanine	alanine	NOUN
bionys-572	164	16	aminotransferase	aminotransferase	NOUN
bionys-572	164	17	(	(	PUNCT
bionys-572	164	18	alt	alt	ADJ
bionys-572	164	19	)	)	PUNCT
bionys-572	164	20	and	and	CCONJ
bionys-572	164	21	ast	ast	NOUN
bionys-572	164	22	showed	show	VERB
bionys-572	164	23	a	a	DET
bionys-572	164	24	moderate	moderate	ADJ
bionys-572	164	25	correlation	correlation	NOUN
bionys-572	164	26	with	with	ADP
bionys-572	164	27	glycoproteins	glycoprotein	NOUN
bionys-572	164	28	(	(	PUNCT
bionys-572	164	29	r=0.66	r=0.66	NOUN
bionys-572	164	30	)	)	PUNCT
bionys-572	164	31	.	.	PUNCT
bionys-572	165	1	chondroitin	chondroitin	NOUN
bionys-572	165	2	sulfate	sulfate	NOUN
bionys-572	165	3	levels	level	NOUN
bionys-572	165	4	were	be	AUX
bionys-572	165	5	also	also	ADV
bionys-572	165	6	weakly	weakly	ADV
bionys-572	165	7	associated	associate	VERB
bionys-572	165	8	with	with	ADP
bionys-572	165	9	total	total	ADJ
bionys-572	165	10	protein	protein	NOUN
bionys-572	165	11	(	(	PUNCT
bionys-572	165	12	r=0.25	r=0.25	NOUN
bionys-572	165	13	)	)	PUNCT
bionys-572	165	14	and	and	CCONJ
bionys-572	165	15	glycoproteins	glycoprotein	NOUN
bionys-572	165	16	(	(	PUNCT
bionys-572	165	17	r=0.25	r=0.25	NOUN
bionys-572	165	18	)	)	PUNCT
bionys-572	165	19	(	(	PUNCT
bionys-572	165	20	p<0.05	p<0.05	NOUN
bionys-572	165	21	)	)	PUNCT
bionys-572	165	22	.	.	PUNCT
bionys-572	166	1	patients	patient	NOUN
bionys-572	166	2	with	with	ADP
bionys-572	166	3	bone	bone	NOUN
bionys-572	166	4	fractures	fracture	NOUN
bionys-572	166	5	exhibited	exhibit	VERB
bionys-572	166	6	increased	increase	VERB
bionys-572	166	7	serum	serum	NOUN
bionys-572	166	8	glucose	glucose	NOUN
bionys-572	166	9	levels	level	NOUN
bionys-572	166	10	by	by	ADP
bionys-572	166	11	17	17	NUM
bionys-572	166	12	%	%	NOUN
bionys-572	166	13	and	and	CCONJ
bionys-572	166	14	thymol	thymol	NOUN
bionys-572	166	15	turbidity	turbidity	NOUN
bionys-572	166	16	values	value	NOUN
bionys-572	166	17	by	by	ADP
bionys-572	166	18	34	34	NUM
bionys-572	166	19	%	%	NOUN
bionys-572	166	20	(	(	PUNCT
bionys-572	166	21	p<0.05	p<0.05	NOUN
bionys-572	166	22	)	)	PUNCT
bionys-572	166	23	.	.	PUNCT
bionys-572	167	1	this	this	DET
bionys-572	167	2	study	study	NOUN
bionys-572	167	3	aimed	aim	VERB
bionys-572	167	4	to	to	PART
bionys-572	167	5	investigate	investigate	VERB
bionys-572	167	6	differences	difference	NOUN
bionys-572	167	7	in	in	ADP
bionys-572	167	8	biochemical	biochemical	ADJ
bionys-572	167	9	parameters	parameter	NOUN
bionys-572	167	10	among	among	ADP
bionys-572	167	11	patients	patient	NOUN
bionys-572	167	12	with	with	ADP
bionys-572	167	13	bone	bone	NOUN
bionys-572	167	14	and	and	CCONJ
bionys-572	167	15	joint	joint	ADJ
bionys-572	167	16	tissue	tissue	NOUN
bionys-572	167	17	pathology	pathology	NOUN
bionys-572	167	18	based	base	VERB
bionys-572	167	19	on	on	ADP
bionys-572	167	20	the	the	DET
bionys-572	167	21	type	type	NOUN
bionys-572	167	22	of	of	ADP
bionys-572	167	23	crystalluria	crystalluria	PROPN
bionys-572	167	24	,	,	PUNCT
bionys-572	167	25	and	and	CCONJ
bionys-572	167	26	to	to	PART
bionys-572	167	27	compare	compare	VERB
bionys-572	167	28	these	these	DET
bionys-572	167	29	findings	finding	NOUN
bionys-572	167	30	to	to	ADP
bionys-572	167	31	a	a	DET
bionys-572	167	32	control	control	NOUN
bionys-572	167	33	group	group	NOUN
bionys-572	167	34	.	.	PUNCT
bionys-572	168	1	additionally	additionally	ADV
bionys-572	168	2	,	,	PUNCT
bionys-572	168	3	the	the	DET
bionys-572	168	4	potential	potential	ADJ
bionys-572	168	5	association	association	NOUN
bionys-572	168	6	between	between	ADP
bionys-572	168	7	crystalluria	crystalluria	PROPN
bionys-572	168	8	type	type	NOUN
bionys-572	168	9	and	and	CCONJ
bionys-572	168	10	bone	bone	NOUN
bionys-572	168	11	or	or	CCONJ
bionys-572	168	12	joint	joint	ADJ
bionys-572	168	13	complications	complication	NOUN
bionys-572	168	14	was	be	AUX
bionys-572	168	15	explored	explore	VERB
bionys-572	168	16	.	.	PUNCT
bionys-572	169	1	bone	bone	NOUN
bionys-572	169	2	and	and	CCONJ
bionys-572	169	3	joint	joint	ADJ
bionys-572	169	4	tissue	tissue	NOUN
bionys-572	169	5	pathology	pathology	NOUN
bionys-572	169	6	remains	remain	VERB
bionys-572	169	7	a	a	DET
bionys-572	169	8	leading	lead	VERB
bionys-572	169	9	cause	cause	NOUN
bionys-572	169	10	of	of	ADP
bionys-572	169	11	morbidity	morbidity	NOUN
bionys-572	169	12	and	and	CCONJ
bionys-572	169	13	mortality	mortality	NOUN
bionys-572	169	14	,	,	PUNCT
bionys-572	169	15	particularly	particularly	ADV
bionys-572	169	16	in	in	ADP
bionys-572	169	17	aging	age	VERB
bionys-572	169	18	populations	population	NOUN
bionys-572	169	19	.	.	PUNCT
bionys-572	170	1	identifying	identify	VERB
bionys-572	170	2	and	and	CCONJ
bionys-572	170	3	managing	manage	VERB
bionys-572	170	4	risk	risk	NOUN
bionys-572	170	5	factors	factor	NOUN
bionys-572	170	6	is	be	AUX
bionys-572	170	7	therefore	therefore	ADV
bionys-572	170	8	essential	essential	ADJ
bionys-572	170	9	for	for	ADP
bionys-572	170	10	prevention	prevention	NOUN
bionys-572	170	11	and	and	CCONJ
bionys-572	170	12	treatment	treatment	NOUN
bionys-572	170	13	.	.	PUNCT
bionys-572	171	1	numerous	numerous	ADJ
bionys-572	171	2	risk	risk	NOUN
bionys-572	171	3	factors	factor	NOUN
bionys-572	171	4	have	have	AUX
bionys-572	171	5	been	be	AUX
bionys-572	171	6	implicated	implicate	VERB
bionys-572	171	7	in	in	ADP
bionys-572	171	8	the	the	DET
bionys-572	171	9	development	development	NOUN
bionys-572	171	10	of	of	ADP
bionys-572	171	11	such	such	ADJ
bionys-572	171	12	pathologies	pathology	NOUN
bionys-572	171	13	,	,	PUNCT
bionys-572	171	14	including	include	VERB
bionys-572	171	15	elevated	elevate	VERB
bionys-572	171	16	blood	blood	NOUN
bionys-572	171	17	glucose	glucose	NOUN
bionys-572	171	18	,	,	PUNCT
bionys-572	171	19	kidney	kidney	NOUN
bionys-572	171	20	disease	disease	NOUN
bionys-572	171	21	,	,	PUNCT
bionys-572	171	22	obesity	obesity	NOUN
bionys-572	171	23	,	,	PUNCT
bionys-572	171	24	and	and	CCONJ
bionys-572	171	25	dyslipidemia	dyslipidemia	NOUN
bionys-572	171	26	(	(	PUNCT
bionys-572	171	27	i̇zki	i̇zki	NOUN
bionys-572	171	28	et	et	PROPN
bionys-572	171	29	al	al	PROPN
bionys-572	171	30	.	.	PROPN
bionys-572	171	31	,	,	PUNCT
bionys-572	171	32	2024	2024	NUM
bionys-572	171	33	)	)	PUNCT
bionys-572	171	34	.	.	PUNCT
bionys-572	172	1	kidney	kidney	NOUN
bionys-572	172	2	dysfunction	dysfunction	NOUN
bionys-572	172	3	has	have	AUX
bionys-572	172	4	also	also	ADV
bionys-572	172	5	been	be	AUX
bionys-572	172	6	associated	associate	VERB
bionys-572	172	7	with	with	ADP
bionys-572	172	8	vascular	vascular	ADJ
bionys-572	172	9	wall	wall	NOUN
bionys-572	172	10	changes	change	NOUN
bionys-572	172	11	,	,	PUNCT
bionys-572	172	12	leading	lead	VERB
bionys-572	172	13	to	to	ADP
bionys-572	172	14	decreased	decrease	VERB
bionys-572	172	15	arterial	arterial	ADJ
bionys-572	172	16	elasticity	elasticity	NOUN
bionys-572	172	17	(	(	PUNCT
bionys-572	172	18	sarısoy	sarısoy	NOUN
bionys-572	172	19	et	et	PROPN
bionys-572	172	20	al	al	PROPN
bionys-572	172	21	.	.	PROPN
bionys-572	172	22	,	,	PUNCT
bionys-572	172	23	2024	2024	NUM
bionys-572	172	24	)	)	PUNCT
bionys-572	172	25	.	.	PUNCT
bionys-572	173	1	however	however	ADV
bionys-572	173	2	,	,	PUNCT
bionys-572	173	3	the	the	DET
bionys-572	173	4	role	role	NOUN
bionys-572	173	5	of	of	ADP
bionys-572	173	6	dysmetabolic	dysmetabolic	ADJ
bionys-572	173	7	nephropathy	nephropathy	NOUN
bionys-572	173	8	in	in	ADP
bionys-572	173	9	bone	bone	NOUN
bionys-572	173	10	and	and	CCONJ
bionys-572	173	11	joint	joint	ADJ
bionys-572	173	12	pathology	pathology	NOUN
bionys-572	173	13	remains	remains	AUX
bionys-572	173	14	poorly	poorly	ADV
bionys-572	173	15	defined	define	VERB
bionys-572	173	16	.	.	PUNCT
bionys-572	174	1	crystalluria	crystalluria	PROPN
bionys-572	174	2	,	,	PUNCT
bionys-572	174	3	characterized	characterize	VERB
bionys-572	174	4	by	by	ADP
bionys-572	174	5	increased	increase	VERB
bionys-572	174	6	urinary	urinary	ADJ
bionys-572	174	7	excretion	excretion	NOUN
bionys-572	174	8	of	of	ADP
bionys-572	174	9	oxalates	oxalate	NOUN
bionys-572	174	10	,	,	PUNCT
bionys-572	174	11	urates	urate	NOUN
bionys-572	174	12	,	,	PUNCT
bionys-572	174	13	and	and	CCONJ
bionys-572	174	14	phosphates	phosphate	NOUN
bionys-572	174	15	,	,	PUNCT
bionys-572	174	16	has	have	AUX
bionys-572	174	17	been	be	AUX
bionys-572	174	18	associated	associate	VERB
bionys-572	174	19	with	with	ADP
bionys-572	174	20	disorders	disorder	NOUN
bionys-572	174	21	of	of	ADP
bionys-572	174	22	connective	connective	ADJ
bionys-572	174	23	tissue	tissue	NOUN
bionys-572	174	24	metabolism	metabolism	NOUN
bionys-572	174	25	,	,	PUNCT
bionys-572	174	26	which	which	PRON
bionys-572	174	27	may	may	AUX
bionys-572	174	28	contribute	contribute	VERB
bionys-572	174	29	to	to	ADP
bionys-572	174	30	degenerative	degenerative	ADJ
bionys-572	174	31	and	and	CCONJ
bionys-572	174	32	dystrophic	dystrophic	ADJ
bionys-572	174	33	changes	change	NOUN
bionys-572	174	34	in	in	ADP
bionys-572	174	35	bones	bone	NOUN
bionys-572	174	36	and	and	CCONJ
bionys-572	174	37	joints	joint	NOUN
bionys-572	174	38	(	(	PUNCT
bionys-572	174	39	burlaka	burlaka	PROPN
bionys-572	174	40	et	et	PROPN
bionys-572	174	41	al	al	PROPN
bionys-572	174	42	.	.	PROPN
bionys-572	174	43	,	,	PUNCT
bionys-572	174	44	2021	2021	NUM
bionys-572	174	45	)	)	PUNCT
bionys-572	174	46	.	.	PUNCT
bionys-572	175	1	the	the	DET
bionys-572	175	2	"	"	PUNCT
bionys-572	175	3	calcium	calcium	NOUN
bionys-572	175	4	paradox	paradox	NOUN
bionys-572	175	5	,	,	PUNCT
bionys-572	175	6	"	"	PUNCT
bionys-572	175	7	whereby	whereby	SCONJ
bionys-572	175	8	endothelial	endothelial	ADJ
bionys-572	175	9	cells	cell	NOUN
bionys-572	175	10	adopt	adopt	VERB
bionys-572	175	11	osteoblast	osteoblast	ADJ
bionys-572	175	12	-	-	PUNCT
bionys-572	175	13	like	like	ADJ
bionys-572	175	14	characteristics	characteristic	NOUN
bionys-572	175	15	and	and	CCONJ
bionys-572	175	16	sequester	sequester	NOUN
bionys-572	175	17	calcium	calcium	NOUN
bionys-572	175	18	crystals	crystal	NOUN
bionys-572	175	19	,	,	PUNCT
bionys-572	175	20	has	have	AUX
bionys-572	175	21	been	be	AUX
bionys-572	175	22	proposed	propose	VERB
bionys-572	175	23	as	as	ADP
bionys-572	175	24	a	a	DET
bionys-572	175	25	contributing	contribute	VERB
bionys-572	175	26	factor	factor	NOUN
bionys-572	175	27	in	in	ADP
bionys-572	175	28	bone	bone	NOUN
bionys-572	175	29	fragility	fragility	NOUN
bionys-572	175	30	and	and	CCONJ
bionys-572	175	31	calcinosis	calcinosis	NOUN
bionys-572	175	32	(	(	PUNCT
bionys-572	175	33	seker	seker	NOUN
bionys-572	175	34	et	et	PROPN
bionys-572	175	35	al	al	PROPN
bionys-572	175	36	.	.	PROPN
bionys-572	175	37	,	,	PUNCT
bionys-572	175	38	2024	2024	NUM
bionys-572	175	39	)	)	PUNCT
bionys-572	175	40	.	.	PUNCT
bionys-572	176	1	this	this	DET
bionys-572	176	2	study	study	NOUN
bionys-572	176	3	therefore	therefore	ADV
bionys-572	176	4	sought	seek	VERB
bionys-572	176	5	to	to	PART
bionys-572	176	6	determine	determine	VERB
bionys-572	176	7	the	the	DET
bionys-572	176	8	incidence	incidence	NOUN
bionys-572	176	9	and	and	CCONJ
bionys-572	176	10	structural	structural	ADJ
bionys-572	176	11	distribution	distribution	NOUN
bionys-572	176	12	of	of	ADP
bionys-572	176	13	crystalluria	crystalluria	NOUN
bionys-572	176	14	in	in	ADP
bionys-572	176	15	patients	patient	NOUN
bionys-572	176	16	with	with	ADP
bionys-572	176	17	bone	bone	NOUN
bionys-572	176	18	and	and	CCONJ
bionys-572	176	19	joint	joint	ADJ
bionys-572	176	20	tissue	tissue	NOUN
bionys-572	176	21	pathology	pathology	NOUN
bionys-572	176	22	and	and	CCONJ
bionys-572	176	23	to	to	PART
bionys-572	176	24	analyze	analyze	VERB
bionys-572	176	25	biochemical	biochemical	ADJ
bionys-572	176	26	profiles	profile	NOUN
bionys-572	176	27	according	accord	VERB
bionys-572	176	28	to	to	ADP
bionys-572	176	29	the	the	DET
bionys-572	176	30	type	type	NOUN
bionys-572	176	31	of	of	ADP
bionys-572	176	32	crystalluria	crystalluria	PROPN
bionys-572	176	33	(	(	PUNCT
bionys-572	176	34	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	176	35	,	,	PUNCT
bionys-572	176	36	uraturia	uraturia	NOUN
bionys-572	176	37	,	,	PUNCT
bionys-572	176	38	phosphaturia	phosphaturia	NOUN
bionys-572	176	39	)	)	PUNCT
bionys-572	176	40	.	.	PUNCT
bionys-572	177	1	crystalluria	crystalluria	PROPN
bionys-572	177	2	was	be	AUX
bionys-572	177	3	present	present	ADJ
bionys-572	177	4	in	in	ADP
bionys-572	177	5	9	9	NUM
bionys-572	177	6	%	%	NOUN
bionys-572	177	7	of	of	ADP
bionys-572	177	8	the	the	DET
bionys-572	177	9	728	728	NUM
bionys-572	177	10	patients	patient	NOUN
bionys-572	177	11	with	with	ADP
bionys-572	177	12	bone	bone	NOUN
bionys-572	177	13	and	and	CCONJ
bionys-572	177	14	joint	joint	ADJ
bionys-572	177	15	tissue	tissue	NOUN
bionys-572	177	16	pathology	pathology	NOUN
bionys-572	177	17	.	.	PUNCT
bionys-572	178	1	among	among	ADP
bionys-572	178	2	these	these	PRON
bionys-572	178	3	,	,	PUNCT
bionys-572	178	4	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	178	5	was	be	AUX
bionys-572	178	6	the	the	DET
bionys-572	178	7	most	most	ADV
bionys-572	178	8	common	common	ADJ
bionys-572	178	9	form	form	NOUN
bionys-572	178	10	(	(	PUNCT
bionys-572	178	11	59	59	NUM
bionys-572	178	12	%	%	NOUN
bionys-572	178	13	)	)	PUNCT
bionys-572	178	14	,	,	PUNCT
bionys-572	178	15	followed	follow	VERB
bionys-572	178	16	by	by	ADP
bionys-572	178	17	uraturia	uraturia	PROPN
bionys-572	178	18	(	(	PUNCT
bionys-572	178	19	25.7	25.7	NUM
bionys-572	178	20	%	%	NOUN
bionys-572	178	21	)	)	PUNCT
bionys-572	178	22	and	and	CCONJ
bionys-572	178	23	phosphaturia	phosphaturia	PROPN
bionys-572	178	24	(	(	PUNCT
bionys-572	178	25	15.1	15.1	NUM
bionys-572	178	26	%	%	NOUN
bionys-572	178	27	)	)	PUNCT
bionys-572	178	28	.	.	PUNCT
bionys-572	179	1	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	179	2	has	have	AUX
bionys-572	179	3	been	be	AUX
bionys-572	179	4	linked	link	VERB
bionys-572	179	5	to	to	ADP
bionys-572	179	6	gastrointestinal	gastrointestinal	ADJ
bionys-572	179	7	disorders	disorder	NOUN
bionys-572	179	8	such	such	ADJ
bionys-572	179	9	as	as	ADP
bionys-572	179	10	chronic	chronic	ADJ
bionys-572	179	11	gastritis	gastritis	NOUN
bionys-572	179	12	,	,	PUNCT
bionys-572	179	13	biliary	biliary	ADJ
bionys-572	179	14	tract	tract	NOUN
bionys-572	179	15	dysfunction	dysfunction	NOUN
bionys-572	179	16	,	,	PUNCT
bionys-572	179	17	duodenal	duodenal	ADJ
bionys-572	179	18	ulcers	ulcer	NOUN
bionys-572	179	19	,	,	PUNCT
bionys-572	179	20	chronic	chronic	ADJ
bionys-572	179	21	enterocolitis	enterocolitis	NOUN
bionys-572	179	22	,	,	PUNCT
bionys-572	179	23	and	and	CCONJ
bionys-572	179	24	crohn	crohn	PROPN
bionys-572	179	25	’s	’s	PART
bionys-572	179	26	disease	disease	NOUN
bionys-572	179	27	(	(	PUNCT
bionys-572	179	28	basoglu	basoglu	PROPN
bionys-572	179	29	et	et	PROPN
bionys-572	179	30	al	al	PROPN
bionys-572	179	31	.	.	PROPN
bionys-572	179	32	,	,	PUNCT
bionys-572	179	33	2023	2023	NUM
bionys-572	179	34	)	)	PUNCT
bionys-572	179	35	,	,	PUNCT
bionys-572	179	36	as	as	ADV
bionys-572	179	37	well	well	ADV
bionys-572	179	38	as	as	ADP
bionys-572	179	39	joint	joint	ADJ
bionys-572	179	40	dysfunction	dysfunction	NOUN
bionys-572	179	41	and	and	CCONJ
bionys-572	179	42	oxalate	oxalate	NOUN
bionys-572	179	43	osteopathy	osteopathy	NOUN
bionys-572	179	44	(	(	PUNCT
bionys-572	179	45	hortabaas	hortabaas	NOUN
bionys-572	179	46	et	et	PROPN
bionys-572	179	47	al	al	PROPN
bionys-572	179	48	.	.	PROPN
bionys-572	179	49	,	,	PUNCT
bionys-572	179	50	2013	2013	NUM
bionys-572	179	51	;	;	PUNCT
bionys-572	179	52	hassona	hassona	NOUN
bionys-572	179	53	et	et	PROPN
bionys-572	179	54	al	al	PROPN
bionys-572	179	55	.	.	PROPN
bionys-572	179	56	,	,	PUNCT
bionys-572	179	57	2024	2024	NUM
bionys-572	179	58	)	)	PUNCT
bionys-572	179	59	.	.	PUNCT
bionys-572	180	1	several	several	ADJ
bionys-572	180	2	studies	study	NOUN
bionys-572	180	3	have	have	AUX
bionys-572	180	4	reported	report	VERB
bionys-572	180	5	skeletal	skeletal	ADJ
bionys-572	180	6	abnormalities	abnormality	NOUN
bionys-572	180	7	in	in	ADP
bionys-572	180	8	patients	patient	NOUN
bionys-572	180	9	with	with	ADP
bionys-572	180	10	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	180	11	(	(	PUNCT
bionys-572	180	12	bacchetta	bacchetta	NOUN
bionys-572	180	13	et	et	PROPN
bionys-572	180	14	al	al	PROPN
bionys-572	180	15	.	.	PROPN
bionys-572	180	16	,	,	PUNCT
bionys-572	180	17	2016	2016	NUM
bionys-572	180	18	)	)	PUNCT
bionys-572	180	19	.	.	PUNCT
bionys-572	181	1	an	an	DET
bionys-572	181	2	inverse	inverse	NOUN
bionys-572	181	3	relationship	relationship	NOUN
bionys-572	181	4	between	between	ADP
bionys-572	181	5	dietary	dietary	ADJ
bionys-572	181	6	calcium	calcium	NOUN
bionys-572	181	7	intake	intake	NOUN
bionys-572	181	8	and	and	CCONJ
bionys-572	181	9	the	the	DET
bionys-572	181	10	risk	risk	NOUN
bionys-572	181	11	of	of	ADP
bionys-572	181	12	stone	stone	NOUN
bionys-572	181	13	formation	formation	NOUN
bionys-572	181	14	has	have	AUX
bionys-572	181	15	also	also	ADV
bionys-572	181	16	been	be	AUX
bionys-572	181	17	observed	observe	VERB
bionys-572	181	18	.	.	PUNCT
bionys-572	182	1	notably	notably	ADV
bionys-572	182	2	,	,	PUNCT
bionys-572	182	3	elevated	elevated	ADJ
bionys-572	182	4	serum	serum	NOUN
bionys-572	182	5	alkaline	alkaline	NOUN
bionys-572	182	6	phosphatase	phosphatase	NOUN
bionys-572	182	7	in	in	ADP
bionys-572	182	8	individuals	individual	NOUN
bionys-572	182	9	with	with	ADP
bionys-572	182	10	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	182	11	has	have	AUX
bionys-572	182	12	been	be	AUX
bionys-572	182	13	linked	link	VERB
bionys-572	182	14	to	to	ADP
bionys-572	182	15	low	low	ADJ
bionys-572	182	16	-	-	PUNCT
bionys-572	182	17	calcium	calcium	NOUN
bionys-572	182	18	diets	diet	NOUN
bionys-572	182	19	.	.	PUNCT
bionys-572	183	1	the	the	DET
bionys-572	183	2	ratio	ratio	NOUN
bionys-572	183	3	of	of	ADP
bionys-572	183	4	ionized	ionized	ADJ
bionys-572	183	5	to	to	ADP
bionys-572	183	6	bound	bind	VERB
bionys-572	183	7	calcium	calcium	NOUN
bionys-572	183	8	is	be	AUX
bionys-572	183	9	influenced	influence	VERB
bionys-572	183	10	by	by	ADP
bionys-572	183	11	serum	serum	NOUN
bionys-572	183	12	albumin	albumin	ADJ
bionys-572	183	13	levels	level	NOUN
bionys-572	183	14	(	(	PUNCT
bionys-572	183	15	lalayiannis	lalayiannis	NOUN
bionys-572	183	16	et	et	PROPN
bionys-572	183	17	al	al	PROPN
bionys-572	183	18	.	.	PROPN
bionys-572	183	19	,	,	PUNCT
bionys-572	183	20	2024	2024	NUM
bionys-572	183	21	)	)	PUNCT
bionys-572	183	22	,	,	PUNCT
bionys-572	183	23	and	and	CCONJ
bionys-572	183	24	our	our	PRON
bionys-572	183	25	study	study	NOUN
bionys-572	183	26	confirmed	confirm	VERB
bionys-572	183	27	a	a	DET
bionys-572	183	28	strong	strong	ADJ
bionys-572	183	29	correlation	correlation	NOUN
bionys-572	183	30	between	between	ADP
bionys-572	183	31	total	total	ADJ
bionys-572	183	32	protein	protein	NOUN
bionys-572	183	33	and	and	CCONJ
bionys-572	183	34	calcium	calcium	NOUN
bionys-572	183	35	levels	level	NOUN
bionys-572	183	36	(	(	PUNCT
bionys-572	183	37	r=0.87	r=0.87	NOUN
bionys-572	183	38	,	,	PUNCT
bionys-572	183	39	p<0.05	p<0.05	NOUN
bionys-572	183	40	)	)	PUNCT
bionys-572	183	41	.	.	PUNCT
bionys-572	184	1	low	low	ADJ
bionys-572	184	2	dietary	dietary	ADJ
bionys-572	184	3	calcium	calcium	NOUN
bionys-572	184	4	intake	intake	NOUN
bionys-572	184	5	contributes	contribute	VERB
bionys-572	184	6	to	to	ADP
bionys-572	184	7	bone	bone	NOUN
bionys-572	184	8	demineralization	demineralization	NOUN
bionys-572	184	9	,	,	PUNCT
bionys-572	184	10	and	and	CCONJ
bionys-572	184	11	individuals	individual	NOUN
bionys-572	184	12	with	with	ADP
bionys-572	184	13	kidney	kidney	NOUN
bionys-572	184	14	stones	stone	NOUN
bionys-572	184	15	are	be	AUX
bionys-572	184	16	at	at	ADP
bionys-572	184	17	increased	increase	VERB
bionys-572	184	18	risk	risk	NOUN
bionys-572	184	19	for	for	ADP
bionys-572	184	20	osteoporotic	osteoporotic	ADJ
bionys-572	184	21	fractures	fracture	NOUN
bionys-572	184	22	.	.	PUNCT
bionys-572	185	1	other	other	ADJ
bionys-572	185	2	studies	study	NOUN
bionys-572	185	3	have	have	AUX
bionys-572	185	4	confirmed	confirm	VERB
bionys-572	185	5	a	a	DET
bionys-572	185	6	correlation	correlation	NOUN
bionys-572	185	7	between	between	ADP
bionys-572	185	8	low	low	ADJ
bionys-572	185	9	calcium	calcium	NOUN
bionys-572	185	10	intake	intake	NOUN
bionys-572	185	11	and	and	CCONJ
bionys-572	185	12	reduced	reduce	VERB
bionys-572	185	13	bone	bone	NOUN
bionys-572	185	14	mineral	mineral	NOUN
bionys-572	185	15	density	density	NOUN
bionys-572	185	16	(	(	PUNCT
bionys-572	185	17	joshi	joshi	PROPN
bionys-572	185	18	et	et	PROPN
bionys-572	185	19	al	al	PROPN
bionys-572	185	20	.	.	PROPN
bionys-572	185	21	,	,	PUNCT
bionys-572	185	22	2015	2015	NUM
bionys-572	185	23	)	)	PUNCT
bionys-572	185	24	.	.	PUNCT
bionys-572	186	1	supplementation	supplementation	NOUN
bionys-572	186	2	with	with	ADP
bionys-572	186	3	calcium	calcium	NOUN
bionys-572	186	4	and	and	CCONJ
bionys-572	186	5	lactose	lactose	NOUN
bionys-572	186	6	has	have	AUX
bionys-572	186	7	been	be	AUX
bionys-572	186	8	shown	show	VERB
bionys-572	186	9	to	to	PART
bionys-572	186	10	elevate	elevate	VERB
bionys-572	186	11	serum	serum	NOUN
bionys-572	186	12	calcium	calcium	NOUN
bionys-572	186	13	and	and	CCONJ
bionys-572	186	14	alkaline	alkaline	NOUN
bionys-572	186	15	phosphatase	phosphatase	NOUN
bionys-572	186	16	levels	level	NOUN
bionys-572	186	17	(	(	PUNCT
bionys-572	186	18	yang	yang	PROPN
bionys-572	186	19	et	et	PROPN
bionys-572	186	20	al	al	PROPN
bionys-572	186	21	.	.	PROPN
bionys-572	186	22	,	,	PUNCT
bionys-572	186	23	2024	2024	NUM
bionys-572	186	24	)	)	PUNCT
bionys-572	186	25	.	.	PUNCT
bionys-572	187	1	studies	study	NOUN
bionys-572	187	2	examining	examine	VERB
bionys-572	187	3	the	the	DET
bionys-572	187	4	association	association	NOUN
bionys-572	187	5	between	between	ADP
bionys-572	187	6	serum	serum	PROPN
bionys-572	187	7	uric	uric	ADJ
bionys-572	187	8	acid	acid	NOUN
bionys-572	187	9	and	and	CCONJ
bionys-572	187	10	bone	bone	NOUN
bionys-572	187	11	mineral	mineral	NOUN
bionys-572	187	12	density	density	NOUN
bionys-572	187	13	have	have	AUX
bionys-572	187	14	produced	produce	VERB
bionys-572	187	15	conflicting	conflicting	ADJ
bionys-572	187	16	results	result	NOUN
bionys-572	187	17	.	.	PUNCT
bionys-572	188	1	some	some	PRON
bionys-572	188	2	report	report	VERB
bionys-572	188	3	a	a	DET
bionys-572	188	4	positive	positive	ADJ
bionys-572	188	5	association	association	NOUN
bionys-572	188	6	between	between	ADP
bionys-572	188	7	uric	uric	ADJ
bionys-572	188	8	acid	acid	NOUN
bionys-572	188	9	levels	level	NOUN
bionys-572	188	10	and	and	CCONJ
bionys-572	188	11	bone	bone	NOUN
bionys-572	188	12	density	density	NOUN
bionys-572	188	13	(	(	PUNCT
bionys-572	188	14	ibrahim	ibrahim	PROPN
bionys-572	188	15	et	et	PROPN
bionys-572	188	16	al	al	PROPN
bionys-572	188	17	.	.	PROPN
bionys-572	188	18	,	,	PUNCT
bionys-572	188	19	2021	2021	NUM
bionys-572	188	20	;	;	PUNCT
bionys-572	188	21	kim	kim	PROPN
bionys-572	188	22	et	et	PROPN
bionys-572	188	23	al	al	PROPN
bionys-572	188	24	.	.	PROPN
bionys-572	188	25	,	,	PUNCT
bionys-572	188	26	2023	2023	NUM
bionys-572	188	27	;	;	PUNCT
bionys-572	188	28	li	li	PROPN
bionys-572	188	29	et	et	PROPN
bionys-572	188	30	al	al	PROPN
bionys-572	188	31	.	.	PROPN
bionys-572	188	32	,	,	PUNCT
bionys-572	188	33	2023	2023	NUM
bionys-572	188	34	)	)	PUNCT
bionys-572	188	35	,	,	PUNCT
bionys-572	188	36	while	while	SCONJ
bionys-572	188	37	others	other	NOUN
bionys-572	188	38	have	have	AUX
bionys-572	188	39	found	find	VERB
bionys-572	188	40	that	that	SCONJ
bionys-572	188	41	increased	increase	VERB
bionys-572	188	42	uric	uric	ADJ
bionys-572	188	43	acid	acid	NOUN
bionys-572	188	44	may	may	AUX
bionys-572	188	45	reduce	reduce	VERB
bionys-572	188	46	the	the	DET
bionys-572	188	47	risk	risk	NOUN
bionys-572	188	48	of	of	ADP
bionys-572	188	49	osteoporosis	osteoporosis	NOUN
bionys-572	188	50	(	(	PUNCT
bionys-572	188	51	lin	lin	PROPN
bionys-572	188	52	et	et	PROPN
bionys-572	188	53	al	al	PROPN
bionys-572	188	54	.	.	PROPN
bionys-572	188	55	,	,	PUNCT
bionys-572	188	56	2019	2019	NUM
bionys-572	188	57	)	)	PUNCT
bionys-572	188	58	.	.	PUNCT
bionys-572	189	1	at	at	ADP
bionys-572	189	2	physiological	physiological	ADJ
bionys-572	189	3	levels	level	NOUN
bionys-572	189	4	,	,	PUNCT
bionys-572	189	5	uric	uric	ADJ
bionys-572	189	6	acid	acid	NOUN
bionys-572	189	7	may	may	AUX
bionys-572	189	8	offer	offer	VERB
bionys-572	189	9	protection	protection	NOUN
bionys-572	189	10	against	against	ADP
bionys-572	189	11	bone	bone	NOUN
bionys-572	189	12	fractures	fracture	NOUN
bionys-572	189	13	.	.	PUNCT
bionys-572	190	1	however	however	ADV
bionys-572	190	2	,	,	PUNCT
bionys-572	190	3	in	in	ADP
bionys-572	190	4	cases	case	NOUN
bionys-572	190	5	of	of	ADP
bionys-572	190	6	hyperuricemia	hyperuricemia	NOUN
bionys-572	190	7	and	and	CCONJ
bionys-572	190	8	gout	gout	NOUN
bionys-572	190	9	,	,	PUNCT
bionys-572	190	10	uric	uric	ADJ
bionys-572	190	11	acid	acid	NOUN
bionys-572	190	12	is	be	AUX
bionys-572	190	13	associated	associate	VERB
bionys-572	190	14	with	with	ADP
bionys-572	190	15	increased	increase	VERB
bionys-572	190	16	bone	bone	NOUN
bionys-572	190	17	resorption	resorption	NOUN
bionys-572	190	18	and	and	CCONJ
bionys-572	190	19	fracture	fracture	NOUN
bionys-572	190	20	risk	risk	NOUN
bionys-572	190	21	(	(	PUNCT
bionys-572	190	22	yan	yan	PROPN
bionys-572	190	23	et	et	PROPN
bionys-572	190	24	al	al	PROPN
bionys-572	190	25	.	.	PROPN
bionys-572	190	26	,	,	PUNCT
bionys-572	190	27	2017	2017	NUM
bionys-572	190	28	)	)	PUNCT
bionys-572	190	29	.	.	PUNCT
bionys-572	191	1	some	some	DET
bionys-572	191	2	researchers	researcher	NOUN
bionys-572	191	3	have	have	AUX
bionys-572	191	4	identified	identify	VERB
bionys-572	191	5	a	a	DET
bionys-572	191	6	significant	significant	ADJ
bionys-572	191	7	negative	negative	ADJ
bionys-572	191	8	correlation	correlation	NOUN
bionys-572	191	9	between	between	ADP
bionys-572	191	10	serum	serum	NOUN
bionys-572	191	11	uric	uric	ADJ
bionys-572	191	12	acid	acid	NOUN
bionys-572	191	13	and	and	CCONJ
bionys-572	191	14	trabecular	trabecular	ADJ
bionys-572	191	15	bone	bone	NOUN
bionys-572	191	16	score	score	NOUN
bionys-572	191	17	(	(	PUNCT
bionys-572	191	18	kuwabara	kuwabara	PROPN
bionys-572	191	19	et	et	PROPN
bionys-572	191	20	al	al	PROPN
bionys-572	191	21	.	.	PROPN
bionys-572	191	22	,	,	PUNCT
bionys-572	191	23	2023	2023	NUM
bionys-572	191	24	)	)	PUNCT
bionys-572	191	25	.	.	PUNCT
bionys-572	192	1	uric	uric	ADJ
bionys-572	192	2	acid	acid	PROPN
bionys-572	192	3	has	have	AUX
bionys-572	192	4	also	also	ADV
bionys-572	192	5	been	be	AUX
bionys-572	192	6	associated	associate	VERB
bionys-572	192	7	with	with	ADP
bionys-572	192	8	altered	altered	ADJ
bionys-572	192	9	liver	liver	NOUN
bionys-572	192	10	enzyme	enzyme	NOUN
bionys-572	192	11	profiles	profile	NOUN
bionys-572	192	12	,	,	PUNCT
bionys-572	192	13	including	include	VERB
bionys-572	192	14	elevated	elevate	VERB
bionys-572	192	15	alt	alt	NOUN
bionys-572	192	16	levels	level	NOUN
bionys-572	192	17	.	.	PUNCT
bionys-572	193	1	high	high	ADJ
bionys-572	193	2	uric	uric	ADJ
bionys-572	193	3	acid	acid	NOUN
bionys-572	193	4	concentrations	concentration	NOUN
bionys-572	193	5	may	may	AUX
bionys-572	193	6	disrupt	disrupt	VERB
bionys-572	193	7	254	254	NUM
bionys-572	193	8	antioxidant	antioxidant	ADJ
bionys-572	193	9	defenses	defense	NOUN
bionys-572	193	10	and	and	CCONJ
bionys-572	193	11	contribute	contribute	VERB
bionys-572	193	12	to	to	ADP
bionys-572	193	13	liver	liver	NOUN
bionys-572	193	14	damage	damage	NOUN
bionys-572	193	15	(	(	PUNCT
bionys-572	193	16	anothaisintawee	anothaisintawee	NOUN
bionys-572	193	17	et	et	PROPN
bionys-572	193	18	al	al	PROPN
bionys-572	193	19	.	.	PROPN
bionys-572	193	20	,	,	PUNCT
bionys-572	193	21	2017	2017	NUM
bionys-572	193	22	)	)	PUNCT
bionys-572	193	23	.	.	PUNCT
bionys-572	194	1	increased	increase	VERB
bionys-572	194	2	levels	level	NOUN
bionys-572	194	3	of	of	ADP
bionys-572	194	4	both	both	DET
bionys-572	194	5	alt	alt	ADJ
bionys-572	194	6	and	and	CCONJ
bionys-572	194	7	uric	uric	ADJ
bionys-572	194	8	acid	acid	NOUN
bionys-572	194	9	have	have	AUX
bionys-572	194	10	been	be	AUX
bionys-572	194	11	linked	link	VERB
bionys-572	194	12	to	to	ADP
bionys-572	194	13	a	a	DET
bionys-572	194	14	higher	high	ADJ
bionys-572	194	15	incidence	incidence	NOUN
bionys-572	194	16	of	of	ADP
bionys-572	194	17	metabolic	metabolic	NOUN
bionys-572	194	18	syndrome	syndrome	NOUN
bionys-572	194	19	.	.	PUNCT
bionys-572	195	1	importantly	importantly	ADV
bionys-572	195	2	,	,	PUNCT
bionys-572	195	3	this	this	DET
bionys-572	195	4	study	study	NOUN
bionys-572	195	5	revealed	reveal	VERB
bionys-572	195	6	significant	significant	ADJ
bionys-572	195	7	differences	difference	NOUN
bionys-572	195	8	in	in	ADP
bionys-572	195	9	platelet	platelet	NOUN
bionys-572	195	10	counts	count	NOUN
bionys-572	195	11	depending	depend	VERB
bionys-572	195	12	on	on	ADP
bionys-572	195	13	the	the	DET
bionys-572	195	14	type	type	NOUN
bionys-572	195	15	of	of	ADP
bionys-572	195	16	crystalluria	crystalluria	PROPN
bionys-572	195	17	.	.	PUNCT
bionys-572	196	1	patients	patient	NOUN
bionys-572	196	2	with	with	ADP
bionys-572	196	3	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	196	4	had	have	VERB
bionys-572	196	5	significantly	significantly	ADV
bionys-572	196	6	higher	high	ADJ
bionys-572	196	7	platelet	platelet	NOUN
bionys-572	196	8	counts	count	NOUN
bionys-572	196	9	compared	compare	VERB
bionys-572	196	10	to	to	ADP
bionys-572	196	11	those	those	PRON
bionys-572	196	12	with	with	ADP
bionys-572	196	13	uraturia	uraturia	PROPN
bionys-572	196	14	(	(	PUNCT
bionys-572	196	15	p<0.05	p<0.05	PROPN
bionys-572	196	16	)	)	PUNCT
bionys-572	196	17	.	.	PUNCT
bionys-572	197	1	phosphaturia	phosphaturia	PROPN
bionys-572	197	2	has	have	AUX
bionys-572	197	3	been	be	AUX
bionys-572	197	4	associated	associate	VERB
bionys-572	197	5	with	with	ADP
bionys-572	197	6	skeletal	skeletal	ADJ
bionys-572	197	7	abnormalities	abnormality	NOUN
bionys-572	197	8	,	,	PUNCT
bionys-572	197	9	osteopenia	osteopenia	NOUN
bionys-572	197	10	,	,	PUNCT
bionys-572	197	11	and	and	CCONJ
bionys-572	197	12	osteoporosis	osteoporosis	NOUN
bionys-572	197	13	(	(	PUNCT
bionys-572	197	14	benson	benson	PROPN
bionys-572	197	15	et	et	PROPN
bionys-572	197	16	al	al	PROPN
bionys-572	197	17	.	.	PROPN
bionys-572	197	18	,	,	PUNCT
bionys-572	197	19	2022	2022	NUM
bionys-572	197	20	)	)	PUNCT
bionys-572	197	21	.	.	PUNCT
bionys-572	198	1	excessive	excessive	ADJ
bionys-572	198	2	phosphate	phosphate	ADJ
bionys-572	198	3	excretion	excretion	NOUN
bionys-572	198	4	in	in	ADP
bionys-572	198	5	urine	urine	NOUN
bionys-572	198	6	may	may	AUX
bionys-572	198	7	result	result	VERB
bionys-572	198	8	in	in	ADP
bionys-572	198	9	hypophosphatemia	hypophosphatemia	NOUN
bionys-572	198	10	due	due	ADP
bionys-572	198	11	to	to	ADP
bionys-572	198	12	reduced	reduce	VERB
bionys-572	198	13	intestinal	intestinal	ADJ
bionys-572	198	14	absorption	absorption	NOUN
bionys-572	198	15	.	.	PUNCT
bionys-572	199	1	renal	renal	ADJ
bionys-572	199	2	phosphate	phosphate	ADJ
bionys-572	199	3	waste	waste	NOUN
bionys-572	199	4	may	may	AUX
bionys-572	199	5	be	be	AUX
bionys-572	199	6	secondary	secondary	ADJ
bionys-572	199	7	to	to	ADP
bionys-572	199	8	elevated	elevate	VERB
bionys-572	199	9	parathyroid	parathyroid	ADJ
bionys-572	199	10	hormone	hormone	NOUN
bionys-572	199	11	levels	level	NOUN
bionys-572	199	12	or	or	CCONJ
bionys-572	199	13	the	the	DET
bionys-572	199	14	use	use	NOUN
bionys-572	199	15	of	of	ADP
bionys-572	199	16	loop	loop	NOUN
bionys-572	199	17	and	and	CCONJ
bionys-572	199	18	thiazide	thiazide	ADP
bionys-572	199	19	diuretics	diuretic	NOUN
bionys-572	199	20	.	.	PUNCT
bionys-572	200	1	phosphaturia	phosphaturia	PROPN
bionys-572	200	2	is	be	AUX
bionys-572	200	3	linked	link	VERB
bionys-572	200	4	to	to	ADP
bionys-572	200	5	decreased	decrease	VERB
bionys-572	200	6	bone	bone	NOUN
bionys-572	200	7	strength	strength	NOUN
bionys-572	200	8	and	and	CCONJ
bionys-572	200	9	typically	typically	ADV
bionys-572	200	10	presents	present	VERB
bionys-572	200	11	with	with	ADP
bionys-572	200	12	a	a	DET
bionys-572	200	13	low	low	ADJ
bionys-572	200	14	urinary	urinary	ADJ
bionys-572	200	15	calcium	calcium	NOUN
bionys-572	200	16	-	-	PUNCT
bionys-572	200	17	to	to	ADP
bionys-572	200	18	-	-	PUNCT
bionys-572	200	19	creatinine	creatinine	NOUN
bionys-572	200	20	ratio	ratio	NOUN
bionys-572	200	21	and	and	CCONJ
bionys-572	200	22	a	a	DET
bionys-572	200	23	serum	serum	NOUN
bionys-572	200	24	calcium	calcium	NOUN
bionys-572	200	25	×	×	NOUN
bionys-572	200	26	phosphorus	phosphorus	NOUN
bionys-572	200	27	product	product	NOUN
bionys-572	200	28	below	below	ADP
bionys-572	200	29	30	30	NUM
bionys-572	200	30	(	(	PUNCT
bionys-572	200	31	mitri	mitri	PROPN
bionys-572	200	32	et	et	PROPN
bionys-572	200	33	al	al	PROPN
bionys-572	200	34	.	.	PROPN
bionys-572	200	35	,	,	PUNCT
bionys-572	200	36	2012	2012	NUM
bionys-572	200	37	)	)	PUNCT
bionys-572	200	38	.	.	PUNCT
bionys-572	201	1	in	in	ADP
bionys-572	201	2	summary	summary	NOUN
bionys-572	201	3	,	,	PUNCT
bionys-572	201	4	this	this	DET
bionys-572	201	5	study	study	NOUN
bionys-572	201	6	demonstrated	demonstrate	VERB
bionys-572	201	7	distinct	distinct	ADJ
bionys-572	201	8	biochemical	biochemical	ADJ
bionys-572	201	9	profiles	profile	NOUN
bionys-572	201	10	associated	associate	VERB
bionys-572	201	11	with	with	ADP
bionys-572	201	12	different	different	ADJ
bionys-572	201	13	types	type	NOUN
bionys-572	201	14	of	of	ADP
bionys-572	201	15	crystalluria	crystalluria	PROPN
bionys-572	201	16	in	in	ADP
bionys-572	201	17	patients	patient	NOUN
bionys-572	201	18	with	with	ADP
bionys-572	201	19	bone	bone	NOUN
bionys-572	201	20	and	and	CCONJ
bionys-572	201	21	joint	joint	ADJ
bionys-572	201	22	tissue	tissue	NOUN
bionys-572	201	23	pathology	pathology	NOUN
bionys-572	201	24	.	.	PUNCT
bionys-572	202	1	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	202	2	was	be	AUX
bionys-572	202	3	associated	associate	VERB
bionys-572	202	4	with	with	ADP
bionys-572	202	5	inflammation	inflammation	NOUN
bionys-572	202	6	(	(	PUNCT
bionys-572	202	7	leukocytosis	leukocytosis	PROPN
bionys-572	202	8	,	,	PUNCT
bionys-572	202	9	elevated	elevated	ADJ
bionys-572	202	10	esr	esr	NOUN
bionys-572	202	11	)	)	PUNCT
bionys-572	202	12	,	,	PUNCT
bionys-572	202	13	thrombocytosis	thrombocytosis	NOUN
bionys-572	202	14	(	(	PUNCT
bionys-572	202	15	increased	increase	VERB
bionys-572	202	16	platelet	platelet	NOUN
bionys-572	202	17	count	count	NOUN
bionys-572	202	18	)	)	PUNCT
bionys-572	202	19	,	,	PUNCT
bionys-572	202	20	and	and	CCONJ
bionys-572	202	21	bile	bile	NOUN
bionys-572	202	22	stagnation	stagnation	NOUN
bionys-572	202	23	(	(	PUNCT
bionys-572	202	24	elevated	elevated	ADJ
bionys-572	202	25	alkaline	alkaline	NOUN
bionys-572	202	26	phosphatase	phosphatase	NOUN
bionys-572	202	27	)	)	PUNCT
bionys-572	202	28	.	.	PUNCT
bionys-572	203	1	hyperglycemia	hyperglycemia	NOUN
bionys-572	203	2	was	be	AUX
bionys-572	203	3	observed	observe	VERB
bionys-572	203	4	in	in	ADP
bionys-572	203	5	patients	patient	NOUN
bionys-572	203	6	with	with	ADP
bionys-572	203	7	uraturia	uraturia	NOUN
bionys-572	203	8	,	,	PUNCT
bionys-572	203	9	underscoring	underscore	VERB
bionys-572	203	10	the	the	DET
bionys-572	203	11	need	need	NOUN
bionys-572	203	12	for	for	ADP
bionys-572	203	13	glucose	glucose	NOUN
bionys-572	203	14	monitoring	monitoring	NOUN
bionys-572	203	15	in	in	ADP
bionys-572	203	16	this	this	DET
bionys-572	203	17	population	population	NOUN
bionys-572	203	18	.	.	PUNCT
bionys-572	204	1	elevated	elevated	ADJ
bionys-572	204	2	ast	ast	NOUN
bionys-572	204	3	levels	level	NOUN
bionys-572	204	4	were	be	AUX
bionys-572	204	5	found	find	VERB
bionys-572	204	6	in	in	ADP
bionys-572	204	7	individuals	individual	NOUN
bionys-572	204	8	with	with	ADP
bionys-572	204	9	phosphaturia	phosphaturia	PROPN
bionys-572	204	10	.	.	PUNCT
bionys-572	205	1	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	205	2	was	be	AUX
bionys-572	205	3	also	also	ADV
bionys-572	205	4	associated	associate	VERB
bionys-572	205	5	with	with	ADP
bionys-572	205	6	an	an	DET
bionys-572	205	7	increased	increase	VERB
bionys-572	205	8	risk	risk	NOUN
bionys-572	205	9	of	of	ADP
bionys-572	205	10	bone	bone	NOUN
bionys-572	205	11	fractures	fracture	NOUN
bionys-572	205	12	.	.	PUNCT
bionys-572	206	1	while	while	SCONJ
bionys-572	206	2	dysmetabolic	dysmetabolic	ADJ
bionys-572	206	3	changes	change	NOUN
bionys-572	206	4	are	be	AUX
bionys-572	206	5	often	often	ADV
bionys-572	206	6	difficult	difficult	ADJ
bionys-572	206	7	to	to	PART
bionys-572	206	8	reverse	reverse	VERB
bionys-572	206	9	,	,	PUNCT
bionys-572	206	10	dietary	dietary	ADJ
bionys-572	206	11	modifications	modification	NOUN
bionys-572	206	12	and	and	CCONJ
bionys-572	206	13	appropriate	appropriate	ADJ
bionys-572	206	14	treatment	treatment	NOUN
bionys-572	206	15	of	of	ADP
bionys-572	206	16	crystalluria	crystalluria	NOUN
bionys-572	206	17	may	may	AUX
bionys-572	206	18	substantially	substantially	ADV
bionys-572	206	19	improve	improve	VERB
bionys-572	206	20	clinical	clinical	ADJ
bionys-572	206	21	outcomes	outcome	NOUN
bionys-572	206	22	in	in	ADP
bionys-572	206	23	patients	patient	NOUN
bionys-572	206	24	with	with	ADP
bionys-572	206	25	bone	bone	NOUN
bionys-572	206	26	and	and	CCONJ
bionys-572	206	27	joint	joint	ADJ
bionys-572	206	28	tissue	tissue	NOUN
bionys-572	206	29	pathology	pathology	NOUN
bionys-572	206	30	.	.	PUNCT
bionys-572	207	1	prior	prior	ADJ
bionys-572	207	2	studies	study	NOUN
bionys-572	207	3	have	have	AUX
bionys-572	207	4	shown	show	VERB
bionys-572	207	5	that	that	SCONJ
bionys-572	207	6	even	even	ADV
bionys-572	207	7	in	in	ADP
bionys-572	207	8	advanced	advanced	ADJ
bionys-572	207	9	stages	stage	NOUN
bionys-572	207	10	of	of	ADP
bionys-572	207	11	renal	renal	ADJ
bionys-572	207	12	dysfunction	dysfunction	NOUN
bionys-572	207	13	,	,	PUNCT
bionys-572	207	14	reducing	reduce	VERB
bionys-572	207	15	dietary	dietary	ADJ
bionys-572	207	16	oxalate	oxalate	NOUN
bionys-572	207	17	intake	intake	NOUN
bionys-572	207	18	may	may	AUX
bionys-572	207	19	normalize	normalize	VERB
bionys-572	207	20	serum	serum	NOUN
bionys-572	207	21	creatinine	creatinine	NOUN
bionys-572	207	22	and	and	CCONJ
bionys-572	207	23	urinary	urinary	ADJ
bionys-572	207	24	markers	marker	NOUN
bionys-572	207	25	(	(	PUNCT
bionys-572	207	26	sun	sun	PROPN
bionys-572	207	27	et	et	PROPN
bionys-572	207	28	al	al	PROPN
bionys-572	207	29	.	.	PROPN
bionys-572	207	30	,	,	PUNCT
bionys-572	207	31	2017	2017	NUM
bionys-572	207	32	)	)	PUNCT
bionys-572	207	33	.	.	PUNCT
bionys-572	208	1	conclusion	conclusion	NOUN
bionys-572	208	2	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	208	3	in	in	ADP
bionys-572	208	4	individuals	individual	NOUN
bionys-572	208	5	with	with	ADP
bionys-572	208	6	bone	bone	NOUN
bionys-572	208	7	and	and	CCONJ
bionys-572	208	8	joint	joint	ADJ
bionys-572	208	9	tissue	tissue	NOUN
bionys-572	208	10	pathology	pathology	NOUN
bionys-572	208	11	was	be	AUX
bionys-572	208	12	associated	associate	VERB
bionys-572	208	13	with	with	ADP
bionys-572	208	14	leukocytosis	leukocytosis	NOUN
bionys-572	208	15	,	,	PUNCT
bionys-572	208	16	eosinophilia	eosinophilia	PROPN
bionys-572	208	17	,	,	PUNCT
bionys-572	208	18	and	and	CCONJ
bionys-572	208	19	elevated	elevated	ADJ
bionys-572	208	20	levels	level	NOUN
bionys-572	208	21	of	of	ADP
bionys-572	208	22	both	both	DET
bionys-572	208	23	platelets	platelet	NOUN
bionys-572	208	24	and	and	CCONJ
bionys-572	208	25	serum	serum	NOUN
bionys-572	208	26	alkaline	alkaline	NOUN
bionys-572	208	27	phosphatase	phosphatase	NOUN
bionys-572	208	28	.	.	PUNCT
bionys-572	209	1	in	in	ADP
bionys-572	209	2	contrast	contrast	NOUN
bionys-572	209	3	,	,	PUNCT
bionys-572	209	4	individuals	individual	NOUN
bionys-572	209	5	with	with	ADP
bionys-572	209	6	uraturia	uraturia	PROPN
bionys-572	209	7	demonstrated	demonstrate	VERB
bionys-572	209	8	increased	increase	VERB
bionys-572	209	9	serum	serum	NOUN
bionys-572	209	10	levels	level	NOUN
bionys-572	209	11	of	of	ADP
bionys-572	209	12	glucose	glucose	NOUN
bionys-572	209	13	,	,	PUNCT
bionys-572	209	14	uric	uric	ADJ
bionys-572	209	15	acid	acid	NOUN
bionys-572	209	16	,	,	PUNCT
bionys-572	209	17	and	and	CCONJ
bionys-572	209	18	creatinine	creatinine	NOUN
bionys-572	209	19	,	,	PUNCT
bionys-572	209	20	alongside	alongside	ADP
bionys-572	209	21	a	a	DET
bionys-572	209	22	decreased	decrease	VERB
bionys-572	209	23	platelet	platelet	NOUN
bionys-572	209	24	count	count	NOUN
bionys-572	209	25	.	.	PUNCT
bionys-572	210	1	patients	patient	NOUN
bionys-572	210	2	with	with	ADP
bionys-572	210	3	phosphaturia	phosphaturia	PROPN
bionys-572	210	4	exhibited	exhibit	VERB
bionys-572	210	5	elevated	elevated	ADJ
bionys-572	210	6	serum	serum	NOUN
bionys-572	210	7	aspartate	aspartate	NOUN
bionys-572	210	8	aminotransferase	aminotransferase	PROPN
bionys-572	210	9	(	(	PUNCT
bionys-572	210	10	ast	ast	NOUN
bionys-572	210	11	)	)	PUNCT
bionys-572	210	12	levels	level	NOUN
bionys-572	210	13	.	.	PUNCT
bionys-572	211	1	these	these	DET
bionys-572	211	2	findings	finding	NOUN
bionys-572	211	3	suggest	suggest	VERB
bionys-572	211	4	that	that	SCONJ
bionys-572	211	5	clinicians	clinician	NOUN
bionys-572	211	6	should	should	AUX
bionys-572	211	7	closely	closely	ADV
bionys-572	211	8	monitor	monitor	VERB
bionys-572	211	9	leukocyte	leukocyte	NOUN
bionys-572	211	10	count	count	NOUN
bionys-572	211	11	,	,	PUNCT
bionys-572	211	12	eosinophils	eosinophil	NOUN
bionys-572	211	13	,	,	PUNCT
bionys-572	211	14	platelet	platelet	NOUN
bionys-572	211	15	levels	level	NOUN
bionys-572	211	16	,	,	PUNCT
bionys-572	211	17	and	and	CCONJ
bionys-572	211	18	serum	serum	NOUN
bionys-572	211	19	alkaline	alkaline	NOUN
bionys-572	211	20	phosphatase	phosphatase	NOUN
bionys-572	211	21	in	in	ADP
bionys-572	211	22	patients	patient	NOUN
bionys-572	211	23	with	with	ADP
bionys-572	211	24	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	211	25	;	;	PUNCT
bionys-572	211	26	platelet	platelet	NOUN
bionys-572	211	27	count	count	NOUN
bionys-572	211	28	,	,	PUNCT
bionys-572	211	29	uric	uric	ADJ
bionys-572	211	30	acid	acid	NOUN
bionys-572	211	31	,	,	PUNCT
bionys-572	211	32	glucose	glucose	NOUN
bionys-572	211	33	,	,	PUNCT
bionys-572	211	34	and	and	CCONJ
bionys-572	211	35	creatinine	creatinine	NOUN
bionys-572	211	36	in	in	ADP
bionys-572	211	37	those	those	PRON
bionys-572	211	38	with	with	ADP
bionys-572	211	39	uraturia	uraturia	NOUN
bionys-572	211	40	;	;	PUNCT
bionys-572	211	41	and	and	CCONJ
bionys-572	211	42	ast	ast	VERB
bionys-572	211	43	in	in	ADP
bionys-572	211	44	patients	patient	NOUN
bionys-572	211	45	with	with	ADP
bionys-572	211	46	phosphaturia	phosphaturia	NOUN
bionys-572	211	47	during	during	ADP
bionys-572	211	48	the	the	DET
bionys-572	211	49	treatment	treatment	NOUN
bionys-572	211	50	of	of	ADP
bionys-572	211	51	bone	bone	NOUN
bionys-572	211	52	and	and	CCONJ
bionys-572	211	53	joint	joint	ADJ
bionys-572	211	54	tissue	tissue	NOUN
bionys-572	211	55	pathology	pathology	NOUN
bionys-572	211	56	.	.	PUNCT
bionys-572	212	1	the	the	DET
bionys-572	212	2	observed	observe	VERB
bionys-572	212	3	differences	difference	NOUN
bionys-572	212	4	in	in	ADP
bionys-572	212	5	platelet	platelet	NOUN
bionys-572	212	6	levels	level	NOUN
bionys-572	212	7	,	,	PUNCT
bionys-572	212	8	elevated	elevate	VERB
bionys-572	212	9	in	in	ADP
bionys-572	212	10	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	212	11	and	and	CCONJ
bionys-572	212	12	reduced	reduce	VERB
bionys-572	212	13	in	in	ADP
bionys-572	212	14	uraturia	uraturia	PROPN
bionys-572	212	15	,	,	PUNCT
bionys-572	212	16	represent	represent	VERB
bionys-572	212	17	a	a	DET
bionys-572	212	18	novel	novel	ADJ
bionys-572	212	19	finding	finding	NOUN
bionys-572	212	20	of	of	ADP
bionys-572	212	21	this	this	DET
bionys-572	212	22	study	study	NOUN
bionys-572	212	23	and	and	CCONJ
bionys-572	212	24	warrant	warrant	VERB
bionys-572	212	25	further	further	ADJ
bionys-572	212	26	investigation	investigation	NOUN
bionys-572	212	27	.	.	PUNCT
bionys-572	213	1	acknowledgements	acknowledgement	NOUN
bionys-572	213	2	.	.	PUNCT
bionys-572	214	1	the	the	DET
bionys-572	214	2	authors	author	NOUN
bionys-572	214	3	would	would	AUX
bionys-572	214	4	like	like	VERB
bionys-572	214	5	to	to	PART
bionys-572	214	6	thank	thank	VERB
bionys-572	214	7	the	the	DET
bionys-572	214	8	laboratory	laboratory	NOUN
bionys-572	214	9	staff	staff	NOUN
bionys-572	214	10	for	for	ADP
bionys-572	214	11	their	their	PRON
bionys-572	214	12	assistance	assistance	NOUN
bionys-572	214	13	in	in	ADP
bionys-572	214	14	carrying	carry	VERB
bionys-572	214	15	out	out	ADP
bionys-572	214	16	the	the	DET
bionys-572	214	17	analyses	analysis	NOUN
bionys-572	214	18	.	.	PUNCT
bionys-572	215	1	references	reference	NOUN
bionys-572	215	2	alan	alan	PROPN
bionys-572	215	3	,	,	PUNCT
bionys-572	215	4	h.	h.	PROPN
bionys-572	215	5	b.	b.	PROPN
bionys-572	215	6	wu	wu	PROPN
bionys-572	215	7	.	.	PUNCT
bionys-572	216	1	(	(	PUNCT
bionys-572	216	2	2006	2006	NUM
bionys-572	216	3	)	)	PUNCT
bionys-572	216	4	.	.	PUNCT
bionys-572	217	1	tietz	tietz	VERB
bionys-572	217	2	clinical	clinical	ADJ
bionys-572	217	3	guide	guide	NOUN
bionys-572	217	4	to	to	ADP
bionys-572	217	5	laboratory	laboratory	NOUN
bionys-572	217	6	tests	test	NOUN
bionys-572	217	7	(	(	PUNCT
bionys-572	217	8	4th	4th	ADJ
bionys-572	217	9	ed	ed	NOUN
bionys-572	217	10	.	.	PUNCT
bionys-572	217	11	)	)	PUNCT
bionys-572	217	12	.	.	PUNCT
bionys-572	218	1	1857	1857	NUM
bionys-572	218	2	p.	p.	NOUN
bionys-572	218	3	anothaisintawee	anothaisintawee	PROPN
bionys-572	218	4	,	,	PUNCT
bionys-572	218	5	t.	t.	PROPN
bionys-572	218	6	,	,	PUNCT
bionys-572	218	7	lertrattananon	lertrattananon	PROPN
bionys-572	218	8	,	,	PUNCT
bionys-572	218	9	d.	d.	PROPN
bionys-572	218	10	,	,	PUNCT
bionys-572	218	11	thamakaison	thamakaison	PROPN
bionys-572	218	12	,	,	PUNCT
bionys-572	218	13	s.	s.	PROPN
bionys-572	218	14	,	,	PUNCT
bionys-572	218	15	reutrakul	reutrakul	NOUN
bionys-572	218	16	,	,	PUNCT
bionys-572	218	17	s.	s.	PROPN
bionys-572	218	18	,	,	PUNCT
bionys-572	218	19	ongphiphadhanakul	ongphiphadhanakul	NOUN
bionys-572	218	20	,	,	PUNCT
bionys-572	218	21	b.	b.	PROPN
bionys-572	218	22	,	,	PUNCT
bionys-572	218	23	thakkinstian	thakkinstian	ADJ
bionys-572	218	24	,	,	PUNCT
bionys-572	218	25	a.	a.	NOUN
bionys-572	218	26	(	(	PUNCT
bionys-572	218	27	2017	2017	NUM
bionys-572	218	28	)	)	PUNCT
bionys-572	218	29	.	.	PUNCT
bionys-572	219	1	direct	direct	ADJ
bionys-572	219	2	and	and	CCONJ
bionys-572	219	3	indirect	indirect	ADJ
bionys-572	219	4	effects	effect	NOUN
bionys-572	219	5	of	of	ADP
bionys-572	219	6	serum	serum	NOUN
bionys-572	219	7	uric	uric	ADJ
bionys-572	219	8	acid	acid	NOUN
bionys-572	219	9	on	on	ADP
bionys-572	219	10	blood	blood	NOUN
bionys-572	219	11	sugar	sugar	NOUN
bionys-572	219	12	levels	level	NOUN
bionys-572	219	13	in	in	ADP
bionys-572	219	14	patients	patient	NOUN
bionys-572	219	15	with	with	ADP
bionys-572	219	16	prediabetes	prediabete	NOUN
bionys-572	219	17	:	:	PUNCT
bionys-572	219	18	a	a	DET
bionys-572	219	19	mediation	mediation	NOUN
bionys-572	219	20	analysis	analysis	NOUN
bionys-572	219	21	.	.	PUNCT
bionys-572	220	1	journal	journal	PROPN
bionys-572	220	2	of	of	ADP
bionys-572	220	3	diabetes	diabetes	NOUN
bionys-572	220	4	research	research	NOUN
bionys-572	220	5	,	,	PUNCT
bionys-572	220	6	2017	2017	NUM
bionys-572	220	7	,	,	PUNCT
bionys-572	220	8	6830671	6830671	NUM
bionys-572	220	9	.	.	PUNCT
bionys-572	221	1	https://	https://	PROPN
bionys-572	221	2	doi.org/10.1155/2017/6830671	doi.org/10.1155/2017/6830671	PROPN
bionys-572	221	3	bacchetta	bacchetta	NOUN
bionys-572	221	4	,	,	PUNCT
bionys-572	221	5	j.	j.	PROPN
bionys-572	221	6	,	,	PUNCT
bionys-572	221	7	boivin	boivin	PROPN
bionys-572	221	8	,	,	PUNCT
bionys-572	221	9	g.	g.	PROPN
bionys-572	221	10	,	,	PUNCT
bionys-572	221	11	cochat	cochat	ADV
bionys-572	221	12	,	,	PUNCT
bionys-572	221	13	p.	p.	NOUN
bionys-572	221	14	(	(	PUNCT
bionys-572	221	15	2016	2016	NUM
bionys-572	221	16	)	)	PUNCT
bionys-572	221	17	.	.	PUNCT
bionys-572	222	1	bone	bone	NOUN
bionys-572	222	2	impairment	impairment	NOUN
bionys-572	222	3	in	in	ADP
bionys-572	222	4	primary	primary	ADJ
bionys-572	222	5	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	222	6	:	:	PUNCT
bionys-572	222	7	a	a	DET
bionys-572	222	8	review	review	NOUN
bionys-572	222	9	.	.	PUNCT
bionys-572	223	1	pediatric	pediatric	ADJ
bionys-572	223	2	nephrology	nephrology	NOUN
bionys-572	223	3	,	,	PUNCT
bionys-572	223	4	31	31	NUM
bionys-572	223	5	,	,	PUNCT
bionys-572	223	6	1–6	1–6	NUM
bionys-572	223	7	.	.	PUNCT
bionys-572	224	1	https://doi	https://doi	X
bionys-572	224	2	.	.	PUNCT
bionys-572	224	3	org/10.1007	org/10.1007	PROPN
bionys-572	224	4	/	/	SYM
bionys-572	224	5	s00467	s00467	NOUN
bionys-572	224	6	-	-	PUNCT
bionys-572	224	7	015	015	NUM
bionys-572	224	8	-	-	PUNCT
bionys-572	224	9	3048	3048	NUM
bionys-572	224	10	-	-	PUNCT
bionys-572	224	11	z	z	NOUN
bionys-572	224	12	başoğlu	başoğlu	NOUN
bionys-572	224	13	,	,	PUNCT
bionys-572	224	14	i.	i.	PROPN
bionys-572	224	15	a.	a.	PROPN
bionys-572	224	16	,	,	PUNCT
bionys-572	224	17	karakoyun	karakoyun	PROPN
bionys-572	224	18	,	,	PUNCT
bionys-572	224	19	b.	b.	PROPN
bionys-572	224	20	(	(	PUNCT
bionys-572	224	21	2023	2023	NUM
bionys-572	224	22	)	)	PUNCT
bionys-572	224	23	.	.	PUNCT
bionys-572	225	1	crohn	crohn	PROPN
bionys-572	225	2	’s	’s	PART
bionys-572	225	3	disease	disease	NOUN
bionys-572	225	4	:	:	PUNCT
bionys-572	225	5	etiology	etiology	NOUN
bionys-572	225	6	,	,	PUNCT
bionys-572	225	7	pathogenesis	pathogenesis	NOUN
bionys-572	225	8	and	and	CCONJ
bionys-572	225	9	treatment	treatment	NOUN
bionys-572	225	10	strategies	strategy	NOUN
bionys-572	225	11	.	.	PUNCT
bionys-572	226	1	marmara	marmara	PROPN
bionys-572	226	2	medical	medical	PROPN
bionys-572	226	3	journal	journal	PROPN
bionys-572	226	4	,	,	PUNCT
bionys-572	226	5	36(2	36(2	NUM
bionys-572	226	6	)	)	PUNCT
bionys-572	226	7	,	,	PUNCT
bionys-572	226	8	249	249	NUM
bionys-572	226	9	–	–	PUNCT
bionys-572	226	10	254	254	NUM
bionys-572	226	11	.	.	PUNCT
bionys-572	227	1	https://doi.org/10.5472/marumj.1307982	https://doi.org/10.5472/marumj.1307982	ADJ
bionys-572	227	2	bchir	bchir	NOUN
bionys-572	227	3	,	,	PUNCT
bionys-572	227	4	s.	s.	PROPN
bionys-572	227	5	,	,	PUNCT
bionys-572	227	6	salem	salem	PROPN
bionys-572	227	7	,	,	PUNCT
bionys-572	227	8	m.	m.	PROPN
bionys-572	227	9	b.	b.	PROPN
bionys-572	227	10	,	,	PUNCT
bionys-572	227	11	manaa	manaa	PROPN
bionys-572	227	12	,	,	PUNCT
bionys-572	227	13	r.	r.	PROPN
bionys-572	227	14	,	,	PUNCT
bionys-572	227	15	aloui	aloui	ADV
bionys-572	227	16	,	,	PUNCT
bionys-572	227	17	s.	s.	PROPN
bionys-572	227	18	(	(	PUNCT
bionys-572	227	19	2022	2022	NUM
bionys-572	227	20	)	)	PUNCT
bionys-572	227	21	.	.	PUNCT
bionys-572	228	1	pos-433	pos-433	X
bionys-572	228	2	systemic	systemic	ADJ
bionys-572	228	3	manifest	manifest	ADJ
bionys-572	228	4	antigens	antigen	NOUN
bionys-572	228	5	of	of	ADP
bionys-572	228	6	primary	primary	ADJ
bionys-572	228	7	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	228	8	in	in	ADP
bionys-572	228	9	adult	adult	NOUN
bionys-572	228	10	patients	patient	NOUN
bionys-572	228	11	:	:	PUNCT
bionys-572	228	12	a	a	DET
bionys-572	228	13	monocentric	monocentric	ADJ
bionys-572	228	14	tunisian	tunisian	ADJ
bionys-572	228	15	study	study	NOUN
bionys-572	228	16	.	.	PUNCT
bionys-572	229	1	kidney	kidney	PROPN
bionys-572	229	2	international	international	ADJ
bionys-572	229	3	reports	report	NOUN
bionys-572	229	4	,	,	PUNCT
bionys-572	229	5	7(2	7(2	NUM
bionys-572	229	6	)	)	PUNCT
bionys-572	229	7	,	,	PUNCT
bionys-572	229	8	s193	s193	PROPN
bionys-572	229	9	.	.	PUNCT
bionys-572	230	1	https://doi.org/10.1016/j.ekir.2022.01.460	https://doi.org/10.1016/j.ekir.2022.01.460	PROPN
bionys-572	230	2	ben	ben	PROPN
bionys-572	230	3	-	-	PROPN
bionys-572	230	4	shalom	shalom	PROPN
bionys-572	230	5	,	,	PUNCT
bionys-572	230	6	e.	e.	PROPN
bionys-572	230	7	,	,	PUNCT
bionys-572	230	8	cytter	cytter	NOUN
bionys-572	230	9	-	-	PUNCT
bionys-572	230	10	kuint	kuint	PROPN
bionys-572	230	11	,	,	PUNCT
bionys-572	230	12	r.	r.	PROPN
bionys-572	230	13	,	,	PUNCT
bionys-572	230	14	rinat	rinat	NOUN
bionys-572	230	15	,	,	PUNCT
bionys-572	230	16	c.	c.	PROPN
bionys-572	230	17	,	,	PUNCT
bionys-572	230	18	becker	becker	PROPN
bionys-572	230	19	-	-	PUNCT
bionys-572	230	20	cohen	cohen	PROPN
bionys-572	230	21	,	,	PUNCT
bionys-572	230	22	r.	r.	PROPN
bionys-572	230	23	,	,	PUNCT
bionys-572	230	24	tzvi	tzvi	NOUN
bionys-572	230	25	-	-	PUNCT
bionys-572	230	26	behr	behr	NOUN
bionys-572	230	27	,	,	PUNCT
bionys-572	230	28	s.	s.	PROPN
bionys-572	230	29	,	,	PUNCT
bionys-572	230	30	goichberg	goichberg	PROPN
bionys-572	230	31	,	,	PUNCT
bionys-572	230	32	j.	j.	PROPN
bionys-572	230	33	,	,	PUNCT
bionys-572	230	34	peles	pele	NOUN
bionys-572	230	35	,	,	PUNCT
bionys-572	230	36	v.	v.	ADV
bionys-572	230	37	,	,	PUNCT
bionys-572	230	38	frishberg	frishberg	NOUN
bionys-572	230	39	,	,	PUNCT
bionys-572	230	40	y.	y.	PROPN
bionys-572	230	41	(	(	PUNCT
bionys-572	230	42	2021	2021	NUM
bionys-572	230	43	)	)	PUNCT
bionys-572	230	44	.	.	PUNCT
bionys-572	231	1	long	long	ADJ
bionys-572	231	2	-	-	PUNCT
bionys-572	231	3	term	term	NOUN
bionys-572	231	4	complications	complication	NOUN
bionys-572	231	5	of	of	ADP
bionys-572	231	6	systemic	systemic	ADJ
bionys-572	231	7	oxalosis	oxalosis	NOUN
bionys-572	231	8	in	in	ADP
bionys-572	231	9	children	child	NOUN
bionys-572	231	10	:	:	PUNCT
bionys-572	231	11	a	a	DET
bionys-572	231	12	retrospective	retrospective	ADJ
bionys-572	231	13	single	single	ADJ
bionys-572	231	14	-	-	PUNCT
bionys-572	231	15	center	center	NOUN
bionys-572	231	16	cohort	cohort	NOUN
bionys-572	231	17	study	study	NOUN
bionys-572	231	18	.	.	PUNCT
bionys-572	232	1	pediatric	pediatric	ADJ
bionys-572	232	2	nephrology	nephrology	NOUN
bionys-572	232	3	,	,	PUNCT
bionys-572	232	4	36(10	36(10	NUM
bionys-572	232	5	)	)	PUNCT
bionys-572	232	6	,	,	PUNCT
bionys-572	232	7	3123–3132	3123–3132	NUM
bionys-572	232	8	.	.	PUNCT
bionys-572	233	1	https://doi	https://doi	NOUN
bionys-572	233	2	.	.	PUNCT
bionys-572	233	3	org/10.1007	org/10.1007	PROPN
bionys-572	233	4	/	/	SYM
bionys-572	233	5	s00467	s00467	NOUN
bionys-572	233	6	-	-	PUNCT
bionys-572	233	7	021	021	NUM
bionys-572	233	8	-	-	PUNCT
bionys-572	233	9	05002	05002	NUM
bionys-572	233	10	-	-	SYM
bionys-572	233	11	1	1	NUM
bionys-572	233	12	benson	benson	PROPN
bionys-572	233	13	,	,	PUNCT
bionys-572	233	14	j.	j.	PROPN
bionys-572	233	15	c.	c.	PROPN
bionys-572	233	16	,	,	PUNCT
bionys-572	233	17	trejo	trejo	PROPN
bionys-572	233	18	-	-	PUNCT
bionys-572	233	19	lopez	lopez	PROPN
bionys-572	233	20	,	,	PUNCT
bionys-572	233	21	j.	j.	PROPN
bionys-572	233	22	a.	a.	PROPN
bionys-572	233	23	,	,	PUNCT
bionys-572	233	24	nassiri	nassiri	NOUN
bionys-572	233	25	,	,	PUNCT
bionys-572	233	26	a.	a.	NOUN
bionys-572	233	27	m.	m.	NOUN
bionys-572	233	28	,	,	PUNCT
bionys-572	233	29	eschbacher	eschbacher	ADV
bionys-572	233	30	,	,	PUNCT
bionys-572	233	31	k.	k.	PROPN
bionys-572	233	32	,	,	PUNCT
bionys-572	233	33	link	link	PROPN
bionys-572	233	34	,	,	PUNCT
bionys-572	233	35	m.	m.	NOUN
bionys-572	233	36	j.	j.	PROPN
bionys-572	233	37	,	,	PUNCT
bionys-572	233	38	driscoll	driscoll	PROPN
bionys-572	233	39	,	,	PUNCT
bionys-572	233	40	c.	c.	PROPN
bionys-572	233	41	l.	l.	PROPN
bionys-572	233	42	,	,	PUNCT
bionys-572	233	43	tiegs	tiegs	PROPN
bionys-572	233	44	,	,	PUNCT
bionys-572	233	45	r.	r.	PROPN
bionys-572	233	46	d.	d.	PROPN
bionys-572	233	47	,	,	PUNCT
bionys-572	233	48	sfeir	sfeir	PROPN
bionys-572	233	49	,	,	PUNCT
bionys-572	233	50	j.	j.	PROPN
bionys-572	233	51	,	,	PUNCT
bionys-572	233	52	delone	delone	PROPN
bionys-572	233	53	,	,	PUNCT
bionys-572	233	54	d.	d.	PROPN
bionys-572	233	55	r.	r.	PROPN
bionys-572	233	56	(	(	PUNCT
bionys-572	233	57	2022	2022	NUM
bionys-572	233	58	)	)	PUNCT
bionys-572	233	59	.	.	PUNCT
bionys-572	234	1	phosphaturic	phosphaturic	ADJ
bionys-572	234	2	mesenchymal	mesenchymal	ADJ
bionys-572	234	3	tumor	tumor	NOUN
bionys-572	234	4	.	.	PUNCT
bionys-572	235	1	american	american	PROPN
bionys-572	235	2	journal	journal	PROPN
bionys-572	235	3	of	of	ADP
bionys-572	235	4	neuroradiology	neuroradiology	PROPN
bionys-572	235	5	,	,	PUNCT
bionys-572	235	6	43(6	43(6	NOUN
bionys-572	235	7	)	)	PUNCT
bionys-572	235	8	,	,	PUNCT
bionys-572	235	9	817–822	817–822	NUM
bionys-572	235	10	.	.	PUNCT
bionys-572	236	1	https://	https://	PROPN
bionys-572	236	2	doi.org/10.3174/ajnr.a7513	doi.org/10.3174/ajnr.a7513	PROPN
bionys-572	236	3	hoppe	hoppe	PROPN
bionys-572	236	4	,	,	PUNCT
bionys-572	236	5	b.	b.	PROPN
bionys-572	236	6	,	,	PUNCT
bionys-572	236	7	beck	beck	PROPN
bionys-572	236	8	,	,	PUNCT
bionys-572	236	9	b.	b.	PROPN
bionys-572	236	10	b.	b.	PROPN
bionys-572	236	11	,	,	PUNCT
bionys-572	236	12	milliner	milliner	PROPN
bionys-572	236	13	,	,	PUNCT
bionys-572	236	14	d.	d.	PROPN
bionys-572	236	15	s.	s.	PROPN
bionys-572	236	16	(	(	PUNCT
bionys-572	236	17	2009	2009	NUM
bionys-572	236	18	)	)	PUNCT
bionys-572	236	19	.	.	PUNCT
bionys-572	237	1	the	the	DET
bionys-572	237	2	primary	primary	ADJ
bionys-572	237	3	hyperoxalurias	hyperoxaluria	NOUN
bionys-572	237	4	.	.	PUNCT
bionys-572	238	1	kidney	kidney	PROPN
bionys-572	238	2	international	international	PROPN
bionys-572	238	3	,	,	PUNCT
bionys-572	238	4	75(12	75(12	NUM
bionys-572	238	5	)	)	PUNCT
bionys-572	238	6	,	,	PUNCT
bionys-572	238	7	1264–1271	1264–1271	NUM
bionys-572	238	8	.	.	PUNCT
bionys-572	239	1	https://doi.org/10.1038/	https://doi.org/10.1038/	NOUN
bionys-572	239	2	ki.2009.32	ki.2009.32	PROPN
bionys-572	239	3	burlaka	burlaka	PROPN
bionys-572	239	4	,	,	PUNCT
bionys-572	239	5	i.	i.	PROPN
bionys-572	239	6	a.	a.	PROPN
bionys-572	239	7	,	,	PUNCT
bionys-572	239	8	mityuryayeva	mityuryayeva	PROPN
bionys-572	239	9	,	,	PUNCT
bionys-572	239	10	i.	i.	PROPN
bionys-572	239	11	o.	o.	PROPN
bionys-572	239	12	,	,	PUNCT
bionys-572	239	13	shevchenko	shevchenko	PROPN
bionys-572	239	14	,	,	PUNCT
bionys-572	239	15	biologica	biologica	PROPN
bionys-572	239	16	nyssana	nyssana	PROPN
bionys-572	240	1	●	●	PUNCT
bionys-572	240	2	16	16	NUM
bionys-572	240	3	(	(	PUNCT
bionys-572	240	4	1	1	NUM
bionys-572	240	5	)	)	PUNCT
bionys-572	240	6	june	june	PROPN
bionys-572	240	7	2025	2025	NUM
bionys-572	240	8	:	:	PUNCT
bionys-572	240	9	247	247	NUM
bionys-572	240	10	-	-	SYM
bionys-572	240	11	257	257	NUM
bionys-572	240	12	kravchun	kravchun	NOUN
bionys-572	240	13	et	et	PROPN
bionys-572	240	14	al	al	PROPN
bionys-572	240	15	.	.	PUNCT
bionys-572	240	16	●	●	PUNCT
bionys-572	240	17	different	different	ADJ
bionys-572	240	18	types	type	NOUN
bionys-572	240	19	of	of	ADP
bionys-572	240	20	crystalluria	crystalluria	PROPN
bionys-572	240	21	in	in	ADP
bionys-572	240	22	patients	patient	NOUN
bionys-572	240	23	with	with	ADP
bionys-572	240	24	bone	bone	NOUN
bionys-572	240	25	and	and	CCONJ
bionys-572	240	26	joint	joint	ADJ
bionys-572	240	27	tissue	tissue	NOUN
bionys-572	240	28	pathology	pathology	NOUN
bionys-572	240	29	:	:	PUNCT
bionys-572	240	30	hematological	hematological	ADJ
bionys-572	240	31	and	and	CCONJ
bionys-572	240	32	biochemical	biochemical	ADJ
bionys-572	240	33	profiles	profile	NOUN
bionys-572	240	34	255	255	NUM
bionys-572	240	35	biologica	biologica	PROPN
bionys-572	240	36	nyssana	nyssana	PROPN
bionys-572	241	1	●	●	PUNCT
bionys-572	241	2	16	16	NUM
bionys-572	241	3	(	(	PUNCT
bionys-572	241	4	1	1	NUM
bionys-572	241	5	)	)	PUNCT
bionys-572	241	6	june	june	PROPN
bionys-572	241	7	2025	2025	NUM
bionys-572	241	8	:	:	PUNCT
bionys-572	241	9	247	247	NUM
bionys-572	241	10	-	-	SYM
bionys-572	241	11	257	257	NUM
bionys-572	241	12	kravchun	kravchun	NOUN
bionys-572	241	13	et	et	PROPN
bionys-572	241	14	al	al	PROPN
bionys-572	241	15	.	.	PUNCT
bionys-572	242	1	●	●	PUNCT
bionys-572	242	2	different	different	ADJ
bionys-572	242	3	types	type	NOUN
bionys-572	242	4	of	of	ADP
bionys-572	242	5	crystalluria	crystalluria	PROPN
bionys-572	242	6	in	in	ADP
bionys-572	242	7	patients	patient	NOUN
bionys-572	242	8	with	with	ADP
bionys-572	242	9	bone	bone	NOUN
bionys-572	242	10	and	and	CCONJ
bionys-572	242	11	joint	joint	ADJ
bionys-572	242	12	tissue	tissue	NOUN
bionys-572	242	13	pathology	pathology	NOUN
bionys-572	242	14	:	:	PUNCT
bionys-572	242	15	hematological	hematological	ADJ
bionys-572	242	16	and	and	CCONJ
bionys-572	242	17	biochemical	biochemical	ADJ
bionys-572	242	18	profiles	profile	NOUN
bionys-572	242	19	t.	t.	PROPN
bionys-572	242	20	a.	a.	NOUN
bionys-572	242	21	,	,	PUNCT
bionys-572	242	22	kovalenko	kovalenko	PROPN
bionys-572	242	23	,	,	PUNCT
bionys-572	242	24	v.	v.	ADP
bionys-572	242	25	m.	m.	NOUN
bionys-572	242	26	,	,	PUNCT
bionys-572	242	27	kovalenko	kovalenko	PROPN
bionys-572	242	28	,	,	PUNCT
bionys-572	242	29	t.	t.	NOUN
bionys-572	242	30	m.	m.	NOUN
bionys-572	242	31	,	,	PUNCT
bionys-572	242	32	kovalenko	kovalenko	PROPN
bionys-572	242	33	,	,	PUNCT
bionys-572	242	34	m.	m.	NOUN
bionys-572	242	35	m.	m.	NOUN
bionys-572	242	36	,	,	PUNCT
bionys-572	242	37	kovalenko	kovalenko	PROPN
bionys-572	242	38	,	,	PUNCT
bionys-572	242	39	o.	o.	NOUN
bionys-572	242	40	m.	m.	NOUN
bionys-572	242	41	(	(	PUNCT
bionys-572	242	42	2021	2021	NUM
bionys-572	242	43	)	)	PUNCT
bionys-572	242	44	.	.	PUNCT
bionys-572	243	1	clinical	clinical	ADJ
bionys-572	243	2	,	,	PUNCT
bionys-572	243	3	laboratory	laboratory	NOUN
bionys-572	243	4	,	,	PUNCT
bionys-572	243	5	instrumental	instrumental	ADJ
bionys-572	243	6	,	,	PUNCT
bionys-572	243	7	anamnestic	anamnestic	ADJ
bionys-572	243	8	characteristics	characteristic	NOUN
bionys-572	243	9	in	in	ADP
bionys-572	243	10	children	child	NOUN
bionys-572	243	11	with	with	ADP
bionys-572	243	12	type	type	NOUN
bionys-572	244	1	i	i	PRON
bionys-572	244	2	diabetes	diabete	VERB
bionys-572	244	3	mellitus	mellitus	NOUN
bionys-572	244	4	and	and	CCONJ
bionys-572	244	5	early	early	ADJ
bionys-572	244	6	stage	stage	NOUN
bionys-572	244	7	of	of	ADP
bionys-572	244	8	diabetic	diabetic	ADJ
bionys-572	244	9	nephropathy	nephropathy	NOUN
bionys-572	244	10	.	.	PUNCT
bionys-572	245	1	global	global	ADJ
bionys-572	245	2	pediatric	pediatric	ADJ
bionys-572	245	3	health	health	NOUN
bionys-572	245	4	,	,	PUNCT
bionys-572	245	5	8	8	NUM
bionys-572	245	6	,	,	PUNCT
bionys-572	245	7	2333794x211063052	2333794x211063052	PROPN
bionys-572	245	8	.	.	PUNCT
bionys-572	246	1	https://doi.org/10.1177/2333794x211063052	https://doi.org/10.1177/2333794x211063052	PRON
bionys-572	246	2	büscher	büscher	PROPN
bionys-572	246	3	,	,	PUNCT
bionys-572	246	4	r.	r.	PROPN
bionys-572	246	5	,	,	PUNCT
bionys-572	246	6	pape	pape	NOUN
bionys-572	246	7	,	,	PUNCT
bionys-572	246	8	l.	l.	PROPN
bionys-572	246	9	,	,	PUNCT
bionys-572	246	10	büscher	büscher	PROPN
bionys-572	246	11	,	,	PUNCT
bionys-572	246	12	a.	a.	PROPN
bionys-572	246	13	k.	k.	PROPN
bionys-572	246	14	(	(	PUNCT
bionys-572	246	15	2024	2024	NUM
bionys-572	246	16	)	)	PUNCT
bionys-572	246	17	.	.	PUNCT
bionys-572	247	1	bone	bone	NOUN
bionys-572	247	2	health	health	NOUN
bionys-572	247	3	in	in	ADP
bionys-572	247	4	children	child	NOUN
bionys-572	247	5	with	with	ADP
bionys-572	247	6	primary	primary	ADJ
bionys-572	247	7	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	247	8	type	type	NOUN
bionys-572	247	9	1	1	NUM
bionys-572	247	10	following	follow	VERB
bionys-572	247	11	liver	liver	NOUN
bionys-572	247	12	and	and	CCONJ
bionys-572	247	13	kidney	kidney	NOUN
bionys-572	247	14	transplantation	transplantation	NOUN
bionys-572	247	15	.	.	PUNCT
bionys-572	248	1	frontiers	frontier	NOUN
bionys-572	248	2	in	in	ADP
bionys-572	248	3	pediatrics	pediatric	NOUN
bionys-572	248	4	,	,	PUNCT
bionys-572	248	5	12	12	NUM
bionys-572	248	6	,	,	PUNCT
bionys-572	248	7	1353880	1353880	NUM
bionys-572	248	8	.	.	PUNCT
bionys-572	249	1	https://doi.org/10.3389/	https://doi.org/10.3389/	PROPN
bionys-572	249	2	fped.2024.1353880	fped.2024.1353880	PROPN
bionys-572	249	3	chen	chen	PROPN
bionys-572	249	4	,	,	PUNCT
bionys-572	249	5	s.	s.	PROPN
bionys-572	249	6	,	,	PUNCT
bionys-572	249	7	guo	guo	PROPN
bionys-572	249	8	,	,	PUNCT
bionys-572	249	9	x.	x.	PROPN
bionys-572	249	10	,	,	PUNCT
bionys-572	249	11	yu	yu	PROPN
bionys-572	249	12	,	,	PUNCT
bionys-572	249	13	s.	s.	PROPN
bionys-572	249	14	,	,	PUNCT
bionys-572	249	15	sun	sun	PROPN
bionys-572	249	16	,	,	PUNCT
bionys-572	249	17	g.	g.	PROPN
bionys-572	249	18	,	,	PUNCT
bionys-572	249	19	yang	yang	PROPN
bionys-572	249	20	,	,	PUNCT
bionys-572	249	21	h.	h.	PROPN
bionys-572	249	22	,	,	PUNCT
bionys-572	249	23	li	li	PROPN
bionys-572	249	24	,	,	PUNCT
bionys-572	249	25	z.	z.	PROPN
bionys-572	249	26	,	,	PUNCT
bionys-572	249	27	li	li	PROPN
bionys-572	249	28	,	,	PUNCT
bionys-572	249	29	l.	l.	PROPN
bionys-572	249	30	,	,	PUNCT
bionys-572	249	31	zhang	zhang	PROPN
bionys-572	249	32	,	,	PUNCT
bionys-572	249	33	y.	y.	PROPN
bionys-572	249	34	,	,	PUNCT
bionys-572	249	35	zhang	zhang	PROPN
bionys-572	249	36	,	,	PUNCT
bionys-572	249	37	w.	w.	PROPN
bionys-572	249	38	(	(	PUNCT
bionys-572	249	39	2016	2016	NUM
bionys-572	249	40	)	)	PUNCT
bionys-572	249	41	.	.	PUNCT
bionys-572	250	1	association	association	NOUN
bionys-572	250	2	between	between	ADP
bionys-572	250	3	serum	serum	PROPN
bionys-572	250	4	uric	uric	ADJ
bionys-572	250	5	acid	acid	PROPN
bionys-572	250	6	and	and	CCONJ
bionys-572	250	7	elevated	elevated	ADJ
bionys-572	250	8	alanine	alanine	NOUN
bionys-572	250	9	aminotransferase	aminotransferase	NOUN
bionys-572	250	10	in	in	ADP
bionys-572	250	11	the	the	DET
bionys-572	250	12	general	general	ADJ
bionys-572	250	13	population	population	NOUN
bionys-572	250	14	.	.	PUNCT
bionys-572	251	1	international	international	ADJ
bionys-572	251	2	journal	journal	PROPN
bionys-572	251	3	of	of	ADP
bionys-572	251	4	environmental	environmental	ADJ
bionys-572	251	5	research	research	NOUN
bionys-572	251	6	and	and	CCONJ
bionys-572	251	7	public	public	ADJ
bionys-572	251	8	health	health	NOUN
bionys-572	251	9	,	,	PUNCT
bionys-572	251	10	13(9	13(9	NUM
bionys-572	251	11	)	)	PUNCT
bionys-572	251	12	,	,	PUNCT
bionys-572	251	13	841	841	NUM
bionys-572	251	14	.	.	PUNCT
bionys-572	252	1	https://doi	https://doi	X
bionys-572	252	2	.	.	PUNCT
bionys-572	252	3	org/10.3390	org/10.3390	PROPN
bionys-572	252	4	/	/	SYM
bionys-572	252	5	ijerph13090841	ijerph13090841	PROPN
bionys-572	252	6	colaci	colaci	PROPN
bionys-572	252	7	,	,	PUNCT
bionys-572	252	8	c.	c.	PROPN
bionys-572	252	9	,	,	PUNCT
bionys-572	252	10	gambardella	gambardella	PROPN
bionys-572	252	11	,	,	PUNCT
bionys-572	252	12	m.	m.	NOUN
bionys-572	252	13	l.	l.	PROPN
bionys-572	252	14	,	,	PUNCT
bionys-572	252	15	scarlata	scarlata	PROPN
bionys-572	252	16	,	,	PUNCT
bionys-572	252	17	g.	g.	PROPN
bionys-572	252	18	g.	g.	PROPN
bionys-572	252	19	m.	m.	PROPN
bionys-572	252	20	,	,	PUNCT
bionys-572	252	21	boccuto	boccuto	PROPN
bionys-572	252	22	,	,	PUNCT
bionys-572	252	23	l.	l.	PROPN
bionys-572	252	24	,	,	PUNCT
bionys-572	252	25	colica	colica	PROPN
bionys-572	252	26	,	,	PUNCT
bionys-572	252	27	c.	c.	PROPN
bionys-572	252	28	,	,	PUNCT
bionys-572	252	29	luzza	luzza	PROPN
bionys-572	252	30	,	,	PUNCT
bionys-572	252	31	f.	f.	PROPN
bionys-572	252	32	,	,	PUNCT
bionys-572	252	33	scarpellini	scarpellini	PROPN
bionys-572	252	34	,	,	PUNCT
bionys-572	252	35	e.	e.	PROPN
bionys-572	252	36	,	,	PUNCT
bionys-572	252	37	mendez	mendez	PROPN
bionys-572	252	38	-	-	PUNCT
bionys-572	252	39	sanchez	sanchez	PROPN
bionys-572	252	40	,	,	PUNCT
bionys-572	252	41	n.	n.	PROPN
bionys-572	252	42	,	,	PUNCT
bionys-572	252	43	abenavoli	abenavoli	ADV
bionys-572	252	44	,	,	PUNCT
bionys-572	252	45	l.	l.	PROPN
bionys-572	252	46	(	(	PUNCT
bionys-572	252	47	2024	2024	NUM
bionys-572	252	48	)	)	PUNCT
bionys-572	252	49	.	.	PUNCT
bionys-572	253	1	dysmetabolic	dysmetabolic	ADJ
bionys-572	253	2	comorbidities	comorbiditie	NOUN
bionys-572	253	3	and	and	CCONJ
bionys-572	253	4	non	non	ADJ
bionys-572	253	5	-	-	ADJ
bionys-572	253	6	alcoholic	alcoholic	ADJ
bionys-572	253	7	fatty	fatty	NOUN
bionys-572	253	8	liver	liver	NOUN
bionys-572	253	9	disease	disease	NOUN
bionys-572	253	10	:	:	PUNCT
bionys-572	253	11	a	a	DET
bionys-572	253	12	stairway	stairway	NOUN
bionys-572	253	13	to	to	ADP
bionys-572	253	14	metabolic	metabolic	NOUN
bionys-572	253	15	dysfunctionassociated	dysfunctionassociate	VERB
bionys-572	253	16	steatotic	steatotic	ADJ
bionys-572	253	17	liver	liver	NOUN
bionys-572	253	18	disease	disease	NOUN
bionys-572	253	19	.	.	PUNCT
bionys-572	254	1	hepatoma	hepatoma	PROPN
bionys-572	254	2	research	research	NOUN
bionys-572	254	3	,	,	PUNCT
bionys-572	254	4	10	10	NUM
bionys-572	254	5	,	,	PUNCT
bionys-572	254	6	16	16	NUM
bionys-572	254	7	.	.	PUNCT
bionys-572	255	1	https://doi.org/10.20517/23945079.2023.134	https://doi.org/10.20517/23945079.2023.134	PROPN
bionys-572	255	2	cooper	cooper	PROPN
bionys-572	255	3	,	,	PUNCT
bionys-572	255	4	m.	m.	PROPN
bionys-572	255	5	s.	s.	PROPN
bionys-572	255	6	,	,	PUNCT
bionys-572	255	7	gittoes	gittoe	NOUN
bionys-572	255	8	,	,	PUNCT
bionys-572	255	9	n.	n.	PROPN
bionys-572	255	10	j.	j.	PROPN
bionys-572	255	11	(	(	PUNCT
bionys-572	255	12	2008	2008	NUM
bionys-572	255	13	)	)	PUNCT
bionys-572	255	14	.	.	PUNCT
bionys-572	256	1	diagnosis	diagnosis	NOUN
bionys-572	256	2	and	and	CCONJ
bionys-572	256	3	management	management	NOUN
bionys-572	256	4	of	of	ADP
bionys-572	256	5	hypocalcaemia	hypocalcaemia	PROPN
bionys-572	256	6	.	.	PUNCT
bionys-572	257	1	bmj	bmj	PROPN
bionys-572	257	2	,	,	PUNCT
bionys-572	257	3	336(7656	336(7656	NUM
bionys-572	257	4	)	)	PUNCT
bionys-572	257	5	,	,	PUNCT
bionys-572	257	6	1298–1302	1298–1302	NUM
bionys-572	257	7	.	.	PUNCT
bionys-572	258	1	https://doi.org/10.1136/	https://doi.org/10.1136/	PROPN
bionys-572	258	2	bmj.39582.589433.be	bmj.39582.589433.be	PROPN
bionys-572	258	3	de	de	PROPN
bionys-572	258	4	jong	jong	PROPN
bionys-572	258	5	,	,	PUNCT
bionys-572	258	6	j.g.n	j.g.n	PROPN
bionys-572	258	7	.	.	PROPN
bionys-572	258	8	,	,	PUNCT
bionys-572	258	9	wevers	wever	NOUN
bionys-572	258	10	,	,	PUNCT
bionys-572	258	11	r.a	r.a	PROPN
bionys-572	258	12	.	.	PROPN
bionys-572	258	13	,	,	PUNCT
bionys-572	258	14	lefeber	lefeber	PROPN
bionys-572	258	15	,	,	PUNCT
bionys-572	258	16	d.j	d.j	PROPN
bionys-572	258	17	.	.	PROPN
bionys-572	258	18	(	(	PUNCT
bionys-572	258	19	1989	1989	NUM
bionys-572	258	20	)	)	PUNCT
bionys-572	258	21	.	.	PUNCT
bionys-572	259	1	dimethylmethylene	dimethylmethylene	PROPN
bionys-572	259	2	blue	blue	PROPN
bionys-572	259	3	-	-	PUNCT
bionys-572	259	4	based	base	VERB
bionys-572	259	5	spectrophotometric	spectrophotometric	ADJ
bionys-572	259	6	assay	assay	NOUN
bionys-572	259	7	for	for	ADP
bionys-572	259	8	glycosaminoglycans	glycosaminoglycan	NOUN
bionys-572	259	9	:	:	PUNCT
bionys-572	259	10	application	application	NOUN
bionys-572	259	11	in	in	ADP
bionys-572	259	12	mucopolysaccharidosis	mucopolysaccharidosis	NOUN
bionys-572	259	13	screening	screening	NOUN
bionys-572	259	14	.	.	PUNCT
bionys-572	260	1	clinical	clinical	ADJ
bionys-572	260	2	chemistry	chemistry	NOUN
bionys-572	260	3	,	,	PUNCT
bionys-572	260	4	35(8	35(8	NUM
bionys-572	260	5	)	)	PUNCT
bionys-572	260	6	,	,	PUNCT
bionys-572	260	7	1472–1476	1472–1476	NUM
bionys-572	260	8	.	.	PUNCT
bionys-572	261	1	pmid	pmid	NOUN
bionys-572	261	2	:	:	PUNCT
bionys-572	261	3	2667889	2667889	NUM
bionys-572	261	4	demoulin	demoulin	PROPN
bionys-572	261	5	,	,	PUNCT
bionys-572	261	6	n.	n.	NOUN
bionys-572	261	7	,	,	PUNCT
bionys-572	261	8	aydin	aydin	PROPN
bionys-572	261	9	,	,	PUNCT
bionys-572	261	10	s.	s.	PROPN
bionys-572	261	11	,	,	PUNCT
bionys-572	261	12	gillion	gillion	NOUN
bionys-572	261	13	,	,	PUNCT
bionys-572	261	14	v.	v.	ADV
bionys-572	261	15	,	,	PUNCT
bionys-572	261	16	morelle	morelle	NOUN
bionys-572	261	17	,	,	PUNCT
bionys-572	261	18	j.	j.	PROPN
bionys-572	261	19	,	,	PUNCT
bionys-572	261	20	jadoul	jadoul	PROPN
bionys-572	261	21	,	,	PUNCT
bionys-572	261	22	m.	m.	NOUN
bionys-572	261	23	(	(	PUNCT
bionys-572	261	24	2022	2022	NUM
bionys-572	261	25	)	)	PUNCT
bionys-572	261	26	.	.	PUNCT
bionys-572	262	1	pathophysiology	pathophysiology	NOUN
bionys-572	262	2	and	and	CCONJ
bionys-572	262	3	management	management	NOUN
bionys-572	262	4	of	of	ADP
bionys-572	262	5	hyperoxaluria	hyperoxaluria	PROPN
bionys-572	262	6	and	and	CCONJ
bionys-572	262	7	oxalate	oxalate	PROPN
bionys-572	262	8	nephropathy	nephropathy	NOUN
bionys-572	262	9	:	:	PUNCT
bionys-572	262	10	a	a	DET
bionys-572	262	11	review	review	NOUN
bionys-572	262	12	.	.	PUNCT
bionys-572	263	1	american	american	PROPN
bionys-572	263	2	journal	journal	PROPN
bionys-572	263	3	of	of	ADP
bionys-572	263	4	kidney	kidney	NOUN
bionys-572	263	5	diseases	disease	NOUN
bionys-572	263	6	,	,	PUNCT
bionys-572	263	7	79(5	79(5	NOUN
bionys-572	263	8	)	)	PUNCT
bionys-572	263	9	,	,	PUNCT
bionys-572	263	10	717–727	717–727	NUM
bionys-572	263	11	.	.	PUNCT
bionys-572	264	1	https://doi.org/10.1053/j	https://doi.org/10.1053/j	PROPN
bionys-572	264	2	.	.	PROPN
bionys-572	264	3	ajkd.2021.07.018	ajkd.2021.07.018	PROPN
bionys-572	264	4	el	el	PROPN
bionys-572	264	5	hage	hage	PROPN
bionys-572	264	6	,	,	PUNCT
bionys-572	264	7	s.	s.	PROPN
bionys-572	264	8	,	,	PUNCT
bionys-572	264	9	ghanem	ghanem	PROPN
bionys-572	264	10	,	,	PUNCT
bionys-572	264	11	i.	i.	PROPN
bionys-572	264	12	,	,	PUNCT
bionys-572	264	13	baradhi	baradhi	PROPN
bionys-572	264	14	,	,	PUNCT
bionys-572	264	15	a.	a.	NOUN
bionys-572	264	16	,	,	PUNCT
bionys-572	264	17	mourani	mourani	PROPN
bionys-572	264	18	,	,	PUNCT
bionys-572	264	19	c.	c.	NOUN
bionys-572	264	20	,	,	PUNCT
bionys-572	264	21	mallat	mallat	PROPN
bionys-572	264	22	,	,	PUNCT
bionys-572	264	23	s.	s.	PROPN
bionys-572	264	24	,	,	PUNCT
bionys-572	264	25	dagher	dagher	PROPN
bionys-572	264	26	,	,	PUNCT
bionys-572	264	27	f.	f.	PROPN
bionys-572	264	28	,	,	PUNCT
bionys-572	264	29	kharrat	kharrat	PROPN
bionys-572	264	30	,	,	PUNCT
bionys-572	264	31	k.	k.	PROPN
bionys-572	264	32	(	(	PUNCT
bionys-572	264	33	2008	2008	NUM
bionys-572	264	34	)	)	PUNCT
bionys-572	264	35	.	.	PUNCT
bionys-572	265	1	skeletal	skeletal	ADJ
bionys-572	265	2	features	feature	NOUN
bionys-572	265	3	of	of	ADP
bionys-572	265	4	primary	primary	ADJ
bionys-572	265	5	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	265	6	type	type	NOUN
bionys-572	265	7	1	1	NUM
bionys-572	265	8	,	,	PUNCT
bionys-572	265	9	revisited	revisit	VERB
bionys-572	265	10	.	.	PUNCT
bionys-572	266	1	journal	journal	NOUN
bionys-572	266	2	of	of	ADP
bionys-572	266	3	children	child	NOUN
bionys-572	266	4	's	's	PART
bionys-572	266	5	orthopaedics	orthopaedic	NOUN
bionys-572	266	6	,	,	PUNCT
bionys-572	266	7	2(3	2(3	NUM
bionys-572	266	8	)	)	PUNCT
bionys-572	266	9	,	,	PUNCT
bionys-572	266	10	205–210	205–210	NUM
bionys-572	266	11	.	.	PUNCT
bionys-572	267	1	https://doi.org/10.1007/s11832-008-00824	https://doi.org/10.1007/s11832-008-00824	NOUN
bionys-572	267	2	gapparova	gapparova	PROPN
bionys-572	267	3	,	,	PUNCT
bionys-572	267	4	g.	g.	PROPN
bionys-572	267	5	n.	n.	PROPN
bionys-572	267	6	,	,	PUNCT
bionys-572	267	7	&	&	CCONJ
bionys-572	267	8	utamurodova	utamurodova	PROPN
bionys-572	267	9	,	,	PUNCT
bionys-572	267	10	n.	n.	PROPN
bionys-572	267	11	a.	a.	PROPN
bionys-572	267	12	(	(	PUNCT
bionys-572	267	13	2023	2023	NUM
bionys-572	267	14	)	)	PUNCT
bionys-572	267	15	.	.	PUNCT
bionys-572	268	1	clinical	clinical	ADJ
bionys-572	268	2	and	and	CCONJ
bionys-572	268	3	laboratory	laboratory	NOUN
bionys-572	268	4	features	feature	NOUN
bionys-572	268	5	of	of	ADP
bionys-572	268	6	nephropathy	nephropathy	NOUN
bionys-572	268	7	in	in	ADP
bionys-572	268	8	children	child	NOUN
bionys-572	268	9	with	with	ADP
bionys-572	268	10	diabetes	diabetes	NOUN
bionys-572	268	11	mellitus	mellitus	NOUN
bionys-572	268	12	.	.	PUNCT
bionys-572	269	1	journalnx	journalnx	NOUN
bionys-572	269	2	–	–	PUNCT
bionys-572	269	3	a	a	DET
bionys-572	269	4	multidisciplinary	multidisciplinary	ADJ
bionys-572	269	5	peer	peer	NOUN
bionys-572	269	6	reviewed	review	VERB
bionys-572	269	7	journal	journal	NOUN
bionys-572	269	8	,	,	PUNCT
bionys-572	269	9	9(2	9(2	NUM
bionys-572	269	10	)	)	PUNCT
bionys-572	269	11	,	,	PUNCT
bionys-572	269	12	116–122	116–122	NUM
bionys-572	269	13	.	.	PUNCT
bionys-572	270	1	https://doi.org/10.17605/osf.io/2sfzg	https://doi.org/10.17605/osf.io/2sfzg	PROPN
bionys-572	270	2	grover	grover	PROPN
bionys-572	270	3	,	,	PUNCT
bionys-572	270	4	p.	p.	PROPN
bionys-572	270	5	k.	k.	PROPN
bionys-572	270	6	,	,	PUNCT
bionys-572	270	7	&	&	CCONJ
bionys-572	270	8	ryall	ryall	PROPN
bionys-572	270	9	,	,	PUNCT
bionys-572	270	10	r.	r.	PROPN
bionys-572	270	11	l.	l.	PROPN
bionys-572	270	12	(	(	PUNCT
bionys-572	270	13	1999	1999	NUM
bionys-572	270	14	)	)	PUNCT
bionys-572	270	15	.	.	PUNCT
bionys-572	271	1	inhibition	inhibition	NOUN
bionys-572	271	2	of	of	ADP
bionys-572	271	3	calcium	calcium	NOUN
bionys-572	271	4	oxalate	oxalate	NOUN
bionys-572	271	5	crystal	crystal	NOUN
bionys-572	271	6	growth	growth	NOUN
bionys-572	271	7	and	and	CCONJ
bionys-572	271	8	aggregation	aggregation	NOUN
bionys-572	271	9	by	by	ADP
bionys-572	271	10	prothrombin	prothrombin	NOUN
bionys-572	271	11	and	and	CCONJ
bionys-572	271	12	its	its	PRON
bionys-572	271	13	fragments	fragment	NOUN
bionys-572	271	14	in	in	ADP
bionys-572	271	15	vitro	vitro	X
bionys-572	271	16	:	:	PUNCT
bionys-572	271	17	relationship	relationship	NOUN
bionys-572	271	18	between	between	ADP
bionys-572	271	19	protein	protein	NOUN
bionys-572	271	20	structure	structure	NOUN
bionys-572	271	21	and	and	CCONJ
bionys-572	271	22	inhibitory	inhibitory	ADJ
bionys-572	271	23	activity	activity	NOUN
bionys-572	271	24	.	.	PUNCT
bionys-572	272	1	european	european	PROPN
bionys-572	272	2	journal	journal	PROPN
bionys-572	272	3	of	of	ADP
bionys-572	272	4	biochemistry	biochemistry	NOUN
bionys-572	272	5	,	,	PUNCT
bionys-572	272	6	263(1	263(1	NUM
bionys-572	272	7	)	)	PUNCT
bionys-572	272	8	,	,	PUNCT
bionys-572	272	9	50–56	50–56	NUM
bionys-572	272	10	.	.	PUNCT
bionys-572	273	1	https://doi.org/10.1046/j.1432-1327.1999.00448.x	https://doi.org/10.1046/j.1432-1327.1999.00448.x	ADJ
bionys-572	273	2	guo	guo	PROPN
bionys-572	273	3	,	,	PUNCT
bionys-572	273	4	s.	s.	PROPN
bionys-572	273	5	,	,	PUNCT
bionys-572	273	6	wang	wang	PROPN
bionys-572	273	7	,	,	PUNCT
bionys-572	273	8	m.	m.	NOUN
bionys-572	273	9	,	,	PUNCT
bionys-572	273	10	yu	yu	PROPN
bionys-572	273	11	,	,	PUNCT
bionys-572	273	12	y.	y.	PROPN
bionys-572	273	13	,	,	PUNCT
bionys-572	273	14	li	li	PROPN
bionys-572	273	15	,	,	PUNCT
bionys-572	273	16	y.	y.	PROPN
bionys-572	273	17	,	,	PUNCT
bionys-572	273	18	&	&	CCONJ
bionys-572	273	19	wang	wang	PROPN
bionys-572	273	20	,	,	PUNCT
bionys-572	273	21	y.	y.	PROPN
bionys-572	273	22	(	(	PUNCT
bionys-572	273	23	2020	2020	NUM
bionys-572	273	24	)	)	PUNCT
bionys-572	273	25	.	.	PUNCT
bionys-572	274	1	the	the	DET
bionys-572	274	2	association	association	PROPN
bionys-572	274	3	of	of	ADP
bionys-572	274	4	erythrocyte	erythrocyte	PROPN
bionys-572	274	5	sedimentation	sedimentation	NOUN
bionys-572	274	6	rate	rate	NOUN
bionys-572	274	7	,	,	PUNCT
bionys-572	274	8	high	high	ADJ
bionys-572	274	9	-	-	PUNCT
bionys-572	274	10	sensitivity	sensitivity	NOUN
bionys-572	274	11	c	c	NOUN
bionys-572	274	12	-	-	PUNCT
bionys-572	274	13	reactive	reactive	ADJ
bionys-572	274	14	protein	protein	NOUN
bionys-572	274	15	and	and	CCONJ
bionys-572	274	16	diabetic	diabetic	ADJ
bionys-572	274	17	kidney	kidney	NOUN
bionys-572	274	18	disease	disease	NOUN
bionys-572	274	19	in	in	ADP
bionys-572	274	20	patients	patient	NOUN
bionys-572	274	21	with	with	ADP
bionys-572	274	22	type	type	NOUN
bionys-572	274	23	2	2	NUM
bionys-572	274	24	diabetes	diabetes	NOUN
bionys-572	274	25	.	.	PUNCT
bionys-572	275	1	bmc	bmc	ADJ
bionys-572	275	2	endocrine	endocrine	NOUN
bionys-572	275	3	disorders	disorder	NOUN
bionys-572	275	4	,	,	PUNCT
bionys-572	275	5	20(1	20(1	NUM
bionys-572	275	6	)	)	PUNCT
bionys-572	275	7	,	,	PUNCT
bionys-572	275	8	103	103	NUM
bionys-572	275	9	.	.	PUNCT
bionys-572	276	1	https://doi	https://doi	X
bionys-572	276	2	.	.	PUNCT
bionys-572	276	3	org/10.1186	org/10.1186	PROPN
bionys-572	276	4	/	/	SYM
bionys-572	276	5	s12902	s12902	PROPN
bionys-572	276	6	-	-	PUNCT
bionys-572	276	7	020	020	NUM
bionys-572	276	8	-	-	PUNCT
bionys-572	276	9	00584	00584	NUM
bionys-572	276	10	-	-	SYM
bionys-572	276	11	7	7	NUM
bionys-572	276	12	han	han	PROPN
bionys-572	276	13	,	,	PUNCT
bionys-572	276	14	t.	t.	PROPN
bionys-572	276	15	,	,	PUNCT
bionys-572	276	16	chen	chen	PROPN
bionys-572	276	17	,	,	PUNCT
bionys-572	276	18	w.	w.	PROPN
bionys-572	276	19	,	,	PUNCT
bionys-572	276	20	qiu	qiu	PROPN
bionys-572	276	21	,	,	PUNCT
bionys-572	276	22	x.	x.	PROPN
bionys-572	276	23	,	,	PUNCT
bionys-572	276	24	&	&	CCONJ
bionys-572	276	25	wang	wang	PROPN
bionys-572	276	26	,	,	PUNCT
bionys-572	276	27	w.	w.	PROPN
bionys-572	276	28	(	(	PUNCT
bionys-572	276	29	2024	2024	NUM
bionys-572	276	30	)	)	PUNCT
bionys-572	276	31	.	.	PUNCT
bionys-572	277	1	epidemiology	epidemiology	NOUN
bionys-572	277	2	of	of	ADP
bionys-572	277	3	gout	gout	NOUN
bionys-572	277	4	:	:	PUNCT
bionys-572	277	5	global	global	ADJ
bionys-572	277	6	burden	burden	NOUN
bionys-572	277	7	of	of	ADP
bionys-572	277	8	disease	disease	NOUN
bionys-572	277	9	research	research	NOUN
bionys-572	277	10	from	from	ADP
bionys-572	277	11	1990	1990	NUM
bionys-572	277	12	to	to	ADP
bionys-572	277	13	2019	2019	NUM
bionys-572	277	14	and	and	CCONJ
bionys-572	277	15	future	future	ADJ
bionys-572	277	16	trend	trend	NOUN
bionys-572	277	17	predictions	prediction	NOUN
bionys-572	277	18	.	.	PUNCT
bionys-572	278	1	therapeutic	therapeutic	ADJ
bionys-572	278	2	advances	advance	NOUN
bionys-572	278	3	in	in	ADP
bionys-572	278	4	endocrinology	endocrinology	NOUN
bionys-572	278	5	and	and	CCONJ
bionys-572	278	6	metabolism	metabolism	NOUN
bionys-572	278	7	,	,	PUNCT
bionys-572	278	8	15	15	NUM
bionys-572	278	9	,	,	PUNCT
bionys-572	278	10	20420188241227295	20420188241227295	NUM
bionys-572	278	11	.	.	PUNCT
bionys-572	279	1	https://	https://	PROPN
bionys-572	279	2	doi.org/10.1177/20420188241227295	doi.org/10.1177/20420188241227295	PROPN
bionys-572	279	3	hassona	hassona	NOUN
bionys-572	279	4	,	,	PUNCT
bionys-572	279	5	y.	y.	PROPN
bionys-572	279	6	,	,	PUNCT
bionys-572	279	7	hassan	hassan	PROPN
bionys-572	279	8	,	,	PUNCT
bionys-572	279	9	s.	s.	PROPN
bionys-572	279	10	,	,	PUNCT
bionys-572	279	11	atef	atef	PROPN
bionys-572	279	12	,	,	PUNCT
bionys-572	279	13	a.	a.	PROPN
bionys-572	279	14	,	,	PUNCT
bionys-572	279	15	abou	abou	PROPN
bionys-572	279	16	-	-	PUNCT
bionys-572	279	17	elezz	elezz	PROPN
bionys-572	279	18	,	,	PUNCT
bionys-572	279	19	a.	a.	NOUN
bionys-572	279	20	,	,	PUNCT
bionys-572	279	21	&	&	CCONJ
bionys-572	279	22	ghallab	ghallab	PROPN
bionys-572	279	23	,	,	PUNCT
bionys-572	279	24	n.	n.	PROPN
bionys-572	279	25	a.	a.	PROPN
bionys-572	279	26	(	(	PUNCT
bionys-572	279	27	2024	2024	NUM
bionys-572	279	28	)	)	PUNCT
bionys-572	279	29	.	.	PUNCT
bionys-572	280	1	primary	primary	ADJ
bionys-572	280	2	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	280	3	:	:	PUNCT
bionys-572	280	4	description	description	NOUN
bionys-572	280	5	of	of	ADP
bionys-572	280	6	a	a	DET
bionys-572	280	7	new	new	ADJ
bionys-572	280	8	oral	oral	ADJ
bionys-572	280	9	finding	finding	NOUN
bionys-572	280	10	and	and	CCONJ
bionys-572	280	11	review	review	NOUN
bionys-572	280	12	of	of	ADP
bionys-572	280	13	literature	literature	NOUN
bionys-572	280	14	.	.	PUNCT
bionys-572	281	1	special	special	ADJ
bionys-572	281	2	care	care	NOUN
bionys-572	281	3	in	in	ADP
bionys-572	281	4	dentistry	dentistry	NOUN
bionys-572	281	5	,	,	PUNCT
bionys-572	281	6	44(4	44(4	NOUN
bionys-572	281	7	)	)	PUNCT
bionys-572	281	8	,	,	PUNCT
bionys-572	281	9	1041	1041	NUM
bionys-572	281	10	–	–	PUNCT
bionys-572	281	11	1048	1048	NUM
bionys-572	281	12	.	.	PUNCT
bionys-572	282	1	https://doi.org/10.1111/scd.12968	https://doi.org/10.1111/scd.12968	PROPN
bionys-572	282	2	hesse	hesse	PROPN
bionys-572	282	3	,	,	PUNCT
bionys-572	282	4	a.	a.	NOUN
bionys-572	282	5	,	,	PUNCT
bionys-572	282	6	wuzel	wuzel	NOUN
bionys-572	282	7	,	,	PUNCT
bionys-572	282	8	h.	h.	PROPN
bionys-572	282	9	,	,	PUNCT
bionys-572	282	10	&	&	CCONJ
bionys-572	282	11	vahlensieck	vahlensieck	PROPN
bionys-572	282	12	,	,	PUNCT
bionys-572	282	13	w.	w.	PROPN
bionys-572	282	14	(	(	PUNCT
bionys-572	282	15	1991	1991	NUM
bionys-572	282	16	)	)	PUNCT
bionys-572	282	17	.	.	PUNCT
bionys-572	283	1	significance	significance	NOUN
bionys-572	283	2	of	of	ADP
bionys-572	283	3	glycosaminoglycans	glycosaminoglycan	NOUN
bionys-572	283	4	for	for	ADP
bionys-572	283	5	the	the	DET
bionys-572	283	6	formation	formation	NOUN
bionys-572	283	7	of	of	ADP
bionys-572	283	8	calcium	calcium	NOUN
bionys-572	283	9	oxalate	oxalate	NOUN
bionys-572	283	10	stones	stone	NOUN
bionys-572	283	11	.	.	PUNCT
bionys-572	284	1	american	american	PROPN
bionys-572	284	2	journal	journal	PROPN
bionys-572	284	3	of	of	ADP
bionys-572	284	4	kidney	kidney	NOUN
bionys-572	284	5	diseases	disease	NOUN
bionys-572	284	6	,	,	PUNCT
bionys-572	284	7	17(4	17(4	NUM
bionys-572	284	8	)	)	PUNCT
bionys-572	284	9	,	,	PUNCT
bionys-572	284	10	414–419	414–419	NUM
bionys-572	284	11	.	.	PUNCT
bionys-572	285	1	https://	https://	PROPN
bionys-572	285	2	doi.org/10.1016/s0272-6386(12)80634-2	doi.org/10.1016/s0272-6386(12)80634-2	PROPN
bionys-572	285	3	horta	horta	PROPN
bionys-572	285	4	-	-	PUNCT
bionys-572	285	5	baas	baas	NOUN
bionys-572	285	6	,	,	PUNCT
bionys-572	285	7	g.	g.	PROPN
bionys-572	285	8	,	,	PUNCT
bionys-572	285	9	vargas	vargas	NOUN
bionys-572	285	10	-	-	PUNCT
bionys-572	285	11	gutiérrez	gutiérrez	NOUN
bionys-572	285	12	,	,	PUNCT
bionys-572	285	13	c.	c.	PROPN
bionys-572	285	14	,	,	PUNCT
bionys-572	285	15	&	&	CCONJ
bionys-572	285	16	barile	barile	NOUN
bionys-572	285	17	-	-	PUNCT
bionys-572	285	18	fabris	fabris	NOUN
bionys-572	285	19	,	,	PUNCT
bionys-572	285	20	l.	l.	PROPN
bionys-572	285	21	(	(	PUNCT
bionys-572	285	22	2013	2013	NUM
bionys-572	285	23	)	)	PUNCT
bionys-572	285	24	.	.	PUNCT
bionys-572	286	1	large	large	ADJ
bionys-572	286	2	joint	joint	ADJ
bionys-572	286	3	destructive	destructive	ADJ
bionys-572	286	4	arthropathy	arthropathy	ADJ
bionys-572	286	5	and	and	CCONJ
bionys-572	286	6	tumoral	tumoral	ADJ
bionys-572	286	7	calcinosis	calcinosis	NOUN
bionys-572	286	8	associated	associate	VERB
bionys-572	286	9	to	to	ADP
bionys-572	286	10	primary	primary	ADJ
bionys-572	286	11	oxalosis	oxalosis	NOUN
bionys-572	286	12	:	:	PUNCT
bionys-572	286	13	case	case	NOUN
bionys-572	286	14	report	report	NOUN
bionys-572	286	15	and	and	CCONJ
bionys-572	286	16	literature	literature	PROPN
bionys-572	286	17	review	review	PROPN
bionys-572	286	18	.	.	PUNCT
bionys-572	287	1	reumatología	reumatología	PROPN
bionys-572	287	2	clínica	clínica	PROPN
bionys-572	287	3	,	,	PUNCT
bionys-572	287	4	9(3	9(3	NUM
bionys-572	287	5	)	)	PUNCT
bionys-572	287	6	,	,	PUNCT
bionys-572	287	7	181–185	181–185	NUM
bionys-572	287	8	.	.	PUNCT
bionys-572	288	1	https://doi	https://doi	NOUN
bionys-572	288	2	.	.	PUNCT
bionys-572	288	3	org/10.1016	org/10.1016	PROPN
bionys-572	288	4	/	/	SYM
bionys-572	288	5	j.reuma.2012.09.009	j.reuma.2012.09.009	PROPN
bionys-572	288	6	huang	huang	PROPN
bionys-572	288	7	,	,	PUNCT
bionys-572	288	8	x.-j	x.-j	PROPN
bionys-572	288	9	.	.	PROPN
bionys-572	288	10	,	,	PUNCT
bionys-572	288	11	choi	choi	NOUN
bionys-572	288	12	,	,	PUNCT
bionys-572	288	13	y.-k	y.-k	PROPN
bionys-572	288	14	.	.	PUNCT
bionys-572	288	15	,	,	PUNCT
bionys-572	288	16	i	i	PRON
bionys-572	288	17	m	m	PROPN
bionys-572	288	18	,	,	PUNCT
bionys-572	288	19	h.-s	h.-s	PROPN
bionys-572	288	20	.	.	PUNCT
bionys-572	288	21	,	,	PUNCT
bionys-572	288	22	yarimaga	yarimaga	NOUN
bionys-572	288	23	,	,	PUNCT
bionys-572	288	24	o.	o.	PROPN
bionys-572	288	25	,	,	PUNCT
bionys-572	288	26	yoon	yoon	PROPN
bionys-572	288	27	,	,	PUNCT
bionys-572	288	28	e.	e.	PROPN
bionys-572	288	29	,	,	PUNCT
bionys-572	288	30	&	&	CCONJ
bionys-572	288	31	kim	kim	PROPN
bionys-572	288	32	,	,	PUNCT
bionys-572	288	33	h.-s	h.-s	PROPN
bionys-572	288	34	.	.	PUNCT
bionys-572	289	1	(	(	PUNCT
bionys-572	289	2	2006	2006	NUM
bionys-572	289	3	)	)	PUNCT
bionys-572	289	4	.	.	PUNCT
bionys-572	290	1	aspartate	aspartate	PROPN
bionys-572	290	2	aminotransferase	aminotransferase	PROPN
bionys-572	290	3	(	(	PUNCT
bionys-572	290	4	ast	ast	PROPN
bionys-572	290	5	/	/	PUNCT
bionys-572	290	6	got	got	NOUN
bionys-572	290	7	)	)	PUNCT
bionys-572	290	8	and	and	CCONJ
bionys-572	290	9	alanine	alanine	NOUN
bionys-572	290	10	aminotransferase	aminotransferase	PROPN
bionys-572	290	11	(	(	PUNCT
bionys-572	290	12	alt	alt	ADJ
bionys-572	290	13	/	/	SYM
bionys-572	290	14	gpt	gpt	NOUN
bionys-572	290	15	)	)	PUNCT
bionys-572	290	16	detection	detection	NOUN
bionys-572	290	17	techniques	technique	NOUN
bionys-572	290	18	.	.	PUNCT
bionys-572	291	1	sensors	sensor	NOUN
bionys-572	291	2	,	,	PUNCT
bionys-572	291	3	6	6	NUM
bionys-572	291	4	,	,	PUNCT
bionys-572	291	5	756–782	756–782	NUM
bionys-572	291	6	.	.	PUNCT
bionys-572	292	1	https://doi.org/10.3390/	https://doi.org/10.3390/	PROPN
bionys-572	292	2	s6070756	s6070756	PROPN
bionys-572	292	3	ibrahim	ibrahim	PROPN
bionys-572	292	4	,	,	PUNCT
bionys-572	292	5	w.	w.	PROPN
bionys-572	292	6	n.	n.	PROPN
bionys-572	292	7	,	,	PUNCT
bionys-572	292	8	younes	youne	NOUN
bionys-572	292	9	,	,	PUNCT
bionys-572	292	10	n.	n.	PROPN
bionys-572	292	11	,	,	PUNCT
bionys-572	292	12	shi	shi	PROPN
bionys-572	292	13	,	,	PUNCT
bionys-572	292	14	z.	z.	PROPN
bionys-572	292	15	,	,	PUNCT
bionys-572	292	16	&	&	CCONJ
bionys-572	292	17	abu	abu	PROPN
bionys-572	292	18	-	-	PUNCT
bionys-572	292	19	madi	madi	PROPN
bionys-572	292	20	,	,	PUNCT
bionys-572	292	21	m.	m.	NOUN
bionys-572	292	22	a.	a.	NOUN
bionys-572	292	23	(	(	PUNCT
bionys-572	292	24	2021	2021	NUM
bionys-572	292	25	)	)	PUNCT
bionys-572	292	26	.	.	PUNCT
bionys-572	293	1	serum	serum	PROPN
bionys-572	293	2	uric	uric	ADJ
bionys-572	293	3	acid	acid	NOUN
bionys-572	293	4	level	level	NOUN
bionys-572	293	5	is	be	AUX
bionys-572	293	6	positively	positively	ADV
bionys-572	293	7	associated	associate	VERB
bionys-572	293	8	with	with	ADP
bionys-572	293	9	higher	high	ADJ
bionys-572	293	10	bone	bone	NOUN
bionys-572	293	11	mineral	mineral	NOUN
bionys-572	293	12	density	density	NOUN
bionys-572	293	13	at	at	ADP
bionys-572	293	14	multiple	multiple	ADJ
bionys-572	293	15	skeletal	skeletal	ADJ
bionys-572	293	16	sites	site	NOUN
bionys-572	293	17	among	among	ADP
bionys-572	293	18	healthy	healthy	ADJ
bionys-572	293	19	qataris	qataris	NOUN
bionys-572	293	20	.	.	PUNCT
bionys-572	294	1	frontiers	frontier	NOUN
bionys-572	294	2	in	in	ADP
bionys-572	294	3	endocrinology	endocrinology	NOUN
bionys-572	294	4	,	,	PUNCT
bionys-572	294	5	12	12	NUM
bionys-572	294	6	,	,	PUNCT
bionys-572	294	7	653685	653685	NUM
bionys-572	294	8	.	.	PUNCT
bionys-572	295	1	https://doi	https://doi	PROPN
bionys-572	295	2	.	.	PUNCT
bionys-572	295	3	org/10.3389	org/10.3389	PROPN
bionys-572	295	4	/	/	SYM
bionys-572	295	5	fendo.2021.653685	fendo.2021.653685	NOUN
bionys-572	295	6	i̇zki	i̇zki	PROPN
bionys-572	295	7	,	,	PUNCT
bionys-572	295	8	a.	a.	NOUN
bionys-572	295	9	a.	a.	PROPN
bionys-572	295	10	,	,	PUNCT
bionys-572	295	11	yılmaz	yılmaz	PROPN
bionys-572	295	12	,	,	PUNCT
bionys-572	295	13	h.	h.	PROPN
bionys-572	295	14	,	,	PUNCT
bionys-572	295	15	&	&	CCONJ
bionys-572	295	16	göksu	göksu	PROPN
bionys-572	295	17	,	,	PUNCT
bionys-572	295	18	h.	h.	PROPN
bionys-572	295	19	(	(	PUNCT
bionys-572	295	20	2024	2024	NUM
bionys-572	295	21	)	)	PUNCT
bionys-572	295	22	.	.	PUNCT
bionys-572	296	1	evaluation	evaluation	NOUN
bionys-572	296	2	of	of	ADP
bionys-572	296	3	balance	balance	NOUN
bionys-572	296	4	disorder	disorder	NOUN
bionys-572	296	5	and	and	CCONJ
bionys-572	296	6	associated	associated	ADJ
bionys-572	296	7	factors	factor	NOUN
bionys-572	296	8	in	in	ADP
bionys-572	296	9	patients	patient	NOUN
bionys-572	296	10	with	with	ADP
bionys-572	296	11	ankylosing	ankylose	VERB
bionys-572	296	12	spondylitis	spondylitis	NOUN
bionys-572	296	13	.	.	PUNCT
bionys-572	297	1	marmara	marmara	PROPN
bionys-572	297	2	medical	medical	PROPN
bionys-572	297	3	journal	journal	PROPN
bionys-572	297	4	,	,	PUNCT
bionys-572	297	5	37(3	37(3	NUM
bionys-572	297	6	)	)	PUNCT
bionys-572	297	7	,	,	PUNCT
bionys-572	297	8	332–337	332–337	NUM
bionys-572	297	9	.	.	PUNCT
bionys-572	298	1	https://	https://	PROPN
bionys-572	298	2	256	256	NUM
bionys-572	298	3	biologica	biologica	PROPN
bionys-572	298	4	nyssana	nyssana	PROPN
bionys-572	298	5	●	●	PUNCT
bionys-572	298	6	16	16	NUM
bionys-572	298	7	(	(	PUNCT
bionys-572	298	8	1	1	NUM
bionys-572	298	9	)	)	PUNCT
bionys-572	298	10	june	june	PROPN
bionys-572	298	11	2025	2025	NUM
bionys-572	298	12	:	:	PUNCT
bionys-572	298	13	247	247	NUM
bionys-572	298	14	-	-	SYM
bionys-572	298	15	257	257	NUM
bionys-572	298	16	kravchun	kravchun	NOUN
bionys-572	298	17	et	et	PROPN
bionys-572	298	18	al	al	PROPN
bionys-572	298	19	.	.	PUNCT
bionys-572	299	1	●	●	PUNCT
bionys-572	299	2	different	different	ADJ
bionys-572	299	3	types	type	NOUN
bionys-572	299	4	of	of	ADP
bionys-572	299	5	crystalluria	crystalluria	PROPN
bionys-572	299	6	in	in	ADP
bionys-572	299	7	patients	patient	NOUN
bionys-572	299	8	with	with	ADP
bionys-572	299	9	bone	bone	NOUN
bionys-572	299	10	and	and	CCONJ
bionys-572	299	11	joint	joint	ADJ
bionys-572	299	12	tissue	tissue	NOUN
bionys-572	299	13	pathology	pathology	NOUN
bionys-572	299	14	:	:	PUNCT
bionys-572	299	15	hematological	hematological	ADJ
bionys-572	299	16	and	and	CCONJ
bionys-572	299	17	biochemical	biochemical	ADJ
bionys-572	299	18	profiles	profile	NOUN
bionys-572	299	19	doi.org/10.5472/marumj.1573709	doi.org/10.5472/marumj.1573709	PROPN
bionys-572	299	20	joshi	joshi	PROPN
bionys-572	299	21	,	,	PUNCT
bionys-572	299	22	s.	s.	PROPN
bionys-572	299	23	,	,	PUNCT
bionys-572	299	24	clapp	clapp	PROPN
bionys-572	299	25	,	,	PUNCT
bionys-572	299	26	w.	w.	PROPN
bionys-572	299	27	l.	l.	PROPN
bionys-572	299	28	,	,	PUNCT
bionys-572	299	29	wang	wang	PROPN
bionys-572	299	30	,	,	PUNCT
bionys-572	299	31	w.	w.	PROPN
bionys-572	299	32	,	,	PUNCT
bionys-572	299	33	&	&	CCONJ
bionys-572	299	34	khan	khan	PROPN
bionys-572	299	35	,	,	PUNCT
bionys-572	299	36	s.	s.	PROPN
bionys-572	299	37	r.	r.	PROPN
bionys-572	299	38	(	(	PUNCT
bionys-572	299	39	2015	2015	NUM
bionys-572	299	40	)	)	PUNCT
bionys-572	299	41	.	.	PUNCT
bionys-572	300	1	osteogenic	osteogenic	ADJ
bionys-572	300	2	changes	change	NOUN
bionys-572	300	3	in	in	ADP
bionys-572	300	4	kidneys	kidney	NOUN
bionys-572	300	5	of	of	ADP
bionys-572	300	6	hyperoxaluric	hyperoxaluric	ADJ
bionys-572	300	7	rats	rat	NOUN
bionys-572	300	8	.	.	PUNCT
bionys-572	301	1	biochimica	biochimica	PROPN
bionys-572	301	2	et	et	PROPN
bionys-572	301	3	biophysica	biophysica	PROPN
bionys-572	301	4	acta	acta	PROPN
bionys-572	301	5	(	(	PUNCT
bionys-572	301	6	bba	bba	NOUN
bionys-572	301	7	)	)	PUNCT
bionys-572	301	8	molecular	molecular	ADJ
bionys-572	301	9	basis	basis	NOUN
bionys-572	301	10	of	of	ADP
bionys-572	301	11	disease	disease	NOUN
bionys-572	301	12	,	,	PUNCT
bionys-572	301	13	1852(9	1852(9	NUM
bionys-572	301	14	)	)	PUNCT
bionys-572	301	15	,	,	PUNCT
bionys-572	301	16	2000	2000	NUM
bionys-572	301	17	–	–	PUNCT
bionys-572	301	18	2012	2012	NUM
bionys-572	301	19	.	.	PUNCT
bionys-572	302	1	https://doi.org/10.1016/j.bbadis.2015.06.020	https://doi.org/10.1016/j.bbadis.2015.06.020	PROPN
bionys-572	302	2	kim	kim	PROPN
bionys-572	302	3	,	,	PUNCT
bionys-572	302	4	s.	s.	PROPN
bionys-572	302	5	,	,	PUNCT
bionys-572	302	6	lee	lee	PROPN
bionys-572	302	7	,	,	PUNCT
bionys-572	302	8	s.	s.	PROPN
bionys-572	302	9	,	,	PUNCT
bionys-572	302	10	&	&	CCONJ
bionys-572	302	11	kwon	kwon	PROPN
bionys-572	302	12	,	,	PUNCT
bionys-572	302	13	h.	h.	PROPN
bionys-572	302	14	(	(	PUNCT
bionys-572	302	15	2023	2023	NUM
bionys-572	302	16	)	)	PUNCT
bionys-572	302	17	.	.	PUNCT
bionys-572	303	1	association	association	NOUN
bionys-572	303	2	between	between	ADP
bionys-572	303	3	serum	serum	PROPN
bionys-572	303	4	uric	uric	ADJ
bionys-572	303	5	acid	acid	NOUN
bionys-572	303	6	level	level	NOUN
bionys-572	303	7	and	and	CCONJ
bionys-572	303	8	bone	bone	NOUN
bionys-572	303	9	mineral	mineral	NOUN
bionys-572	303	10	density	density	NOUN
bionys-572	303	11	in	in	ADP
bionys-572	303	12	men	man	NOUN
bionys-572	303	13	more	more	ADJ
bionys-572	303	14	than	than	ADP
bionys-572	303	15	50	50	NUM
bionys-572	303	16	years	year	NOUN
bionys-572	303	17	of	of	ADP
bionys-572	303	18	age	age	NOUN
bionys-572	303	19	.	.	PUNCT
bionys-572	304	1	frontiers	frontier	NOUN
bionys-572	304	2	in	in	ADP
bionys-572	304	3	endocrinology	endocrinology	NOUN
bionys-572	304	4	,	,	PUNCT
bionys-572	304	5	14	14	NUM
bionys-572	304	6	,	,	PUNCT
bionys-572	304	7	1259077	1259077	NUM
bionys-572	304	8	.	.	PUNCT
bionys-572	305	1	https://doi	https://doi	PROPN
bionys-572	305	2	.	.	PUNCT
bionys-572	305	3	org/10.3389	org/10.3389	PROPN
bionys-572	305	4	/	/	SYM
bionys-572	305	5	fendo.2023.1259077	fendo.2023.1259077	PROPN
bionys-572	305	6	ibrahim	ibrahim	PROPN
bionys-572	305	7	,	,	PUNCT
bionys-572	305	8	w.	w.	PROPN
bionys-572	305	9	n.	n.	PROPN
bionys-572	305	10	,	,	PUNCT
bionys-572	305	11	younes	youne	NOUN
bionys-572	305	12	,	,	PUNCT
bionys-572	305	13	n.	n.	PROPN
bionys-572	305	14	,	,	PUNCT
bionys-572	305	15	shi	shi	PROPN
bionys-572	305	16	,	,	PUNCT
bionys-572	305	17	z.	z.	PROPN
bionys-572	305	18	,	,	PUNCT
bionys-572	305	19	&	&	CCONJ
bionys-572	305	20	abu	abu	PROPN
bionys-572	305	21	-	-	PUNCT
bionys-572	305	22	madi	madi	PROPN
bionys-572	305	23	,	,	PUNCT
bionys-572	305	24	m.	m.	NOUN
bionys-572	305	25	a.	a.	NOUN
bionys-572	305	26	(	(	PUNCT
bionys-572	305	27	2021	2021	NUM
bionys-572	305	28	)	)	PUNCT
bionys-572	305	29	.	.	PUNCT
bionys-572	306	1	serum	serum	PROPN
bionys-572	306	2	uric	uric	ADJ
bionys-572	306	3	acid	acid	NOUN
bionys-572	306	4	level	level	NOUN
bionys-572	306	5	is	be	AUX
bionys-572	306	6	positively	positively	ADV
bionys-572	306	7	associated	associate	VERB
bionys-572	306	8	with	with	ADP
bionys-572	306	9	higher	high	ADJ
bionys-572	306	10	bone	bone	NOUN
bionys-572	306	11	mineral	mineral	NOUN
bionys-572	306	12	density	density	NOUN
bionys-572	306	13	at	at	ADP
bionys-572	306	14	multiple	multiple	ADJ
bionys-572	306	15	skeletal	skeletal	ADJ
bionys-572	306	16	sites	site	NOUN
bionys-572	306	17	among	among	ADP
bionys-572	306	18	healthy	healthy	ADJ
bionys-572	306	19	qataris	qataris	NOUN
bionys-572	306	20	.	.	PUNCT
bionys-572	307	1	frontiers	frontier	NOUN
bionys-572	307	2	in	in	ADP
bionys-572	307	3	endocrinology	endocrinology	NOUN
bionys-572	307	4	,	,	PUNCT
bionys-572	307	5	12	12	NUM
bionys-572	307	6	,	,	PUNCT
bionys-572	307	7	653685	653685	NUM
bionys-572	307	8	.	.	PUNCT
bionys-572	308	1	https://doi	https://doi	PROPN
bionys-572	308	2	.	.	PUNCT
bionys-572	308	3	org/10.3389	org/10.3389	PROPN
bionys-572	308	4	/	/	SYM
bionys-572	308	5	fendo.2021.653685	fendo.2021.653685	PROPN
bionys-572	308	6	lin	lin	PROPN
bionys-572	308	7	,	,	PUNCT
bionys-572	308	8	k.	k.	PROPN
bionys-572	308	9	m.	m.	PROPN
bionys-572	308	10	,	,	PUNCT
bionys-572	308	11	lu	lu	PROPN
bionys-572	308	12	,	,	PUNCT
bionys-572	308	13	c.	c.	PROPN
bionys-572	308	14	l.	l.	PROPN
bionys-572	308	15	,	,	PUNCT
bionys-572	308	16	hung	hung	PROPN
bionys-572	308	17	,	,	PUNCT
bionys-572	308	18	k.	k.	PROPN
bionys-572	308	19	c.	c.	PROPN
bionys-572	308	20	,	,	PUNCT
bionys-572	308	21	huang	huang	PROPN
bionys-572	308	22	,	,	PUNCT
bionys-572	308	23	y.	y.	PROPN
bionys-572	308	24	c.	c.	PROPN
bionys-572	308	25	,	,	PUNCT
bionys-572	308	26	&	&	CCONJ
bionys-572	308	27	huang	huang	PROPN
bionys-572	308	28	,	,	PUNCT
bionys-572	308	29	y.	y.	PROPN
bionys-572	308	30	t.	t.	PROPN
bionys-572	308	31	(	(	PUNCT
bionys-572	308	32	2019	2019	NUM
bionys-572	308	33	)	)	PUNCT
bionys-572	308	34	.	.	PUNCT
bionys-572	309	1	the	the	DET
bionys-572	309	2	paradoxical	paradoxical	ADJ
bionys-572	309	3	role	role	NOUN
bionys-572	309	4	of	of	ADP
bionys-572	309	5	uric	uric	ADJ
bionys-572	309	6	acid	acid	NOUN
bionys-572	309	7	in	in	ADP
bionys-572	309	8	osteoporosis	osteoporosis	NOUN
bionys-572	309	9	.	.	PUNCT
bionys-572	310	1	nutrients	nutrient	NOUN
bionys-572	310	2	,	,	PUNCT
bionys-572	310	3	11(9	11(9	PROPN
bionys-572	310	4	)	)	PUNCT
bionys-572	310	5	,	,	PUNCT
bionys-572	310	6	2111	2111	NUM
bionys-572	310	7	.	.	PUNCT
bionys-572	311	1	https://	https://	PROPN
bionys-572	311	2	doi.org/10.3390/nu11092111	doi.org/10.3390/nu11092111	PROPN
bionys-572	311	3	li	li	PROPN
bionys-572	311	4	,	,	PUNCT
bionys-572	311	5	y.	y.	PROPN
bionys-572	311	6	,	,	PUNCT
bionys-572	311	7	tan	tan	PROPN
bionys-572	311	8	,	,	PUNCT
bionys-572	311	9	j.	j.	PROPN
bionys-572	311	10	,	,	PUNCT
bionys-572	311	11	tian	tian	PROPN
bionys-572	311	12	,	,	PUNCT
bionys-572	311	13	j.	j.	PROPN
bionys-572	311	14	,	,	PUNCT
bionys-572	311	15	zhao	zhao	PROPN
bionys-572	311	16	,	,	PUNCT
bionys-572	311	17	j.	j.	PROPN
bionys-572	311	18	,	,	PUNCT
bionys-572	311	19	zhou	zhou	PROPN
bionys-572	311	20	,	,	PUNCT
bionys-572	311	21	y.	y.	PROPN
bionys-572	311	22	,	,	PUNCT
bionys-572	311	23	&	&	CCONJ
bionys-572	311	24	shi	shi	PROPN
bionys-572	311	25	,	,	PUNCT
bionys-572	311	26	y.	y.	PROPN
bionys-572	311	27	(	(	PUNCT
bionys-572	311	28	2023	2023	NUM
bionys-572	311	29	)	)	PUNCT
bionys-572	311	30	.	.	PUNCT
bionys-572	312	1	cross	cross	ADJ
bionys-572	312	2	-	-	ADJ
bionys-572	312	3	sectional	sectional	ADJ
bionys-572	312	4	analysis	analysis	NOUN
bionys-572	312	5	of	of	ADP
bionys-572	312	6	the	the	DET
bionys-572	312	7	correlation	correlation	NOUN
bionys-572	312	8	between	between	ADP
bionys-572	312	9	serum	serum	NOUN
bionys-572	312	10	uric	uric	ADJ
bionys-572	312	11	acid	acid	NOUN
bionys-572	312	12	and	and	CCONJ
bionys-572	312	13	trabecular	trabecular	ADJ
bionys-572	312	14	bone	bone	NOUN
bionys-572	312	15	score	score	NOUN
bionys-572	312	16	:	:	PUNCT
bionys-572	312	17	nhanes	nhane	VERB
bionys-572	312	18	2005–2008	2005–2008	NOUN
bionys-572	312	19	.	.	PUNCT
bionys-572	313	1	scientific	scientific	ADJ
bionys-572	313	2	reports	report	NOUN
bionys-572	313	3	,	,	PUNCT
bionys-572	313	4	13	13	NUM
bionys-572	313	5	,	,	PUNCT
bionys-572	313	6	21546	21546	NUM
bionys-572	313	7	.	.	PUNCT
bionys-572	314	1	https://doi.org/10.1038/s41598-023-48739-5	https://doi.org/10.1038/s41598-023-48739-5	PROPN
bionys-572	314	2	kuwabara	kuwabara	PROPN
bionys-572	314	3	,	,	PUNCT
bionys-572	314	4	m.	m.	NOUN
bionys-572	314	5	,	,	PUNCT
bionys-572	314	6	fukuuchi	fukuuchi	PROPN
bionys-572	314	7	,	,	PUNCT
bionys-572	314	8	t.	t.	PROPN
bionys-572	314	9	,	,	PUNCT
bionys-572	314	10	aoki	aoki	PROPN
bionys-572	314	11	,	,	PUNCT
bionys-572	314	12	y.	y.	PROPN
bionys-572	314	13	,	,	PUNCT
bionys-572	314	14	uesugi	uesugi	ADJ
bionys-572	314	15	,	,	PUNCT
bionys-572	314	16	t.	t.	PROPN
bionys-572	314	17	,	,	PUNCT
bionys-572	314	18	nakagawa	nakagawa	PROPN
bionys-572	314	19	,	,	PUNCT
bionys-572	314	20	t.	t.	PROPN
bionys-572	314	21	,	,	PUNCT
bionys-572	314	22	&	&	CCONJ
bionys-572	314	23	kanbay	kanbay	PROPN
bionys-572	314	24	,	,	PUNCT
bionys-572	314	25	m.	m.	NOUN
bionys-572	314	26	(	(	PUNCT
bionys-572	314	27	2023	2023	NUM
bionys-572	314	28	)	)	PUNCT
bionys-572	314	29	.	.	PUNCT
bionys-572	315	1	exploring	explore	VERB
bionys-572	315	2	the	the	DET
bionys-572	315	3	multifaceted	multifaceted	ADJ
bionys-572	315	4	nexus	nexus	NOUN
bionys-572	315	5	of	of	ADP
bionys-572	315	6	uric	uric	ADJ
bionys-572	315	7	acid	acid	NOUN
bionys-572	315	8	and	and	CCONJ
bionys-572	315	9	health	health	NOUN
bionys-572	315	10	:	:	PUNCT
bionys-572	315	11	a	a	DET
bionys-572	315	12	review	review	NOUN
bionys-572	315	13	of	of	ADP
bionys-572	315	14	recent	recent	ADJ
bionys-572	315	15	studies	study	NOUN
bionys-572	315	16	on	on	ADP
bionys-572	315	17	diverse	diverse	ADJ
bionys-572	315	18	diseases	disease	NOUN
bionys-572	315	19	.	.	PUNCT
bionys-572	316	1	biomolecules	biomolecule	NOUN
bionys-572	316	2	,	,	PUNCT
bionys-572	316	3	13(10	13(10	NUM
bionys-572	316	4	)	)	PUNCT
bionys-572	316	5	,	,	PUNCT
bionys-572	316	6	1519	1519	NUM
bionys-572	316	7	.	.	PUNCT
bionys-572	317	1	https://doi.org/10.3390/	https://doi.org/10.3390/	PROPN
bionys-572	317	2	biom13101519	biom13101519	PROPN
bionys-572	317	3	lalayiannis	lalayiannis	NOUN
bionys-572	317	4	,	,	PUNCT
bionys-572	317	5	a.	a.	PROPN
bionys-572	317	6	d.	d.	PROPN
bionys-572	317	7	,	,	PUNCT
bionys-572	317	8	soeiro	soeiro	PROPN
bionys-572	317	9	,	,	PUNCT
bionys-572	317	10	e.	e.	PROPN
bionys-572	317	11	m.	m.	PROPN
bionys-572	317	12	d.	d.	PROPN
bionys-572	317	13	,	,	PUNCT
bionys-572	317	14	moysés	moysés	PROPN
bionys-572	317	15	,	,	PUNCT
bionys-572	317	16	r.	r.	PROPN
bionys-572	317	17	m.	m.	PROPN
bionys-572	317	18	a.	a.	PROPN
bionys-572	317	19	,	,	PUNCT
bionys-572	317	20	&	&	CCONJ
bionys-572	317	21	shroff	shroff	PROPN
bionys-572	317	22	,	,	PUNCT
bionys-572	317	23	r.	r.	PROPN
bionys-572	317	24	(	(	PUNCT
bionys-572	317	25	2024	2024	NUM
bionys-572	317	26	)	)	PUNCT
bionys-572	317	27	.	.	PUNCT
bionys-572	318	1	chronic	chronic	ADJ
bionys-572	318	2	kidney	kidney	NOUN
bionys-572	318	3	disease	disease	NOUN
bionys-572	318	4	mineral	mineral	NOUN
bionys-572	318	5	bone	bone	NOUN
bionys-572	318	6	disorder	disorder	NOUN
bionys-572	318	7	in	in	ADP
bionys-572	318	8	childhood	childhood	NOUN
bionys-572	318	9	and	and	CCONJ
bionys-572	318	10	young	young	ADJ
bionys-572	318	11	adulthood	adulthood	NOUN
bionys-572	318	12	:	:	PUNCT
bionys-572	318	13	a	a	DET
bionys-572	318	14	‘	'	PUNCT
bionys-572	318	15	growing	grow	VERB
bionys-572	318	16	’	'	PUNCT
bionys-572	318	17	understanding	understanding	NOUN
bionys-572	318	18	.	.	PUNCT
bionys-572	319	1	pediatric	pediatric	ADJ
bionys-572	319	2	nephrology	nephrology	NOUN
bionys-572	319	3	,	,	PUNCT
bionys-572	319	4	39(3	39(3	NUM
bionys-572	319	5	)	)	PUNCT
bionys-572	319	6	,	,	PUNCT
bionys-572	319	7	723–739	723–739	NUM
bionys-572	319	8	.	.	PUNCT
bionys-572	320	1	https://doi	https://doi	NOUN
bionys-572	320	2	.	.	PUNCT
bionys-572	320	3	org/10.1007	org/10.1007	PROPN
bionys-572	320	4	/	/	SYM
bionys-572	320	5	s00467	s00467	NOUN
bionys-572	320	6	-	-	PUNCT
bionys-572	320	7	023	023	NUM
bionys-572	320	8	-	-	PUNCT
bionys-572	320	9	06109	06109	NUM
bionys-572	320	10	-	-	PUNCT
bionys-572	320	11	3	3	NUM
bionys-572	320	12	langenfeld	langenfeld	NOUN
bionys-572	320	13	,	,	PUNCT
bionys-572	320	14	n.	n.	PROPN
bionys-572	320	15	j.	j.	PROPN
bionys-572	320	16	,	,	PUNCT
bionys-572	320	17	payne	payne	PROPN
bionys-572	320	18	,	,	PUNCT
bionys-572	320	19	l.	l.	PROPN
bionys-572	320	20	e.	e.	PROPN
bionys-572	320	21	,	,	PUNCT
bionys-572	320	22	&	&	CCONJ
bionys-572	320	23	bugbee	bugbee	PROPN
bionys-572	320	24	,	,	PUNCT
bionys-572	320	25	b.	b.	PROPN
bionys-572	320	26	(	(	PUNCT
bionys-572	320	27	2021	2021	NUM
bionys-572	320	28	)	)	PUNCT
bionys-572	320	29	.	.	PUNCT
bionys-572	321	1	colorimetric	colorimetric	ADJ
bionys-572	321	2	determination	determination	NOUN
bionys-572	321	3	of	of	ADP
bionys-572	321	4	urea	urea	NOUN
bionys-572	321	5	using	use	VERB
bionys-572	321	6	diacetyl	diacetyl	NOUN
bionys-572	321	7	monoxime	monoxime	NOUN
bionys-572	321	8	with	with	ADP
bionys-572	321	9	strong	strong	ADJ
bionys-572	321	10	acids	acid	NOUN
bionys-572	321	11	.	.	PUNCT
bionys-572	322	1	plos	plos	PROPN
bionys-572	322	2	one	one	NUM
bionys-572	322	3	,	,	PUNCT
bionys-572	322	4	16(11	16(11	NUM
bionys-572	322	5	)	)	PUNCT
bionys-572	322	6	,	,	PUNCT
bionys-572	322	7	e0259760	e0259760	PROPN
bionys-572	322	8	.	.	PUNCT
bionys-572	322	9	https://doi.org/10.1371/journal	https://doi.org/10.1371/journal	PROPN
bionys-572	322	10	.	.	PUNCT
bionys-572	323	1	pone.0259760	pone.0259760	PROPN
bionys-572	323	2	li	li	PROPN
bionys-572	323	3	,	,	PUNCT
bionys-572	323	4	y.	y.	PROPN
bionys-572	323	5	,	,	PUNCT
bionys-572	323	6	tan	tan	PROPN
bionys-572	323	7	,	,	PUNCT
bionys-572	323	8	j.	j.	PROPN
bionys-572	323	9	,	,	PUNCT
bionys-572	323	10	tian	tian	PROPN
bionys-572	323	11	,	,	PUNCT
bionys-572	323	12	j.	j.	PROPN
bionys-572	323	13	,	,	PUNCT
bionys-572	323	14	zhou	zhou	PROPN
bionys-572	323	15	,	,	PUNCT
bionys-572	323	16	y.	y.	PROPN
bionys-572	323	17	,	,	PUNCT
bionys-572	323	18	&	&	CCONJ
bionys-572	323	19	shi	shi	PROPN
bionys-572	323	20	,	,	PUNCT
bionys-572	323	21	y.	y.	PROPN
bionys-572	323	22	(	(	PUNCT
bionys-572	323	23	2023	2023	NUM
bionys-572	323	24	)	)	PUNCT
bionys-572	323	25	.	.	PUNCT
bionys-572	324	1	cross	cross	ADJ
bionys-572	324	2	-	-	ADJ
bionys-572	324	3	sectional	sectional	ADJ
bionys-572	324	4	analysis	analysis	NOUN
bionys-572	324	5	of	of	ADP
bionys-572	324	6	the	the	DET
bionys-572	324	7	correlation	correlation	NOUN
bionys-572	324	8	between	between	ADP
bionys-572	324	9	serum	serum	NOUN
bionys-572	324	10	uric	uric	ADJ
bionys-572	324	11	acid	acid	NOUN
bionys-572	324	12	and	and	CCONJ
bionys-572	324	13	trabecular	trabecular	ADJ
bionys-572	324	14	bone	bone	NOUN
bionys-572	324	15	score	score	NOUN
bionys-572	324	16	:	:	PUNCT
bionys-572	324	17	nhanes	nhane	VERB
bionys-572	324	18	2005–2008	2005–2008	NOUN
bionys-572	324	19	.	.	PUNCT
bionys-572	325	1	scientific	scientific	ADJ
bionys-572	325	2	reports	report	NOUN
bionys-572	325	3	,	,	PUNCT
bionys-572	325	4	13	13	NUM
bionys-572	325	5	,	,	PUNCT
bionys-572	325	6	21546	21546	NUM
bionys-572	325	7	.	.	PUNCT
bionys-572	326	1	https://doi.org/10.1038/s41598-023-48739-5	https://doi.org/10.1038/s41598-023-48739-5	PROPN
bionys-572	326	2	lin	lin	PROPN
bionys-572	326	3	,	,	PUNCT
bionys-572	326	4	k.	k.	PROPN
bionys-572	326	5	m.	m.	PROPN
bionys-572	326	6	,	,	PUNCT
bionys-572	326	7	lu	lu	PROPN
bionys-572	326	8	,	,	PUNCT
bionys-572	326	9	c.	c.	PROPN
bionys-572	326	10	l.	l.	PROPN
bionys-572	326	11	,	,	PUNCT
bionys-572	326	12	hung	hung	PROPN
bionys-572	326	13	,	,	PUNCT
bionys-572	326	14	k.	k.	PROPN
bionys-572	326	15	c.	c.	PROPN
bionys-572	326	16	,	,	PUNCT
bionys-572	326	17	huang	huang	PROPN
bionys-572	326	18	,	,	PUNCT
bionys-572	326	19	y.	y.	PROPN
bionys-572	326	20	c.	c.	PROPN
bionys-572	326	21	,	,	PUNCT
bionys-572	326	22	&	&	CCONJ
bionys-572	326	23	huang	huang	PROPN
bionys-572	326	24	,	,	PUNCT
bionys-572	326	25	y.	y.	PROPN
bionys-572	326	26	t.	t.	PROPN
bionys-572	326	27	(	(	PUNCT
bionys-572	326	28	2019	2019	NUM
bionys-572	326	29	)	)	PUNCT
bionys-572	326	30	.	.	PUNCT
bionys-572	327	1	the	the	DET
bionys-572	327	2	paradoxical	paradoxical	ADJ
bionys-572	327	3	role	role	NOUN
bionys-572	327	4	of	of	ADP
bionys-572	327	5	uric	uric	ADJ
bionys-572	327	6	acid	acid	NOUN
bionys-572	327	7	in	in	ADP
bionys-572	327	8	osteoporosis	osteoporosis	NOUN
bionys-572	327	9	.	.	PUNCT
bionys-572	328	1	nutrients	nutrient	NOUN
bionys-572	328	2	,	,	PUNCT
bionys-572	328	3	11(9	11(9	PROPN
bionys-572	328	4	)	)	PUNCT
bionys-572	328	5	,	,	PUNCT
bionys-572	328	6	2111	2111	NUM
bionys-572	328	7	.	.	PUNCT
bionys-572	329	1	https://	https://	PROPN
bionys-572	329	2	doi.org/10.3390/nu11092111	doi.org/10.3390/nu11092111	PROPN
bionys-572	329	3	liu	liu	PROPN
bionys-572	329	4	,	,	PUNCT
bionys-572	329	5	l.	l.	PROPN
bionys-572	329	6	,	,	PUNCT
bionys-572	329	7	shao	shao	PROPN
bionys-572	329	8	,	,	PUNCT
bionys-572	329	9	y.	y.	PROPN
bionys-572	329	10	,	,	PUNCT
bionys-572	329	11	li	li	PROPN
bionys-572	329	12	,	,	PUNCT
bionys-572	329	13	x.	x.	PROPN
bionys-572	329	14	,	,	PUNCT
bionys-572	329	15	sun	sun	PROPN
bionys-572	329	16	,	,	PUNCT
bionys-572	329	17	j.	j.	PROPN
bionys-572	329	18	,	,	PUNCT
bionys-572	329	19	&	&	CCONJ
bionys-572	329	20	xing	xing	PROPN
bionys-572	329	21	,	,	PUNCT
bionys-572	329	22	d.	d.	PROPN
bionys-572	329	23	(	(	PUNCT
bionys-572	329	24	2022	2022	NUM
bionys-572	329	25	)	)	PUNCT
bionys-572	329	26	.	.	PUNCT
bionys-572	330	1	individual	individual	ADJ
bionys-572	330	2	and	and	CCONJ
bionys-572	330	3	combined	combined	ADJ
bionys-572	330	4	relationship	relationship	NOUN
bionys-572	330	5	of	of	ADP
bionys-572	330	6	serum	serum	NOUN
bionys-572	330	7	uric	uric	ADJ
bionys-572	330	8	acid	acid	PROPN
bionys-572	330	9	and	and	CCONJ
bionys-572	330	10	alanine	alanine	NOUN
bionys-572	330	11	aminotransferase	aminotransferase	PROPN
bionys-572	330	12	on	on	ADP
bionys-572	330	13	metabolic	metabolic	NOUN
bionys-572	330	14	syndrome	syndrome	NOUN
bionys-572	330	15	in	in	ADP
bionys-572	330	16	adults	adult	NOUN
bionys-572	330	17	in	in	ADP
bionys-572	330	18	qingdao	qingdao	PROPN
bionys-572	330	19	,	,	PUNCT
bionys-572	330	20	china	china	PROPN
bionys-572	330	21	.	.	PUNCT
bionys-572	331	1	nutrition	nutrition	PROPN
bionys-572	331	2	,	,	PUNCT
bionys-572	331	3	metabolism	metabolism	NOUN
bionys-572	331	4	and	and	CCONJ
bionys-572	331	5	cardiovascular	cardiovascular	ADJ
bionys-572	331	6	diseases	disease	NOUN
bionys-572	331	7	,	,	PUNCT
bionys-572	331	8	32(12	32(12	NUM
bionys-572	331	9	)	)	PUNCT
bionys-572	331	10	,	,	PUNCT
bionys-572	331	11	2822–2829	2822–2829	NUM
bionys-572	331	12	.	.	PUNCT
bionys-572	332	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
bionys-572	332	2	.	.	PUNCT
bionys-572	333	1	numecd.2022.08.014	numecd.2022.08.014	PROPN
bionys-572	334	1	liu	liu	PROPN
bionys-572	334	2	,	,	PUNCT
bionys-572	334	3	y.	y.	PROPN
bionys-572	334	4	,	,	PUNCT
bionys-572	334	5	zhao	zhao	PROPN
bionys-572	334	6	,	,	PUNCT
bionys-572	334	7	y.	y.	PROPN
bionys-572	334	8	,	,	PUNCT
bionys-572	334	9	shukla	shukla	NOUN
bionys-572	334	10	,	,	PUNCT
bionys-572	334	11	y.	y.	PROPN
bionys-572	334	12	,	,	PUNCT
bionys-572	334	13	tan	tan	PROPN
bionys-572	334	14	,	,	PUNCT
bionys-572	334	15	w.	w.	PROPN
bionys-572	334	16	,	,	PUNCT
bionys-572	334	17	wang	wang	PROPN
bionys-572	334	18	,	,	PUNCT
bionys-572	334	19	y.	y.	PROPN
bionys-572	334	20	,	,	PUNCT
bionys-572	334	21	&	&	CCONJ
bionys-572	334	22	tang	tang	PROPN
bionys-572	334	23	,	,	PUNCT
bionys-572	334	24	h.	h.	PROPN
bionys-572	334	25	(	(	PUNCT
bionys-572	334	26	2021	2021	NUM
bionys-572	334	27	)	)	PUNCT
bionys-572	334	28	.	.	PUNCT
bionys-572	335	1	dysregulated	dysregulate	VERB
bionys-572	335	2	oxalate	oxalate	NOUN
bionys-572	335	3	metabolism	metabolism	NOUN
bionys-572	335	4	is	be	AUX
bionys-572	335	5	a	a	DET
bionys-572	335	6	driver	driver	NOUN
bionys-572	335	7	and	and	CCONJ
bionys-572	335	8	therapeutic	therapeutic	ADJ
bionys-572	335	9	target	target	NOUN
bionys-572	335	10	in	in	ADP
bionys-572	335	11	atherosclerosis	atherosclerosis	NOUN
bionys-572	335	12	.	.	PUNCT
bionys-572	336	1	cell	cell	NOUN
bionys-572	336	2	reports	report	NOUN
bionys-572	336	3	,	,	PUNCT
bionys-572	336	4	36(4	36(4	NUM
bionys-572	336	5	)	)	PUNCT
bionys-572	336	6	,	,	PUNCT
bionys-572	336	7	109420	109420	NUM
bionys-572	336	8	.	.	PUNCT
bionys-572	337	1	https://	https://	PROPN
bionys-572	337	2	doi.org/10.1016/j.celrep.2021.109420	doi.org/10.1016/j.celrep.2021.109420	PROPN
bionys-572	337	3	mitri	mitri	PROPN
bionys-572	337	4	,	,	PUNCT
bionys-572	337	5	z.	z.	PROPN
bionys-572	337	6	,	,	PUNCT
bionys-572	337	7	&	&	CCONJ
bionys-572	337	8	tangpricha	tangpricha	PROPN
bionys-572	337	9	,	,	PUNCT
bionys-572	337	10	v.	v.	PROPN
bionys-572	337	11	(	(	PUNCT
bionys-572	337	12	2012	2012	NUM
bionys-572	337	13	)	)	PUNCT
bionys-572	337	14	.	.	PUNCT
bionys-572	338	1	osteopetrosis	osteopetrosis	NOUN
bionys-572	338	2	,	,	PUNCT
bionys-572	338	3	hypophosphatemia	hypophosphatemia	NOUN
bionys-572	338	4	,	,	PUNCT
bionys-572	338	5	and	and	CCONJ
bionys-572	338	6	phosphaturia	phosphaturia	NOUN
bionys-572	338	7	in	in	ADP
bionys-572	338	8	a	a	DET
bionys-572	338	9	young	young	ADJ
bionys-572	338	10	man	man	NOUN
bionys-572	338	11	:	:	PUNCT
bionys-572	338	12	a	a	DET
bionys-572	338	13	case	case	NOUN
bionys-572	338	14	presentation	presentation	NOUN
bionys-572	338	15	and	and	CCONJ
bionys-572	338	16	differential	differential	ADJ
bionys-572	338	17	diagnosis	diagnosis	NOUN
bionys-572	338	18	.	.	PUNCT
bionys-572	339	1	case	case	NOUN
bionys-572	339	2	reports	report	VERB
bionys-572	339	3	in	in	ADP
bionys-572	339	4	endocrinology	endocrinology	NOUN
bionys-572	339	5	,	,	PUNCT
bionys-572	339	6	2012	2012	NUM
bionys-572	339	7	,	,	PUNCT
bionys-572	339	8	238364	238364	NUM
bionys-572	339	9	.	.	PUNCT
bionys-572	340	1	https://doi.org/10.1155/2012/238364	https://doi.org/10.1155/2012/238364	PROPN
bionys-572	340	2	moya	moya	PROPN
bionys-572	340	3	,	,	PUNCT
bionys-572	340	4	f.j	f.j	PROPN
bionys-572	340	5	.	.	PROPN
bionys-572	340	6	,	,	PUNCT
bionys-572	340	7	rodríguez	rodríguez	PROPN
bionys-572	340	8	-	-	PUNCT
bionys-572	340	9	perales	perales	PROPN
bionys-572	340	10	,	,	PUNCT
bionys-572	340	11	s.	s.	PROPN
bionys-572	340	12	,	,	PUNCT
bionys-572	340	13	garcíaescudero	garcíaescudero	PROPN
bionys-572	340	14	,	,	PUNCT
bionys-572	340	15	r.	r.	PROPN
bionys-572	340	16	,	,	PUNCT
bionys-572	340	17	nieto	nieto	PROPN
bionys-572	340	18	-	-	PUNCT
bionys-572	340	19	romero	romero	PROPN
bionys-572	340	20	,	,	PUNCT
bionys-572	340	21	v.	v.	PROPN
bionys-572	340	22	,	,	PUNCT
bionys-572	340	23	garcia	garcia	PROPN
bionys-572	340	24	-	-	PUNCT
bionys-572	340	25	torralba	torralba	PROPN
bionys-572	340	26	,	,	PUNCT
bionys-572	340	27	a.	a.	NOUN
bionys-572	340	28	,	,	PUNCT
bionys-572	340	29	molinos	molinos	PROPN
bionys-572	340	30	-	-	PUNCT
bionys-572	340	31	vicente	vicente	PROPN
bionys-572	340	32	,	,	PUNCT
bionys-572	340	33	a.	a.	PROPN
bionys-572	340	34	,	,	PUNCT
bionys-572	340	35	salido	salido	PROPN
bionys-572	340	36	,	,	PUNCT
bionys-572	340	37	e.	e.	PROPN
bionys-572	340	38	,	,	PUNCT
bionys-572	340	39	segovia	segovia	PROPN
bionys-572	340	40	,	,	PUNCT
bionys-572	340	41	j.c	j.c	PROPN
bionys-572	340	42	.	.	PROPN
bionys-572	340	43	,	,	PUNCT
bionys-572	340	44	&	&	CCONJ
bionys-572	340	45	garcia	garcia	PROPN
bionys-572	340	46	-	-	PUNCT
bionys-572	340	47	bravo	bravo	PROPN
bionys-572	340	48	,	,	PUNCT
bionys-572	340	49	m.	m.	NOUN
bionys-572	340	50	(	(	PUNCT
bionys-572	340	51	2024	2024	NUM
bionys-572	340	52	)	)	PUNCT
bionys-572	340	53	.	.	PUNCT
bionys-572	341	1	restored	restore	VERB
bionys-572	341	2	glyoxylate	glyoxylate	NOUN
bionys-572	341	3	metabolism	metabolism	NOUN
bionys-572	341	4	after	after	ADP
bionys-572	341	5	agxt	agxt	PROPN
bionys-572	341	6	gene	gene	NOUN
bionys-572	341	7	correction	correction	NOUN
bionys-572	341	8	and	and	CCONJ
bionys-572	341	9	direct	direct	ADJ
bionys-572	341	10	reprogramming	reprogramming	NOUN
bionys-572	341	11	of	of	ADP
bionys-572	341	12	primary	primary	ADJ
bionys-572	341	13	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	341	14	type	type	NOUN
bionys-572	341	15	1	1	NUM
bionys-572	341	16	fibroblasts	fibroblast	NOUN
bionys-572	341	17	.	.	PUNCT
bionys-572	342	1	iscience	iscience	NOUN
bionys-572	342	2	,	,	PUNCT
bionys-572	342	3	27(4	27(4	PROPN
bionys-572	342	4	)	)	PUNCT
bionys-572	342	5	,	,	PUNCT
bionys-572	342	6	109530	109530	NUM
bionys-572	342	7	.	.	PUNCT
bionys-572	343	1	https://doi	https://doi	X
bionys-572	343	2	.	.	PUNCT
bionys-572	344	1	org/10.1016	org/10.1016	PROPN
bionys-572	344	2	/	/	SYM
bionys-572	344	3	j.isci.2024.109530	j.isci.2024.109530	ADJ
bionys-572	344	4	national	national	ADJ
bionys-572	344	5	center	center	NOUN
bionys-572	344	6	for	for	ADP
bionys-572	344	7	biotechnology	biotechnology	NOUN
bionys-572	344	8	information	information	NOUN
bionys-572	344	9	.	.	PUNCT
bionys-572	345	1	(	(	PUNCT
bionys-572	345	2	2025	2025	NUM
bionys-572	345	3	)	)	PUNCT
bionys-572	345	4	.	.	PUNCT
bionys-572	346	1	pubchem	pubchem	PROPN
bionys-572	346	2	compound	compound	NOUN
bionys-572	346	3	summary	summary	NOUN
bionys-572	346	4	for	for	ADP
bionys-572	346	5	cid	cid	NOUN
bionys-572	346	6	971	971	NUM
bionys-572	346	7	,	,	PUNCT
bionys-572	346	8	oxalic	oxalic	NOUN
bionys-572	346	9	acid	acid	NOUN
bionys-572	346	10	.	.	PUNCT
bionys-572	347	1	retrieved	retrieve	VERB
bionys-572	347	2	february	february	PROPN
bionys-572	347	3	24	24	NUM
bionys-572	347	4	,	,	PUNCT
bionys-572	347	5	2025	2025	NUM
bionys-572	347	6	,	,	PUNCT
bionys-572	347	7	from	from	ADP
bionys-572	347	8	https://pubchem.ncbi.nlm.nih.gov/compound/	https://pubchem.ncbi.nlm.nih.gov/compound/	X
bionys-572	347	9	oxalic	oxalic	ADJ
bionys-572	347	10	-	-	PUNCT
bionys-572	347	11	acid	acid	NOUN
bionys-572	347	12	nazzal	nazzal	NOUN
bionys-572	347	13	,	,	PUNCT
bionys-572	347	14	l.	l.	PROPN
bionys-572	347	15	,	,	PUNCT
bionys-572	347	16	francois	francois	PROPN
bionys-572	347	17	,	,	PUNCT
bionys-572	347	18	f.	f.	PROPN
bionys-572	347	19	,	,	PUNCT
bionys-572	347	20	henderson	henderson	PROPN
bionys-572	347	21	,	,	PUNCT
bionys-572	347	22	n.	n.	PROPN
bionys-572	347	23	,	,	PUNCT
bionys-572	347	24	li	li	PROPN
bionys-572	347	25	,	,	PUNCT
bionys-572	347	26	x.	x.	PROPN
bionys-572	347	27	,	,	PUNCT
bionys-572	347	28	&	&	CCONJ
bionys-572	347	29	asplin	asplin	PROPN
bionys-572	347	30	,	,	PUNCT
bionys-572	347	31	j.r	j.r	PROPN
bionys-572	347	32	.	.	PROPN
bionys-572	347	33	(	(	PUNCT
bionys-572	347	34	2021	2021	NUM
bionys-572	347	35	)	)	PUNCT
bionys-572	347	36	.	.	PUNCT
bionys-572	348	1	effect	effect	NOUN
bionys-572	348	2	of	of	ADP
bionys-572	348	3	antibiotic	antibiotic	ADJ
bionys-572	348	4	treatment	treatment	NOUN
bionys-572	348	5	on	on	ADP
bionys-572	348	6	oxalobacter	oxalobacter	ADJ
bionys-572	348	7	formigenes	formigene	NOUN
bionys-572	348	8	colonization	colonization	NOUN
bionys-572	348	9	of	of	ADP
bionys-572	348	10	the	the	DET
bionys-572	348	11	gut	gut	NOUN
bionys-572	348	12	microbiome	microbiome	NOUN
bionys-572	348	13	and	and	CCONJ
bionys-572	348	14	urinary	urinary	ADJ
bionys-572	348	15	oxalate	oxalate	NOUN
bionys-572	348	16	excretion	excretion	NOUN
bionys-572	348	17	.	.	PUNCT
bionys-572	349	1	scientific	scientific	ADJ
bionys-572	349	2	reports	report	NOUN
bionys-572	349	3	,	,	PUNCT
bionys-572	349	4	11	11	NUM
bionys-572	349	5	,	,	PUNCT
bionys-572	349	6	16428	16428	NUM
bionys-572	349	7	.	.	PUNCT
bionys-572	350	1	https://doi.org/10.1038/s41598021-95992-7	https://doi.org/10.1038/s41598021-95992-7	PROPN
bionys-572	350	2	qian	qian	PROPN
bionys-572	350	3	,	,	PUNCT
bionys-572	350	4	x.	x.	PROPN
bionys-572	350	5	,	,	PUNCT
bionys-572	350	6	wan	wan	PROPN
bionys-572	350	7	,	,	PUNCT
bionys-572	350	8	j.	j.	PROPN
bionys-572	350	9	,	,	PUNCT
bionys-572	350	10	xu	xu	PROPN
bionys-572	350	11	,	,	PUNCT
bionys-572	350	12	j.	j.	PROPN
bionys-572	350	13	,	,	PUNCT
bionys-572	350	14	liu	liu	PROPN
bionys-572	350	15	,	,	PUNCT
bionys-572	350	16	c.	c.	PROPN
bionys-572	350	17	,	,	PUNCT
bionys-572	350	18	zhong	zhong	PROPN
bionys-572	350	19	,	,	PUNCT
bionys-572	350	20	m.	m.	NOUN
bionys-572	350	21	,	,	PUNCT
bionys-572	350	22	zhang	zhang	PROPN
bionys-572	350	23	,	,	PUNCT
bionys-572	350	24	j.	j.	PROPN
bionys-572	350	25	,	,	PUNCT
bionys-572	350	26	zhang	zhang	PROPN
bionys-572	350	27	,	,	PUNCT
bionys-572	350	28	y.	y.	PROPN
bionys-572	350	29	,	,	PUNCT
bionys-572	350	30	&	&	CCONJ
bionys-572	350	31	wang	wang	PROPN
bionys-572	350	32	,	,	PUNCT
bionys-572	350	33	s.	s.	PROPN
bionys-572	350	34	(	(	PUNCT
bionys-572	350	35	2022	2022	NUM
bionys-572	350	36	)	)	PUNCT
bionys-572	350	37	.	.	PUNCT
bionys-572	351	1	epidemiological	epidemiological	ADJ
bionys-572	351	2	trends	trend	NOUN
bionys-572	351	3	of	of	ADP
bionys-572	351	4	urolithiasis	urolithiasis	NOUN
bionys-572	351	5	at	at	ADP
bionys-572	351	6	the	the	DET
bionys-572	351	7	global	global	ADJ
bionys-572	351	8	,	,	PUNCT
bionys-572	351	9	regional	regional	ADJ
bionys-572	351	10	,	,	PUNCT
bionys-572	351	11	and	and	CCONJ
bionys-572	351	12	national	national	ADJ
bionys-572	351	13	levels	level	NOUN
bionys-572	351	14	:	:	PUNCT
bionys-572	351	15	a	a	DET
bionys-572	351	16	population	population	NOUN
bionys-572	351	17	-	-	PUNCT
bionys-572	351	18	based	base	VERB
bionys-572	351	19	study	study	NOUN
bionys-572	351	20	.	.	PUNCT
bionys-572	352	1	international	international	ADJ
bionys-572	352	2	journal	journal	NOUN
bionys-572	352	3	of	of	ADP
bionys-572	352	4	clinical	clinical	ADJ
bionys-572	352	5	practice	practice	NOUN
bionys-572	352	6	,	,	PUNCT
bionys-572	352	7	2022	2022	NUM
bionys-572	352	8	,	,	PUNCT
bionys-572	352	9	6807203	6807203	NUM
bionys-572	352	10	.	.	PUNCT
bionys-572	353	1	https://doi.org/10.1155/2022/6807203	https://doi.org/10.1155/2022/6807203	PROPN
bionys-572	353	2	rabinovitch	rabinovitch	PROPN
bionys-572	353	3	,	,	PUNCT
bionys-572	353	4	a.	a.	NOUN
bionys-572	353	5	,	,	PUNCT
bionys-572	353	6	arzoumanian	arzoumanian	PROPN
bionys-572	353	7	,	,	PUNCT
bionys-572	353	8	l.	l.	PROPN
bionys-572	353	9	,	,	PUNCT
bionys-572	353	10	curcio	curcio	PROPN
bionys-572	353	11	,	,	PUNCT
bionys-572	353	12	k.m	k.m	PROPN
bionys-572	353	13	.	.	PROPN
bionys-572	353	14	,	,	PUNCT
bionys-572	353	15	dougherty	dougherty	PROPN
bionys-572	353	16	,	,	PUNCT
bionys-572	353	17	b.	b.	PROPN
bionys-572	353	18	,	,	PUNCT
bionys-572	353	19	halim	halim	PROPN
bionys-572	353	20	,	,	PUNCT
bionys-572	353	21	a.	a.	NOUN
bionys-572	353	22	(	(	PUNCT
bionys-572	353	23	2009	2009	NUM
bionys-572	353	24	)	)	PUNCT
bionys-572	353	25	.	.	PUNCT
bionys-572	354	1	urinalysis	urinalysis	NOUN
bionys-572	354	2	:	:	PUNCT
bionys-572	354	3	approved	approve	VERB
bionys-572	354	4	guideline	guideline	NOUN
bionys-572	354	5	,	,	PUNCT
bionys-572	354	6	3rd	3rd	ADJ
bionys-572	354	7	ed	ed	NOUN
bionys-572	354	8	.	.	PUNCT
bionys-572	355	1	clinical	clinical	ADJ
bionys-572	355	2	and	and	CCONJ
bionys-572	355	3	laboratory	laboratory	NOUN
bionys-572	355	4	standards	standards	PROPN
bionys-572	355	5	institute	institute	PROPN
bionys-572	355	6	,	,	PUNCT
bionys-572	355	7	29(4	29(4	NOUN
bionys-572	355	8	)	)	PUNCT
bionys-572	355	9	,	,	PUNCT
bionys-572	355	10	41	41	NUM
bionys-572	355	11	p.	p.	NOUN
bionys-572	355	12	ritgen	ritgen	NOUN
bionys-572	355	13	,	,	PUNCT
bionys-572	355	14	u.	u.	PROPN
bionys-572	355	15	(	(	PUNCT
bionys-572	355	16	2023	2023	NUM
bionys-572	355	17	)	)	PUNCT
bionys-572	355	18	.	.	PUNCT
bionys-572	356	1	analytical	analytical	ADJ
bionys-572	356	2	chemistry	chemistry	NOUN
bionys-572	356	3	.	.	PUNCT
bionys-572	357	1	springer	springer	NOUN
bionys-572	357	2	,	,	PUNCT
bionys-572	357	3	308	308	NUM
bionys-572	357	4	p.	p.	NOUN
bionys-572	357	5	sarısoy	sarısoy	NOUN
bionys-572	357	6	,	,	PUNCT
bionys-572	357	7	ö.	ö.	PROPN
bionys-572	357	8	,	,	PUNCT
bionys-572	357	9	arıcı	arıcı	NOUN
bionys-572	357	10	,	,	PUNCT
bionys-572	357	11	ş	ş	X
bionys-572	357	12	.	.	PROPN
bionys-572	357	13	,	,	PUNCT
bionys-572	357	14	demirci	demirci	PROPN
bionys-572	357	15	bodur	bodur	PROPN
bionys-572	357	16	,	,	PUNCT
bionys-572	357	17	e.	e.	PROPN
bionys-572	357	18	,	,	PUNCT
bionys-572	357	19	tezel	tezel	PROPN
bionys-572	357	20	,	,	PUNCT
bionys-572	357	21	o.	o.	PROPN
bionys-572	357	22	,	,	PUNCT
bionys-572	357	23	alpay	alpay	PROPN
bionys-572	357	24	,	,	PUNCT
bionys-572	357	25	h.	h.	PROPN
bionys-572	357	26	,	,	PUNCT
bionys-572	357	27	akalın	akalın	ADV
bionys-572	357	28	,	,	PUNCT
bionys-572	357	29	f.	f.	PROPN
bionys-572	357	30	(	(	PUNCT
bionys-572	357	31	2024	2024	NUM
bionys-572	357	32	)	)	PUNCT
bionys-572	357	33	.	.	PUNCT
bionys-572	358	1	is	be	AUX
bionys-572	358	2	aortic	aortic	ADJ
bionys-572	358	3	elasticity	elasticity	NOUN
bionys-572	358	4	257	257	NUM
bionys-572	358	5	biologica	biologica	PROPN
bionys-572	358	6	nyssana	nyssana	PROPN
bionys-572	358	7	●	●	PUNCT
bionys-572	358	8	16	16	NUM
bionys-572	358	9	(	(	PUNCT
bionys-572	358	10	1	1	NUM
bionys-572	358	11	)	)	PUNCT
bionys-572	358	12	june	june	PROPN
bionys-572	358	13	2025	2025	NUM
bionys-572	358	14	:	:	PUNCT
bionys-572	358	15	247	247	NUM
bionys-572	358	16	-	-	SYM
bionys-572	358	17	257	257	NUM
bionys-572	358	18	kravchun	kravchun	NOUN
bionys-572	358	19	et	et	PROPN
bionys-572	358	20	al	al	PROPN
bionys-572	358	21	.	.	PUNCT
bionys-572	359	1	●	●	PUNCT
bionys-572	359	2	different	different	ADJ
bionys-572	359	3	types	type	NOUN
bionys-572	359	4	of	of	ADP
bionys-572	359	5	crystalluria	crystalluria	PROPN
bionys-572	359	6	in	in	ADP
bionys-572	359	7	patients	patient	NOUN
bionys-572	359	8	with	with	ADP
bionys-572	359	9	bone	bone	NOUN
bionys-572	359	10	and	and	CCONJ
bionys-572	359	11	joint	joint	ADJ
bionys-572	359	12	tissue	tissue	NOUN
bionys-572	359	13	pathology	pathology	NOUN
bionys-572	359	14	:	:	PUNCT
bionys-572	359	15	hematological	hematological	ADJ
bionys-572	359	16	and	and	CCONJ
bionys-572	359	17	biochemical	biochemical	ADJ
bionys-572	359	18	profiles	profile	NOUN
bionys-572	359	19	associated	associate	VERB
bionys-572	359	20	with	with	ADP
bionys-572	359	21	hydration	hydration	NOUN
bionys-572	359	22	status	status	NOUN
bionys-572	359	23	in	in	ADP
bionys-572	359	24	stage	stage	NOUN
bionys-572	359	25	of	of	ADP
bionys-572	359	26	chronic	chronic	ADJ
bionys-572	359	27	renal	renal	ADJ
bionys-572	359	28	disease	disease	NOUN
bionys-572	359	29	in	in	ADP
bionys-572	359	30	children	child	NOUN
bionys-572	359	31	?	?	PUNCT
bionys-572	360	1	marmara	marmara	PROPN
bionys-572	360	2	medical	medical	ADJ
bionys-572	360	3	journal	journal	PROPN
bionys-572	360	4	,	,	PUNCT
bionys-572	360	5	37(3	37(3	NUM
bionys-572	360	6	)	)	PUNCT
bionys-572	360	7	,	,	PUNCT
bionys-572	360	8	311–317	311–317	NUM
bionys-572	360	9	.	.	PUNCT
bionys-572	361	1	doi	doi	NOUN
bionys-572	361	2	:	:	PUNCT
bionys-572	361	3	10.5472	10.5472	NUM
bionys-572	361	4	/	/	SYM
bionys-572	361	5	marumj.1573657	marumj.1573657	PROPN
bionys-572	361	6	seker	seker	PROPN
bionys-572	361	7	,	,	PUNCT
bionys-572	361	8	a.	a.	PROPN
bionys-572	361	9	,	,	PUNCT
bionys-572	361	10	gogas	gogas	PROPN
bionys-572	361	11	yavuz	yavuz	PROPN
bionys-572	361	12	,	,	PUNCT
bionys-572	361	13	d.	d.	PROPN
bionys-572	361	14	(	(	PUNCT
bionys-572	361	15	2024	2024	NUM
bionys-572	361	16	)	)	PUNCT
bionys-572	361	17	.	.	PUNCT
bionys-572	362	1	bone	bone	NOUN
bionys-572	362	2	mineral	mineral	NOUN
bionys-572	362	3	density	density	NOUN
bionys-572	362	4	in	in	ADP
bionys-572	362	5	patients	patient	NOUN
bionys-572	362	6	with	with	ADP
bionys-572	362	7	cushing	cushing	NOUN
bionys-572	362	8	’s	’s	PART
bionys-572	362	9	syndrome	syndrome	NOUN
bionys-572	362	10	.	.	PUNCT
bionys-572	363	1	marmara	marmara	PROPN
bionys-572	363	2	medical	medical	PROPN
bionys-572	363	3	journal	journal	PROPN
bionys-572	363	4	,	,	PUNCT
bionys-572	363	5	37(2	37(2	PROPN
bionys-572	363	6	)	)	PUNCT
bionys-572	363	7	,	,	PUNCT
bionys-572	363	8	185–191	185–191	NUM
bionys-572	363	9	.	.	PUNCT
bionys-572	364	1	shastri	shastri	PROPN
bionys-572	364	2	,	,	PUNCT
bionys-572	364	3	s.	s.	PROPN
bionys-572	364	4	,	,	PUNCT
bionys-572	364	5	patel	patel	PROPN
bionys-572	364	6	,	,	PUNCT
bionys-572	364	7	j.	j.	PROPN
bionys-572	364	8	,	,	PUNCT
bionys-572	364	9	sambandam	sambandam	PROPN
bionys-572	364	10	,	,	PUNCT
bionys-572	364	11	k.k	k.k	PROPN
bionys-572	364	12	.	.	PROPN
bionys-572	364	13	,	,	PUNCT
bionys-572	364	14	lederer	lederer	PROPN
bionys-572	364	15	,	,	PUNCT
bionys-572	364	16	e.d	e.d	PROPN
bionys-572	364	17	.	.	PROPN
bionys-572	364	18	(	(	PUNCT
bionys-572	364	19	2023	2023	NUM
bionys-572	364	20	)	)	PUNCT
bionys-572	364	21	.	.	PUNCT
bionys-572	365	1	kidney	kidney	NOUN
bionys-572	365	2	stone	stone	NOUN
bionys-572	365	3	pathophysiology	pathophysiology	NOUN
bionys-572	365	4	,	,	PUNCT
bionys-572	365	5	evaluation	evaluation	NOUN
bionys-572	365	6	and	and	CCONJ
bionys-572	365	7	management	management	NOUN
bionys-572	365	8	:	:	PUNCT
bionys-572	365	9	core	core	NOUN
bionys-572	365	10	curriculum	curriculum	NOUN
bionys-572	365	11	.	.	PUNCT
bionys-572	366	1	american	american	PROPN
bionys-572	366	2	journal	journal	PROPN
bionys-572	366	3	of	of	ADP
bionys-572	366	4	kidney	kidney	NOUN
bionys-572	366	5	diseases	disease	NOUN
bionys-572	366	6	,	,	PUNCT
bionys-572	366	7	82(5	82(5	NUM
bionys-572	366	8	)	)	PUNCT
bionys-572	366	9	,	,	PUNCT
bionys-572	366	10	617	617	NUM
bionys-572	366	11	–	–	PUNCT
bionys-572	366	12	634	634	NUM
bionys-572	366	13	.	.	PUNCT
bionys-572	367	1	doi	doi	NOUN
bionys-572	367	2	:	:	PUNCT
bionys-572	367	3	10.1053	10.1053	NUM
bionys-572	367	4	/	/	SYM
bionys-572	367	5	j.ajkd.2023.03.017	j.ajkd.2023.03.017	X
bionys-572	367	6	shtenberg	shtenberg	PROPN
bionys-572	367	7	,	,	PUNCT
bionys-572	367	8	o.p	o.p	PROPN
bionys-572	367	9	.	.	PROPN
bionys-572	367	10	(	(	PUNCT
bionys-572	367	11	1962	1962	NUM
bionys-572	367	12	)	)	PUNCT
bionys-572	367	13	.	.	PUNCT
bionys-572	368	1	determination	determination	NOUN
bionys-572	368	2	of	of	ADP
bionys-572	368	3	glycoproteins	glycoprotein	NOUN
bionys-572	368	4	in	in	ADP
bionys-572	368	5	blood	blood	NOUN
bionys-572	368	6	serum	serum	NOUN
bionys-572	368	7	.	.	PUNCT
bionys-572	369	1	doctor	doctor	NOUN
bionys-572	369	2	's	's	PART
bionys-572	369	3	case	case	NOUN
bionys-572	369	4	,	,	PUNCT
bionys-572	369	5	12	12	NUM
bionys-572	369	6	,	,	PUNCT
bionys-572	369	7	43–45	43–45	NOUN
bionys-572	369	8	.	.	PUNCT
bionys-572	369	9	sun	sun	PROPN
bionys-572	369	10	,	,	PUNCT
bionys-572	369	11	y.	y.	PROPN
bionys-572	369	12	,	,	PUNCT
bionys-572	369	13	horowitz	horowitz	PROPN
bionys-572	369	14	,	,	PUNCT
bionys-572	369	15	b.l	b.l	PROPN
bionys-572	369	16	.	.	PROPN
bionys-572	369	17	,	,	PUNCT
bionys-572	369	18	servilla	servilla	PROPN
bionys-572	369	19	,	,	PUNCT
bionys-572	369	20	k.s	k.s	PROPN
bionys-572	369	21	.	.	PROPN
bionys-572	369	22	,	,	PUNCT
bionys-572	369	23	fair	fair	PROPN
bionys-572	369	24	,	,	PUNCT
bionys-572	369	25	j.r	j.r	PROPN
bionys-572	369	26	.	.	PROPN
bionys-572	369	27	(	(	PUNCT
bionys-572	369	28	2017	2017	NUM
bionys-572	369	29	)	)	PUNCT
bionys-572	369	30	.	.	PUNCT
bionys-572	370	1	chronic	chronic	ADJ
bionys-572	370	2	nephropathy	nephropathy	NOUN
bionys-572	370	3	from	from	ADP
bionys-572	370	4	dietary	dietary	ADJ
bionys-572	370	5	hyperoxaluria	hyperoxaluria	NOUN
bionys-572	370	6	:	:	PUNCT
bionys-572	370	7	sustained	sustained	ADJ
bionys-572	370	8	improvement	improvement	NOUN
bionys-572	370	9	of	of	ADP
bionys-572	370	10	renal	renal	ADJ
bionys-572	370	11	function	function	NOUN
bionys-572	370	12	after	after	ADP
bionys-572	370	13	dietary	dietary	ADJ
bionys-572	370	14	intervention	intervention	NOUN
bionys-572	370	15	.	.	PUNCT
bionys-572	371	1	cureus	cureus	NOUN
bionys-572	371	2	,	,	PUNCT
bionys-572	371	3	9(3	9(3	NUM
bionys-572	371	4	)	)	PUNCT
bionys-572	371	5	,	,	PUNCT
bionys-572	371	6	e1105	e1105	PROPN
bionys-572	371	7	.	.	PUNCT
bionys-572	371	8	doi	doi	PROPN
bionys-572	371	9	:	:	PUNCT
bionys-572	371	10	10.7759	10.7759	NUM
bionys-572	371	11	/	/	SYM
bionys-572	371	12	cureus.1105	cureus.1105	PROPN
bionys-572	371	13	țăpoi	țăpoi	PROPN
bionys-572	371	14	,	,	PUNCT
bionys-572	371	15	l.	l.	PROPN
bionys-572	371	16	,	,	PUNCT
bionys-572	371	17	șalaru	șalaru	PROPN
bionys-572	371	18	,	,	PUNCT
bionys-572	371	19	d.l	d.l	PROPN
bionys-572	371	20	.	.	PROPN
bionys-572	371	21	,	,	PUNCT
bionys-572	371	22	sascău	sascău	PROPN
bionys-572	371	23	,	,	PUNCT
bionys-572	371	24	r.	r.	PROPN
bionys-572	371	25	,	,	PUNCT
bionys-572	371	26	stătescu	stătescu	PROPN
bionys-572	371	27	,	,	PUNCT
bionys-572	371	28	c.	c.	PROPN
bionys-572	371	29	(	(	PUNCT
bionys-572	371	30	2021	2021	NUM
bionys-572	371	31	)	)	PUNCT
bionys-572	371	32	.	.	PUNCT
bionys-572	372	1	uric	uric	ADJ
bionys-572	372	2	acid	acid	NOUN
bionys-572	372	3	—	—	PUNCT
bionys-572	372	4	an	an	DET
bionys-572	372	5	emergent	emergent	ADJ
bionys-572	372	6	risk	risk	NOUN
bionys-572	372	7	marker	marker	NOUN
bionys-572	372	8	for	for	ADP
bionys-572	372	9	thrombosis	thrombosis	NOUN
bionys-572	372	10	?	?	PUNCT
bionys-572	373	1	journal	journal	NOUN
bionys-572	373	2	of	of	ADP
bionys-572	373	3	clinical	clinical	ADJ
bionys-572	373	4	medicine	medicine	NOUN
bionys-572	373	5	,	,	PUNCT
bionys-572	373	6	10(10	10(10	NUM
bionys-572	373	7	)	)	PUNCT
bionys-572	373	8	,	,	PUNCT
bionys-572	373	9	2062	2062	NUM
bionys-572	373	10	.	.	PUNCT
bionys-572	374	1	doi	doi	NOUN
bionys-572	374	2	:	:	PUNCT
bionys-572	374	3	10.3390	10.3390	NUM
bionys-572	374	4	/	/	SYM
bionys-572	374	5	jcm10102062	jcm10102062	NOUN
bionys-572	374	6	tayefi	tayefi	VERB
bionys-572	374	7	,	,	PUNCT
bionys-572	374	8	m.	m.	NOUN
bionys-572	374	9	,	,	PUNCT
bionys-572	374	10	hassanian	hassanian	PROPN
bionys-572	374	11	,	,	PUNCT
bionys-572	374	12	s.m	s.m	PROPN
bionys-572	374	13	.	.	PROPN
bionys-572	374	14	,	,	PUNCT
bionys-572	374	15	maftouh	maftouh	NOUN
bionys-572	374	16	,	,	PUNCT
bionys-572	374	17	m.	m.	NOUN
bionys-572	374	18	,	,	PUNCT
bionys-572	374	19	moohebati	moohebati	PROPN
bionys-572	374	20	,	,	PUNCT
bionys-572	374	21	m.	m.	NOUN
bionys-572	374	22	,	,	PUNCT
bionys-572	374	23	bahrami	bahrami	NOUN
bionys-572	374	24	,	,	PUNCT
bionys-572	374	25	a.	a.	NOUN
bionys-572	374	26	,	,	PUNCT
bionys-572	374	27	parizadeh	parizadeh	PROPN
bionys-572	374	28	,	,	PUNCT
bionys-572	374	29	s.m	s.m	PROPN
bionys-572	374	30	.	.	PROPN
bionys-572	374	31	,	,	PUNCT
bionys-572	374	32	mahdizadeh	mahdizadeh	PROPN
bionys-572	374	33	,	,	PUNCT
bionys-572	374	34	a.	a.	NOUN
bionys-572	374	35	,	,	PUNCT
bionys-572	374	36	ghazizadeh	ghazizadeh	PROPN
bionys-572	374	37	,	,	PUNCT
bionys-572	374	38	h.	h.	PROPN
bionys-572	374	39	,	,	PUNCT
bionys-572	374	40	bazeli	bazeli	PROPN
bionys-572	374	41	,	,	PUNCT
bionys-572	374	42	j.	j.	PROPN
bionys-572	374	43	,	,	PUNCT
bionys-572	374	44	heidari	heidari	PROPN
bionys-572	374	45	-	-	PUNCT
bionys-572	374	46	bakavoli	bakavoli	PROPN
bionys-572	374	47	,	,	PUNCT
bionys-572	374	48	a.	a.	NOUN
bionys-572	374	49	(	(	PUNCT
bionys-572	374	50	2018	2018	NUM
bionys-572	374	51	)	)	PUNCT
bionys-572	374	52	.	.	PUNCT
bionys-572	375	1	relationship	relationship	NOUN
bionys-572	375	2	between	between	ADP
bionys-572	375	3	platelet	platelet	NOUN
bionys-572	375	4	count	count	NOUN
bionys-572	375	5	and	and	CCONJ
bionys-572	375	6	platelet	platelet	NOUN
bionys-572	375	7	width	width	ADJ
bionys-572	375	8	distribution	distribution	NOUN
bionys-572	375	9	and	and	CCONJ
bionys-572	375	10	serum	serum	VERB
bionys-572	375	11	uric	uric	ADJ
bionys-572	375	12	acid	acid	NOUN
bionys-572	375	13	concentrations	concentration	NOUN
bionys-572	375	14	in	in	ADP
bionys-572	375	15	patients	patient	NOUN
bionys-572	375	16	with	with	ADP
bionys-572	375	17	untreated	untreated	ADJ
bionys-572	375	18	essential	essential	ADJ
bionys-572	375	19	hypertension	hypertension	NOUN
bionys-572	375	20	.	.	PUNCT
bionys-572	376	1	biofactors	biofactor	NOUN
bionys-572	376	2	,	,	PUNCT
bionys-572	376	3	44(6	44(6	PROPN
bionys-572	376	4	)	)	PUNCT
bionys-572	376	5	,	,	PUNCT
bionys-572	376	6	532–538	532–538	NUM
bionys-572	376	7	.	.	PUNCT
bionys-572	377	1	doi	doi	NOUN
bionys-572	377	2	:	:	PUNCT
bionys-572	377	3	10.1002	10.1002	NUM
bionys-572	377	4	/	/	SYM
bionys-572	377	5	biof.1453	biof.1453	PROPN
bionys-572	377	6	toora	toora	PROPN
bionys-572	377	7	,	,	PUNCT
bionys-572	377	8	b.d	b.d	PROPN
bionys-572	377	9	.	.	PROPN
bionys-572	377	10	,	,	PUNCT
bionys-572	377	11	rajagopal	rajagopal	PROPN
bionys-572	377	12	,	,	PUNCT
bionys-572	377	13	g.	g.	PROPN
bionys-572	377	14	(	(	PUNCT
bionys-572	377	15	2002	2002	NUM
bionys-572	377	16	)	)	PUNCT
bionys-572	377	17	.	.	PUNCT
bionys-572	378	1	measurement	measurement	NOUN
bionys-572	378	2	of	of	ADP
bionys-572	378	3	creatinine	creatinine	NOUN
bionys-572	378	4	by	by	ADP
bionys-572	378	5	jaffe	jaffe	PROPN
bionys-572	378	6	's	's	PART
bionys-572	378	7	reaction	reaction	NOUN
bionys-572	378	8	—	—	PUNCT
bionys-572	378	9	determination	determination	NOUN
bionys-572	378	10	of	of	ADP
bionys-572	378	11	concentration	concentration	NOUN
bionys-572	378	12	of	of	ADP
bionys-572	378	13	sodium	sodium	NOUN
bionys-572	378	14	hydroxide	hydroxide	NOUN
bionys-572	378	15	required	require	VERB
bionys-572	378	16	for	for	ADP
bionys-572	378	17	maximum	maximum	ADJ
bionys-572	378	18	color	color	NOUN
bionys-572	378	19	development	development	NOUN
bionys-572	378	20	in	in	ADP
bionys-572	378	21	standard	standard	ADJ
bionys-572	378	22	,	,	PUNCT
bionys-572	378	23	urine	urine	NOUN
bionys-572	378	24	and	and	CCONJ
bionys-572	378	25	protein	protein	NOUN
bionys-572	378	26	free	free	ADJ
bionys-572	378	27	filtrate	filtrate	NOUN
bionys-572	378	28	of	of	ADP
bionys-572	378	29	serum	serum	NOUN
bionys-572	378	30	.	.	PUNCT
bionys-572	379	1	indian	indian	ADJ
bionys-572	379	2	journal	journal	PROPN
bionys-572	379	3	of	of	ADP
bionys-572	379	4	experimental	experimental	ADJ
bionys-572	379	5	biology	biology	NOUN
bionys-572	379	6	,	,	PUNCT
bionys-572	379	7	40(3	40(3	NUM
bionys-572	379	8	)	)	PUNCT
bionys-572	379	9	,	,	PUNCT
bionys-572	379	10	352–354	352–354	NUM
bionys-572	379	11	.	.	PUNCT
bionys-572	380	1	pmid	pmid	NOUN
bionys-572	380	2	:	:	PUNCT
bionys-572	380	3	12635710	12635710	NUM
bionys-572	380	4	verdesca	verdesca	NOUN
bionys-572	380	5	,	,	PUNCT
bionys-572	380	6	s.	s.	PROPN
bionys-572	380	7	,	,	PUNCT
bionys-572	380	8	fogazzi	fogazzi	NOUN
bionys-572	380	9	,	,	PUNCT
bionys-572	380	10	g.b	g.b	PROPN
bionys-572	380	11	.	.	PROPN
bionys-572	380	12	,	,	PUNCT
bionys-572	380	13	garigali	garigali	PROPN
bionys-572	380	14	,	,	PUNCT
bionys-572	380	15	g.	g.	PROPN
bionys-572	380	16	,	,	PUNCT
bionys-572	380	17	messa	messa	PROPN
bionys-572	380	18	,	,	PUNCT
bionys-572	380	19	p.	p.	NOUN
bionys-572	380	20	,	,	PUNCT
bionys-572	380	21	daudon	daudon	NOUN
bionys-572	380	22	,	,	PUNCT
bionys-572	380	23	m.	m.	NOUN
bionys-572	380	24	(	(	PUNCT
bionys-572	380	25	2011	2011	NUM
bionys-572	380	26	)	)	PUNCT
bionys-572	380	27	.	.	PUNCT
bionys-572	381	1	crystalluria	crystalluria	PROPN
bionys-572	381	2	:	:	PUNCT
bionys-572	382	1	prevalence	prevalence	NOUN
bionys-572	382	2	,	,	PUNCT
bionys-572	382	3	different	different	ADJ
bionys-572	382	4	types	type	NOUN
bionys-572	382	5	of	of	ADP
bionys-572	382	6	crystals	crystal	NOUN
bionys-572	382	7	and	and	CCONJ
bionys-572	382	8	the	the	DET
bionys-572	382	9	role	role	NOUN
bionys-572	382	10	of	of	ADP
bionys-572	382	11	infrared	infrared	ADJ
bionys-572	382	12	spectroscopy	spectroscopy	NOUN
bionys-572	382	13	.	.	PUNCT
bionys-572	383	1	clinical	clinical	ADJ
bionys-572	383	2	chemistry	chemistry	NOUN
bionys-572	383	3	and	and	CCONJ
bionys-572	383	4	laboratory	laboratory	NOUN
bionys-572	383	5	medicine	medicine	NOUN
bionys-572	383	6	,	,	PUNCT
bionys-572	383	7	49(3	49(3	PROPN
bionys-572	383	8	)	)	PUNCT
bionys-572	383	9	,	,	PUNCT
bionys-572	383	10	515–520	515–520	NUM
bionys-572	383	11	.	.	PUNCT
bionys-572	384	1	doi	doi	NOUN
bionys-572	384	2	:	:	PUNCT
bionys-572	384	3	10.1515/	10.1515/	NUM
bionys-572	384	4	cclm.2011.078	cclm.2011.078	PROPN
bionys-572	384	5	wang	wang	PROPN
bionys-572	384	6	,	,	PUNCT
bionys-572	384	7	x.	x.	PROPN
bionys-572	384	8	,	,	PUNCT
bionys-572	384	9	zhong	zhong	PROPN
bionys-572	384	10	,	,	PUNCT
bionys-572	384	11	s.	s.	PROPN
bionys-572	384	12	,	,	PUNCT
bionys-572	384	13	guo	guo	PROPN
bionys-572	384	14	,	,	PUNCT
bionys-572	384	15	x.	x.	NOUN
bionys-572	384	16	(	(	PUNCT
bionys-572	384	17	2022	2022	NUM
bionys-572	384	18	)	)	PUNCT
bionys-572	384	19	.	.	PUNCT
bionys-572	385	1	the	the	DET
bionys-572	385	2	associations	association	NOUN
bionys-572	385	3	between	between	ADP
bionys-572	385	4	fasting	fast	VERB
bionys-572	385	5	glucose	glucose	NOUN
bionys-572	385	6	,	,	PUNCT
bionys-572	385	7	lipids	lipids	ADJ
bionys-572	385	8	and	and	CCONJ
bionys-572	385	9	uric	uric	ADJ
bionys-572	385	10	acid	acid	NOUN
bionys-572	385	11	levels	level	NOUN
bionys-572	385	12	strengthen	strengthen	VERB
bionys-572	385	13	with	with	ADP
bionys-572	385	14	the	the	DET
bionys-572	385	15	decile	decile	NOUN
bionys-572	385	16	of	of	ADP
bionys-572	385	17	uric	uric	ADJ
bionys-572	385	18	acid	acid	NOUN
bionys-572	385	19	increase	increase	NOUN
bionys-572	385	20	and	and	CCONJ
bionys-572	385	21	differ	differ	VERB
bionys-572	385	22	by	by	ADP
bionys-572	385	23	sex	sex	NOUN
bionys-572	385	24	.	.	PUNCT
bionys-572	386	1	nutrition	nutrition	NOUN
bionys-572	386	2	,	,	PUNCT
bionys-572	386	3	metabolism	metabolism	NOUN
bionys-572	386	4	and	and	CCONJ
bionys-572	386	5	cardiovascular	cardiovascular	ADJ
bionys-572	386	6	diseases	disease	NOUN
bionys-572	386	7	,	,	PUNCT
bionys-572	386	8	32(12	32(12	NUM
bionys-572	386	9	)	)	PUNCT
bionys-572	386	10	,	,	PUNCT
bionys-572	386	11	2786–2793	2786–2793	NUM
bionys-572	386	12	.	.	PUNCT
bionys-572	387	1	doi	doi	NOUN
bionys-572	387	2	:	:	PUNCT
bionys-572	387	3	10.1016	10.1016	NUM
bionys-572	387	4	/	/	SYM
bionys-572	387	5	j.numecd.2022.09.004	j.numecd.2022.09.004	PROPN
bionys-572	387	6	wang	wang	PROPN
bionys-572	387	7	,	,	PUNCT
bionys-572	387	8	z.	z.	PROPN
bionys-572	387	9	,	,	PUNCT
bionys-572	387	10	zhang	zhang	PROPN
bionys-572	387	11	,	,	PUNCT
bionys-572	387	12	y.	y.	PROPN
bionys-572	387	13	,	,	PUNCT
bionys-572	387	14	zhang	zhang	PROPN
bionys-572	387	15	,	,	PUNCT
bionys-572	387	16	j.	j.	PROPN
bionys-572	387	17	,	,	PUNCT
bionys-572	387	18	deng	deng	PROPN
bionys-572	387	19	,	,	PUNCT
bionys-572	387	20	q.	q.	PROPN
bionys-572	387	21	,	,	PUNCT
bionys-572	387	22	liang	liang	PROPN
bionys-572	387	23	,	,	PUNCT
bionys-572	387	24	h.	h.	PROPN
bionys-572	387	25	(	(	PUNCT
bionys-572	387	26	2021	2021	NUM
bionys-572	387	27	)	)	PUNCT
bionys-572	387	28	.	.	PUNCT
bionys-572	388	1	recent	recent	ADJ
bionys-572	388	2	advances	advance	NOUN
bionys-572	388	3	on	on	ADP
bionys-572	388	4	the	the	DET
bionys-572	388	5	mechanisms	mechanism	NOUN
bionys-572	388	6	of	of	ADP
bionys-572	388	7	kidney	kidney	NOUN
bionys-572	388	8	stone	stone	NOUN
bionys-572	388	9	formation	formation	NOUN
bionys-572	388	10	(	(	PUNCT
bionys-572	388	11	review	review	NOUN
bionys-572	388	12	)	)	PUNCT
bionys-572	388	13	.	.	PUNCT
bionys-572	389	1	international	international	ADJ
bionys-572	389	2	journal	journal	NOUN
bionys-572	389	3	of	of	ADP
bionys-572	389	4	molecular	molecular	ADJ
bionys-572	389	5	medicine	medicine	NOUN
bionys-572	389	6	,	,	PUNCT
bionys-572	389	7	48(2	48(2	NUM
bionys-572	389	8	)	)	PUNCT
bionys-572	389	9	,	,	PUNCT
bionys-572	389	10	149	149	NUM
bionys-572	389	11	.	.	PUNCT
bionys-572	390	1	doi	doi	NOUN
bionys-572	390	2	:	:	PUNCT
bionys-572	390	3	10.3892	10.3892	NUM
bionys-572	390	4	/	/	SYM
bionys-572	390	5	ijmm.2021.4982	ijmm.2021.4982	PROPN
bionys-572	390	6	wardhana	wardhana	NOUN
bionys-572	390	7	,	,	PUNCT
bionys-572	390	8	w.	w.	PROPN
bionys-572	390	9	,	,	PUNCT
bionys-572	390	10	rudijanto	rudijanto	PROPN
bionys-572	390	11	,	,	PUNCT
bionys-572	390	12	a.	a.	NOUN
bionys-572	390	13	(	(	PUNCT
bionys-572	390	14	2018	2018	NUM
bionys-572	390	15	)	)	PUNCT
bionys-572	390	16	.	.	PUNCT
bionys-572	391	1	effect	effect	NOUN
bionys-572	391	2	of	of	ADP
bionys-572	391	3	uric	uric	ADJ
bionys-572	391	4	acid	acid	NOUN
bionys-572	391	5	on	on	ADP
bionys-572	391	6	blood	blood	NOUN
bionys-572	391	7	glucose	glucose	NOUN
bionys-572	391	8	levels	level	NOUN
bionys-572	391	9	.	.	PUNCT
bionys-572	392	1	acta	acta	PROPN
bionys-572	392	2	medica	medica	PROPN
bionys-572	392	3	indonesiana	indonesiana	PROPN
bionys-572	392	4	,	,	PUNCT
bionys-572	392	5	50(3	50(3	NUM
bionys-572	392	6	)	)	PUNCT
bionys-572	392	7	,	,	PUNCT
bionys-572	392	8	253–256	253–256	NUM
bionys-572	392	9	.	.	PUNCT
bionys-572	393	1	pmid	pmid	NOUN
bionys-572	393	2	:	:	PUNCT
bionys-572	393	3	30333276	30333276	NUM
bionys-572	393	4	weng	weng	PROPN
bionys-572	393	5	,	,	PUNCT
bionys-572	393	6	h.	h.	PROPN
bionys-572	393	7	,	,	PUNCT
bionys-572	393	8	li	li	PROPN
bionys-572	393	9	,	,	PUNCT
bionys-572	393	10	h.	h.	PROPN
bionys-572	393	11	,	,	PUNCT
bionys-572	393	12	zhang	zhang	PROPN
bionys-572	393	13	,	,	PUNCT
bionys-572	393	14	z.	z.	PROPN
bionys-572	393	15	,	,	PUNCT
bionys-572	393	16	et	et	PROPN
bionys-572	393	17	al	al	PROPN
bionys-572	393	18	.	.	PROPN
bionys-572	394	1	(	(	PUNCT
bionys-572	394	2	2023	2023	NUM
bionys-572	394	3	)	)	PUNCT
bionys-572	394	4	.	.	PUNCT
bionys-572	395	1	association	association	NOUN
bionys-572	395	2	between	between	ADP
bionys-572	395	3	uric	uric	ADJ
bionys-572	395	4	acid	acid	NOUN
bionys-572	395	5	and	and	CCONJ
bionys-572	395	6	risk	risk	NOUN
bionys-572	395	7	of	of	ADP
bionys-572	395	8	venous	venous	ADJ
bionys-572	395	9	thromboembolism	thromboembolism	NOUN
bionys-572	395	10	in	in	ADP
bionys-572	395	11	east	east	ADJ
bionys-572	395	12	asian	asian	ADJ
bionys-572	395	13	populations	population	NOUN
bionys-572	395	14	:	:	PUNCT
bionys-572	395	15	a	a	DET
bionys-572	395	16	cohort	cohort	NOUN
bionys-572	395	17	and	and	CCONJ
bionys-572	395	18	mendelian	mendelian	ADJ
bionys-572	395	19	randomization	randomization	NOUN
bionys-572	395	20	study	study	NOUN
bionys-572	395	21	.	.	PUNCT
bionys-572	396	1	the	the	DET
bionys-572	396	2	lancet	lancet	PROPN
bionys-572	396	3	regional	regional	PROPN
bionys-572	396	4	health	health	PROPN
bionys-572	396	5	–	–	PUNCT
bionys-572	396	6	western	western	ADJ
bionys-572	396	7	pacific	pacific	PROPN
bionys-572	396	8	,	,	PUNCT
bionys-572	396	9	39	39	NUM
bionys-572	396	10	,	,	PUNCT
bionys-572	396	11	100848	100848	NUM
bionys-572	396	12	.	.	PUNCT
bionys-572	397	1	doi	doi	NOUN
bionys-572	397	2	:	:	PUNCT
bionys-572	397	3	10.1016	10.1016	NUM
bionys-572	397	4	/	/	SYM
bionys-572	397	5	j.lanwpc.2023.100848	j.lanwpc.2023.100848	PROPN
bionys-572	397	6	yan	yan	PROPN
bionys-572	397	7	,	,	PUNCT
bionys-572	397	8	d.d	d.d	PROPN
bionys-572	397	9	.	.	PROPN
bionys-572	397	10	,	,	PUNCT
bionys-572	397	11	wang	wang	PROPN
bionys-572	397	12	,	,	PUNCT
bionys-572	397	13	j.	j.	PROPN
bionys-572	397	14	,	,	PUNCT
bionys-572	397	15	hou	hou	PROPN
bionys-572	397	16	,	,	PUNCT
bionys-572	397	17	x.h	x.h	PROPN
bionys-572	397	18	.	.	PROPN
bionys-572	397	19	,	,	PUNCT
bionys-572	397	20	et	et	PROPN
bionys-572	397	21	al	al	PROPN
bionys-572	397	22	.	.	PUNCT
bionys-572	398	1	(	(	PUNCT
bionys-572	398	2	2018	2018	NUM
bionys-572	398	3	)	)	PUNCT
bionys-572	398	4	.	.	PUNCT
bionys-572	399	1	association	association	NOUN
bionys-572	399	2	of	of	ADP
bionys-572	399	3	serum	serum	PROPN
bionys-572	399	4	uric	uric	ADJ
bionys-572	399	5	acid	acid	PROPN
bionys-572	399	6	levels	level	NOUN
bionys-572	399	7	with	with	ADP
bionys-572	399	8	osteoporosis	osteoporosis	NOUN
bionys-572	399	9	and	and	CCONJ
bionys-572	399	10	bone	bone	NOUN
bionys-572	399	11	turnover	turnover	NOUN
bionys-572	399	12	markers	marker	NOUN
bionys-572	399	13	in	in	ADP
bionys-572	399	14	a	a	DET
bionys-572	399	15	chinese	chinese	ADJ
bionys-572	399	16	population	population	NOUN
bionys-572	399	17	.	.	PUNCT
bionys-572	400	1	acta	acta	PROPN
bionys-572	400	2	pharmacologica	pharmacologica	PROPN
bionys-572	400	3	sinica	sinica	PROPN
bionys-572	400	4	,	,	PUNCT
bionys-572	400	5	39(4	39(4	NOUN
bionys-572	400	6	)	)	PUNCT
bionys-572	400	7	,	,	PUNCT
bionys-572	400	8	626–632	626–632	NUM
bionys-572	400	9	.	.	PUNCT
bionys-572	400	10	doi	doi	NOUN
bionys-572	400	11	:	:	PUNCT
bionys-572	400	12	10.1038	10.1038	NUM
bionys-572	400	13	/	/	SYM
bionys-572	400	14	aps.2017.165	aps.2017.165	PROPN
bionys-572	400	15	yang	yang	PROPN
bionys-572	400	16	,	,	PUNCT
bionys-572	400	17	c.	c.	PROPN
bionys-572	400	18	,	,	PUNCT
bionys-572	400	19	wu	wu	PROPN
bionys-572	400	20	,	,	PUNCT
bionys-572	400	21	s.	s.	PROPN
bionys-572	400	22	,	,	PUNCT
bionys-572	400	23	lan	lan	PROPN
bionys-572	400	24	,	,	PUNCT
bionys-572	400	25	y.	y.	PROPN
bionys-572	400	26	,	,	PUNCT
bionys-572	400	27	et	et	PROPN
bionys-572	400	28	al	al	PROPN
bionys-572	400	29	.	.	PROPN
bionys-572	400	30	(	(	PUNCT
bionys-572	400	31	2023	2023	NUM
bionys-572	400	32	)	)	PUNCT
bionys-572	400	33	.	.	PUNCT
bionys-572	401	1	association	association	NOUN
bionys-572	401	2	between	between	ADP
bionys-572	401	3	blood	blood	NOUN
bionys-572	401	4	calcium	calcium	NOUN
bionys-572	401	5	,	,	PUNCT
bionys-572	401	6	magnesium	magnesium	NOUN
bionys-572	401	7	,	,	PUNCT
bionys-572	401	8	and	and	CCONJ
bionys-572	401	9	nonalcoholic	nonalcoholic	NOUN
bionys-572	401	10	fatty	fatty	NOUN
bionys-572	401	11	liver	liver	NOUN
bionys-572	401	12	disease	disease	NOUN
bionys-572	401	13	in	in	ADP
bionys-572	401	14	adults	adult	NOUN
bionys-572	401	15	:	:	PUNCT
bionys-572	401	16	a	a	DET
bionys-572	401	17	cohortbased	cohortbased	ADJ
bionys-572	401	18	case	case	NOUN
bionys-572	401	19	-	-	PUNCT
bionys-572	401	20	control	control	NOUN
bionys-572	401	21	study	study	NOUN
bionys-572	401	22	.	.	PUNCT
bionys-572	402	1	biological	biological	ADJ
bionys-572	402	2	trace	trace	NOUN
bionys-572	402	3	element	element	NOUN
bionys-572	402	4	research	research	NOUN
bionys-572	402	5	,	,	PUNCT
bionys-572	402	6	201(10	201(10	NUM
bionys-572	402	7	)	)	PUNCT
bionys-572	402	8	,	,	PUNCT
bionys-572	402	9	4625–4636	4625–4636	NUM
bionys-572	402	10	.	.	PUNCT
bionys-572	403	1	doi	doi	NOUN
bionys-572	403	2	:	:	PUNCT
bionys-572	403	3	10.1007/	10.1007/	NUM
bionys-572	403	4	s12011	s12011	PROPN
bionys-572	403	5	-	-	PUNCT
bionys-572	403	6	022	022	NUM
bionys-572	403	7	-	-	PUNCT
bionys-572	403	8	03543	03543	NUM
bionys-572	403	9	-	-	SYM
bionys-572	403	10	6	6	NUM
bionys-572	403	11	yang	yang	PROPN
bionys-572	403	12	,	,	PUNCT
bionys-572	403	13	r.	r.	PROPN
bionys-572	403	14	,	,	PUNCT
bionys-572	403	15	ding	ding	NOUN
bionys-572	403	16	,	,	PUNCT
bionys-572	403	17	n.	n.	PROPN
bionys-572	403	18	,	,	PUNCT
bionys-572	403	19	qin	qin	PROPN
bionys-572	403	20	,	,	PUNCT
bionys-572	403	21	j.	j.	PROPN
bionys-572	403	22	,	,	PUNCT
bionys-572	403	23	peng	peng	PROPN
bionys-572	403	24	,	,	PUNCT
bionys-572	403	25	h.	h.	PROPN
bionys-572	403	26	(	(	PUNCT
bionys-572	403	27	2024	2024	NUM
bionys-572	403	28	)	)	PUNCT
bionys-572	403	29	.	.	PUNCT
bionys-572	404	1	the	the	DET
bionys-572	404	2	relationship	relationship	NOUN
bionys-572	404	3	between	between	ADP
bionys-572	404	4	uric	uric	ADJ
bionys-572	404	5	acid	acid	NOUN
bionys-572	404	6	and	and	CCONJ
bionys-572	404	7	bone	bone	NOUN
bionys-572	404	8	mineral	mineral	NOUN
bionys-572	404	9	density	density	NOUN
bionys-572	404	10	in	in	ADP
bionys-572	404	11	the	the	DET
bionys-572	404	12	intermediate	intermediate	ADJ
bionys-572	404	13	stage	stage	NOUN
bionys-572	404	14	of	of	ADP
bionys-572	404	15	ckd	ckd	PROPN
bionys-572	404	16	1–3	1–3	PROPN
bionys-572	404	17	.	.	PUNCT
bionys-572	404	18	bmc	bmc	PROPN
bionys-572	404	19	nephrology	nephrology	NOUN
bionys-572	404	20	,	,	PUNCT
bionys-572	404	21	25(1	25(1	NUM
bionys-572	404	22	)	)	PUNCT
bionys-572	404	23	,	,	PUNCT
bionys-572	404	24	219	219	NUM
bionys-572	404	25	.	.	PUNCT
bionys-572	405	1	doi	doi	NOUN
bionys-572	405	2	:	:	PUNCT
bionys-572	405	3	10.1186	10.1186	NUM
bionys-572	405	4	/	/	SYM
bionys-572	405	5	s12882	s12882	NOUN
bionys-572	405	6	-	-	PUNCT
bionys-572	405	7	02403650	02403650	NUM
bionys-572	405	8	-	-	SYM
bionys-572	405	9	7	7	NUM
bionys-572	405	10	zechner	zechner	NOUN
bionys-572	405	11	,	,	PUNCT
bionys-572	405	12	c.	c.	PROPN
bionys-572	405	13	,	,	PUNCT
bionys-572	405	14	adams	adams	PROPN
bionys-572	405	15	-	-	PUNCT
bionys-572	405	16	huet	huet	PROPN
bionys-572	405	17	,	,	PUNCT
bionys-572	405	18	b.	b.	PROPN
bionys-572	405	19	,	,	PUNCT
bionys-572	405	20	gregory	gregory	PROPN
bionys-572	405	21	,	,	PUNCT
bionys-572	405	22	b.	b.	PROPN
bionys-572	405	23	,	,	PUNCT
bionys-572	405	24	neyra	neyra	PROPN
bionys-572	405	25	,	,	PUNCT
bionys-572	405	26	j.a	j.a	PROPN
bionys-572	405	27	.	.	PROPN
bionys-572	405	28	,	,	PUNCT
bionys-572	405	29	rule	rule	NOUN
bionys-572	405	30	,	,	PUNCT
bionys-572	405	31	j.a	j.a	PROPN
bionys-572	405	32	.	.	PROPN
bionys-572	405	33	,	,	PUNCT
bionys-572	405	34	li	li	PROPN
bionys-572	405	35	,	,	PUNCT
bionys-572	405	36	x.	x.	PROPN
bionys-572	405	37	,	,	PUNCT
bionys-572	405	38	rakela	rakela	PROPN
bionys-572	405	39	,	,	PUNCT
bionys-572	405	40	j.	j.	PROPN
bionys-572	405	41	,	,	PUNCT
bionys-572	405	42	moe	moe	PROPN
bionys-572	405	43	,	,	PUNCT
bionys-572	405	44	o.w	o.w	PROPN
bionys-572	405	45	.	.	PROPN
bionys-572	405	46	,	,	PUNCT
bionys-572	405	47	lee	lee	PROPN
bionys-572	405	48	,	,	PUNCT
bionys-572	405	49	w.m	w.m	PROPN
bionys-572	405	50	.	.	PROPN
bionys-572	405	51	(	(	PUNCT
bionys-572	405	52	2021	2021	NUM
bionys-572	405	53	)	)	PUNCT
bionys-572	405	54	.	.	PUNCT
bionys-572	406	1	hypophosphatemia	hypophosphatemia	NOUN
bionys-572	406	2	in	in	ADP
bionys-572	406	3	acute	acute	ADJ
bionys-572	406	4	liver	liver	NOUN
bionys-572	406	5	failure	failure	NOUN
bionys-572	406	6	of	of	ADP
bionys-572	406	7	a	a	DET
bionys-572	406	8	broad	broad	ADJ
bionys-572	406	9	range	range	NOUN
bionys-572	406	10	of	of	ADP
bionys-572	406	11	etiologies	etiology	NOUN
bionys-572	406	12	is	be	AUX
bionys-572	406	13	associated	associate	VERB
bionys-572	406	14	with	with	ADP
bionys-572	406	15	phosphaturia	phosphaturia	NOUN
bionys-572	406	16	without	without	ADP
bionys-572	406	17	kidney	kidney	NOUN
bionys-572	406	18	damage	damage	NOUN
bionys-572	406	19	or	or	CCONJ
bionys-572	406	20	phosphatonin	phosphatonin	NOUN
bionys-572	406	21	elevation	elevation	NOUN
bionys-572	406	22	.	.	PUNCT
bionys-572	407	1	translational	translational	ADJ
bionys-572	407	2	research	research	NOUN
bionys-572	407	3	,	,	PUNCT
bionys-572	407	4	238	238	NUM
bionys-572	407	5	,	,	PUNCT
bionys-572	407	6	1–11	1–11	PROPN
bionys-572	407	7	.	.	PUNCT
bionys-572	408	1	doi	doi	NOUN
bionys-572	408	2	:	:	PUNCT
bionys-572	408	3	10.1016	10.1016	NUM
bionys-572	408	4	/	/	SYM
bionys-572	408	5	j.trsl.2021.07.003	j.trsl.2021.07.003	PROPN